Molecule ChEMBL ID,Molecule Name,Smiles,Standard Type,pChEMBL Value,Assay ChEMBL ID,Assay Description,Cell Name,InChIKey,Incubation Time Hours,Property Measured,Assay
CHEMBL1224279,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCc6ccc7c(c6)OCO7)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.14,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,ZEAZBNWVIIXFJZ-JNLDGDHFSA-N,72.0,Cytotoxicity,MTS
CHEMBL1224363,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCc6ccc7c(c6)OCO7)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,JFJDNAMZIYNXPC-CNHRZFDUSA-N,72.0,Cytotoxicity,MTS
CHEMBL1269453,,COCOc1cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc(OC)c1C/C=C(\C)C/C=C/C(C)COC(=O)CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21,EC50,5.57,CHEMBL1273920,Cytotoxicity against human SF295 cells,SF295,MYAJMYWMOPXPGG-IYWZCBGFSA-N,,Cytotoxicity,Unspecified
CHEMBL1269454,,COCOc1cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc(OC)c1C/C=C(\C)C/C=C/C(C)CNC(=O)CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21,EC50,5.96,CHEMBL1273920,Cytotoxicity against human SF295 cells,SF295,NEFHRHHZCAEVPZ-IYWZCBGFSA-N,,Cytotoxicity,Unspecified
CHEMBL4062767,,C=C(c1ccc(OC)cc1)c1cc(C)cc2ccccc12,IC50,6.85,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,DBNFLZAGLUSXCU-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL498271,,C=C(c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.11,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,CNGKIRSNRQSORA-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL2164695,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,4.85,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CHTGQWXZLQUCQI-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164718,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.22,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HDGXFFZEDXJLJV-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164716,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.32,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SEZZOMVRRQGVSJ-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL1645544,,C=CCOc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,4.5,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,JBSMSTGKQFHUBO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1822932,,CCCCOc1c(OC)ccc2cc(C(=O)NCC(F)c3ccccc3)c(=O)[nH]c12,Ki,9.1,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,FNTMGRNAIKUGDA-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL125395,,COc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,LSUJEFUOJJOYDR-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1164496,,COc1ccc(-c2nnn(CCCCCCCn3nnc(-c4ccc(OC)c(OC)c4)n3)n2)cc1OC,IC50,4.4,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,KKLBOXOFXWBVGV-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163276,,O=C(OCc1cc(COC(=O)c2ccc(O)c(F)c2)cc(COC(=O)c2ccc(O)c(F)c2)c1)c1ccc(O)c(F)c1,IC50,4.43,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,FWATVAIBJMWBSG-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163275,,COc1cc(C(=O)OCc2cc(COC(=O)c3ccc(O)c(OC)c3)cc(COC(=O)c3ccc(O)c(OC)c3)c2)ccc1O,IC50,4.55,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,SRTMPHPQVYKQHX-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1164563,,COc1cc(C(=O)OCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.25,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,HMQDKFDLCCFFNU-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL253178,,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(O)c2)c(OC)c1,IC50,8.15,CHEMBL926537,Antitumor activity against human U87 cells by trypan blue exclusion assay,U-87MG ATCC,GHPUSRLWNSTQIK-BQYQJAHWSA-N,,Unspecified,trypan blue exclusion
CHEMBL2419667,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.75,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHBKQWXDUHRNOS-HASSKWOGSA-N,72.0,Cytotoxicity,MTT
CHEMBL1171448,CIRENSENOSIDE O,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.86,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,QDUNASUIHMLOJM-VYEWMGKISA-N,72.0,Cytotoxicity,MTT
CHEMBL2430034,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.76,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZPSFHHIZWMURAT-GSDJGKHLSA-N,72.0,Cytotoxicity,MTT
CHEMBL2397982,,COc1ccc(NS(=O)(=O)/C=C/c2c(OC)cc(OC)cc2OC)cc1,IC50,6.64,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,CNXODVDGIBSDFK-MDZDMXLPSA-N,96.0,Cytotoxicity,sulforhodamine B
CHEMBL192687,,Oc1cc(-c2ccccc2)nc2c1ccc1[nH]ccc12,IC50,4.0,CHEMBL833357,Cytotoxic activity against human tumor A-172 cell line,A-172,UNOZBASOWIOTMS-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL240954,,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,IC50,5.32,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,SXOZSDJHGMAEGZ-IGKKHSBFSA-N,,Growth inhibition,Unspecified
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.39,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PKCDDUHJAFVJJB-VLZXCDOPSA-N,,Growth inhibition,Unspecified
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,5.67,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AVLYNJZZQYEFEA-XDJHFCHBSA-N,,Growth inhibition,Unspecified
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.79,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XCDIRYDKECHIPE-QHEQPUDQSA-N,,Growth inhibition,Unspecified
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,5.72,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,FBOZXECLQNJBKD-ZDUSSCGKSA-N,,Growth inhibition,Unspecified
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.68,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,5.92,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IAYGCINLNONXHY-LBPRGKRZSA-N,,Growth inhibition,Unspecified
CHEMBL110525,,CCOC(=O)c1cnc2c(c1)-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,NJGLKAOBESXCHS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL87506,,CCOC(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,RRACHVADVPJIDE-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL316130,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCN(C)C)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,GGCKHBAUSWWNEQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL220172,,Cc1cc(N2CCC[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,5.19,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LBCGUKCXRVUULK-KRWDZBQOSA-N,,Unspecified,Unspecified
CHEMBL220880,,CCc1cc(N2CCC[C@@H]2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.89,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QZMBUROFNSSUCP-GOSISDBHSA-N,,Unspecified,Unspecified
CHEMBL119,TRIMETREXATE,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,IC50,7.96,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,NOYPYLRCIDNJJB-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL85742,,COc1cc(OC)c2cc(-c3ccc(OCc4ccccc4)cc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,QPBWAIBGHJOAES-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL110730,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1,IC50,8.19,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,NSNVDTQEDMRJDI-QCKNELIISA-N,,Unspecified,Unspecified
CHEMBL2349385,(2-PHENYL-1H-INDOL-3-YL)METHANOL,OCc1c(-c2ccccc2)[nH]c2ccccc12,EC50,4.52,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,WWOMARKUBVSTBK-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL1760592,,COc1cc(C[C@@H](CO)[C@](O)(CO)Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.56,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,INPPVVSEQRZCLJ-MGPUTAFESA-N,,Anticancer activity,SRB
CHEMBL2313472,,COc1cc(Sc2c(-c3ccncc3)[nH]c3ccccc23)cc(OC)c1OC,IC50,6.99,CHEMBL2321142,Cytotoxicity against human U87MG cells assessed as cell survival after 24 hrs by MTS conversion assay,U-87MG ATCC,SXKCLXVXENOBLF-UHFFFAOYSA-N,24.0,Cytotoxicity,MTS conversion
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,6.72,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,KVLFRAWTRWDEDF-IRXDYDNUSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4282544,,CCn1c2ccccc2c2cc(C(=O)c3cccc4ccccc34)ccc21,EC50,5.77,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,HQBBGYZHBSZKQC-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4292529,,CCn1c2ccccc2c2cc(C(=O)c3ccc(C)c4ccccc34)ccc21,EC50,7.06,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,JHYURZUKNMASQT-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4284603,,CCn1c2ccccc2c2cc(C(O)c3ccc(C)c4ccccc34)ccc21,EC50,6.25,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,WWVXNRZZDMWJNK-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL3410531,,O=C1/C(=C/c2cccc([N+](=O)[O-])c2)CS(=O)(=O)C/C1=C\c1cccc([N+](=O)[O-])c1,IC50,6.12,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,OEBPTKPFIJYBCZ-BGPOSVGRSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410533,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc([N+](=O)[O-])cc3)C2=O)cc1,IC50,5.68,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,NWUHGYXUFVOVSZ-OTYYAQKOSA-N,48.0,Cytotoxicity,resazurin
CHEMBL473087,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CCC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.56,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IBFHBKDCSZGUSP-UNZYHPAISA-N,48.0,Cytotoxicity,resazurin
CHEMBL4075572,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.51,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,MJUNOVRHVGCIDZ-RZPOAMPKSA-N,24.0,Cytotoxicity,MTT
CHEMBL3347578,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.17,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,IAOFKRFVYOFYTI-KEQPWATNSA-N,24.0,Cytotoxicity,MTT
CHEMBL4102380,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(C#N)c1)CC(C)(C)O2,IC50,4.85,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CJYMCBSCMOLHIE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2069126,CORNUSALTERIN C,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.75,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,AHAJUDPVPSLOAM-MCTQLSMQSA-N,,Cytotoxicity,SRB
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.75,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N,48.0,Cytotoxicity,[3H]thymidine incorporation
CHEMBL4459518,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccc(F)cc1,IC50,5.01,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RJGWWNVHLMPYEN-BUHFOSPRSA-N,72.0,Cytotoxicity,MTT
CHEMBL4787717,,COc1cc(C(=O)NC2CCNCC2)ccc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.19,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,PAQTVICEMANNAC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL446591,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc(Cl)c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.08,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,IOFPYWWAVQTBSB-ALMBTRMVSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.88,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,VJJPUSNTGOMMGY-MRVIYFEKSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL229727,,COc1cc(OC)c2nc3c(nc2c1)C(=O)c1cnncc1C3=O,IC50,7.48,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,ONAIIUROHYQSCU-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL5087462,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc1,IC50,5.32,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,FZEOLZCBYJQGGE-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5082822,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(C)c2C)cc1,IC50,4.13,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,VRMIGBQDTMKLPK-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5076815,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,YSEVIHSXDAOIMX-VZHCALMGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL301982,CELASTROL,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C,IC50,5.64,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,KQJSQWZMSAGSHN-JJWQIEBTSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5090187,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GAKKQBFYSNJTAZ-CDKFMWKUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5091306,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C(C)(C)C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.31,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RVEWODMIOUUZJR-CHFKRMNXSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5080560,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(F)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.66,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,NSHNVMIURYQLAG-MCLIRCHUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4777873,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc(N3CCOCC3)n2)cc1,IC50,5.88,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,WPUHLJLOCQBRHP-YIXHJXPBSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4758970,,CN(C)C(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,6.28,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,AVWRCFPHHWUSFI-CAOOACKPSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL244034,,CC(COc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O)N(C)C,IC50,7.0,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,LEFCTXDNQSIXLV-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL575196,,COC(=O)[C@H](Cc1ccc(O)cc1)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](Cc3ccc(O)cc3)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21,IC50,4.49,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AFCGYIWULPMWPT-ZXRMINHTSA-N,48.0,Anticancer activity,MTT
CHEMBL4436062,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1NC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,6.14,CHEMBL4430445,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability by Alamar blue assay,SF295,ZONXPAWDWNRZKV-VEDKGFTPSA-N,,Antiproliferative activity,Alamar blue
CHEMBL3262852,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Cl)c3Cl)cc2F)ccn1,IC50,4.88,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WAXOCTYMPSZMGB-AMVVHIIESA-N,72.0,Cytotoxicity,MTT
CHEMBL3262861,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)cc3O)cc2F)ccn1,IC50,4.81,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GBBGXHSEQRXIMO-CCVNUDIWSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262867,,COc1ccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c(OC)c1,IC50,4.9,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DIRAYSYIKRPJSE-OKCVXOCRSA-N,72.0,Cytotoxicity,MTT
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.82,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4450269,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.04,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,XHHHLVOLGLLDQG-QRDFGAMCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL229004,,O=C1c2cnncc2C(=O)c2nc3cc(C(F)(F)F)ccc3nc21,IC50,6.94,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JUMAJRYRBLTOKZ-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL229680,,O=C1C(=O)c2c(nc3ncccn23)-c2ncccc21,IC50,6.86,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,ANQNFFOSXIYUIE-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL229678,,CCc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.89,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JNVMLBLPMYUGCM-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL65633,,COc1cc(N2C(=O)C(O)C2c2ccc3c(c2)OCO3)cc(OC)c1OC,IC50,6.1,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,RVUVVQHETFFQKU-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2338397,CRENIGACESTAT,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21,IC50,9.55,CHEMBL2344616,Inhibition of gamma-secretase mediated cleavage of Notch 1 in human U-87-MG cells assessed as nuclear accumulation of Notch 1 intracellular domain (N1ICD) after 24 hrs by ELISA,U-87MG ATCC,YCBAQKQAINQRFW-UGSOOPFHSA-N,24.0,Unspecified,ELISA
CHEMBL4519381,,N#Cc1cccc(/C=C/C(=O)c2ccc(F)c(O)c2)c1,IC50,4.78,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,WHPARJMPPFCLBF-QPJJXVBHSA-N,72.0,Cytotoxicity,MTT
CHEMBL4460678,,N#Cc1cccc(/C=C/C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c1,IC50,4.54,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,YOHPFXYRYBLWTK-NTEUORMPSA-N,72.0,Cytotoxicity,MTT
CHEMBL4584988,,CCCCN(CCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.17,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,PZRIKWNOAQZQDI-XNTDXEJSSA-N,72.0,Cytotoxicity,MTT
CHEMBL4550951,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(F)c2)cc1,IC50,4.54,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,KWEGBFABGINGLE-FNORWQNLSA-N,72.0,Cytotoxicity,MTT
CHEMBL4459949,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,5.25,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,KSVZDKHRYOARAP-SFQUDFHCSA-N,72.0,Cytotoxicity,MTT
CHEMBL2237333,,COc1cc(/C=C(\C(=O)O)c2ccccc2)cc(OC)c1OC,IC50,4.06,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,YITBDTHDPPLHMZ-ZROIWOOFSA-N,48.0,Cytotoxicity,SRB
CHEMBL2237334,,COc1cccc(/C=C(\C(=O)O)c2ccccc2)c1OC,IC50,5.41,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,MVBILHILDTUHOK-KAMYIIQDSA-N,48.0,Cytotoxicity,SRB
CHEMBL2172478,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cnn(C(C)C)c4)cn23)nc(C)n1,IC50,6.16,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,QNSXRDAUAHBZSB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172474,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3cccnn23)nc(C)n1,IC50,5.91,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CWCIJIQAVFNXDY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172630,,Cc1nc(Nc2cnccn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,7.18,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,ABQRVDGZZXHLLT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172629,,CC(=O)Nc1cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)nc(C)n1,IC50,7.35,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CCXBYTLKYILHRE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172628,,Cc1nccc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,5.66,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CWYLZDNXUUUUJJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL575456,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C2C(C)C,IC50,4.88,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,FVNKIYDSILCLGI-BDXXZCQXSA-N,48.0,Anticancer activity,MTT
CHEMBL4079155,,Cc1cc(=O)n(-c2ccccc2F)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.31,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDOXNDLQNWWSNK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4088695,,Cc1cc(=O)n(-c2cccc(C(F)(F)F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.03,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NTRGHCZYFVEYHO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL496556,,CNC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,4.75,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,UATVIEUDDKLRJY-YEFHWUCQSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL4439979,,CC(C)(C)OC(=O)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1Cn1cc(CNc2ccn([C@@H]3O[C@H](CO)[C@@H](O)C3(F)F)c(=O)n2)nn1,IC50,5.33,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,PRCCOEONMPKMOZ-ZLIPZANWSA-N,72.0,Cytotoxicity,SRB
CHEMBL444437,,C=C(C)[C@@H]1CC[C@]2(COC3CCCCO3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.68,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,COQXEBGTMOMMEH-XIYJGOOFSA-N,72.0,Antiproliferative activity,MTS
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.42,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,KTUFNOKKBVMGRW-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar-blue cell viability
CHEMBL475796,,Cc1ccc(NCc2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.8,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,JLIZHCYTSUGKKN-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar-blue cell viability
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,6.02,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL1095626,,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,IC50,6.22,CHEMBL1104677,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OFIHBQUKIUHAHV-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4535437,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccncc4)o3)C2=O)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,OHCVPSMPLCUVNE-MORMLQEESA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL4566955,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ncc[nH]1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,OIBPYKJPDLXDIT-NCUFVCKSSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL4442904,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Br)cc1,IC50,5.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,ULBOWKXOFOTCMU-NLDKGBHCSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,EC50,6.92,CHEMBL4387155,Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,UZWDCWONPYILKI-UHFFFAOYSA-N,120.0,Antiproliferative activity,CyQuantGR dye-based fluorescence
CHEMBL4440980,,C[C@@H]1CCCCn2ncc(-c3nc(Nc4ccc(N5CCN(C)CC5)cn4)ncc3F)c21,EC50,6.46,CHEMBL4387155,Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,UHCMUGYUWQCODZ-MRXNPFEDSA-N,120.0,Antiproliferative activity,CyQuantGR dye-based fluorescence
CHEMBL514389,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(Br)cc1,IC50,5.74,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YLDUQUOZOMZQEQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2180728,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,IC50,6.62,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,QGBXSUVTQOBSQO-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL2180730,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,IC50,6.72,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,SPSSOXNPEUCMPB-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL597550,,COc1cc(CCc2cc(O)c(CCC(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.55,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,VRQABKBYQHWBDG-YCVRVPNXSA-N,44.0,Cytotoxicity,MTT
CHEMBL599633,,COc1cc(/C=C/c2cc(O)c3ccoc3c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.32,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,CHOAALBWVLPKBQ-WPCAQGITSA-N,44.0,Cytotoxicity,MTT
CHEMBL597175,,COc1cc(/C=C/c2cc(O)c(CCCO)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.6,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,NRMPJPAJOFYRHT-RPYFTWFOSA-N,44.0,Cytotoxicity,MTT
CHEMBL597174,,CCCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,6.05,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,ZVLHXOXBQCYIGF-RSOHHRNFSA-N,44.0,Cytotoxicity,MTT
CHEMBL1760591,,COc1cc([C@@H](O)[C@@H](CO)Oc2ccc(CCCO)cc2OC)ccc1O,IC50,4.58,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,DBIKJXXBCAHHMC-WOJBJXKFSA-N,,Anticancer activity,SRB
CHEMBL3967430,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CCS(N)(=O)=O,IC50,6.51,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,ASNVRAUVNPTTIK-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3898090,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.42,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,QNIIODKUCXZOMU-RPWWTVJQSA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL4877280,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(C(F)(F)F)c2)ccc1O,IC50,4.05,CHEMBL4810781,Neurotoxicity in human U87 MG cells assessed as cell viability for 24 hrs by MTT assay,U-87MG ATCC,AUSDOGATGBZSJY-XVYDYJIPSA-N,24.0,Unspecified,MTT
CHEMBL3612320,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.98,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UWYTUSAPPUVSIF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL170937,,CCNCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC,IC50,7.07,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,ZSBHNAMMFVRBAT-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3343364,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QOBYLORHSHBOAP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343393,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BSPWNQRKZFSVIY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL301393,,COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CCl)OCCO3,IC50,7.54,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,NDTNRXBJYADVNN-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL300396,,CC(=O)O.CCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,5.26,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,ADVSJECXSHTRHA-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5083386,,CCN(C(=O)[C@H](Cc1ccccc1)NS(=O)(=O)c1cccc2nsnc12)c1ccccc1,IC50,4.18,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,AJDKKWMQQBSNBG-FQEVSTJZSA-N,24.0,Cytotoxicity,CCK8
CHEMBL1165205,,O=C(OCc1cc(COC(=O)c2ccc(O)c(Cl)c2)cc(COC(=O)c2ccc(O)c(Cl)c2)c1)c1ccc(O)c(Cl)c1,IC50,4.6,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,MKXWHCDJKDVLAD-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL502860,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc(Cl)c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.51,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,YHRBSJUMRRQWAQ-GVQBMFDGSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL5220389,,COc1ccc(-c2ncccc2CNc2ccc(Cl)cc2)cc1OC,IC50,4.36,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,RKDQLJLYASYZAO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5219943,,COc1ccc(NCc2cccnc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.71,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,KGWSULVXWYWPRK-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1822938,,CCCCOc1c(OC)ccc2cc(C(=O)NCCc3cn(CCF)nn3)c(=O)[nH]c12,Ki,5.62,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,UUDSOVGGCULQFR-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL575446,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)C)C(=O)C(O)=C3C(C)C)/C(=C/NC(C)C)C(=O)C(O)=C2C(C)C,IC50,4.61,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SSSPNLJUJBETHQ-GACBQCINSA-N,48.0,Anticancer activity,MTT
CHEMBL334217,,COc1ccc2c(n1)C(=O)c1ncc(OC)c3ccnc-2c13,IC50,6.16,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,VADKSBGLASVELY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL558927,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C=C[C@]3(C)CC[C@@H]12,IC50,5.57,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SOEFILJAGJAINE-XEGUGMAKSA-N,72.0,Cytotoxicity,MTT
CHEMBL1683544,ERIBULIN MESYLATE,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O,IC50,7.55,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,QAMYWGZHLCQOOJ-WRNBYXCMSA-N,,Antiproliferative activity,Unspecified
CHEMBL443885,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,6.18,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,BKQUQGAKNSXOHH-PLDABBGUSA-N,3.0,Unspecified,Unspecified
CHEMBL474038,,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H](C(C)C)NC1=O,IC50,8.4,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,CXMBFUMTPNXCMT-HDHGSYJOSA-N,3.0,Unspecified,Unspecified
CHEMBL474037,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC1=O,IC50,8.3,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZWHILRBVKJAMNY-FELOTHHLSA-N,3.0,Unspecified,Unspecified
CHEMBL3290919,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WFFFXRJVCFPXNE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290916,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.86,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,AZBIXVOPJHAERT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290915,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)c(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.85,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,GBUGDGGIILOEGB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290923,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5Cl)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MKIUQQULMXHCND-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290935,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.71,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,ZJCUQDMGHWMKKH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290930,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.7,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HECDTLBFMUFDFS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL342137,,Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1,IC50,8.84,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,UMOFYSFQZJYWNT-RXVVDRJESA-N,,Unspecified,Unspecified
CHEMBL4585178,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccccc1)O2,IC50,6.96,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,IWMAWSKAKALHJM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL511104,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CO)nn1,IC50,5.47,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,REMSSOCTCKAZGO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3401523,,NC(=O)c1cc(O)cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1,IC50,5.49,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZCPYNPIIHNPQA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3401525,,NC(=O)c1cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc(C(F)(F)F)c1,IC50,4.95,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VZDKMEUDDGIPDW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3401532,,CN(c1nc(-c2cc(C(N)=O)cc(C(F)(F)F)c2)nc(N2CCOCC2)n1)C1CCN(S(C)(=O)=O)CC1,IC50,5.33,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKGPDSVLACYRJW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL236780,,COCc1cn(-c2ncc(F)c3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)nn1,IC50,6.24,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DRVFDOLVHIQECA-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL239424,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)ncc(F)c12,IC50,8.15,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,UWEPTEGNPCLLAE-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238266,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)ncc(F)c12,IC50,7.44,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RASBPZQXUFEKOD-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238111,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)nccc12,IC50,7.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ARHPJYQUPRCXQA-MRXNPFEDSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL235969,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(Cl)nccc12,IC50,4.96,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LXWTXPDNOXWULE-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL235966,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)ccc(F)c12,IC50,6.82,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OZBFRVOUNCCDAV-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL235964,,COc1cccc2[nH]cc(S(=O)(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,IC50,5.38,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BPXPAHHGBSRISR-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392342,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(F)c(F)c(F)c(F)c12,IC50,5.33,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,IMXHQIHAYMWELJ-LLVKDONJSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL429809,,Cc1csc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)[C@H](C)C2)c1,IC50,5.72,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,UWPGHMBUNAKEOQ-CYBMUJFWSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240049,,C[C@@H]1CN(C(=O)c2csc(N)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.28,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CTFBUNZARCVBPA-SNVBAGLBSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL390452,,O=C(/C=C/c1cccc(C(=O)c2cc3ccccc3o2)c1)NO,IC50,5.96,CHEMBL895813,Cytotoxicity against human U87MG cells,U-87MG ATCC,KMVDSQMVUNRCNZ-CMDGGOBGSA-N,,Cytotoxicity,Unspecified
CHEMBL210065,,CCN(CC)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1,IC50,6.68,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,UJOQSHCJYVRZKJ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL385325,,O=C(CC1CN(c2cccc(F)n2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZYJJCOLCHBJORK-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL375404,,CC(C)CCN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,SRHJPUAVXACAOL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL373623,,CN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.32,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GSOOHDJMKOKFNJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223614,,COc1ccc(NC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,7.18,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,AYNOIPXHVJCQGG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL215803,,C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2,IC50,8.44,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,PAXKGQZKOJPPEG-OLZOCXBDSA-N,,Unspecified,Unspecified
CHEMBL443999,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1,IC50,8.85,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,GXJXVSDXVMSAIP-QCWLDUFUSA-N,,Unspecified,Unspecified
CHEMBL519575,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3cccs3)cc1OC2(C)C,EC50,5.7,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,HBOZOOYIOXJZFX-IAGOWNOFSA-N,18.0,Cytotoxicity,Unspecified
CHEMBL106209,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1,IC50,7.92,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,FMNMLKWJLFYSMF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL302778,,O=C(OCCS(=O)(=O)c1ccccc1)N1c2ccc(OCCO)cc2[C@@]23O[C@]24CCC[C@H]3C#C/C=C\C#C[C@H]14,IC50,6.11,CHEMBL873998,Cytotoxic activity against U-87 UG astrocytoma tumor cell lines.,U-87MG ATCC,ZNWSAFOOCBOGNX-GCAOFRLQSA-N,,Cytotoxicity,Unspecified
CHEMBL357557,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.92,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QWZMAQRSGSBPHQ-RXVVDRJESA-N,,Unspecified,Unspecified
CHEMBL416673,,COc1ccc(C2C(O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,6.96,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,DWPCTWGZTVHWRA-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2172487,,CC(=O)Nc1cccc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)c1,IC50,7.54,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ZOHYOLFOCULNKX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172484,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)ccn1,IC50,7.64,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,JLLAMEOULOFCQI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172636,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4)cn23)n1,IC50,7.92,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,TVEHRMCNBMAAEH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172639,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccc(F)c4)cn23)n1,IC50,7.14,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ZTOKQSUVJJWFOD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172638,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4F)cn23)n1,IC50,7.19,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,UUUGUCCOXDAVOY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL315414,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZDDUTRUNORAGJX-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL82808,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,GPCBCTZRCDKMOS-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL112299,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1,IC50,8.4,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,DCQTZTFWQIEXHS-VXKWHMMOSA-N,,Unspecified,Unspecified
CHEMBL409,BICALUTAMIDE,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,4.14,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,LKJPYSCBVHEWIU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,6.33,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,NEZONWMXZKDMKF-SNVBAGLBSA-N,,Growth inhibition,Unspecified
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,5.06,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IRSFLDGTOHBADP-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL6067492,BLEOMYCIN,,IC50,4.4,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,,,Growth inhibition,Unspecified
CHEMBL1927610,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(C)c23)C1=O,IC50,6.35,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AEOMJRRZAWZFQF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1081831,,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.2,CHEMBL1102927,Cytotoxicity against human U87MG cells after 3 days by alamar blue assay,U-87MG ATCC,XPPKIHZJFAAJLB-INIZCTEOSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL316168,,CCN(CC)C(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,CNUXSSQGSIPTFQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL599424,,C#CCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,5.89,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,RQPZMGVXRCJPRD-RSOHHRNFSA-N,44.0,Cytotoxicity,MTT
CHEMBL598811,,C=CCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,5.77,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,HBUUYTBAEDPLTF-RSOHHRNFSA-N,44.0,Cytotoxicity,MTT
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,5.77,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,DXCUKNQANPLTEJ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL106790,,CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.36,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,AKFKVWRGZGPBHW-PJJLUWSFSA-N,,Unspecified,Unspecified
CHEMBL112760,,CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.55,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,VCJCJIKWNXQAAJ-BXVZCJGGSA-N,,Unspecified,Unspecified
CHEMBL324671,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.92,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,VCJCJIKWNXQAAJ-URGPHPNLSA-N,,Unspecified,Unspecified
CHEMBL1822053,,O=S(=O)(Nc1cc(-c2ccc3ncsc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.11,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,KUFZSPXXONLZCF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914712,,O=S(=O)(Nc1cc(-c2ccc3ncccc3n2)cnc1Cl)c1ccc(F)cc1,IC50,6.11,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,WYYOJVMTMUWNGA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914716,,O=S(=O)(Nc1cc(-c2ccc3ncncc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.64,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FDCNRCBAXUDBRG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914734,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCc4ccccc4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.62,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,NISINSDPCKGKBV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL324780,,CC(=O)Nc1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.22,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,HOHZUMHEHJGFEE-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL103807,,O=C1c2cccnc2C(=O)c2ncc(CO)cc21,IC50,6.52,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,ZKEHMUGJKIDIOH-UHFFFAOYSA-N,,Cytotoxicity,using SRB
CHEMBL1170263,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,5.71,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,ZFGTXXFHVWNYLH-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL406863,,NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.23,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,QOZMRRGNAZNWDN-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL236390,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)[C@@]4(F)CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.94,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,VJJYWDCQJZRPAN-XJGQKTCCSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL2146208,"cis-Dichloro[(2S,3R,4S)-2-aminomethyl-3,4-dihydroxypyrrolidine]platinum (II)",,IC50,4.83,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,,,Cytotoxicity,Unspecified
CHEMBL1165315,,COc1cc(C(=O)O[C@@H]2CCCC[C@H]2OC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.16,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CJJVDYUOTKHCBA-QZTJIDSGSA-N,24.0,Anticancer activity,MTT
CHEMBL1164769,,COc1cc(C(=O)OCC#CCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.14,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,XKOVVSUTLGCEFP-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163850,,COc1ccc(C(=O)OCCCCCCCOC(=O)c2ccc(OC)c(O)c2)cc1O,IC50,4.51,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,WBYUPSSWONGLLF-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163848,,COc1cc(C(=O)OCCCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.5,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,JBWXEGPMCYLSHT-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL239423,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)ncc(F)c12,IC50,7.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,IAXDMWLLSCYANC-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL439564,,C[C@@H]1CN(C(=O)c2ccn(C)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DYNYBLGPTLDVGR-GFCCVEGCSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL3092911,,Cn1c2cnc1ONC(=O)CCCCCCCCCOc1ccccc1-2,IC50,4.19,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,SDJYAZMSSOETBA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL1224208,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.4,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,HCDMYGHVGDBONW-SJOMWMNGSA-N,72.0,Cytotoxicity,MTS
CHEMBL1097312,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.13,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RLWAAPCVGFLZKM-ZIDCOHPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL139942,,Cc1ccc2c(O)nc(-c3ccccc3C)cc2c1,IC50,5.7,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,JFNDUQYQBKMAEG-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL141254,,Cc1ccc(-c2cc3cc(C)ccc3c(O)n2)cc1,IC50,4.95,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,KYDUBVYKIUREAK-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.7,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,GBABOYUKABKIAF-IELIFDKJSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL3291067,,CCC1=C[C@@H]2CN(C1)C[C@H](CN1CCC[C@H]1C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.6,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,UJSDIMPPELQZCW-TZZICCFCSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL223782,,O=C(CC1CN(C(=O)c2ccco2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.17,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LODDVTSCZXYADZ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223384,,CNC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PIQCDPVLMAIZFH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3343382,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.96,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OIIPGLWIAWFBQK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343383,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.6,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WRHLIOGWJHQBHX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,5.14,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,TZYWCYJVHRLUCT-VABKMULXSA-N,,Growth inhibition,Unspecified
CHEMBL515416,,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1,IC50,4.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,PELFTNQHGSITLB-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,6.94,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YWTBGJGMTBHQTM-IBGZPJMESA-N,,Growth inhibition,Unspecified
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.52,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NWIBSHFKIJFRCO-WUDYKRTCSA-N,,Growth inhibition,Unspecified
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,4.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AQGNHMOJWBZFQQ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.49,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AXNUEXXEQGQWPA-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,7.49,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IXFPJGBNCFXKPI-FSIHEZPISA-N,,Growth inhibition,Unspecified
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,6.17,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,LQVXSNNAFNGRAH-QHCPKHFHSA-N,,Growth inhibition,Unspecified
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,4.97,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NAVMQTYZDKMPEU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,5.29,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,ZFKXDVMHNXPEIY-PEZBNFGJSA-N,,Growth inhibition,Unspecified
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.55,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,RDSACQWTXKSHJT-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,4.32,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,FDLYAMZZIXQODN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,5.0,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,RITAVMQDGBJQJZ-FMIVXFBMSA-N,,Growth inhibition,Unspecified
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,5.24,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CEGSUKYESLWKJP-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL505699,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,5.78,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,XYNAVBNWRSKIDD-RNBUTDDUSA-N,3.0,Unspecified,Unspecified
CHEMBL1782906,,CCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.37,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,LOWADNGIIGYMOB-QNMIOERPSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL563437,,CC(=O)Oc1ccc(/C=C/c2cc(F)cc(F)c2)cc1,IC50,4.22,CHEMBL1053287,Anticancer activity against human SNB75 cells,SNB-75,DZZTWCXKYNKNQY-NSCUHMNNSA-N,,Anticancer activity,Unspecified
CHEMBL3359305,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.61,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,LWABSVMRKSAHOW-LWXWOMNKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359306,,C=C(CCCC(C)(C)OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,5.0,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,UPLCUOLYACCTIC-LWXWOMNKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1652079,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3O)[nH]c21,IC50,5.41,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PXQACXGBBNTXJM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL155771,,CC(C)CCC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.69,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBIBTBSDPZSTOE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652067,,C=C1C2=C(CCCC2)C(=O)C(OC2(CCC(C)C)C(=O)C(=O)C3=C(CCCC3)C2=O)=C1CCC(C)C,IC50,5.0,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QOOFFZTYUAIZLG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652074,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3F)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HBMPNWGFWNUSJV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652078,,Cc1cccc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)c1,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZPORFQBPMNEZCQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL383961,,O=c1c2cccc3c2sn1CCNCCOc1cccc2nc(O)c-3nc12,IC50,6.22,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,DZSJECNZKMWWQI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL448434,,C=CCN(C)CCCCC[C@H]1CC[C@H](N(C)C(=O)Oc2ccc(C(F)(F)F)cc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,IC50,5.08,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,MUWQVRLDCKDCPR-URGWDIIDSA-N,72.0,Cytotoxicity,MTT
CHEMBL324162,,C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1.O=C(O)/C=C/C(=O)O,IC50,5.06,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,XCYAYLWZCRGKDS-WLHGVMLRSA-N,72.0,Cytotoxicity,MTT
CHEMBL2172486,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4C)cn23)n1,IC50,7.24,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,FEKALHVHQQPGPI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL514869,,CC1(C)CNC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1,IC50,5.46,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,ZCCMLCRXWWFYEG-HNNXBMFYSA-N,,Antiproliferative activity,Unspecified
CHEMBL121802,,COc1ccnc2c1C(=O)c1nc3ccccc3c3ccnc-2c13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,NPMBMAQAWUDHLX-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL166487,,COCCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.39,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,AUEXEZJNTMMGJV-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1164847,,CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl,IC50,5.9,CHEMBL1169191,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NKLGZZXEURDTLU-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL1095627,,CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,IC50,7.92,CHEMBL1104677,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OHKRUKRKVNWNNT-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1823147,,COc1cc(C(=O)c2c(C)oc3c(O)c(OC)ccc23)cc(OC)c1OC,IC50,9.39,CHEMBL1828312,Antiproliferative activity against human U87MG after 48 hrs by spectrophotometry,U-87MG ATCC,RADMJHVVIZTENA-UHFFFAOYSA-N,48.0,Antiproliferative activity,Unspecified
CHEMBL51483,GOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,IC50,4.52,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QBKSWRVVCFFDOT-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL124315,,O=C1c2cccnc2-c2nccc3c2c1nc1cc(Br)ccc13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,CPXBDTZAJSRIKJ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1080569,,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,EC50,6.42,CHEMBL1104227,Cytotoxicity against human U87MG cells after 3 days by alamar blue staining,U-87MG ATCC,WZOVTPHXONVIIJ-SFHVURJKSA-N,72.0,Cytotoxicity,Alamar Blue
CHEMBL1224359,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(N)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.92,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,NUMDCZFKPVPXKE-SJOMWMNGSA-N,72.0,Cytotoxicity,MTS
CHEMBL1927616,,CCCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCCN(C)C)C3=O,IC50,5.2,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDIILIISLKWYOH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL561281,LUMISANTONIN,C[C@@H]1C(=O)O[C@H]2[C@H]1CC[C@]1(C)C3(C)C(=O)C=CC231,IC50,4.16,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DAGAGXCQQYCLAE-VADQIUEASA-N,72.0,Cytotoxicity,MTT
CHEMBL61102,,COc1ccc(C2C(OC(C)=O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,6.84,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,URXLBKJEOVKBRG-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3659990,,O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F,IC50,5.1,CHEMBL4220076,Antiproliferative activity against human U87 cells,U-87MG ATCC,PVMIBRDKTVSNOE-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4225608,,CCCC(=O)Nc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.64,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,OCZKWWSNGOLFQE-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL324643,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.96,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KFNRGFZWGOCXDB-TVKQRKNISA-N,,Unspecified,Unspecified
CHEMBL1095527,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccc(F)cc3)nn2)[C@H]1Br,IC50,5.75,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NRONRYWDUHRKEF-PGRDOPGGSA-N,72.0,Cytotoxicity,MTT
CHEMBL1095548,,COc1ccc(-c2cn([C@H]3C4=C(OC(C)(C)[C@@H]3Br)c3ccccc3C(=O)C4=O)nn2)cc1,IC50,5.52,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WMMRPQPHXVNHGI-WMZHIEFXSA-N,72.0,Cytotoxicity,MTT
CHEMBL1095549,,CC(C)=CCC1=C(OC2(CC=C(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.99,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VJAAOWAHJDQBCD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,5.39,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,ULXXDDBFHOBEHA-CWDCEQMOSA-N,,Growth inhibition,Unspecified
CHEMBL5220190,,CCOC(=O)c1c(NC(=O)CC#N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.37,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,UTBGHGVZAUCAKQ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5220279,,CCOC(=O)c1c(N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,5.13,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,BAUNUTNFPSWYHZ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261885,Cytotoxicity against human T98G cells measured after 8 days,T98G,JGOZUFGBTSAWEI-NSCUHMNNSA-N,192.0,Cytotoxicity,Unspecified
CHEMBL1643048,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(OC)cc2)n2c1Cc1ccccc1C2,IC50,4.77,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,DPYIEPVHRLMFQA-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL321413,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1,IC50,8.68,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XBGWFPDHOIKUGB-YQCHCMBFSA-N,,Unspecified,Unspecified
CHEMBL1807797,,CC(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.62,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,JNXQZEQTCNUMCM-WBVHZDCISA-N,,Antiproliferative activity,Unspecified
CHEMBL1807803,,COCCC(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.27,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,YCWFAWGWYOUCKZ-MJGOQNOKSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807809,,Cc1c2c(n3c1CCN(C(=O)C1(N)CCCC1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.36,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OQCZXOJFRLBCCF-QUCCMNQESA-N,,Antiproliferative activity,Unspecified
CHEMBL313230,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,RPVDOUORCPXFHC-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1087476,,Cn1cc(NC(=O)CCCCCCCCCCCN)c(-c2ccccn2)n1,IC50,4.05,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,JMEQPFASHHJIDA-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL109158,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1,IC50,9.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,SIGNOFGQWWUQJS-QCWLDUFUSA-N,,Unspecified,Unspecified
CHEMBL323454,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1,IC50,7.12,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,IYUGABYSRYTCQT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3093025,,Cn1c2cnc1OCCCCCCCCOc1cc3ccccc3cc1-2,IC50,4.5,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QGVMDYASGGDBIO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093030,,Cn1c2cnc1OCCCCCCCCOc1ccccc1-2,IC50,4.08,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GOQRJMXCBGQPQO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3114587,,CC1(C)CC(Nc2ccc(I)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.04,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,BYEGKHWKKSCKSO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL373751,GSK-319347A,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,IC50,4.08,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,LDTAHRLHGHFHKP-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1090771,AVAGACESTAT,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,IC50,4.45,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XEAOPVUAMONVLA-QGZVFWFLSA-N,,Growth inhibition,Unspecified
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,6.1,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PQAPVTKIEGUPRN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.86,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,HMABYWSNWIZPAG-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2144069,,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,IC50,5.01,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,ZGBGPEDJXCYQPH-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,5.0,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GCIKSSRWRFVXBI-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,9.04,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GXJABQQUPOEUTA-RDJZCZTQSA-N,,Growth inhibition,Unspecified
CHEMBL1673039,,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,IC50,5.13,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DDTPGANIPBKTNU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.01,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,CTESJDQKVOEUOY-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.26,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IRTDIKMSKMREGO-OAHLLOKOSA-N,,Growth inhibition,Unspecified
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,6.25,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AHMHIFXJPSHHPH-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.39,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JWQOJVOKBAAAAR-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.42,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,XGALLCVXEZPNRQ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,4.73,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JLYAXFNOILIKPP-KXQOOQHDSA-N,,Growth inhibition,Unspecified
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,5.05,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,GFMMXOIFOQCCGU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,7.46,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,BKJIXTWSNXCKJH-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,5.7,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AHJRHEGDXFFMBM-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4066144,,O=C(O)c1cc2nc(N3CCOCC3)nc(N3CCOCC3)c2s1,IC50,5.61,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,LYAOGFDLXPWLNU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL2165005,,COc1ccc(Nc2ncc(CN3CCS(=O)(=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.92,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NYHQXLSMSMLVGN-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165028,,COCCNCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,JRWLTKDVIINVLC-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165006,,COc1ccc(Nc2ncc(Cc3ccccc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.16,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,CGJYZCCLUUIRAJ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165010,,COc1ccc(Nc2ncc(CN3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.89,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OIPZJHZMJMKKBK-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2164704,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccc(F)cc3)c(C)c21.[Br-],IC50,5.24,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SIVFFLFLAHGUGB-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164702,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccccc3)c(C)c21.[Br-],IC50,5.77,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FWTWQWOYZONKGF-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL23293,SALIRASIB,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,IC50,4.27,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WUILNKCFCLNXOK-CFBAGHHKSA-N,48.0,Cytotoxicity,MTT
CHEMBL2165012,,COc1ccc(Nc2ncc(CN3CC[C@@H](CO)C3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.41,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NOEYFOUOAVCIAX-CQSZACIVSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165008,,COc1ccc(Nc2ncc(CN3CCCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.66,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KPKRMMWVCSAMKZ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2164703,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccccc3F)c(C)c21.[Br-],IC50,5.75,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VJJUFPUKYWKJQJ-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164719,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,5.62,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DNGGRJSXRCAZDO-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164717,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.43,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,QFZTVBUSKCUSJG-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164715,,Cc1c2[nH]c3cc(OCc4ccccc4)ccc3c2cc[n+]1Cc1ccccc1.[Br-],IC50,5.25,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,GYPXDFJYZGSDLJ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164710,,Cc1nccc2c3ccc(OCc4cccc(F)c4)cc3n(Cc3cccc(F)c3)c12,IC50,4.57,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,YLPZZFNUBHIQQA-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164707,,Cc1nccc2c1[nH]c1cc(OCc3cccc4ccccc34)ccc12,IC50,4.92,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,UDUMVLIVSFJGGL-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645553,,Cc1nccc2c1[nH]c1cc(OCc3ccncc3)ccc12,IC50,5.44,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,JAZIJXBWEKKRAM-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645552,,Cc1nccc2c1[nH]c1cc(OCc3cccnc3)ccc12,IC50,4.54,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DBVRCFMRLBRLQE-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645549,,Cc1nccc2c1[nH]c1cc(OCc3ccccc3)ccc12,IC50,4.77,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CGOCGPOAPLNJFM-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645548,,Cc1nccc2c1[nH]c1cc(OCC3CCCCC3)ccc12,IC50,5.14,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XPNBZXYLKBNCSU-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645545,,Cc1nccc2c1[nH]c1cc(OCC(C)C)ccc12,IC50,4.66,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VRVCIYIVKIFEPH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1089308,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3OC(=O)CCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)CCCC(=O)O[C@H]3[C@H](O[C@@H]5c6cc7c(cc6[C@@H](c6cc(OC)c(OC(=O)CN(C)C)c(OC)c6)[C@H]6C(=O)OC[C@@H]65)OCO7)O[C@@H]5CO[C@@H](C)O[C@H]5[C@@H]3O)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCNC(=O)CCCC(=O)O[C@H]3[C@H](O[C@@H]5c6cc7c(cc6[C@@H](c6cc(OC)c(OC(=O)CN(C)C)c(OC)c6)[C@H]6C(=O)OC[C@@H]65)OCO7)O[C@@H]5CO[C@@H](C)O[C@H]5[C@@H]3O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC(=O)CN(C)C,IC50,6.48,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,XFDBHMKNWWTEFD-KBLHWHQNSA-N,48.0,Cytotoxicity,[3H]thymidine incorporation
CHEMBL1807790,,Cc1c2c(n3c1CCCN[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.21,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,NPICSXCYDBJDTM-HOTGVXAUSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807795,,Cc1c2c(n3c1CCN(CCO)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.26,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KVCRXCKHFUBLBP-AEFFLSMTSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807800,,Cc1c2c(n3c1CCCN(C(=O)CO)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.96,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,GUYAKTTZJAARFK-IRXDYDNUSA-N,,Antiproliferative activity,Unspecified
CHEMBL1738703,,Cc1c2c(n3c1CCCNC[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.44,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,DGOVAFNEOBXFEF-AWEZNQCLSA-N,,Antiproliferative activity,Unspecified
CHEMBL1801525,,NCCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.O=C(O)C(F)(F)F,IC50,5.55,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,WBFRIIZROPKMQJ-UHFFFAOYSA-N,48.0,Unspecified,MTT
CHEMBL318721,,CCC(CC)n1ccc2c3c(N)nc(N)nc3ccc21,IC50,8.1,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,GCPJCLJGTVTGRF-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2164402,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,5.92,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LORBSHDWYPHBDQ-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164720,,CCC[n+]1ccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c2c1C.[Br-],IC50,4.96,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XEXWDDVPJQEIJG-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL3358285,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(S(C)(=O)=O)c2)n1,IC50,5.94,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFOXDJCJLFNLBY-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357868,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.89,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JTIBGKGGRQKKJP-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357865,,COc1ncc(Nc2ncc([C@@H](C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.7,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFMMTRCKHHKIJM-MRVPVSSYSA-N,2.0,Unspecified,cell-based
CHEMBL3343372,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FLHSLGFLDYONEF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1096180,,O=C(CCCCCCCCCCS)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.05,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,DAPWSEDEJZAZHD-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL85989,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCCC#N)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,QCKSYPIYXKRMJG-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL314863,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC#N)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,FLSXZIXQFOPKOC-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,4.26,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,XHXFZZNHDVTMLI-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,5.42,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IYNDTACKOAXKBJ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL244452,,CC(COc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O)N(C)C,IC50,6.85,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,MHLDFTSFDRBGTQ-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL213100,,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,IC50,5.76,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NBTNHSGBRGTFJS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.92,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AYUNIORJHRXIBJ-TXHRRWQRSA-N,,Growth inhibition,Unspecified
CHEMBL337547,,Cc1ccc2c(S)nc(-c3ccccc3)cc2c1,IC50,5.04,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,RRJXVVWHJOHBHM-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,6.85,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,VSJKWCGYPAHWDS-FQEVSTJZSA-N,,Cytotoxicity,Unspecified
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.04,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL572083,,COc1ccc(NC2C3C(=O)C(=O)c4ccccc4C3OC2(C)C)c([N+](=O)[O-])c1,IC50,5.75,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,LPJIUFZAZCYEPO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL263664,,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.3,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,RZIDZIGAXXNODG-UHFFFAOYSA-N,,Growth inhibition,SRB
CHEMBL259998,,NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.33,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,ZYRDOEVRNXUXJJ-UHFFFAOYSA-N,,Growth inhibition,SRB
CHEMBL550042,,CCc1c(CO)c(CO)c2n1-c1ccccc1C2,IC50,4.74,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,TXHCNERZHOYNLK-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL497610,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)OCc1ccccc1,IC50,4.52,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,QFZPEVVEVPCUQT-JYPYDPOKSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL407718,,Fc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,IC50,7.12,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,MYTFOQDJGMLDRY-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL608114,,C[C@@]12CCC[C@H]1[C@@H]1CCc3cc(O)c(NC=O)cc3[C@H]1CC2,IC50,4.37,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,DYFCAFGQZNSPOB-MVWRLGRASA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL5435752,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(S(=O)(=O)c3ccc(/C=C/C(=O)NO)cc3)CC1)C2,IC50,4.77,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,JPKJGEMGVPIVPZ-VMPITWQZSA-N,,Cytotoxicity,MTT
CHEMBL5423994,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(NC(=O)CCCCCCC(=O)NO)c3)CC1)C2,IC50,5.31,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,WCCIPIPPRWMNTJ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL3115967,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccccc4)nn3)[C@@H]2CC1,IC50,4.68,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,FERFPBUFCCVQNY-VMAZJTETSA-N,,Cytotoxicity,colorimetric sulphorhodamine B
CHEMBL568180,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCNC(=O)CC[C@H](NC(=O)CC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)C(=O)NCC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,4.94,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,XGNWNLOBVKYAFF-FLSZHKJKSA-N,,Anticancer activity,sulforhodamine B
CHEMBL469099,,CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1,IC50,4.96,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,DZXMARZBAUMWLK-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5435760,,O=C(C#Cc1ccccc1)Nc1cc(-c2ccsc2)ccc1F,IC50,5.22,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WIRSQLGKCLDYSJ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL2311578,,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,IC50,5.21,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,UJGTUKMAJVCBIS-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5396390,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCCCN1CCOCC1,IC50,7.82,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,CMRWPDQPAFWOQN-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5281194,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.01,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,YBQNXTFBUCVWQQ-NBTZWHCOSA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.03,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,MZDKLVOWGIOKTN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL38,TRETINOIN,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,IC50,4.68,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,SHGAZHPCJJPHSC-YCNIQYBTSA-N,,Growth inhibition,Unspecified
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JAMULYFATHSZJM-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL269277,BETULINIC ACID,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.21,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,QGJZLNKBHJESQX-FZFNOLFKSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,4.73,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,KTEXNACQROZXEV-JADZJFIVSA-N,,Growth inhibition,Unspecified
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,4.49,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DOKZLKDGUQWMSX-HKBQPEDESA-N,,Growth inhibition,Unspecified
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,6.77,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PHXJVRSECIGDHY-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4079222,,COc1cc(CO)c(Br)c(Br)c1OCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,4.95,CHEMBL4026219,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HVZPIWMCNYUSFV-DSPGLSBSSA-N,48.0,Antiproliferative activity,MTT
CHEMBL136737,NIMUSTINE,Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1,IC50,6.08,CHEMBL1111856,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VFEDRRNHLBGPNN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL255592,,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21,EC50,7.89,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ISHNPDWTQUXPSY-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL565162,,C=C1C(=O)O[C@H]2[C@H]1CC[C@]1(C)C3(C)C(=O)C=CC231,IC50,5.67,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JQWAZWQLERJUJH-TZGSXBKUSA-N,72.0,Cytotoxicity,MTT
CHEMBL5265884,,C[C@@H]1CC[C@H]2[C@@H](C)C(CCC(=O)NCCCN3CCN(CCCNC(=O)CCC4O[C@H]5O[C@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)CC3)O[C@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,IC50,6.34,CHEMBL5257547,Antiproliferative activity against human XF498 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,XF 498,JVHGAAKZMCRLRS-OAZVRWERSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3884836,,CCOC(=O)c1nc2ccccc2nc1C#Cc1cccc(F)c1,IC50,5.72,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QAOFJXKFKLDPCB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2164398,,Cc1c2c(cc[n+]1CCO)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,5.58,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,KYNZIQWDVRSPNB-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL1782895,,CCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.44,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KFYBQAPIMYJCGR-LVEBQJTPSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782903,,CCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.32,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZPULXJOUYVMUSV-AZIXLERZSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782896,,CCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.09,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,MKGOTFINSHWUCP-QNMIOERPSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782910,,CCCCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.89,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,GEKFEXNIOALNSW-QIXIFPRPSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL210618,,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,IC50,4.67,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,KQMPRSZTUSSXND-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2134202,,CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,IC50,4.44,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,FBLPQCAQRNSVHB-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.71,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UIARLYUEJFELEN-LROUJFHJSA-N,,Growth inhibition,Unspecified
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.61,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,SDUQYLNIPVEERB-QPPQHZFASA-N,,Growth inhibition,Unspecified
CHEMBL3794344,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCCC1,IC50,4.75,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,DWXHGPSLYBTJRB-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL5290709,,Cn1nccc1NC(=O)Nc1ccc(-c2nc(-c3ccc(CN4CCN(S(C)(=O)=O)CC4)s3)nc(N3CCOCC3)n2)cc1,IC50,5.07,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,VXFIQWFKZBLWIN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4551635,BAY-069,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1Cl,IC50,5.7,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,UNSHMXUHOHBLIQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5191892,,C[C@H](NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1)c1ccncc1,EC50,5.63,CHEMBL5167608,Antiproliferative activity against human T98G cells assessed as reduction in cell viability measured after 1 to 7 days by resazurin dye based fluorimetric analysis,T98G,FFVXISWLYSJERX-INIZCTEOSA-N,168.0,Antiproliferative activity,Resazurin
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,7.72,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N,132.0,Antiproliferative activity,MTT
CHEMBL3343411,,CCCC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,IC50,5.21,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,BASPGTBXGXQYJJ-XJPKVNQNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343414,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](OS(C)(=O)=O)[C@H]2O1,IC50,5.2,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SEURMQYJQTWTQJ-NYBGZPCFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343646,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](N)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.53,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,YSSBDFDKGKVQQL-KLIJIXSESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343368,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.93,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XXKOUGFWCFKCQQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343373,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.0,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HHXLIMZXZVZKGQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343375,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.57,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZRHBIYUNDWMKDW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343376,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZVOYCTHEUYIRPQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343392,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UVKUURMGKLVPAN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2180746,,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,IC50,6.24,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,FMROPZMGAOICAF-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL2180740,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,IC50,6.44,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,GJJOEFRKCTWCTH-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL4099523,,CCN1C/C(=C\c2ccc(S(F)(F)(F)(F)F)cc2)C(=O)/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)C1,IC50,6.03,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UVJVSGRLDKINCE-JYFOCSDGSA-N,72.0,Cytotoxicity,MTT
CHEMBL4074549,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2Cl)ccc1OCCCCN1CCCCC1,IC50,5.21,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,JXAMDDJTHWVNQP-YRNVUSSQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4063094,,COc1ccc(C(=O)/C=C/c2ccc(OCCCn3nc(C)cc3C)c(OC)c2)cc1,IC50,5.16,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AXDBXRWTHYFXCA-WUXMJOGZSA-N,48.0,Antiproliferative activity,MTT
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,5.01,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N,48.0,Antiproliferative activity,MTT
CHEMBL344607,,Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.74,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QHHGCBRDJMDQEW-DHLKQENFSA-N,,Unspecified,Unspecified
CHEMBL5418007,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2cccc(c2)CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.84,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,KXMGMIKAPPHCEJ-ZBLPZKBESA-N,48.0,Unspecified,CCK-8
CHEMBL478526,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1O,IC50,5.33,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VDCLTZXJJLMWQH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL584338,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(F)c([N+](=O)[O-])c1,IC50,5.98,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HMKIICIVRKQVLD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL479011,,COc1ccc(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.96,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ULSOSJFIPXSKPO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL50418,,O=C1OCc2c(cc3n(c2=O)Cc2c-3nc3cc4c(cc3c2CCl)OCCO4)C1(O)CCO,IC50,6.41,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,HOVUHWKJLVMZLY-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL299613,2-METHOXYESTRADIOL,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,IC50,5.07,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,CQOQDQWUFQDJMK-SSTWWWIQSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL4070551,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.7,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FDGDLSJCAGGYLQ-HXVQJGFHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4072725,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(C(F)(F)F)cc1)CC(C)(C)O2,IC50,4.82,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CUTXNWJTGUIISR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3353051,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,9.0,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,VBVXAAKYUMLCAV-UHFFFAOYSA-N,48.0,Antiviral activity,luciferase reporter gene
CHEMBL568150,,O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1,IC50,6.5,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,SQWZFLMPDUSYGV-POHAHGRESA-N,96.0,Growth inhibition,MTT
CHEMBL1171647,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,6.51,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,MOZRQQTUYAYCQT-FQEVSTJZSA-N,1.0,Unspecified,ELISA
CHEMBL3765204,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccccc2)nn1,IC50,5.16,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MKCYQHHEJKSONF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3735979,,O=C(c1ccc(I)cc1)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,IC50,8.13,CHEMBL3738637,Inhibition of PARP1 in human T98G cells incubated for 60 mins by immunofluorescence assay,T98G,QOCIPUHZHXLQMK-UHFFFAOYSA-N,1.0,Unspecified,immunofluorescence
CHEMBL222364,,CCOC(=O)CN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.03,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HDVFZTUOHYYUBQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220834,,CC(C)OC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PUXXMEUMZYBGLD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL373919,,O=C(CC1CN(Cc2cccc3ccccc23)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.16,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HSHZHZBGDQDOAU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220270,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(OC(F)(F)F)cc1,IC50,7.72,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MPMCKFDENKJOQC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL222362,,Cc1cc(N2CCN(C(=O)C(C)C)[C@H](CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,9.12,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-HXUWFJFHSA-N,,Unspecified,Unspecified
CHEMBL270639,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,IC50,7.11,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,SUCAWRZDHHYRQV-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL270640,,CCc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,EC50,6.4,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,PPMVOOTZFOABKA-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL385786,TUBEIMOSIDE V,C[C@@H]1O[C@H]2O[C@@H]3[C@H](OC[C@@H](O)[C@H]3O)OC(=O)[C@]34CCC(C)(C)CC3C3=CCC5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@H]7O[C@@H](COC(=O)C[C@](C)(O)CC(=O)O[C@@H]1[C@@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]7O)[C@@](C)(CO)C6CC[C@@]5(C)[C@]3(C)CC4,IC50,5.44,CHEMBL910864,Antiproliferative activity against human U87MG cell line by MTT assay,U-87MG ATCC,LSUWFJVHSNDVLV-LRTBEYQQSA-N,,Antiproliferative activity,MTT
CHEMBL5274469,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccc(OC(F)(F)F)cc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MCSXNLKTLHQAJJ-LBGRBXAQSA-N,,Antiproliferative activity,Unspecified
CHEMBL5268246,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccccc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,XNJGWZUITNZAMR-ZQXPYOPKSA-N,,Antiproliferative activity,Unspecified
CHEMBL261342,,CC(C)n1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.85,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,OGGJXGGVMPYMPS-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL2172489,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnn(C5CC5)c4)cn23)n1,IC50,8.1,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,XODHFMOZHXRSNF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172485,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4)cn23)n1,IC50,8.3,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,VLUBDPDZETYNRC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172481,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4C)cn23)n1,IC50,7.27,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ADTCCVMJGTXFQL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172480,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4C)cn23)n1,IC50,8.0,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,LFOJPPGMFCXNEE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172640,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccncc4)cn23)n1,IC50,7.58,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,LDNZOZBLULAYOM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5284457,,COc1cc(Nc2ccc3nnc(-c4nccs4)n3c2)cc(OC)c1OC,IC50,4.31,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,IMTOIRJXYCGONG-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5273682,,Cc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.69,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,PDEPOPSZQUSURL-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL5283623,,Brc1cccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)c1,IC50,4.83,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,ZLSBTTYHBILXSY-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL473840,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H](C(C)C)NC1=O,IC50,8.26,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,DIDDMMTUXXHTQR-FELOTHHLSA-N,3.0,Unspecified,Unspecified
CHEMBL567524,,COC(=O)[C@@H](CS)N(Cc1ccccc1)C(=O)CC[C@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CCC([C@H]1C)[C@@]24OO3,IC50,5.58,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,YTECTWXLJCDTEL-DOCXZMLISA-N,,Anticancer activity,sulforhodamine B
CHEMBL569027,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCNC(=O)CC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.24,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,QDNYGRJDRIMPOK-BRHROXOMSA-N,,Anticancer activity,sulforhodamine B
CHEMBL478508,,Oc1ccc(CN(Cc2ccccc2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.6,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,LWPMUMIMHKHREW-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5437073,,COc1ccc([C@H]2[C@@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1/C=C/C(=O)NO,IC50,7.64,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,JFCXSUQGICXKPN-HVCBVEAFSA-N,48.0,Antiproliferative activity,MTT
CHEMBL551288,APOGOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O,IC50,4.45,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PBJKWGWHZVXBGU-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL220064,,O=C(CC1CCCCN1c1cc(-c2ccccc2)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.17,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GBJQTVOLZGSIES-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL600476,,O=C(Nc1nonc1NC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1,IC50,4.84,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,KTXZEAQHXYYZGJ-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL386467,,O=c1c2cccc(-c3nc4ccccc4nc3O)c2sn1C1CCCC1,IC50,6.51,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,IWNSRJDVPQNPCB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5428666,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCCC1,IC50,6.9,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RKBZFSLRVDPBOO-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL464587,,C=C1C(=O)O[C@H]2[C@H]1C[C@@H](O)/C(C)=C/CC[C@@]1(C)O[C@@H]21,IC50,4.96,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RZUCCKARTVHQBW-ZFDNOKKTSA-N,72.0,Anticancer activity,MTT
CHEMBL3393284,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nc2nccn12,IC50,6.66,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,OERMTVRXFMLUOQ-UHFFFAOYSA-N,,Unspecified,crystal violet staining-based
CHEMBL1224134,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.3,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,GSBQZUZJHLMNEB-IMKSHNIHSA-N,72.0,Cytotoxicity,MTS
CHEMBL163078,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1,IC50,9.13,CHEMBL815089,Concentration required to inhibit the entry of HIV-1 reported virus (ADA) into U-87 cells,U-87MG ATCC,KRBMMTDOLHPSPA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL315088,,COC(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZTYRLNIVULKCEA-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL2170099,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.15,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,KUGIFHQBIIHRIZ-ZDUSSCGKSA-N,2.0,Unspecified,Unspecified
CHEMBL2170097,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2cncc(F)c2)n1,IC50,7.64,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,MLKLYQDMHYWKGW-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2170094,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2ccc(C(F)(F)F)nc2)n1,IC50,6.62,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,POILOEPNLLDHRQ-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL3809213,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccccc4)n3)ccc21,IC50,4.85,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ONFLBPIRWOZEJY-HZHRSRAPSA-N,48.0,Cytotoxicity,MTT
CHEMBL168215,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(CCO)C(=O)OCc1ccccc1,IC50,5.72,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,YXPPZMUXQULDJR-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL244396,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2C(F)(F)F)n1,IC50,6.66,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,LWYVGRHQPVLTAP-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL244397,,c1cn(-c2ccc(Oc3cc(N4CCOCC4)nc(Cc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,6.08,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,WGFLIJQCXCLGRO-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL243977,,Cc1c(F)c(Oc2ccc(-n3ccnc3)cc2)nc(Oc2ccc3c(c2)OCO3)c1F,IC50,6.35,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,CMSNMPXPGHEGBH-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL1643027,,Cc1c(CO)c(CO)c2n1Cc1ccccc1C2,IC50,4.55,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,BVWJQOIYMKGOCN-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL1643044,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.55,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,IVPXJJIXPOAQMQ-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL43064,CINNARIZINE,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,4.87,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,DERZBLKQOCDDDZ-JLHYYAGUSA-N,120.0,Antiproliferative activity,MTT
CHEMBL1448,NICLOSAMIDE,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,IC50,6.4,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,120.0,Antiproliferative activity,MTT
CHEMBL44,GENISTEIN,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,4.05,CHEMBL1647062,Cytotoxicity against human T98G cells after 72 hrs by SRB assay,T98G,TZBJGXHYKVUXJN-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL1214141,,Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1,IC50,5.22,CHEMBL1217201,Antiproliferative activity against human U87 cells,U-87MG ATCC,SZNYUUZOQHNEKB-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1098108,,COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1,IC50,10.21,CHEMBL1120806,Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA,U-87MG ATCC,YEHUDYLWUFJTMH-UHFFFAOYSA-N,0.5,Unspecified,ELISA
CHEMBL2297274,,COc1cc(OC)c2c(Nc3ccccc3)cc(-c3ccccc3)nc2c1,IC50,5.23,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,GTKIBDAQYUGPCT-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL229627,,Cc1cccc2nc3c(n12)C(=O)C(=O)c1cccnc1-3,IC50,5.59,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,SSOREUPMLYAZHT-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL1169623,,N[C@]1(CNC(=O)c2ccc(F)cc2F)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.55,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,NYXVMGDGFFQGFZ-SFHVURJKSA-N,1.0,Unspecified,ELISA
CHEMBL1170445,,N[C@]1(CNC(=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.46,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,OSIJXFXWDRIUIH-SFHVURJKSA-N,1.0,Unspecified,ELISA
CHEMBL293834,,COc1ccc(C2C(O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-],IC50,7.3,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,GSTOXUGHWJKGFJ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1097309,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.07,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BIZNEWHBFITJQR-YGMZGXMASA-N,48.0,Cytotoxicity,MTT
CHEMBL232825,,c1cn(-c2ccc(OC3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,7.24,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL233441,,CC1CCCCN1CCCNC(=O)CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2,IC50,5.8,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,NWNRAEPFIKOHBQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL232819,,O=C(CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2)NCc1ccc2c(c1)OCO2,IC50,6.19,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,AGKVOYQQFKGLNS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3335779,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(C5=CCNCC5)cn4)CCO3)n2)c1,IC50,5.01,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,WMCUXHSEYQTJIF-QFIPXVFZSA-N,72.0,Cytotoxicity,WST8
CHEMBL272265,,N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,EC50,6.38,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,MBIMERRBQGQJIO-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5431344,,COc1ccc([C@H]2[C@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1OCC(=O)NO,IC50,7.25,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GMAXMNJUVHIKOU-FKIZINRSSA-N,48.0,Antiproliferative activity,MTT
CHEMBL236387,,CC(=O)O[C@@H]1C=C2/C(=N/O)C[C@H]3[C@@H]4CC(C(C)=O)[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1,IC50,4.71,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,SBKHEVXAVZDYFH-CYBCVSRJSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL236425,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]4[C@@H]3C/C(=N\O)[C@@]23O[C@@H]13,IC50,5.97,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,RTCRWUGRLHZHCG-NMKURSGASA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL5219971,,COc1cc(-c2ncccc2CNc2ccc(C)cc2)cc(OC)c1OC,IC50,5.57,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MCPYDEUOPGPYCQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5218803,,COc1cc(-c2ncccc2NCc2ccc(C)cc2)cc(OC)c1OC,IC50,5.24,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,XPPLYXMRHDQZOO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL318311,,CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.74,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,MTHXVPHSKKLNEE-MHTZHOPKSA-N,,Unspecified,Unspecified
CHEMBL3885217,,O=c1c2nc3ccccc3nc2cc(-c2ccccc2)n1-c1ccc(Cl)cc1,IC50,4.46,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TXKLQVPAWQXPLX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2037136,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1C1CC1,IC50,4.13,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,YYCVSLJJJVOYHI-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037147,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1C1CC1,IC50,4.34,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,RQFALKNLPBQTSO-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2035439,,O=C1SC(=Cc2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(F)cc1,IC50,5.25,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,YNCXNVOUFHKLHL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1590709,,O=C(CSc1ncnc2sccc12)N1CCN(C(=O)c2cccs2)CC1,IC50,4.47,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,XFGDIRCPGCBKKS-UHFFFAOYSA-N,48.0,Antiviral activity,cell-based luciferase reporter gene
CHEMBL394005,,Cc1ncn(-c2nccc3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)n1,IC50,6.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RYIOKBONSZPVHX-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL235971,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)nccc12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DLNPHXOJDBJBBK-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392490,,CC1CN(C(=O)c2ccc3scnc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,4.9,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LJOKUTFVULXIIN-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238990,,C[C@@H]1CN(C(=O)c2cc3ccccc3o2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OIMRUVVSIWFMHE-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL397916,,CCOC(=O)CNC(=O)Cc1ccc2c(c1)OCO2,IC50,4.87,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,OCLIQPISHTXIJH-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1645547,,Cc1nccc2c1[nH]c1cc(OCCCC(F)(F)F)ccc12,IC50,4.07,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DTZUQYMIOUZBFU-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1078983,Ku-0063794,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@@H](C)O[C@@H](C)C4)nc3n2)cc1CO,IC50,7.0,CHEMBL1107750,Inhibition of mTORC1 in human U87MG cells assessed as phosphorylated S6 ribosomal protein (Ser235/236) level after 2 hrs by Western blotting,U-87MG ATCC,RFSMUFRPPYDYRD-CALCHBBNSA-N,2.0,Unspecified,Western Blot
CHEMBL3113687,,Oc1cccc(/C=N/Nc2cnc3ccccc3n2)c1O,IC50,5.9,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,UNXJYUGXNLCILS-CAOOACKPSA-N,,Cytotoxicity,MTT
CHEMBL5624633,,O=C(CCl)N1CCN(Cc2ccccc2)C12COC2,IC50,4.94,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RZTRFGKBSUIJJK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5629923,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1,IC50,5.5,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BKUHEMIKRWOYQA-CXUHLZMHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630184,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1cccnc1,IC50,5.14,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NANWLXDTOAZVSU-JLHYYAGUSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630029,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)s1)c1ccsc1,IC50,5.39,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SFJBHUVZDYHTST-SOFGYWHQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL125393,,CO[C@H]1Nc2cc3c(cc2C(=O)N2C=C(/C=C/C(=O)N(C)C)C[C@@H]12)OCO3,IC50,7.42,CHEMBL815849,In vitro cytotoxicity expressed as concentration that inhibits 50% of U87 (glioblastoma) resistant variant cell proliferation,U-87MG ATCC,TZWWXNMHPBLZFA-BYQXYHSISA-N,,Cytotoxicity,Unspecified
CHEMBL4535481,,Cc1cc2ncc(-c3ccc(OCc4ccccc4)c(O)c3)nc2cc1C,IC50,4.8,CHEMBL4342568,Antiangiogenic activity in human U87cells after 24 hrs by MTT assay,U-87MG ATCC,DAIWLKSJIGCCNJ-UHFFFAOYSA-N,24.0,Unspecified,MTT
CHEMBL322251,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,RQDGBNLSKUOAJD-SFTDATJTSA-N,,Unspecified,Unspecified
CHEMBL5396585,,O=C(CSc1nc2ccccc2c(=O)n1-c1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1,IC50,4.32,CHEMBL5386954,Cytotoxicity against human SNB-75 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,SNB-75,GQYAVMYYUMSGCM-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL106813,,CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.29,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,YQCLAYRIYWYIKH-WGPBWIAQSA-N,,Unspecified,Unspecified
CHEMBL480880,,CC(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.52,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,NBQKNTHBFZEQQO-AJNNAGPSSA-N,72.0,Antiproliferative activity,MTS
CHEMBL375563,,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.42,CHEMBL911410,Cytotoxicity against human U87MG cells after 24 hrs,U-87MG ATCC,PYXFVCFISTUSOO-HKUCOEKDSA-N,24.0,Cytotoxicity,Unspecified
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.7,CHEMBL3783554,Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay,SF126,DLGOEMSEDOSKAD-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL3319521,,C[C@]12O[C@@H]1CC[C@@]1(C)O[C@@H]1[C@H]1OC(=O)[C@@H](CN3CCN(c4ccc(Cl)cc4)CC3)[C@@H]1C[C@H]2O,IC50,4.8,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,LATBPYVHKBKUNK-DACOWICCSA-N,72.0,Anticancer activity,MTT
CHEMBL2170081,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.4,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,KUGIFHQBIIHRIZ-CYBMUJFWSA-N,2.0,Unspecified,Unspecified
CHEMBL11359,CISPLATIN,,IC50,4.79,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,,,Growth inhibition,Unspecified
CHEMBL1090090,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,IC50,4.0,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,FYSRKRZDBHOFAY-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.4,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,RAHBGWKEPAQNFF-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL450786,PHA-665752,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,IC50,4.26,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,OYONTEXKYJZFHA-SSHUPFPWSA-N,,Growth inhibition,Unspecified
CHEMBL585517,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)NCc3ccccc3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.46,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BHEURBJFAOJJHD-LDDWIZIVSA-N,,Anticancer activity,sulforhodamine B
CHEMBL568119,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)N3CCC(Cc4ccccc4)CC3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.71,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,DYFZAKQEEPCNLZ-JGOSJKENSA-N,,Anticancer activity,sulforhodamine B
CHEMBL2062866,,C=C(C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.04,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,YKIDGUZXBGGNBZ-GUNZAYKBSA-N,72.0,Antiproliferative activity,cyquant
CHEMBL5270668,,Fc1ccccc1-n1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1,IC50,5.02,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,KAZUDXKVLLJMQV-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL3121275,,CCc1nnc(NC(=O)c2ccoc2COc2ccccc2)s1,EC50,5.65,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KUBMSYDLEOLFPH-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3116234,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.12,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QYRPPRMBXWRGIN-HIXSDJFHSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116440,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.19,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZKQIRZBNHQBAND-YYADALCUSA-N,72.0,Cytotoxicity,MTT
CHEMBL600041,,O=C(CCl)Nc1nonc1NC(=O)CCl,IC50,4.77,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,GCUTXDUNVVYCKK-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL591752,,O=C(Nc1nonc1NC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,4.75,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,VVMXINUGUXFATD-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL1082016,,Cn1c(=O)[nH]c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,IC50,6.2,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,FLAQHSSOAXIOIA-HNNXBMFYSA-N,1.0,Unspecified,ELISA
CHEMBL570552,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1OC1CCCCC1,IC50,5.64,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BETWCXJAIXKAOZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL582830,,COc1ccc(OC)c(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)c1,IC50,6.41,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GLAGCVLUFNSSLD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1165314,,COc1cc(C(=O)OCc2cccc(COC(=O)c3ccc(O)c(OC)c3)c2)ccc1O,IC50,4.34,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,METXUACPHKWTLV-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1164313,,COc1cc(C(=O)OCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.5,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,XCZJDUGEINJHHJ-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163290,,CC(=O)c1ccccc1-c1ccc(-c2ccnc(NC(=O)Nc3cc(N4CCOCC4)cc(C(F)(F)F)c3)n2)cn1,IC50,5.27,CHEMBL1169194,Growth inhibition of human SNB75 cells after 48 hrs by sulforhodamine B assay,SNB-75,NGBOQLIIVBYICP-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL229401,,C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,IC50,6.64,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-SZNDQCEHSA-N,48.0,Unspecified,Unspecified
CHEMBL597549,,COc1cc(/C=C/c2cc(O)c3c(c2)OCC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.54,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,NATVWFRMTJXYMF-WPCAQGITSA-N,44.0,Cytotoxicity,MTT
CHEMBL2385194,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)c(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.27,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FAGHBGHQYBASQO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1910999,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,7.55,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HQXHYGAANFLAOZ-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL1911117,,COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.06,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,GVCOXBXPKBZDEG-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL566534,ARTEMETHER,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,IC50,5.04,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,SXYIRMFQILZOAM-HVNFFKDJSA-N,,Anticancer activity,sulforhodamine B
CHEMBL324274,,C=C/C(C)=C/C[C@@]1(C)[C@@H](C)CCC23C(=C[C@@H](OC(=O)C(C)C)C[C@@H]21)[C@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,5.92,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,ZORWLQPVCJDDHT-GMGUNDJRSA-N,,Cytotoxicity,Unspecified
CHEMBL5412398,,C[C@@H]1CC[C@H]2[C@@H](C)C(OCCOc3ccc(/C=C/S(=O)(=O)Nc4ccc(OC(F)(F)F)cc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,7.3,CHEMBL5355849,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,WSYNOMDLIDKXKP-PTSVAGJUSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.94,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,CBPNZQVSJQDFBE-FUXHJELOSA-N,,Growth inhibition,Unspecified
CHEMBL489474,,Cc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.87,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,SKABNCUDYKCTFK-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL489269,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc(N3CCOCC3)cc2)C1=O,IC50,5.77,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,RLRSGXCHTHBPMX-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5415375,,CCCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.68,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BTVKSBMZVONCPT-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5401866,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(O)c1,IC50,6.62,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,FSNDECYIJRAGKA-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,5.28,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DTEKTGDVSARYDS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,4.41,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DPEXRCOBPACFOO-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.01,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,CYOHGALHFOKKQC-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL5630589,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)s2)cc(OC)c1OC,IC50,5.4,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BIEISJXRFQWQNI-PKNBQFBNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2313862,CCHISANBICOLORIN A,COc1cc2c(c(O)c1OC)-c1c(cc3c(c1OC)CCC3)C[C@H](C)[C@H](C)C2,IC50,4.43,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UYCUEIUSIQQSOB-UONOGXRCSA-N,72.0,Cytotoxicity,MTT
CHEMBL3348846,FEXAGRATINIB,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,IC50,4.59,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VRQMAABPASPXMW-HDICACEKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1822210,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,IC50,5.96,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,QFGPLNAQFOAOAP-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL5289444,,O=[N+]([O-])c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.77,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,JJNCKTDZBWDREE-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL228998,,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,IC50,8.5,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-KZULUSFZSA-N,48.0,Unspecified,Unspecified
CHEMBL1652063,,CC(C)CC1=C(OC2(CC(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.96,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QYDYSRCPCQQVAR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652064,,CC(C)CC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.67,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,OIFDRMACNGIEQC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4103914,,CSc1nc(Nc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1,IC50,4.56,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,FJQQPDTVQFJFJW-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL5179338,,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N1CCN(c2cc(-c3cn(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)CC1,IC50,5.82,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,XJAJDOWMQVDEOT-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5191703,,CCNCc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.22,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,AAIHVZUDNKOBAV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1683556,,C#CCN(C)C[C@H](C[C@H]1O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@H]8[C@@H](O5)[C@H]5O[C@H](CC[C@@H]5O[C@H]8[C@H]7O6)CC(=O)C[C@@H]2[C@H]1OC)CC4=C)C[C@@H](C)C3=C)OC,IC50,9.39,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,REPKIIHCLQBBFO-LINFNXQUSA-N,,Antiproliferative activity,Unspecified
CHEMBL222409,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc(F)c1,EC50,7.52,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,HZSQCVIQVSEACA-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3092023,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O)cc2)c(OC)c1,IC50,5.12,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,UBMQFEPVRWEBRN-UHFFFAOYSA-N,120.0,Cytotoxicity,methylene blue staining
CHEMBL4642264,,CCCc1c(C)nc2c3ccccc3oc(=S)n12,IC50,4.96,CHEMBL4617329,Antimigratory activity against human U87MG cells assessed as inhibition of cell migration measured after 6 hrs by scratch wound healing assay,U-87MG ATCC,OEWGFBGGWFYYNM-UHFFFAOYSA-N,6.0,Unspecified,scratch wound healing
CHEMBL2042556,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(N(C)C)c2ccccc12,IC50,7.69,CHEMBL2044174,Antiproliferative activity against human U87 cells after 5 days by MTT assay,U-87MG ATCC,XWCSZMDVKNZVMD-UHFFFAOYSA-N,120.0,Antiproliferative activity,MTT
CHEMBL1241831,,CC(=O)Oc1ccccc1C(=O)Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,IC50,5.09,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,VDQXNBDUQMASBI-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL166173,,O=C(Nc1ccccc1)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.22,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,XOEACJRWPRVYFO-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL83286,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccc2)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,AGFRIFGJACNPFZ-RFBIWTDZSA-N,,Cytotoxicity,MTT
CHEMBL83200,,COc1cc(OC)c2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZWLSXHYTGYVCSY-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.68,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL1097301,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.69,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MVQBBYMHIJMDSV-FBCWVRNMSA-N,48.0,Cytotoxicity,MTT
CHEMBL1097298,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCCCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.58,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BGQCBRSBPIZVMD-QNKOPLAASA-N,48.0,Cytotoxicity,MTT
CHEMBL3116218,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.17,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BKKCLSKIDFDDGH-FCDQGJHFSA-N,72.0,Cytotoxicity,MTT
CHEMBL3114583,,O=C1C=C(n2cc(CNC3=C(Cl)C(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21,IC50,5.26,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,RPUUVFLDXVKCTF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116438,,COc1cc(N2C(=O)NC(=O)/C(=C\Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)C2=O)c(OC)cc1Cl,IC50,5.47,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PYSDBKNKMBLVPA-NJNXFGOHSA-N,72.0,Cytotoxicity,MTT
CHEMBL4789087,,Cc1ccc(Oc2c(/C=N\CCCCCOc3cc4oc(=O)cc(C)c4cc3Cl)c(C)nn2C)cc1,IC50,5.1,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UYTHBOSJITYGDH-LQNQUEJISA-N,72.0,Antiproliferative activity,MTT
CHEMBL4788103,,Cc1nn(C)c(Oc2ccc(F)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.78,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GHUACRRKNFSTRH-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4742104,,Cc1ccccc1Oc1c(/C=N\CCCCCCOc2cc3oc(=O)cc(C)c3cc2Cl)c(C)nn1C,IC50,5.02,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DOMDKSKJLQRCRN-MNBJERMJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL118201,,O=C1c2nccc(O)c2-c2nccc3ccnc1c23,IC50,5.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,GQWRNDLEPKWUDO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4794646,,CN(C)CCNC(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,5.61,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,OXIICGPNVHPDSH-CAOOACKPSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL1224209,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,NWTSKFFYRKGTAR-OGTXVEBCSA-N,72.0,Cytotoxicity,MTS
CHEMBL118709,,COc1ccnc2c1C(=O)c1ncc(OC)c3ccnc-2c13,IC50,6.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,WZUNGQKHNMOASU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5563749,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.27,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,GIWIRTUVZIJPIP-KCGAXMGVSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL1914726,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4cccnc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.92,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTXWPOABAGXULX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL609566,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12,IC50,6.06,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,XYQNSUIMCBJUCF-MVWRLGRASA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL601898,,O=C(Nc1nonc1NC(=O)c1ccc(I)cc1)c1ccc(I)cc1,IC50,6.0,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,DQBDTCPTGZFPEC-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL4084013,,O=C1/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)CCC/C1=C\c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.5,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GKAZLAVJJMPWTP-UNZYHPAISA-N,72.0,Cytotoxicity,MTT
CHEMBL167864,,CC(C)NC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.95,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,HRTHMRUFYMAULC-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1096754,,Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1,IC50,9.13,CHEMBL1120806,Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA,U-87MG ATCC,QFBYVTZHJZITCY-UHFFFAOYSA-N,0.5,Unspecified,ELISA
CHEMBL352383,,COCC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.75,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,NGWINTPSYNWYMP-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL237676,,Cc1cn(-c2nccc3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)nn1,IC50,6.07,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RCHLTRWNVMJCOU-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL5575173,,N#CC1(C(=O)NCCC(=O)Nc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.84,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SAGAPWLCGLYIQT-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5595450,,CC(=O)C12CC(C#N)(C(=O)NCCc3ccc(F)cc3)C(c3ccccc31)c1ccccc12,IC50,4.53,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,NKMLQGUPJIWQQV-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5597987,,CN1CCN(C(=O)[C@@H]2[C@H](C(=O)O)[C@H]3CC[C@@H]2O3)CC1,IC50,4.59,CHEMBL5587080,Cytotoxicity against human U-87 MG cells incubated for 48 hrs by CCK8 assay,U-87MG ATCC,JUQMLSGOTNKJKI-ZRUFSTJUSA-N,48.0,Cytotoxicity,CCK8
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,4.79,CHEMBL4037663,Antiproliferative activity against human U87MG cells after 72 hrs in presence of ligustrazine by MTT assay,U-87MG ATCC,VABYUUZNAVQNPG-BQYQJAHWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4100831,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(I)C2=O)nc1C,IC50,5.14,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YTDONUVCMOZIEB-VOTSOKGWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5195215,,O=C(NCc1ccc(F)cc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.47,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,NALIAYSLJPZACM-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL4077885,,C=C(c1ccc(OC)c(F)c1)c1cc(C)nc2ccccc12,IC50,8.4,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,VWVGFUVQWMPTRY-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4078810,,C=C(c1ccc(OC)cc1)c1cc(C(=O)O)nc2ccccc12,IC50,7.12,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,BCDOTASWUFYEJI-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL3353050,,COc1ncc(OC)c2c(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c[nH]c12,IC50,7.05,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,QGMJLQAXMOHHGW-UHFFFAOYSA-N,48.0,Antiviral activity,luciferase reporter gene
CHEMBL220472,SCHWEINFURTHIN E,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,7.66,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,IYHZCJNEODJYKB-DMCZWXATSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL1668101,CORNUSALTERIN H,CO[C@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.73,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,UDSUNACNDRCFFJ-QIBYADRPSA-N,,Cytotoxicity,SRB
CHEMBL2172626,,Cc1nc(N)cc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,6.29,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CLXMPSJHRQXOQT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3339356,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.38,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DSPINUQBRPPQOY-QLQYKETESA-N,72.0,Antiproliferative activity,MTT
CHEMBL113387,,O=C1c2nccc(Cl)c2-c2nc3ccccc3c3ccnc1c23,IC50,7.7,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,LWXZWXHVVUIXRN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL386796,,O=c1c2cccc3c2sn1CCCCCOc1cccc2nc(O)c-3nc12,IC50,7.52,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,FJXIQAFPONNXHI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL320502,,CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.96,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JOMKXVYAEOFACX-WGPBWIAQSA-N,,Unspecified,Unspecified
CHEMBL3409458,,CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(C(=O)N4CCC(N5CCCCC5)CC4)cc3Cl)ncc21,EC50,5.43,CHEMBL3412560,Inhibition of IL6 secretion in LPS/IL-1beta-stimulated human U87 cells compound pretreated for 30 mins before stimulation measured after 24 hrs by ELISA,U-87MG ATCC,HVBMWPMWGDVORK-UHFFFAOYSA-N,0.5,Unspecified,ELISA
CHEMBL3335772,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6ccc(F)c(Cl)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.82,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,CVZILHDMXKUPHK-QHCPKHFHSA-N,72.0,Cytotoxicity,WST8
CHEMBL5399070,,COc1ccc(-c2ccc3[nH]c(=O)c4cnn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.9,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RSCTXUZWVYMQTL-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL5406944,,COc1ccc(-c2ccc3[nH]c(=O)c4ncn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.35,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,FAXQWGUHCYAKEC-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL5417476,,COc1ccc(-c2ccc3[nH]c(=O)c4ncc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.41,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,QXWITEPIWDRHEN-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL4534595,,COc1cc(CNC(=O)Nc2ccc([N+](=O)[O-])cc2)ccc1O,IC50,4.01,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,QTLCSBBNMYNBKP-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,6.39,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N,132.0,Antiproliferative activity,CCK8
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.51,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N,132.0,Antiproliferative activity,CCK8
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.5,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N,132.0,Antiproliferative activity,CCK8
CHEMBL5620107,,CCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.01,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,ZWJZSZVFRGWKLP-BHVANESWSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618555,,CCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.72,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,RZJVZXFLQUKHCG-YTTGMZPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL1630322,,C=C1C(=O)O[C@@H]2/C(=C/CC(=O)O)C(=C(C)C)CC[C@@H]12,IC50,4.79,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MUEPVYYLPOSULF-XZWPSAHASA-N,72.0,Cytotoxicity,MTT
CHEMBL3780205,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccc(O)cc5)cc4c32)cc1,IC50,4.53,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,OFZVYEGTPNVALW-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3780458,,O=c1oc2ccc(-c3ccncc3)cc2c2c1[nH]c(=O)n2-c1ccccc1,IC50,4.41,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,WXUKICABEMHKCO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3779950,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1,IC50,4.48,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,MZIDWHSBLDVVHO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3357876,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C(F)(F)F,IC50,6.84,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,DDKMFSTVGYJPSR-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357866,,COc1ncc(Nc2ncc([C@H](C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.58,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFMMTRCKHHKIJM-QMMMGPOBSA-N,2.0,Unspecified,cell-based
CHEMBL353435,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCCO,IC50,4.63,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,FQDACYMEFXKAFU-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3359308,,C/C(=C/CCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.46,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,PXLZXXWHUHFIPW-SXDXVQSQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359310,,C/C(=C/CCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.78,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,IJBKYXUBTDMCDR-JOUREUQLSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359311,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.5,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZLXZHBUQHPKAMH-QUMRLDBXSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1669124,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.56,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,VKYVIIIEJKSVBR-XHJPDDKBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.42,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4287065,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)c2cn(Cc3ccc(OC)c(OC)c3)nn2)cc1,IC50,6.01,CHEMBL4423095,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,HPNCRJJSTODGJI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3400386,,CCCCc1ccc2nc3ccccc3c(NCc3nc4ccccc4[nH]3)c2c1,IC50,5.54,CHEMBL3407283,Antiproliferative activity against human A172 cells after 48 hrs by MTT assay,A-172,OUWVEIMVADFGIW-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL50835,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,6.96,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,LNHWXBUNXOXMRL-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3360267,,O=S(=O)(Nc1ccc([O-])cc1)c1ccc(-c2ccccc2)cc1.[K+],IC50,4.9,CHEMBL3388460,Antitumor activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HKLWSXOMLXBWDQ-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL3343365,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WRZNQISIWPZWOM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343366,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.07,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZISGDYRMAXEPZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343374,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKCPOJBMNFSPJK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL487911,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)C=C(O)C(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.7,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,DHKMDDSMHOBYDQ-OSLPSIGMSA-N,48.0,Cytotoxicity,MTT
CHEMBL464006,MORUSIN,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,4.62,CHEMBL3802627,Cytotoxicity against human T98G cells assessed as reduction in cell viability after 24 hrs by MTT assay,T98G,XFFOMNJIDRDDLQ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4454011,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/OCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,4.85,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,IUYDZEFUPRODML-AWDRCZFNSA-N,24.0,Unspecified,compound washout and further incubation for 48 hrs in presence of serum by MTT
CHEMBL3337799,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.04,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,HCRCCVMNNUECQD-QXUSSCGESA-N,,Cytotoxicity,MTT
CHEMBL85538,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,WBXLVMDMTJKREJ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL3415684,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CCC)c(C)c21.[Br-],IC50,5.92,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,IHMHMQUODBBECO-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL3415680,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CC)c(C)c21.[Br-],IC50,4.96,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,RAYVZVFRTKZJNC-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL3415679,,CCCOc1ccc2c3cc[n+](CCC(C)C)c(C)c3n(CCC)c2c1.[Br-],IC50,5.4,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,IIMDYFGKRXUJCI-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL418997,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1,IC50,8.24,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,RYDCEMWPUOVZIA-PJJLUWSFSA-N,,Unspecified,Unspecified
CHEMBL4754210,,CCN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1cccc(C)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ISQIHGOFCXLDAB-CCEZHUSRSA-N,72.0,Cytotoxicity,MTT
CHEMBL590522,MAHANINE,CC(C)=CCC[C@H]1C=Cc2c(c(C)cc3c2[nH]c2cc(O)ccc23)O1,IC50,5.16,CHEMBL2405049,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTT assay,T98G,UKLOEFBVUZOVRX-INIZCTEOSA-N,48.0,Cytotoxicity,MTT
CHEMBL4757229,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(OC)cccc2C3=O)[C@H]1C(=O)OC,IC50,5.05,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,WBMXRYALFPXLMA-UCPUWLPESA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL4762286,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](C)O1,IC50,6.22,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,JLYYHMATMXHAJD-MUSIKMTQSA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL4757173,,CCC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C,IC50,4.28,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,CTEADNNPWMCNAC-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL2441799,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,6.13,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZOOITGLKRZNSBM-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441794,,COc1cc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,5.99,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KJJFHHZWHXEKEA-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441791,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.4,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,BMOBWMUJOHKEJL-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441788,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.16,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,SPFUMQIYKBQJSC-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL244395,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2Cl)n1,IC50,7.72,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,RUCJHTMNODDPBP-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL243976,,c1cc(Oc2ccc(-n3ccnc3)cc2)nc(Oc2ccc3c(c2)OCO3)c1,IC50,7.11,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,QRKJIRHWSXRMDL-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL390674,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2)n1,IC50,7.05,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,QQBNDYARFVOEGW-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL1610540,,CCOC(=O)c1[nH]c(C)c(C(=O)c2ccc(C)cc2)c1C,EC50,6.28,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RATCNKNLRDSESL-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121284,,COc1ccc(Cl)cc1C(=O)N1CCN(c2cccc(Cl)c2)CC1,EC50,6.77,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XBTHMXPSSTYETL-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1424468,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccco1)C2,EC50,6.17,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LAYLXGGTNSMQEK-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1448054,,COC(=O)c1[nH]c2c(c1C)C(=O)CC(c1cccs1)C2,EC50,6.39,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,JOTFIWPTFIQSLQ-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121276,,NC(=O)c1ccccc1NC(=O)c1cccnc1N1CCCCC1,EC50,5.99,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LUUYUIANPCXSFW-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,8.2,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914718,,COCCNc1ccnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,5.99,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FQTRTFZRCVMEKM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914722,,CC(C)N1CCN(c2ccnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc23)CC1,IC50,7.55,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,SHLRNAMEMGGTKI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914723,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccccc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.87,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ANJMEARDENWYPS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914724,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccncc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.75,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,GHYIOUMBYNIERQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914731,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCC4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.55,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CFKJAZFCOSGTBJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914741,,COC1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1,IC50,7.34,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,AKUBJNKMQOIYPV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4757158,,COC(=O)c1ccc(-c2cccc(C3N(C(=O)OC(C)(C)C)CCC34C(=O)Nc3ccccc34)c2)cc1S(C)(=O)=O,IC50,4.88,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,CSIIUZYJPVSIJG-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL4797369,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(Nc2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.22,CHEMBL4686887,Antiproliferative activity against human A 172 cells measured after 7 days by CCK8 assay,A-172,YIKYKYFYFWNCSE-PDDLMNHVSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL5291472,,OC1CC2CC1CN2c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,5.48,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ZMOMHLVVLVGMBV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5549872,,N[C@@H]1CN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C[C@H]1N,IC50,5.41,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,RKAHXFSNPPPOIR-HUUCEWRRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5566259,,CN1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)CC1,IC50,4.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,SCUPZUNLIPGWSZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5590031,,NC1CCCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,5.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,MBZPJHXHLMKCLE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2037442,,C/C(=N/NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.51,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PMHTWYVKIPHSFS-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL282346,,C/C(=N\NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.17,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VHVSCHSQNUUXNS-GZTJUZNOSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037339,,CC(=NNC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.23,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,KRCPOZLWYUZVBS-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037445,,C/C(=N/NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.77,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,KRCPOZLWYUZVBS-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037439,,C/C(=N\NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,7.16,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NPHJRKXEZJAUIL-LICLKQGHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037437,,C/C(=N\NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,8.0,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,RLHHYLRHRGHQLT-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037337,,CC(=NNC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.75,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VCKFVZSNSWYSKQ-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2419669,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,8.01,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PSTHAQGLUUIJDB-CHSHITCJSA-N,72.0,Cytotoxicity,MTT
CHEMBL2419656,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.72,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CBLOATFLKZWZOJ-QLQYKETESA-N,72.0,Cytotoxicity,MTT
CHEMBL168896,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN1CCCCC1,IC50,4.29,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,PBHONWPIGUOEOK-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.72,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,GKFPROVOIQKYTO-UZLBHIALSA-N,,Growth inhibition,Unspecified
CHEMBL5186278,,CC(C)[C@@H]1[NH2+][B-](c2ccc(F)cc2F)(c2ccc(F)cc2F)OC1=O,IC50,4.31,CHEMBL5105180,Anticancer activity against human LN-229 cells assessed as cell growth inhibition by trypan blue exclusion assay,LN-229,HSYNFCMJBFKUBL-INIZCTEOSA-N,,Anticancer activity,trypan blue exclusion
CHEMBL5202359,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2-c1ccoc1)OCO3,IC50,7.72,CHEMBL5109659,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LQMZOEHJTWUPAV-VWLOTQADSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4752065,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccccc2)n1,IC50,4.54,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VOOMANZTSOAVDY-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4791731,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(OC)c(OC)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.9,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KZQXVJIAETXXPM-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4748897,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)nc(N)c2C#N)cc1,IC50,4.98,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VVCBTDSTDBUAPK-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL106767,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1,IC50,8.4,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JLFLNZCJUVHUGI-XLVZBRSZSA-N,,Unspecified,Unspecified
CHEMBL5178989,,Cc1c2ccncc2c(/C=C/C(C)NC=O)c2c1[nH]c1ccccc12,IC50,5.9,CHEMBL5127175,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,GDXOPVJOVKTUOE-BQYQJAHWSA-N,48.0,Antiproliferative activity,SRB
CHEMBL4763211,,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@]1(C)[C@@H]3C(=O)C(O)[C@@]2(C)[C@H](c3ccoc3)C[C@H]3O[C@@]312,IC50,7.42,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,PUNWVWPDKCBXSA-GVRQUNDGSA-N,,Cytotoxicity,SRB staining
CHEMBL4789549,,CC(=O)OC1C(=O)[C@@H]2[C@@]34COC(O)[C@@](C)([C@H](OC(C)=O)C[C@@H]3O)[C@@H]4C[C@@H](O)[C@@]2(C)[C@@]23O[C@@H]2C[C@@H](c2ccoc2)[C@]13C,IC50,7.92,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,NAHTXVIXCMUDLF-XZEUDTBOSA-N,,Cytotoxicity,SRB staining
CHEMBL236603,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CO)nn3)nccc12,IC50,6.6,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BDDVJFSVJBPFPK-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238108,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ccc(F)c12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,AULYZZBYQNKBBN-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392491,,O=C(c1ccccc1)N1CCN(S(=O)(=O)c2c[nH]c3ncccc23)CC1,IC50,4.66,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LYBYVBOJVKMYLY-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240476,,Cc1ccc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)[C@H](C)C2)s1,IC50,5.64,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,FWSUSEHQAWXGOT-GFCCVEGCSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL106468,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1,IC50,8.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KCYWZQVQSDYWBO-XLVZBRSZSA-N,,Unspecified,Unspecified
CHEMBL5572298,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccccc1,IC50,6.05,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,UCKRTNLJGZCCDX-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL2282592,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(Cl)cc1,IC50,5.09,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,VTGDHSHQGSHPOQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL3612312,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.44,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,NQYTWDAPGKHQPL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612316,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(C)cc4)c3)cc2s1,IC50,6.44,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DKBCPMBCYKHNCR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612317,,COc1ccc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cn1,IC50,5.14,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,BERLCZAODRNRRR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4750472,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc(Cl)c(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.19,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NEGLWDUVROZELR-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4795290,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccccc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.24,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,AVABUZCXDGOVNX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4759883,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4cccc(OC)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DXIRCPPLBMVXNK-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4751620,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(Cl)cc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.34,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,CNNVTNOOYHRZTH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4742679,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccc(Cl)cc2)n1,IC50,4.97,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,CMCDHSYDVQJOGE-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5567409,,NCCCNC(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.41,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,JOYQHIYMPYOIJV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL229628,,O=C1C(=O)c2c(nc3c(C(=O)O)cccn23)-c2ncccc21,IC50,7.02,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,CYMAHFSGLPYKLW-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL229726,,Cc1ccc2nc3c(nc2c1C)C(=O)c1cnncc1C3=O,IC50,7.89,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,WTCLTDFCKVIELS-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL375723,,CCOc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.54,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,VAHWWNLOLGHDEX-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL4450265,,CCOC(=O)C(=O)CSC(=S)N1CCN(C(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)CC1,IC50,5.94,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,SOJDTXKJCFQTHK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL229682,,Cc1cnc2nc3c(n2c1)C(=O)C(=O)c1cccnc1-3,IC50,6.42,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,PAMCROMTZDXCEV-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL4472710,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(CO)c(Br)c2)c1,IC50,4.69,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,LFVVIVJGWWBLKR-VMPITWQZSA-N,72.0,Cytotoxicity,MTT
CHEMBL4513992,,N#Cc1cccc(/C=C/C(=O)c2ccc(B(O)O)cc2)c1,IC50,4.7,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,TXAAMGTWMYWEKM-RUDMXATFSA-N,72.0,Cytotoxicity,MTT
CHEMBL4289953,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(C)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.7,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VWFWRGHAKIARPG-FVNYYNFCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4281496,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(C(=O)N(C)C)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.45,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,WDLHBILECKVIQB-QRPJZNGTSA-N,72.0,Antiproliferative activity,MTT
CHEMBL563939,,C=C1C(=O)O[C@H]2[C@H]1CC/C(CO)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.2,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BAURYGOYSLZFPX-OOCKOLEWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL331562,,COc1cc(OC)c2c(n1)C(=O)c1nccc3ccnc-2c13,IC50,5.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,LPXZPIDBMLWYEL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4214832,,O=C(c1sc(N2CCOCC2)nc1-c1ccccc1)c1cnc2ccccn12,IC50,4.31,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,GBPLYOGNUSFBQU-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL4213059,,CCOC(=O)c1c(Nc2ccccc2)sc(C(=O)c2cnc3ccc(Br)cn23)c1C,IC50,4.35,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,NZASTSOWNIDXGJ-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL4636044,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cc3)cc2)n1,IC50,4.81,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ABPYUTLLWASPRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL84615,,COc1ccc(-c2cc3cccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,HKAWJXBQZFSPAP-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL512404,"6,7-DIHYDROPHOMOPSOLIDE B",C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CC[C@H](O)[C@H](C)O,IC50,4.77,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,ZFVYHTGRRBKBJE-BUEHMHBYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5432753,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,4.59,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,DVDRXPZWLYMDAV-RUZHBQKASA-N,48.0,Unspecified,CCK-8
CHEMBL3343380,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LSMQAIIXZQNXQM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3353052,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)C5=CCCCC5)CC4C3)c12,IC50,8.7,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,LKQWIKPNCGJODX-UHFFFAOYSA-N,48.0,Antiviral activity,luciferase reporter gene
CHEMBL1088479,,Oc1ccc(CN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.14,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,NQZPXVDZVBQIMG-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL3765717,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc3c2OCO3)nn1,IC50,4.87,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NKQQRAOWVIRWMW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3764489,,COc1ccc(OC)c(Cn2cc(CN3C(=O)c4ccccc4Nc4ccccc43)nn2)c1,IC50,4.51,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVXVAXXSEOPHNV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3765034,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc([N+](=O)[O-])c2)nn1,IC50,4.41,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WPNXOFYHYZPMFX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1727312,,O=C1Nc2ccccc2Nc2ccccc21,IC50,5.05,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KVVFXAAMMFTLGN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL589334,,O=C(Nc1nonc1NC(=O)c1ccc(Cl)c(Cl)c1)c1ccc(Cl)c(Cl)c1,IC50,4.62,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,DTRWBMYIPKRKIG-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL590060,,O=C(Nc1nonc1NCc1ccc(C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1,IC50,4.74,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,PWTGEUJARMSQJL-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL589654,,O=C(Nc1nonc1NC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,IC50,4.85,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,KMLMFVHYNPHSKD-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,5.63,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3310803,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(C)=O)sc3n2)cc1C(N)=O,IC50,4.66,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CLWBLMPJCULBNA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3310595,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(C)=O)sc3c2)cc1C(N)=O,IC50,5.32,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOEINCOGUSOUGJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL510689,,CCCCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.08,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,CNHTXGFKRXLTSK-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL455692,,O=C1NN(c2ccc(Cl)cc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.6,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,LQYHJDXUKCOVHT-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1095526,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccc(Br)cc3)nn2)[C@H]1Br,IC50,5.63,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NZVSQWCKQJGRFR-PGRDOPGGSA-N,72.0,Cytotoxicity,MTT
CHEMBL3819467,,COC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C,IC50,6.81,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,ABYIXBHLPAQXPA-GMAHTHKFSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL3823904,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(C)ccc1O,IC50,4.53,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JTPRTYHCGQWTIQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3822526,,Cl.O=C1C(O)=C(C(NCc2ccccn2)c2ccccc2)C(=O)c2ccccc21,IC50,4.87,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BUOKVJTXDXBLGW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3818934,,CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)C(C)C,IC50,7.11,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,SWTHVLJASKSMJY-RTFZILSDSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL3808804,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(Cl)cc4)n3)ccc21,IC50,5.24,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,QLNWHUKZRAWJTQ-OEAKJJBVSA-N,48.0,Cytotoxicity,MTT
CHEMBL3819416,,CCOC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,7.93,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,TXTXUJCZFZSISJ-SVBPBHIXSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL1927620,,COc1ccc(Nc2cc3c4c(cccc4c2)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.6,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SSEXKCGUQBIZQI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4757657,,CC(=O)c1nc(C(=O)NCCc2ccccc2)cc2c3ccccc3n(C)c12,IC50,5.13,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,IXLQKNHMXNZJEX-UHFFFAOYSA-N,,Antiproliferative activity,SRB
CHEMBL4791630,,COc1cc(/C=N/OCCc2ccccc2)nc(-c2ccccn2)c1,IC50,5.19,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,QYSCAYMWRYGKNI-PXLXIMEGSA-N,,Antiproliferative activity,SRB
CHEMBL242273,SAFROLE,C=CCc1ccc2c(c1)OCO2,IC50,4.49,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3823206,,O=C1C(O)=C(C(NCc2ccccc2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.64,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SXDWAISNZRQGAJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3824072,,O=C1C(O)=C(C(NCc2ccco2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.63,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SZWJGUXSXYDHPK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823672,,O=C1C(O)=C(C(NCc2ccco2)c2ccccn2)C(=O)c2ccccc21,IC50,5.48,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PRKREBUEXHLVHP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823768,,Cl.O=C1C(O)=C(C(NCc2ccco2)c2ccccc2O)C(=O)c2ccccc21,IC50,5.75,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MXHHMVOMUIHVFM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL577771,,CC(C)COC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.47,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZZLALCFNNDPTFZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL576075,,CC1(C)OC2c3ccccc3C(=O)C(=O)C2C1Nc1ccc(Br)cc1Br,IC50,5.74,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WSVMBURZMWMWQM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3765812,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccccc2)cc(OC)c1OC,IC50,5.77,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,QBILAUSHKIMZES-QGOAFFKASA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL3618232,,CCOc1ccc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cn1,IC50,6.64,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,GGFHCTGTQGWFGO-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3618243,,COc1ncc(Nc2nc3ccc(N4CCN(C(=O)N(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.7,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,DSSCANDYWLGILC-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3765648,,C#CCN1C(=O)c2ccccc2Nc2ccccc21,IC50,4.65,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FGTQLWWGYPNADS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4465698,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.17,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QXCIEDZGQFZJML-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4573769,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.11,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UKGBKCFHDNJRLB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4562600,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(F)cc3s2)cc1,IC50,5.05,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AJOGVWDWLQQQOQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5630503,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccccn1,IC50,5.28,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,FWVDWLZTKCLROH-SDNWHVSQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630721,,N#Cc1cccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)c1,IC50,5.21,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SNEVTNDOJSNZIN-SDNWHVSQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5629880,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccsc1,IC50,5.07,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,TVQDBFXSSPGEQE-DHZHZOJOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL593789,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](N)CC[C@@H]12,IC50,4.72,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,QZHNTBOWRLWTGQ-SSTWWWIQSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL2152488,,CCCC(=O)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,IC50,5.41,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,WVNHYQZOJMNKPX-YMILTQATSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3588940,,CCC(=O)OC/C=C/c1ccc(OC(=O)CC)c(OC)c1,IC50,4.54,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PSICOQVXYUXPFH-VOTSOKGWSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL2435996,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.75,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JHPYVZOWKUWFIK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435986,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.17,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HSAFYPRFIPETBQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL509032,TAE-684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,4.59,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,QQWUGDVOUVUTOY-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1224212,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](N)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,WCGACJRBLKTESN-ROUWMTJPSA-N,72.0,Cytotoxicity,MTS
CHEMBL1224276,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.43,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,HIGZHNZNMNPJGR-VFUWXHBOSA-N,72.0,Cytotoxicity,MTS
CHEMBL1224277,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,KSWVGOVMAMCCSP-CIKSYDIPSA-N,72.0,Cytotoxicity,MTS
CHEMBL3114585,,CC1(C)CC(Nc2ccc([N+](=O)[O-])cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.22,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,XCOQGXREIJCFKD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116233,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)cc5F)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RHUAFKWPDLSXRB-HIXSDJFHSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116226,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.24,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MNIXGYJFGPTMQH-FCDQGJHFSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343408,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@@](=O)(c3ccccc3)[C@@H](O)[C@H]2O1,IC50,4.87,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-DTNCKUBDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3116441,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.91,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DBSGJIPIKKIBIF-YYADALCUSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343416,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc([N+](=O)[O-])cc3)[C@H]2O1,IC50,5.51,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,IHWLXVIGVQBSQG-KYGNLPSGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3116242,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZNTNQMVEAXDENP-HPNDGRJYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1668102,CORNUSALTERIN I,CO[C@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@@]12C,IC50,4.91,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WISSQECJGFKWLU-NBCACCRGSA-N,,Cytotoxicity,SRB
CHEMBL1668105,CORNUSALTERIN L,CC(C)=C[C@@H]1C[C@@H]([C@@H]2CC[C@]3(C)C4=CCC5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)CO1,IC50,5.24,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WAGHSYJXJAHWPX-DYRFBARISA-N,,Cytotoxicity,SRB
CHEMBL4760225,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CC(O)C3)n2)cc1,IC50,5.88,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,PLUFCDKZJSBUCF-YIXHJXPBSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL3339353,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(OC(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.35,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,APJOVJKWLATWSU-LALXJTNGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339358,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.09,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MYCWVKJMXJUBHH-QLQYKETESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339359,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(OC(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.48,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OLLYZHAQVQRWOV-LALXJTNGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339364,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccncc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.3,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MAQWJQFILIDGFF-XICOUIIWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5287724,,Cl.O=c1oc2ccc(Br)cc2c(Cl)c1-c1nc2cc(C3=NCCN3)ccc2[nH]1,IC50,4.39,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,RKAKZAJBOJDWAM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL5266539,,Cc1ccc2oc(=O)c(-c3nc4cc(C5=NCCN5)ccc4[nH]3)c(Cl)c2c1.Cl,IC50,5.04,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,DWBBQVKIFZYNLH-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL5266313,,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.2,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,OJTTZZCPHGUDDM-KVVVOXFISA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL374319,,O=C(CC1CN(C(=O)Nc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.06,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,FYPLQLJHWZUXDJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL411343,,O=C(CC1CNCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.26,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVRGDTHDSIEZRY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5400611,,O=[N+]([O-])c1ccccc1S(=O)(=O)N1c2ccccc2Sc2ccc(Cl)cc21,IC50,5.29,CHEMBL5345086,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,LADLBLLULGLYTQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5563702,,COc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1OC,IC50,5.31,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,NBCPRDXMNXGMJJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL2037139,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.27,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,MXLWCPNGFWKHOW-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.21,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YQNRVGJCPCNMKT-LFVJCYFKSA-N,,Growth inhibition,Unspecified
CHEMBL5275244,,C/C(=C\CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,IC50,4.65,CHEMBL5225164,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,CCEWBVIQKCUYJV-WOJGMQOQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL477772,PAZOPANIB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,4.35,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CUIHSIWYWATEQL-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,4.93,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,PLHJCIYEEKOWNM-HHHXNRCGSA-N,,Growth inhibition,Unspecified
CHEMBL102714,SB-216763,Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21,IC50,4.63,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JCSGFHVFHSKIJH-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,5.4,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,OGNYUTNQZVRGMN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL209148,,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1,IC50,5.15,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ZHXNIYGJAOPMSO-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1256459,TORIN1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,IC50,7.2,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AKCRNFFTGXBONI-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.11,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,BMGQWWVMWDBQGC-IIFHNQTCSA-N,,Growth inhibition,Unspecified
CHEMBL5422449,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc([N+](=O)[O-])ccc32)cc1,IC50,4.63,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,DFAFUDAUZSLLOV-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5396541,,Cc1cc(Cc2cn(C(=O)c3ccc(N4CCOCC4)cc3)c3ccccc23)cc(C)c1O,IC50,4.9,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,OPTKSQIHKUVTLN-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5409597,,Cc1cc(Cc2cn(C(=O)c3ccc(N4CCN(C)CC4)cc3)c3ccccc23)cc(C)c1O,IC50,5.25,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,UTYASBSXPIEEBV-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5277464,,C/C(=C\CN1CCN(C(=O)C2CCCC2)CC1)c1ccccc1,IC50,7.95,CHEMBL5225165,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,NRJLQONGQFSUJQ-GZTJUZNOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5274257,,c1ccc(Cn2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,5.09,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,TZZYVYSPVJUUAS-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL5284548,,COc1cccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)c1,IC50,4.57,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,COGKKBFAXIHFCH-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL5288388,,CCCCN(CCCC)c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.83,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,UFPJMBOLQATAPQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4871938,,CC12CC3CC(C)(C1)CC(NCc1ccc(NC(=O)CCCCCCC(=O)NO)cc1)(C3)C2,IC50,5.53,CHEMBL5138196,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition,U-87MG ATCC,WLSVOCQBROCUNL-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5180973,,C[C@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6CCC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@@H](O)[C@@H]1O,IC50,4.3,CHEMBL5141038,Cytotoxicity against human T98G cells assessed as cell viability,T98G,JEFAXHDYQYKEJF-PCRCQVQCSA-N,,Cytotoxicity,Unspecified
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.79,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MIDUFIRTIFUTQA-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1923234,WP 1066,C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,IC50,5.25,CHEMBL1925866,Antitumor activity against human U87MG cells after 24 to 72 hrs by MTT assay,U-87MG ATCC,VFUAJMPDXIRPKO-LQELWAHVSA-N,72.0,Unspecified,MTT
CHEMBL2180738,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,IC50,6.54,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,RJMFNCWCWHLUKE-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL2206921,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,7.62,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,KLMZZLVCEDUTEA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4452490,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,5.64,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,MFEBEVDFAFMXRL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4078550,,CC(=O)Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1,EC50,5.8,CHEMBL4008906,Cytotoxicity against human A172 cells assessed as reduction in cell viability after 3 days by Alamar blue assay,A-172,PVFNDFZQGWYILU-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL4096575,,Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1,EC50,5.8,CHEMBL4008906,Cytotoxicity against human A172 cells assessed as reduction in cell viability after 3 days by Alamar blue assay,A-172,ATXGVVQAUKKFAN-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL456237,LXR-623,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1,IC50,5.21,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,KYWWJENKIMRJBI-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL4089188,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.38,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZRKCGJAPYRMUKR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4076472,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(OC(F)(F)F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.91,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SFIKFXAMCYSROC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2088440,,Clc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,4.81,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PQOPXVVBFWJXRY-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL179692,,Cc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,4.0,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,VWGSOKPABCWLQZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3980709,,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cn(C2CCCCC2)nn1,IC50,7.38,CHEMBL4343297,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HYTQLHJUBJETIG-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4285842,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5c4ccn5C)cc3)cc3cccnc32)cc1,IC50,5.29,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XZCWAWCAVJWZRC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4785287,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3CCC(=O)[C@H](C)O3)[C@H](C)O2)[C@H](C)O1,IC50,7.48,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,BUNNANZEUZITRL-KGLUEZTISA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL480881,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.22,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,QOBGUGDUMKZVRC-ZLYZMSFYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL2165024,,COc1ccc(Nc2ncc(C)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.51,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,SZCHCSAKGOOKBA-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL106533,,CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.89,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XTHDDZXLYYZMNX-MHTZHOPKSA-N,,Unspecified,Unspecified
CHEMBL109008,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1,IC50,8.77,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XEXZQYWUVMECQG-VEWQFJOQSA-N,,Unspecified,Unspecified
CHEMBL4757519,,C#CCOc1ccc(/C=C/C(=O)c2cccc(C)c2)cc1OC,IC50,5.75,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,SBSQSTCPERSBLO-CSKARUKUSA-N,72.0,Cytotoxicity,RRA
CHEMBL4788616,,C#CCOc1ccc(/C=C/C(=O)c2ccc(C(C)C)cc2)cc1CC=C,IC50,5.55,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,SZDSTOYHZATNIY-RIYZIHGNSA-N,72.0,Cytotoxicity,RRA
CHEMBL3233842,,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,IC50,7.26,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,PUOOCZVRHBHJRS-NSHDSACASA-N,,Unspecified,fluorescence based
CHEMBL4640030,,CC(=O)NCC(=O)N1CCC[C@@H]1B(O)O,IC50,6.18,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,UUOZISWTWURDGU-SSDOTTSWSA-N,,Unspecified,fluorescence based
CHEMBL5432925,,O=C(Nc1ccc(OS(=O)(=O)c2ccc(F)cc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.74,CHEMBL5332775,Cytotoxicity against human SF-295 cells assessed as cell growth inhibition,SF295,LLXLLGJJXOHBLG-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL534720,,Cl.Oc1cc2c(cc1O)C(Cc1ccc(-c3ccccc3)cc1)NCC2,IC50,4.99,CHEMBL913226,Cytotoxicity against human T98G cell line,T98G,KBMNQYDZBKKKPH-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL505426,,N=C(N)NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCN)NC1=O,IC50,7.95,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,MFWXFNOXLDIPDQ-YSTOQKLRSA-N,,Unspecified,Unspecified
CHEMBL2372257,,CSCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)CCCCCNC(=O)CC[C@H](NC(=O)COCCOCCOCCNC(=O)c1ccc(F)cc1)C(=O)NCCCC[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(C)C)C(N)=O,IC50,7.86,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,DOYWSGYUIHABGZ-ZKRQTGDMSA-N,,Unspecified,Unspecified
CHEMBL2375478,,CCCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,IC50,4.95,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SJBRGTUWMZZBJW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4862917,,O=C(CCCCCNC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)NO,IC50,5.1,CHEMBL4819318,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BWMRGOQFHBXKQR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5276739,,CCN(CC)c1ccc2cc(-c3nc4ccc(C5=NCCCN5)cc4s3)c(=O)oc2c1.Cl,IC50,5.75,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,UKKQYSJWHJRPII-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL3092921,,C=CCCCCOc1ncc(-c2cc(F)c(F)cc2OC)n1C,IC50,4.28,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,VVEQYBXCZNMQNX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092923,,C=CCCCCOc1ncc(-c2cccc(OC)c2OC)n1C,IC50,4.46,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YQSRFHNQNFWUBY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092924,,C=CCCCCOc1ncc(-c2cc(Cl)ccc2OC)n1C,IC50,4.32,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,NKWGZVYZEXLKAP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL4635731,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCCC3)cc2)n1,IC50,4.39,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QYAOLXACVZFCGN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4647086,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1,IC50,4.94,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RQMVMSIAPOLUTD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5177050,,O=C(NCc1ccccc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.01,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,UGPZJVXEWINCSS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5194390,,O=C(c1cc2c(F)cc(F)cc2[nH]1)N1CCN(C(=O)C23CC4CC(CC(C4)C2)C3)CC1,IC50,5.18,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,UDCDUUNSNJZOLI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4556790,,Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1,IC50,5.03,CHEMBL4830056,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,U-87MG ATCC,WHVFOLXIIVBJTJ-ICCPGPOKSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4759393,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2ccccc2)c1,IC50,4.64,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HNKXJPOYCMLZTF-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL5517715,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1ccc(OCc2cccc(-c3ccccc3)c2C)c(C)c1,IC50,6.05,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VHEDXODWNHMDGM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4089730,,COc1nc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCNC(C)=O,IC50,5.43,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JEDPSOYOYVELLZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL106982,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1,IC50,8.15,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JYDQSSJQXSQYRG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206912,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)c3ccc(F)cc3)c2)n1,IC50,6.73,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,MUNMOKXVNKEMSH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3116222,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.07,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BZKQEYSSBLBNPN-YYADALCUSA-N,72.0,Cytotoxicity,MTT
CHEMBL2417829,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.62,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SOQLTQJZRHAVGO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417825,,COc1ncc(-c2ccc3nc(NCC(N)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.24,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NKFBDFWZPCTYSY-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417822,,COCCNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.19,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,DMJWWRFOIPKAKG-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417832,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(C)cc4)c3)cn2n1,IC50,5.42,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OQCDYFGZHKFLRD-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4293675,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(Br)cc5F)c4=O)cc3F)ccnc21,IC50,5.19,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ABHROHNOIKXFRR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3353410,OSIMERTINIB,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,5.35,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,DUYJMQONPNNFPI-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4785096,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCN(C)CC1,IC50,5.06,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,UZCSYQJYKYYMFC-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4743685,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1,IC50,5.44,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,GXMXPDYKQYFDRV-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4558324,LAZERTINIB,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,IC50,4.48,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RRMJMHOQSALEJJ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4755027,,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-n3c(C)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.17,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,BKLRUEWKYUHYEW-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL1652072,,CCCC1=C(OC2(CCC)C(=O)C(=O)C3=C(CCCC3)C2=O)C(=O)C2=C(CCCC2)C1=O,IC50,4.94,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FRQWJNQRFLUIDW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652076,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccc(F)cc3)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VLIGWLHULWIRAT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652080,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3cccc(O)c3)[nH]c21,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JXSAPDKRKSXFLK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3792614,,CCc1c2c(nc3ccc(B(O)O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,IC50,7.33,CHEMBL3795470,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,HYJCSFCPRVFVTP-QFIPXVFZSA-N,72.0,Cytotoxicity,SRB
CHEMBL3410528,,O=C1/C(=C/c2ccc(Oc3ccccc3)cc2)CS(=O)(=O)C/C1=C\c1ccc(Oc2ccccc2)cc1,IC50,5.53,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,MDDJCAZXZQKGCV-FQHZWJPGSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3793128,,CC(C)CCOC(=O)[C@H](CC(=O)OCc1ccccc1)NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1,EC50,4.36,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,UQEANUVGLTTYRD-KLSNLWCXSA-N,72.0,Cytotoxicity,MTS
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.61,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NDAZATDQFDPQBD-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL3793546,,NCCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.29,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,PHLHGJXJLNVFHS-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4299292,,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H]2C)c(N)c1=O,IC50,4.64,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,RJURFGZVJUQBHK-XXEICVIVSA-N,24.0,Cytotoxicity,MTT
CHEMBL4754075,,CO[C@@]1(C)N(/C=C\c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.64,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,KQGIOFULIYUITH-XWDDPXMASA-N,,Antiproliferative activity,SRB
CHEMBL4784386,,CC(=O)NC[C@H](OC(=O)c1cc2c3ccccc3n(C)c2c(=O)[nH]1)c1ccccc1,IC50,4.72,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,DPGAFACESYVFJH-FQEVSTJZSA-N,,Antiproliferative activity,SRB
CHEMBL4787536,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,5.46,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PDWKHLVZXHJEBJ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4753387,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N2CCOCC2)CC1,IC50,4.82,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,LGDFMQYYSVNPIA-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4798480,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)ccc1N(C)CCN(C)C,IC50,5.62,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,NUUYIUFDSIHSCZ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL2172483,,COc1ncccc1-c1ccc2nc(Nc3cc[nH]n3)c(-c3nc(C)nc(N)n3)n2c1,IC50,6.29,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,OEYUWZFJYRUVIQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2037443,,C/C(=N/NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.92,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VCKFVZSNSWYSKQ-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037433,,C/C(=N\NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.21,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NOHGJWJQBAAVFP-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL1771488,,C/C(=N\NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.51,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PMHTWYVKIPHSFS-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037451,,C/C(=N/NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.8,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PTOHINKLMXPSKL-YVLHZVERSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037444,,C/C(=N/NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,8.0,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,RLHHYLRHRGHQLT-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037434,,C/C(=N\NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.23,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NRNNRLWHLIPYQW-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL593296,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(Br)ccc2O1,IC50,5.3,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,WVQRNYQXPPQDMD-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3121280,,CCOc1ccccc1C1C(C#N)=C(N)Oc2cc(N(C)C)ccc21,EC50,6.85,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KJDUDNAIMFWPEI-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL2170088,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,9.0,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-UONOGXRCSA-N,2.0,Unspecified,Unspecified
CHEMBL3114588,,CC1(C)CC(Nc2ccc(Cl)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,7.16,CHEMBL4407636,Anticancer activity against human SF295 cells,SF295,MTKBKUDYIJQHSH-UHFFFAOYSA-N,,Anticancer activity,Unspecified
CHEMBL3628030,,C/C=C(/C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.07,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,NPUVRWFJDAPMIA-IIHJLFQTSA-N,72.0,Antiproliferative activity,cyquant
CHEMBL1241156,,CC(=O)Oc1ccccc1C(=O)Oc1ccc2ccccc2c1/C=N/NC(=O)c1cc(-c2ccc3ccccc3c2)n[nH]1,IC50,5.82,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ICQQXCFFGHOVQV-JEPNHJGPSA-N,72.0,Cytotoxicity,SRB
CHEMBL3622408,,Cl.O=C(CNCc1ccc(Cl)cc1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,5.9,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,NFYHBDUZAGMYBX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3941850,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.54,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,QWEQVKBMVKWEOC-KQNUSQPASA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL2164399,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.37,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LTUZKKASTPUPTL-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2165004,,COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)C3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.42,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WGLLEJISTFRVBO-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2178606,,COC(C)(C)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1,EC50,6.42,CHEMBL2186327,Cytotoxicity against human A172 cells incubated for 4 days,A-172,BRCOIQMZYMWNIS-UHFFFAOYSA-N,96.0,Cytotoxicity,Unspecified
CHEMBL2170083,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.15,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SCIVONNAMHTUEH-ZDUSSCGKSA-N,2.0,Unspecified,Unspecified
CHEMBL2170096,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.22,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,HUIOREQGDCWTAK-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2165017,,COc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.8,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,RNTFRUPRTOCGJO-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL4439727,,C=CC(=O)N1CC(OCc2ccc([C@H](C)Nc3ncc4c(n3)N(CC(C)C)C(=O)OC4)cc2)C1,IC50,5.89,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,CXBUALZPMGDWCK-KRWDZBQOSA-N,132.0,Antiproliferative activity,MTT
CHEMBL265129,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(F)ccc2O1,IC50,4.57,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,UVIYGERZPMGKKA-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2037446,,C/C(=N/NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL3775949,,COc1ccc(/C=C2/SC(=S)NC2=O)cc1,IC50,5.02,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,ORGCJYCWFZQEFX-RMKNXTFCSA-N,96.0,Growth inhibition,MTT
CHEMBL2164697,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,7.16,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,NLEJXNYUARRSPP-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL229677,,COc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.19,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JUNIDICBWWHAIV-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL388108,,Cc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.68,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,NNNYJMAMMVVSGX-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL229725,,CN(C)c1ccc2nc3c(nc2c1)C(=O)c1cnncc1C3=O,IC50,7.16,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,YDLWGYKUXASPDB-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL112210,,C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1.O=C(O)/C=C/C(=O)O,IC50,5.28,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,JSJLJATXQGZYCY-WLHGVMLRSA-N,72.0,Cytotoxicity,MTT
CHEMBL334470,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,9.35,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,JWRNDENHFBRQCM-ROUUACIJSA-N,,Unspecified,Unspecified
CHEMBL3359312,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,5.14,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,BNKPHPSLFQUVGS-QUMRLDBXSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2163592,,CC(C)N(Cc1ccc2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccccn1,IC50,4.0,CHEMBL2169673,Cytotoxicity against human LN229 cells transfected with V6R incubated for 3 days under normoxic condition by SRB assay,LN-229,WHQXEGKAFBEKSG-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL2172635,,COc1cnnc(Nc2cc(-c3c(Nc4cc[nH]n4)nc4cccnn34)nc(C)n2)c1,IC50,7.07,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,UNITWMRQPUTNPC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3263220,,OCCCC[C@@H]1[C@H]2CCCN3CCC[C@H](CN1Cc1ccc(Cl)cc1)[C@@H]23,IC50,5.34,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,RRXAVFYUKAUFBY-NMIHRBCNSA-N,48.0,Antiproliferative activity,MTT
CHEMBL447283,,CC1(C)CC(NC(=S)Nc2ccc(Cl)cc2)c2cc(Br)ccc2O1,IC50,4.66,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,XGJJLDUNEIOCCW-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL595929,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(F)ccc2O1,IC50,4.41,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SVXRPXPNIGGEQX-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL593820,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(Cl)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,AXJORAYOMXRLIH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL608379,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(Cl)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,VGYSEYVWIATBOW-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1770165,,C/C(=N\NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.18,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,MXWJIUNQTNDDFG-LICLKQGHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037343,,CC(=NNC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.18,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,MXWJIUNQTNDDFG-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037338,,CC(=NNC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,7.77,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,RLHHYLRHRGHQLT-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037341,,CC(=NNC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.08,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NOHGJWJQBAAVFP-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2164692,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,5.72,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,URPMXKMVEZFGEM-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL4748534,,C=C(CC)C(=O)c1ccc(OCC(=O)NC2CCN(S(=O)(=O)c3cc(Cl)ccc3OC)CC2)c(Cl)c1Cl,IC50,6.51,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,PWCOCTJTFHMKLC-UHFFFAOYSA-N,,Cytotoxicity,CellTiter Glo luminescent
CHEMBL5429646,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(C(=O)NO)cc3)CC1)C2,IC50,4.34,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YCJALAWIBCRZMO-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5568994,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.19,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,ZWQBUSIGZLXUII-ZFRLZFHFSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL5426295,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.29,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,OMRMOMGAFQHZAC-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5432732,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(OC)c(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,6.66,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MJKBNKOQSZEVKD-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5398502,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.67,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,FVBRYQGAGKRSGL-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1613444,,Cc1cc2cc3c(N)[nH]nc3nc2cc1C,IC50,4.41,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,XSYYLQJMAAYYFC-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL1688535,,COc1ccc2cc3c(N)n[nH]c3nc2c1,IC50,5.11,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,QLIPUPSGLWIGAQ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL1800960,,CC[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,7.75,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,KFRXJKMLZFERKO-KSSFIOAISA-N,48.0,Unspecified,Unspecified
CHEMBL1938594,,O=C(NCCCl)NCCN1c2nc3ccccc3cc2Sc2cc3ccccc3nc21,IC50,6.6,CHEMBL4140038,Cytotoxicity against human SF295 cells assessed as cell growth inhibition after 48 hrs by SRB assay,SF295,UHFHGUCGIVHXGO-UHFFFAOYSA-N,48.0,Cytotoxicity,SRB
CHEMBL301311,,COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.58,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,BTAPSFTYZPKJCW-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5279289,,C=C(C)[C@@H]1CC[C@]2(COCC(O)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.[Br-],IC50,5.39,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,KFHYSMGJXBTWHM-HJZPKLIKSA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL5192457,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(Br)cc1)O2,IC50,6.82,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,BVTMADNSDGGGHL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4594201,,CC1(C)O[C@H]2O[C@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@@H](OCc3ccccc3)[C@H]2O1,IC50,6.8,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,LIRLLGKTZVCTNS-XTNHUWDISA-N,,Cytotoxicity,MTT
CHEMBL3116445,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QKLVIKMIZOEFFF-HPNDGRJYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5179999,,O=C(/C(Cl)=N/Nc1ccc(Cl)cc1Cl)n1c(-c2cc3ccccc3oc2=O)nc2ccccc21,IC50,6.54,CHEMBL5126907,Anticancer activity against human U-87 MG cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,VDAFHRPMWNIKGP-OFWBYEQRSA-N,72.0,Anticancer activity,MTT
CHEMBL4644635,,Nc1nc2cc(-c3nn(C[C@@H]4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-JTQLQIEISA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL109479,,O=C1c2nccc(Cl)c2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,7.3,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,FLQFEOXZDIDKQJ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1927621,,CN(C)CCN1C(=O)c2cccc3cc(Nc4ccc([N+](=O)[O-])cc4)cc(c23)C1=O,IC50,6.21,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XYCUZANBIMHLMM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4866726,,COC(=O)N(C)/N=N/c1ccc(COC(=O)Nc2cc3c4c(cccc4c2)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.56,CHEMBL4831081,Cytotoxicity against human A 172 cells assessed as cell viability measured after 96 hrs by XTT assay,A-172,MWXZUPHVAMRLKE-QVIHXGFCSA-N,96.0,Cytotoxicity,XTT
CHEMBL4871205,,COC(=O)N(C)/N=N/c1ccc(COC(=O)Nc2ccc3c4c(cccc24)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.13,CHEMBL4831081,Cytotoxicity against human A 172 cells assessed as cell viability measured after 96 hrs by XTT assay,A-172,ADBGAYOGSASRBL-QVIHXGFCSA-N,96.0,Cytotoxicity,XTT
CHEMBL313545,,CCN(CC)C(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,KQLZYIAOSLOOPH-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL322816,,Nc1ccnc2c1-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,CTMGEBRFAKYRJS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL325556,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.57,CHEMBL815093,Inhibition of the entry of HIV-1 reporter virus (JrF1) into U-87 cells,U-87MG ATCC,LEFAKKLOKFYYJX-QFIPXVFZSA-N,,Unspecified,Unspecified
CHEMBL4634881,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(F)cc3)c12,IC50,4.18,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ZSYPSJVKCHZRCX-MIGQKNRLSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4647532,,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCN(C(=S)Nc4ccc5c(c4)C(=O)OC54c5ccc(O)cc5Oc5cc(O)ccc54)CC3)cc12,IC50,5.82,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,QDRXRSYKXXJICW-MHZLTWQESA-N,,Unspecified,fluorescence based
CHEMBL5426666,,C#CCN(C)CCCOc1ccc(N(CC)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.05,CHEMBL5371253,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,A-172,UGMCCVYCFXAQTN-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL143637,,Cc1ccc(-c2cc3cc(C)ccc3c(N3CCN(C)CC3)n2)cc1,IC50,5.35,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,TUODPWDNYPDJGL-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL355166,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCCOC(C)=O,IC50,6.13,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,ZCASKJBLWLEZOT-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL352762,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCc1ccccc1,IC50,6.55,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,NWJPFGDQFLWPFI-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2087608,ISOJACAREUBIN,CC1(C)CCc2c(cc(O)c3c(=O)c4ccc(O)c(O)c4oc23)O1,IC50,5.02,CHEMBL2091818,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,NNWFEKLCJFLWGN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL84655,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)O)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,ZPHQIWXAIWECJH-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL200735,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Cl)c3)c1C2,IC50,4.62,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,WVDRRFJDEHTKNN-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5404488,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)c(F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.82,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,ZVDVPNBGOJLJEJ-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5422599,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(SC)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.04,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,JVKAPVVHNMBGTI-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5404834,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,IBISTZATJWFWJX-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2398339,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4ccccc4c3)ccc2NS(C)(=O)=O)c1,IC50,7.17,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,DVARQTHXJDZWTD-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5394831,,CCCCCC(=O)Nc1ccc(NS(C)(=O)=O)c(OCc2cc(OC)ccc2OC)c1,IC50,5.69,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MGSJFAMGQGTRTC-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,4.6,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XQVVPGYIWAGRNI-JOCHJYFZSA-N,,Growth inhibition,Unspecified
CHEMBL2088455,,Clc1ccc(Cn2c(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)nc3ccccc32)cc1,IC50,4.87,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OMXAMGVPMDXNHB-JFLMPSFJSA-N,72.0,Cytotoxicity,MTT
CHEMBL1544486,,CC1=CC(C)(C)N(S(=O)(=O)c2ccc(C)cc2)c2cc(C)ccc21,EC50,5.42,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,AVEDXUCTNRSAQE-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121282,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccccc1Cl)C2,EC50,6.35,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,CTDJJVSXAQPXCB-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3120176,,CCN(CC)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccccc1,EC50,6.77,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,VBWFHJWQMXTBJL-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL142215,,Cc1ccc2c(O)nc(-c3ccccc3)cc2c1,IC50,6.12,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,SYYBWJAZROEWQF-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3092931,,CCCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.24,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GCEVVAXRBXSXKN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093019,,C=CCCCCOc1ccc(OC)cc1-c1cnc(OCCC=C)n1C,IC50,4.13,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DKDCXSIOOOQYBD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL5415723,,CNc1ncc2c(C#CCN3CCCC(N(C)C)C3)nn(CC3CCCC3)c2n1,EC50,5.3,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,CLBVQMOKUUQLEK-UHFFFAOYSA-N,120.0,Antiproliferative activity,PrestoBlue reagent based fluorescence
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.92,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,WST-1
CHEMBL3393268,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nc2nccn12,IC50,5.38,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,PMQDLTHWOPLUQZ-UHFFFAOYSA-N,48.0,Antiproliferative activity,WST-1
CHEMBL3289080,,COc1ccc(C(=O)/C=C/c2nccc3c2[nH]c2ccccc23)cc1OC,IC50,5.48,CHEMBL3295157,Cytotoxicity against human A172 cells after 48 hrs by SRB assay,A-172,ZWEQPXSQLZNQEM-CMDGGOBGSA-N,48.0,Cytotoxicity,SRB
CHEMBL76,CHLOROQUINE,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,5.44,CHEMBL3424559,Cytotoxicity against human LN229 cells after 72 hrs by MTT assay,LN-229,WHTVZRBIWZFKQO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290927,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.1,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FQXLTRHUHXXAPR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343385,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YGRLBDZCAHOYME-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1224281,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.8,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,OHVYRRNDSVHUII-MOFGVCBJSA-N,72.0,Cytotoxicity,MTS
CHEMBL1224282,,C=C(CNCCc1ccc(O)cc1)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,PANRNQMMBRCNTO-UJTBAKDQSA-N,72.0,Cytotoxicity,MTS
CHEMBL3116243,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.04,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,STKSFFDICKIQPP-XAYXJRQQSA-N,72.0,Cytotoxicity,MTT
CHEMBL3114421,,CC1(C)CC(Nc2cccc(Br)c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.06,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,YBHFKMJUPJENGZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2375473,,CC1(C)CC(n2cc(C3CCCCC3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,4.95,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,BSUBEHCTPVPWOF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL8953,,COc1cc(C(=O)c2cc(Cl)ccc2N)cc(OC)c1OC,EC50,7.05,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XNXGUYDYCYSOCU-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1587877,,COc1ccc(S(=O)(=O)N2CCOc3ccccc32)cc1,EC50,5.88,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,QXCCHJXFTBHROS-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121286,,COc1cccc(N2CCN(C(=O)c3cc(C)ccc3OC)CC2)c1,EC50,6.57,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RWRCJPVSRQMKLP-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL225066,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccccc1,EC50,6.92,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FONUMHBHOAHTAW-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121277,,Cc1nc2sccn2c1-c1csc(Nc2ccc(N(C)C)nc2)n1,EC50,6.66,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XSAVJZHRGLMFMA-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3609563,,CCSC1CC2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.73,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,JPXPYTUOLLHURR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.83,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,,Growth inhibition,Unspecified
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,4.81,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,VAVXGGRQQJZYBL-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2088441,,Fc1ccccc1Cn1cc(/C=N/Nc2nc(N3CCOCC3)c3sccc3n2)c2ccccc21,IC50,4.65,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDFJQBTXFHWRJT-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL2035485,,O=c1c2ccc(F)cc2[se]n1CCn1[se]c2cc(F)ccc2c1=O,IC50,4.9,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NVKLMJZXBQGXPP-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4286454,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(Br)cc5)c4=O)cc3F)ccnc21,IC50,5.59,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OPQWJKPTIPCBSL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4286245,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)c(Cl)c2)c1=O,IC50,5.28,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JRXNQABRFABFMW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4285130,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5[nH]ccc45)cc3)cc3cccnc32)cc1,IC50,5.63,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BGBQCPAAOWLCJT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1224366,,C=C(CNCCc1ccc(O)cc1)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.22,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,MGTNLRRVXNVYSH-JEMCJYJNSA-N,72.0,Cytotoxicity,MTS
CHEMBL3781565,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.49,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FBMOENFWKWSJIY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1224280,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCOC)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.42,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,BVLCLVPVXUSVRE-WAEOCRLMSA-N,72.0,Cytotoxicity,MTS
CHEMBL3780204,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1,IC50,4.46,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LZKZPMTXIDEEQT-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL4285631,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(F)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,BASABKRMOALIDI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4739941,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccccc1F,IC50,5.08,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UPYOSHFKFXBBIV-BUHFOSPRSA-N,72.0,Cytotoxicity,MTT
CHEMBL3793469,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.75,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,KVYCFVZPOXFXOY-VTYCOLDWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3983705,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2nncc2-c2ccccc2)[C@H]1Br,IC50,5.8,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,FWRWLRSWPAAQJB-PGRDOPGGSA-N,72.0,Cytotoxicity,MTT
CHEMBL4649216,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4Cl)cc3)n2)cn1,IC50,4.35,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RGSKRIMCTMBWCH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL221190,DIPHYLLIN,COc1cc2c(O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,IC50,4.58,CHEMBL5258260,Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis,U-87MG ATCC,VMEJANRODATDOF-UHFFFAOYSA-N,24.0,Cytotoxicity,Unspecified
CHEMBL4470548,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.82,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RYIJKZMXBBDLBU-SFQUDFHCSA-N,72.0,Cytotoxicity,MTT
CHEMBL596991,,NC1(Cc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,IC50,8.34,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,KOBAABHHGSLFGF-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL597415,,NC1(Cc2c(Cl)cccc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.85,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,XYWQNCIEXBPHRJ-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL598194,,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.77,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,XQPFDQVEBGYLHB-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL3092932,,CCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.02,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,PEWMWQRZPWEVSB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093029,,Cc1ccc2c(c1)-c1cnc(n1C)OCCCCCCCCO2,IC50,4.2,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,ZJPOKDSLAIVQKM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL2037450,,C/C(=N/NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NPHJRKXEZJAUIL-YVLHZVERSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037448,,C/C(=N/NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.19,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NRNNRLWHLIPYQW-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL1987055,,C/C(=N/NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,9.0,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,QJEQNMXYYQUOAY-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL1630580,,C/C(=N\NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.23,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,KRCPOZLWYUZVBS-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037435,,CC(=NNC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PTOHINKLMXPSKL-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037447,,C/C(=N/NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.08,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NOHGJWJQBAAVFP-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037344,,CC(=NNC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,7.16,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NPHJRKXEZJAUIL-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL1867591,,CC(=NNC(=S)Nc1ccccc1)c1ccccn1,IC50,8.85,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VHVSCHSQNUUXNS-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL586702,ZSTK-474,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,7.5,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HGVNLRPZOWWDKD-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL473417,VISMODEGIB,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,IC50,4.43,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BPQMGSKTAYIVFO-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL3954793,,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@@H](N)CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCNC(=O)c1ccc(B(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,5.14,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,VULIYGLYBQXDJR-SHAJCIBYSA-N,1.0,Antiviral activity,viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24
CHEMBL5423568,,C#CCN(C)CCCOc1ccc(N(C)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.46,CHEMBL5371250,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,U-87MG ATCC,JHKZNXCXUMFEOS-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5283179,,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,5.77,CHEMBL5445554,"Affinity Phenotypic Cellular interaction: (ProQinase broad tumor cell line profiling (CellTiterGlo assay, antiproliferative activity in brain, LN229,cancer cell line)) EUB0001183a CSNK2A1",LN-229,YKDZIFFKQUNVHH-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,5.0,CHEMBL3757073,Antiproliferative activity against human T98G cells after 24 hrs by EZ-Tox assay,T98G,VFLDPWHFBUODDF-FCXRPNKRSA-N,24.0,Antiproliferative activity,EZ-Tox
CHEMBL2035460,ETHASELEN,O=c1c2ccccc2[se]n1CCn1[se]c2ccccc2c1=O,IC50,5.3,CHEMBL2039587,Inhibition of TrxR in human U87MG cells after 12 hrs by insulin-reducing method,U-87MG ATCC,SFFSGPCYJCMDJM-UHFFFAOYSA-N,12.0,Unspecified,insulin-reducing
CHEMBL3359307,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.64,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,DVVXEMSAISDIBT-WZXSUGGSSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1224360,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.8,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,UJVDKTULBHBERS-NZVCPMBMSA-N,72.0,Cytotoxicity,MTS
CHEMBL1224364,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCOC)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.55,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,SEIHBOJCUVUPAJ-FDDWVMGPSA-N,72.0,Cytotoxicity,MTS
CHEMBL119592,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C,EC50,5.33,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,GZYXCXRHVALIJD-WOJBJXKFSA-N,18.0,Cytotoxicity,Unspecified
CHEMBL2069125,CORNUSALTERIN B,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.54,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VXRYSPWFQKBSPW-BDROBAENSA-N,,Cytotoxicity,SRB
CHEMBL1668098,CORNUSALTERIN E,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.88,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,ZYAWSDGOPQRREN-VNYVIHJJSA-N,,Cytotoxicity,SRB
CHEMBL343002,,CCOc1ccc(-c2nc3cc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)ccc3[nH]2)cc1,IC50,5.38,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PRDFBSVERLRRMY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL471122,,CCCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.5,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,MZOOIDJUCGIQIU-DHIUTWEWSA-N,,Cytotoxicity,Unspecified
CHEMBL3290910,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FRFNHPYRKFRMMZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290931,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JYBQEMYHVMILOJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2042472,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc2c(F)cccc12,IC50,7.68,CHEMBL2044176,Antiproliferative activity against human A172 cells after 5 days by MTT assay,A-172,YKVMJQBXOMKRHY-UHFFFAOYSA-N,120.0,Antiproliferative activity,MTT
CHEMBL521245,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.75,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,WXZMJXNGGUJSIL-AJNNAGPSSA-N,72.0,Antiproliferative activity,MTS
CHEMBL506074,,CC(C)[C@@H]1CC[C@]2(COC3CCCCO3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.35,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,PKUKASRXVYELCK-AQOUXIAOSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3353046,,O=C(Cc1cccc2ccccc12)N1CCN(C(=O)c2ccco2)CC1,IC50,4.1,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,VMJVAMPNMNAKLD-UHFFFAOYSA-N,48.0,Antiviral activity,cell-based luciferase reporter gene
CHEMBL373587,,CCN(CC)c1ccc2c(C#N)c(-c3nc4ccccc4o3)c(=O)oc2c1,IC50,5.75,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,QCQWADYRINMUHR-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5418475,,CC(=O)OC[C@H]1O[C@H](OC2=CC(=O)c3cccc(O)c3C2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.49,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,CSKWWVYJAXDCIP-MWFZDGHISA-N,24.0,Cytotoxicity,resazurin
CHEMBL4455327,,Oc1ccccc1-c1ccc2ccccc2c1,EC50,4.32,CHEMBL5217394,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,DYXBPOGHFMDEDL-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL222760,,CC(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6nccnc6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.72,CHEMBL916479,Cytotoxicity against human U87-Mg cells after 72 hrs by MTT assay,U-87MG ATCC,VZYGKLAIQLFCPM-JOQCCHAVSA-N,72.0,Cytotoxicity,MTT
CHEMBL5401775,,O=C1c2cc(F)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,4.78,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,DZDTUGJLJYIASD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL244184,,Cc1cnc(Oc2ccc(-n3ccnc3)cc2)nc1Oc1ccc2c(c1)OCO2,IC50,6.89,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,WUDOWDUJLISJRD-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL244182,,c1cn(-c2ccc(Oc3ccnc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,7.13,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,VEWOKEGQNVXJDK-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL3885128,,CCOC(=O)c1nc2ccccc2nc1C#Cc1cccc(C)c1,IC50,5.26,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GANAGRMHJQTADC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1822930,,CCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.62,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,RMDYOOKUYKPFTH-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1822935,,CCCCOc1c(OC)ccc2cc(C(=O)NCCF)c(=O)[nH]c12,Ki,6.31,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,UTFVZMLLHUZJOB-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL119894,,COc1ccc2c(n1)-c1nccc3ccnc(c13)C2=O,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,YTZSQUDIWAXIIV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1779547,,Cc1c2c(n3c1CCCN1CCC[C@@H](C1)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.17,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,PWJSZCCBSVIOCL-KRWDZBQOSA-N,,Antiproliferative activity,luminescence
CHEMBL4205181,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(C(F)(F)F)cc4Cl)c3=O)cc2)ccn1,IC50,4.7,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LRSSWCNWEFCZTP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4207773,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.82,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WSIJRYOXDPXZPL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL480041,,CCN(CC)C(=O)Cc1c(-c2ccc(OC)cc2)nn2c(C)cc(C)nc12,Ki,8.18,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,ILZWUAWCTNWSFZ-UHFFFAOYSA-N,1.5,Unspecified,competition radioligand binding
CHEMBL3634876,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)cc2c(C)cc(C)cc21,Ki,6.09,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,RKBQFQARDYWAHE-UHFFFAOYSA-N,1.5,Unspecified,competition radioligand binding
CHEMBL3144390,,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccc(-c2ccccc2)cc1.Cl.Cl,IC50,5.34,CHEMBL1272663,Cytotoxicity against human A172 cells by MTT assay,A-172,XXBHXAMUPKFGNW-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4285275,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.25,CHEMBL5048136,Cytotoxicity against human U-87 MG cells assessed as cell viability using raw interpretation method,U-87MG ATCC,LNKLNUAMTRHBLB-CGJDGIRVSA-N,,Cytotoxicity,Unspecified
CHEMBL1557864,,COc1cc(C(c2cc3c(cc2O)OCO3)N2CCCC2)cc(OC)c1OC,IC50,4.62,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,QCXGNLZKUHBIHD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL591855,,CCc1ccc(C(Nc2ccccn2)c2ccc3cccnc3c2O)cc1,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GKKHBDOWRWTQKO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3703650,,Cc1ccnc(NC(c2ccccc2Cl)c2ccc3cccnc3c2O)c1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,BKOLRAXMMXDABH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4753606,,Oc1c(C(c2ccncc2)N2CCCCC2)ccc2ccoc12,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GJSGJEFEHZQMOS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4792039,,Oc1ccc2ncccc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,KOSAQWFJCWQDGG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4758830,,Oc1cc2c(cc1C(c1ccccc1)N1CCCCC1)OCO2,IC50,4.77,CHEMBL4729816,Cytotoxicity against human A 172 cells assessed as growth inhibition measured after 72 hrs by MTT assay,A-172,WXERBCAJTBAWGU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4778052,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)OCC,IC50,5.89,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,VVFGHJSVCIICMO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3793197,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1Cl,IC50,5.82,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,YPKZCXHKFPTHFY-YNEHKIRRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL184632,,CCC1(c2ccccc2)CC(=O)C(C(CC(=O)c2ccc(-c3ccc(Br)cc3)cc2)c2ccccc2)=C(O)O1,IC50,5.18,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,BYCOHDXJANLRLB-UHFFFAOYSA-N,72.0,Unspecified,Unspecified
CHEMBL5081822,,Nc1nc2cc3c(cc2cc1C(=O)NCC1CC1)OCO3,IC50,4.11,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,HVQSOLYMHDDJMB-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2441798,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1cccc(C(F)(F)F)c1,IC50,6.02,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,HMZVXEPIWCERKW-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441796,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.82,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KDESCVAKXJMELW-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441795,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,5.86,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,RAYZPAZGZSNIPK-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL1668698,,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(F)cc6F)[nH]c5c4)[nH]c3c2)CC1,IC50,5.26,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GOYTTZQBYVHZNE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2441790,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.08,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,PBHHNPADCVUAJW-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL4762080,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc5c(c4)OCO5)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.18,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,SQHULIWFGOHDAJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4798872,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccccc4)n3)s2)cc1,IC50,5.07,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DEAYOTAXACGNDI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3337789,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.0,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,JSVQEFOTCCULDI-HEVIKAOCSA-N,,Cytotoxicity,MTT
CHEMBL3121272,,O=C(Nc1ccc(I)cn1)c1cccc(F)c1,EC50,6.35,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,PEZBITNWNCFBLF-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL4100560,,C=C(c1ccc(OC)cc1)c1cc(C)nc2ccccc12,IC50,7.68,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,LPJFLJRKCGUKFU-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4076496,,C=C(c1ccc(OC)cc1)c1cc(CO)nc2ccccc12,IC50,6.41,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,HUFYAIZSUXZQDL-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4065521,,C=C(c1ccc(OC)c(O)c1)c1nc(C)nc2ccccc12,IC50,8.21,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,JSUMHLAGZVXBKB-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL524102,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccccc2)C1=O,IC50,5.82,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,VQMSLWWFCNFOAR-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL523801,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccncc2)C1=O,IC50,5.95,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,URKMVTNTRSBXHE-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1668100,CORNUSALTERIN G,CO[C@@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.69,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,UDSUNACNDRCFFJ-SMLRQZPUSA-N,,Cytotoxicity,SRB
CHEMBL1668103,CORNUSALTERIN J,CO[C@@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.74,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,CMYFKSGATOJENB-LRTLWCEFSA-N,,Cytotoxicity,SRB
CHEMBL1652082,,CC1(C)OC2C(=O)c3ccccc3C(=O)C2[C@@H]([N-][N+]#N)[C@@H]1Br,IC50,4.86,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,COAMQTJABBZFQJ-DUHSPSEUSA-N,72.0,Cytotoxicity,MTT
CHEMBL2041934,,O=[N+]([O-])c1ccc(NC(=S)NCc2cccc(Cl)c2)cc1,IC50,4.7,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,LGMWYLBNBHIUMI-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1087935,,Oc1ccc(CN(Cc2cccs2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.06,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,DCSLAAUFCGHSGE-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1080911,,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,IC50,6.45,CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,KRKDQSSYLDUOBP-HNNXBMFYSA-N,1.0,Unspecified,ELISA
CHEMBL1097919,,CCC(CC[C@@H](C)[C@H]1[C@H](O[C@@H]2O[C@@H]([C@@H](O)COC)[C@H](O)[C@H]2O)CC2=C3[C@@H](O[C@@H]4O[C@@H]([C@@H](O)COC)[C@H](O)[C@H]4O)[C@@H](O)[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,IC50,5.44,CHEMBL1111856,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MXFMHAVXAGVCGZ-QLDMGMRTSA-N,72.0,Cytotoxicity,MTT
CHEMBL3963286,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nnc(-c3ccccc3)c1-c1ccccc1)O2,IC50,5.84,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,FHNODQVETSSAOP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3908949,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3(O)CCCCC3)nn1)O2,IC50,4.96,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,NWGUAWJRTBYMNS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3341777,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccc3ccccc3c1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,Ki,6.91,CHEMBL3374643,Antimigratory activity against human SNB75 cells on matrix containing fibronectin after 24 hrs by 2-D migration assay,SNB-75,FWHOARIZUBCNOV-JBNHJABESA-N,24.0,Unspecified,2-D migration
CHEMBL43,AMSACRINE,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,IC50,6.3,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,XCPGHVQEEXUHNC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4095235,,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4cc(N5CC6CCC(C5)O6)c5nccn5n4)cc3)cc2)CC1,IC50,5.37,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,LPJMRYIXYRUNRW-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2088461,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(F)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.11,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,UWIACCOQIIULOL-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL87938,,CCOC(=O)N(C)/N=N\CCCl,IC50,4.75,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,USWACFKAYKLOCN-HJWRWDBZSA-N,,Cytotoxicity,MTT
CHEMBL1170447,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,5.73,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,AUXJPQSJHPPESP-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL3358287,,COc1cc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cnc1OC,IC50,8.0,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,BGEXTJGOTZMOEE-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3358284,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C(C)C,IC50,6.38,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JPHLCGRVFUCWIH-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357877,,CCc1cc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cnc1OC,IC50,6.33,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,BQJPZFLREHORGE-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357872,,COc1ncc(Nc2ncc(C(C)(C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.43,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,VWJMXEJPKWZLNL-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL1224210,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.05,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,QTRBSYDTCOEJBJ-YPAMOFLTSA-N,72.0,Cytotoxicity,MTS
CHEMBL4537633,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)cc1,IC50,4.58,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,REXXXBZPNYDIJX-FNORWQNLSA-N,72.0,Cytotoxicity,MTT
CHEMBL2170086,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.92,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-ZIAGYGMSSA-N,2.0,Unspecified,Unspecified
CHEMBL2170082,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,9.0,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SCIVONNAMHTUEH-CYBMUJFWSA-N,2.0,Unspecified,Unspecified
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.73,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JXLYSJRDGCGARV-CFWMRBGOSA-N,,Growth inhibition,Unspecified
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,SUDAHWBOROXANE-SECBINFHSA-N,,Growth inhibition,Unspecified
CHEMBL176544,,Cn1cc(/C=C2\C(=O)Nc3cccnc32)c2ccccc21,IC50,4.02,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NXNQLECPAXXYTR-LCYFTJDESA-N,,Growth inhibition,Unspecified
CHEMBL2164713,,Cc1nccc2c3ccc(OCCC(C)C)cc3n(CCC(C)C)c12,IC50,4.46,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CYNQFAAXQWCODJ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1739368,,NCCNC(=O)C(CN)(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,IC50,5.6,CHEMBL2154650,Cytotoxicity against human SF295 cells after 4 hrs by MTT assay,SF295,ZOSLLLKFQJEPRK-UHFFFAOYSA-N,4.0,Cytotoxicity,MTT
CHEMBL3805721,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.82,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OHQRSSZZOGZMSW-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL2178608,,COC1(c2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)COC1,EC50,6.85,CHEMBL2186329,Cytotoxicity against human LN229 cells incubated for 4 days,LN-229,XOZLHJMDLKDZAL-UHFFFAOYSA-N,96.0,Cytotoxicity,Unspecified
CHEMBL3781819,LP-184,CC1=C(CN(O)C(N)=O)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,7.3,CHEMBL3783415,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VWMPVAZEBAKLFR-HNNXBMFYSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL5085481,,O=C1c2cc(Cl)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,4.85,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,VONATDVATMYHAA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2022334,,[N-]=[N+]=NC1=CC(=O)c2ccccc2C1=O,IC50,5.47,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,IYUOYLLVOZNGKW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3955548,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C[Se]c3ccccc3)nn1)O2,IC50,6.66,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,SINWVHMPJIQVNR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3939072,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1cccc(-c2cn(C[Se]c3ccccc3)nn2)c1,IC50,6.47,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,PBZDSFFVEZDVJK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3980099,,CC1(C)CC(Nc2cccc(-c3cn(C[Se]c4ccccc4)nn3)c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.73,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RUFWBCRLCZBHGU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2441133,,CC1(C)CC(N=[N+]=[N-])C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.69,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,HKJNKCAALJABOG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3973814,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1nnc(-c2ccccc2)c1I,IC50,5.34,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,WUPZIJXCRARTKU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3945406,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3CCCCC3)nn1)O2,IC50,5.72,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,LJBKUXPERIFYEA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5411549,,COc1ccc(-c2ccc(NC(=O)c3cn(-c4ccc(N5CCNCC5)c(C(F)(F)F)c4)nn3)cc2)cn1,IC50,5.38,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,IZPAMEQTJBTCKQ-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL394956,,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccc(-c2ccccc2)cc1,IC50,5.32,CHEMBL1272663,Cytotoxicity against human A172 cells by MTT assay,A-172,QVXCZTNUVKNCGU-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5417058,,COc1ccc(-c2ccc3[nH]c(=O)c4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1,IC50,5.36,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,AUKAFZKIDXYAHI-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL5416400,,COc1ccc(-c2ccc3[nH]c(=O)c4ccc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.42,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RWVZOVTVZOCLKX-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL180966,,CN(CC[C@@H](Oc1ccc(-c2ccccc2)cc1)c1ccc(F)cc1)CC(=O)O,IC50,8.32,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,FDORQEIHOKEJNX-HSZRJFAPSA-N,3.0,Unspecified,Unspecified
CHEMBL1643112,,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.51,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,YZGGEWBAXPONBE-HAQBABLCSA-N,4.0,Cytotoxicity,MTT
CHEMBL1643113,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.78,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,KSUDUUNNZFFEPI-IUMLOJQTSA-N,4.0,Cytotoxicity,MTT
CHEMBL119700,,COc1ccnc2c1-c1nccc3c(OC)cnc(c13)C2=O,IC50,8.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,MAOQMONYODZXHW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3924500,,S=C(NNc1nncc2ccccc12)Nc1ccccc1,IC50,8.02,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,BJKBZKFIXRDJFX-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3977192,,NC(=S)NNc1nncc2ccccc12,IC50,8.03,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,BRPCQCNGNFEDIO-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3978686,,O=S(=O)(Nc1ccccn1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.08,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,DZQPJZWTLANTON-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL353585,,COCCOCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.36,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,VKHQKJIIXMHWOW-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL87240,,CC(=O)N(C)/N=N\CCCl,IC50,4.7,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,QEIMBUYAZCMEGX-FPLPWBNLSA-N,,Cytotoxicity,MTT
CHEMBL3290901,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.43,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WMQYCMRSTBMSOT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3359309,,C/C(=C/CCC(C)(C)OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.67,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZLAIBROJNOEYDX-JOUREUQLSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359313,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.05,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,RRKKHXNOPJWETM-BVLXKVINSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359314,,CC(C)(CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C)OC(=O)CCl,IC50,4.4,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,VVQMKIXOJQUCSK-BVLXKVINSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3358288,,COc1cncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)c1,IC50,7.15,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,GIJFIWCYFZUZAA-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357874,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(F)c2)n1,IC50,7.01,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,QTCHCGFCYOHSMS-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357871,,COc1ncc(Nc2ncc([C@H](C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.6,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JCDSCTRINIXUJR-SECBINFHSA-N,2.0,Unspecified,cell-based
CHEMBL3357870,,COc1ncc(Nc2ncc([C@@H](C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.51,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JCDSCTRINIXUJR-VIFPVBQESA-N,2.0,Unspecified,cell-based
CHEMBL3357867,,COc1ncc(Nc2ncc(C(O)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.47,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZWLQCJDCCOOFJD-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357864,,COc1ncc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.36,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,YEWABQMWBKESOQ-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3904493,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5ccnc5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.22,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CWZQCUWQHVFQEI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3905333,,CNCCN(C)Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1,IC50,6.59,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZZZGLALTAWYHHN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2313555,,CCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.17,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GYXXUZDCLMAMKS-JCNFZPKBSA-N,72.0,Cytotoxicity,MTT
CHEMBL2333592,WITHAMETELIN F,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45CC=CC(=O)[C@]5(C)[C@H]3CC[C@]12C,IC50,6.25,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,TWSTVCZSHMUIOQ-ZPRSOMTPSA-N,72.0,Cytotoxicity,MTS
CHEMBL2333167,WITHAMETELIN,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3CC=C4CC=CC(=O)[C@]4(C)[C@H]3CC[C@]12C,IC50,6.0,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QUGZOXCXHGEACS-FIPVAASQSA-N,72.0,Cytotoxicity,MTS
CHEMBL2037061,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.81,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,WFPZKOMYUKONFM-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037062,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.68,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,PXJQXEQFTLKFQP-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037066,,COc1ccc(-c2c(CO)c(CO)c3sc4ccccc4n23)cc1,IC50,4.74,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,PXNALHYUQFCUFP-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL258837,,N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,7.3,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,PXAOTHLXABAQIT-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL259163,,Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,6.91,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,ARIHYXITNVJHJL-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL552425,,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1,EC50,7.0,CHEMBL1060001,Inhibition of ephrin-B1-induced autophosphorylation of EphB2 expressed in human U87 cells after 1 hr by Western blot analysis,U-87MG ATCC,SAAYRHKJHDIDPH-UHFFFAOYSA-N,1.0,Unspecified,Western Blot
CHEMBL1779540,,CC(=O)N[C@H]1C[C@@H]2CNc3cc(ccc3C(N)=O)-n3c(c(C)c4c3CC(C)(C)CC4=O)CCCN2C1,EC50,5.44,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,HZDWFQUZDJXVGH-AZUAARDMSA-N,,Antiproliferative activity,luminescence
CHEMBL1779545,,Cc1c2c(n3c1CCCN1CCCC[C@@H]1[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,6.25,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,ZDILAMLZSXMAPA-FDDCHVKYSA-N,,Antiproliferative activity,luminescence
CHEMBL1774417,CASEARUPESTRIN A,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](O)[C@H](OC(=O)/C=C\C=C\CCCCC)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.44,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NWTYSAQBDRQWLF-WWRGVMLBSA-N,72.0,Cytotoxicity,MTT
CHEMBL1807806,,Cc1c2c(n3c1CCN(C(=O)[C@@H](N)C(C)C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.32,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WPQWDLRSWWBTSS-QZXAKIBKSA-N,,Antiproliferative activity,Unspecified
CHEMBL1806511,,Cc1c2c(n3c1CCN(C(=O)[C@@H]1C[C@H](F)CN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KVSGQPCLHVYQMQ-LDQAXMLRSA-N,,Antiproliferative activity,Unspecified
CHEMBL4096164,,CSc1nc(NCc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,PWYVDKFGQPXXFX-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4088440,,CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,BBTSLIHTQGHZBD-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4060227,,COc1cc(Nc2nnc(Cl)c(Nc3cccc(NS(C)(=O)=O)c3)n2)cc(OC)c1OC,IC50,4.9,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,LPANKDJQNNNOIR-UHFFFAOYSA-N,,Cytotoxicity,WST1
CHEMBL3779942,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.29,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,VSLMCBYJVLSIEE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3781674,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.72,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XFVRBLHJVSIYPX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4083156,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.15,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BMPZYKBGNRHAGU-HKIQETCMSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4068953,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@H](C)NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.94,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,MRSHFEIBWJDWOB-PUKOBOIISA-N,72.0,Antiproliferative activity,MTT
CHEMBL3975187,,O=C1C(Br)=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,5.79,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,WCDKOIITNPZJON-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3905337,,CC1(C)CC(n2cc(C[Se]c3ccccc3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.38,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CGPWNKWONXQXKF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3941937,,C[C@H]1NS(=O)(=O)c2ccc(-c3c[nH]c4cc(F)ccc34)cc21,IC50,7.57,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,ZMCRNPLKPSLLOS-SECBINFHSA-N,,Unspecified,Unspecified
CHEMBL3982092,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.24,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,WPYNMQXAUVJGQD-YDVZNJOFSA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL2435999,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.09,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YEGSATWQBXVWBX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3913964,,O=S1(=O)NC(CO)c2cc(-c3c[nH]c4cc(F)ccc34)ccc21,IC50,7.37,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,MUYZCDJFMYXXLU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL260223,,CCCCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.72,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,BRBRLDFWAFXYNB-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL3262848,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Br)c3)cc2F)ccn1,IC50,6.08,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JEHYCMOMKCTLTF-WKULSOCRSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262850,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3F)cc2F)ccn1,IC50,5.72,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QNNAMPWNPKHROX-AMVVHIIESA-N,72.0,Cytotoxicity,MTT
CHEMBL3262858,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3O[N+](=O)[O-])cc2F)ccn1,IC50,5.15,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AGCAIFFALBJUIZ-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL2435961,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5)n4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.04,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YXNVRITWXLFAIM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435980,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(C)cc5)n4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ADJFQXLFIAVQNS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435993,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SNYFYZCQCLHZGW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435989,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5F)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.52,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NVLKRTHPAPBBFA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3793100,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,5.0,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QXYGSSDGMTTZIF-MQUPRSIOSA-N,72.0,Cytotoxicity,MTS
CHEMBL3794299,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(/C=C/Br)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.89,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZZWBRSWYVABVFY-HPGFCBSRSA-N,72.0,Cytotoxicity,MTS
CHEMBL3093024,,Cn1c2cnc1OCCCCCCCCCOc1ccccc1-2,IC50,4.13,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YVXCOBYXMMGCJH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL1834954,,O=C(O)c1cc(C#Cc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.52,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,JJNQWYPLIWCKRB-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL1822057,,CC(=O)Nc1cn2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,6.93,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,XNIJHVMYDIVRJQ-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL3114582,,O=C1C=C(NCc2cn(C3=CC(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21,IC50,5.42,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,HANIQUTYFSDFSY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3263123,,COc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)cc(OC)c1OC,IC50,4.65,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HZBAKOORAWVZFL-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL3259853,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3c(O)ccc4ccccc34)cc2F)ccn1,IC50,6.21,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IDHJQISXCBJVOX-VTNSRFBWSA-N,72.0,Cytotoxicity,MTT
CHEMBL4277900,CROZBACICLIB,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,IC50,7.82,CHEMBL4253572,Antiproliferative activity against human U87MG cells after 72 hrs by DAPI staining based assay,U-87MG ATCC,AEFFENQISAXIKE-UHFFFAOYSA-N,72.0,Antiproliferative activity,DAPI staining based
CHEMBL3121287,,O=C(Nc1ccncc1)C1CCCN1S(=O)(=O)c1ccc2ccccc2c1,EC50,5.82,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FNVOIHVALBDIKK-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1335117,,CCOc1ccc2c(c1)C(C)=CC(C)(C)N2S(=O)(=O)c1ccc(C)cc1,EC50,6.16,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,PAWMDFURAZONCN-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121285,,COc1ccccc1C(=O)N1CCN(c2ccccc2OC)CC1,EC50,5.49,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FFQQPUIDIKZXNZ-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL468756,,Cc1ccn2c(-c3csc(Nc4ccc(N(C)C)cc4)n3)c(C)nc2c1,EC50,6.96,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,CJLBQZGTWTUBJP-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3400567,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(C)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.48,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,XLNNYMWEEGDJEE-KYOITVBSSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL5399572,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCN(S(C)(=O)=O)CC3)CC2)n1,IC50,5.9,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,KOBDMZOFSXEFLG-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5409171,,C[C@@H]1CC[C@H]2[C@@H](C)C(OCCNC(=O)c3ccc(COc4ccc(/C=C/S(=O)(=O)Nc5ccc(OC(F)(F)F)cc5)cc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,7.05,CHEMBL5355849,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,MCSXNLKTLHQAJJ-RYQWKLEYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2392950,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.98,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YCHICXJMFVCFQB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.79,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MJQUEDHRCUIRLF-TVIXENOKSA-N,,Growth inhibition,Unspecified
CHEMBL276820,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.54,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,VSJKWCGYPAHWDS-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1164872,,COc1cc(C(=O)OCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.35,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,NHQAWDYBHFPUKA-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1164564,,COc1cc(C(=O)OCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.24,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LCXOWQVFSXNYSJ-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163821,,COc1cc(C(=O)OCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.23,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LQBNUOMEOUZICV-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL2381444,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc8c(O)cccc78)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.6,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,LGQLUFPPSGZGDH-RKDXGVHHSA-N,48.0,Cytotoxicity,SRB
CHEMBL232255,,c1cn(-c2ccc(OCCNCc3ccc4c(c3)OCO4)cc2)cn1,IC50,6.62,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,AFOSWVDYMVIRPF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL453687,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.11,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ZGMSWLRPBHQCQX-ALMBTRMVSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL61,PODOFILOX,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.25,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,YJGVMLPVUAXIQN-XVVDYKMHSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL3121271,,N#Cc1c(NC(=O)CCc2cccs2)sc2c1CCCC2,EC50,6.82,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,MPEANORHCANUPJ-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3116230,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.5,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MSQYLNJZSXKBIN-HPNDGRJYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116434,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.5,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LRTHSPZKWWSRPY-SZXQPVLSSA-N,72.0,Cytotoxicity,MTT
CHEMBL242772,,CC(COc1cc2oc3c(c2cc1Cl)C(=O)c1ccccc1C3=O)N(C)C,IC50,6.26,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,DUZOVWTWAFRSTO-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL390904,,CCN(CC)CCOc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O,IC50,6.85,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,RPXGBDKJYOGAIK-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL244032,,CC(C)N(CCOc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O)C(C)C,IC50,6.03,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,GZOJTMSHFBQNAX-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL2164234,,CCN(CCO)CCCC#C[C@H]1CC[C@H](N(C)C(=O)Oc2ccc(Cl)cc2)CC1.Cl,IC50,4.68,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,USHZOFAMBDBKIO-URGWDIIDSA-N,72.0,Cytotoxicity,MTT
CHEMBL479464,,CCN(CCO)CCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1.Cl,IC50,5.54,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,JXPRRQCJDYYJLX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3093013,,C=CCCCCOc1ccccc1-c1cnc(OCCCCC=C)n1C,IC50,5.4,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,KYNHZQLXFMOHST-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3091479,,Cn1c2cnc1OCCCCCCCCCCOc1cc3ccccc3cc1-2,IC50,4.66,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,FBYSFKNNHHNVSZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093028,,COc1ccc2c(c1)-c1cnc(n1C)OCCCCCCCCO2,IC50,4.17,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JHFXITBLDXDDDM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL223442,,O=C(CC1CCCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.7,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,AVNPCOQLNCMCEC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220558,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccccn1,IC50,6.27,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NOQHBAPFLBFZJH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2164696,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.8,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,YHSNXFZJLMWETE-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164694,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,6.37,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FLZOCSUEHOIXCV-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164404,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,6.01,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,QKCJTBIHCTYFCD-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164706,,Cc1nccc2c1[nH]c1cc(OC(=O)c3ccccc3)ccc12,IC50,4.38,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,WNUVMMWVNIMADA-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645550,,Cc1nccc2c1[nH]c1cc(OCCc3ccccc3)ccc12,IC50,4.68,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HVODEZHVACXTKZ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1645546,,COCCOc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,4.21,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HSBQAAURJDHACO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL223792,,O=C(CC1CN(C(=O)OCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.1,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JMRAUIYBGKHYPA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL373942,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NC(c1ccccc1)c1ccccc1,IC50,5.74,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DXHWXZWNGYBULD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2165032,,COc1ccc(Nc2ncc(-c3ccc(C)nc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.54,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LJLOTRKTBODGRQ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4071083,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccn[nH]4)cc3n2)C[C@H](C)O1,IC50,6.37,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,CCDCSUFMDNCKDI-BETUJISGSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL2206907,,Cc1nc(N)nc(-c2cc(C3CCOCC3)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,8.85,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FLBPZSHGOYHCPK-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206922,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)c3cccnc3)c2)n1,IC50,6.42,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,ZANRJYMOJHGSLE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL110809,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1,IC50,7.39,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,INGBRKRPMVCKOQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206920,,COc1ncc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cc1NS(C)(=O)=O,IC50,7.02,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,HXWDVFRJZSNMJG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4280206,,C(=C/c1ccc(OCCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.22,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,YSFZVBYOLOCFOX-BXGDTPBJSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4290427,,C(=C/c1ccc(OCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.05,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,BBQBTVXJWMOHMK-IRWWKPKRSA-M,72.0,Antiproliferative activity,MTS
CHEMBL3609555,,CC1(C)OC2=C(CC1[Se]c1ccc(Cl)cc1)C(=O)C(=O)c1ccccc12,IC50,5.58,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,XGDBTKWMCLPMFM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3609556,,CC1(C)OC2=C(CC1[Se]c1ccc(Br)cc1)C(=O)C(=O)c1ccccc12,IC50,6.01,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ZFLSERJFPOCJGJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392955,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.83,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVZRDYCKRBWYLQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3797512,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,7.2,CHEMBL3825128,Antiproliferative activity against human SF295 cells after 48 to 72 hrs by Alamar blue assay,SF295,AIIZZRMMCAVMCU-GXNNERPOSA-N,72.0,Antiproliferative activity,Alamar blue
CHEMBL3793946,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCCCC1,IC50,5.16,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZOSPTFWMMQSWDG-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL334029,,O=C1c2ncccc2-c2nccc3ccnc1c23,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,OPUPHQHVRPYOTC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL117616,,O=C1c2c(Cl)ccnc2-c2nccc3ccnc1c23,IC50,6.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,PRRCPGPQYCZMFC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1782899,,CCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.6,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZAUJDNSJLGGEJJ-ALMBTRMVSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL2381458,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(OC)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,MITHWKIKAGALMC-BJMSDPACSA-N,48.0,Cytotoxicity,SRB
CHEMBL1738705,,Cc1c2c(n3c1CCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.06,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,WQTXERXALASGRT-GOSISDBHSA-N,,Antiproliferative activity,luminescence
CHEMBL506871,VELIPARIB,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,IC50,4.35,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,,Growth inhibition,Unspecified
CHEMBL118218,IROFULVEN,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,6.5,CHEMBL3783415,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NICJCIQSJJKZAH-AWEZNQCLSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL354031,,CC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.82,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,GDQVCIVWZYDXJN-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL86892,,C/N=N\N(C)C(=O)NC,IC50,4.62,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,NEXBHNSUHRMPFL-SREVYHEPSA-N,,Cytotoxicity,MTT
CHEMBL2172475,,CC(=O)Nc1cc(-c2c(Nc3cc[nH]n3)nc3ccccn23)nc(C)n1,IC50,7.22,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,DVKPPCJTWPFHAT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL261294,,CC(C)Cn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.72,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,PCUUECDOHPWNCN-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL3794553,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,IC50,5.4,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,LKSPPCNHWCHCRG-XUVXKRRUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3794362,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)C(Cl)Cl,IC50,5.29,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,AWKSPMWHISBXEP-RRKCRQDMSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793820,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,5.15,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,YRYZCLZPZKWTEP-PWRNOJCPSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3792832,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc(Cl)cc1,IC50,6.38,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,KWNHGHKHLZMRLZ-YNEHKIRRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3609560,,CC1(C)OC2=C(CC1Sc1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.48,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,YPMRQCFLHXEFQA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3618241,,COCCN1CCN(c2ccc3nc(Nc4cnc(OC)c(F)c4)c(-c4nc(C)nc(N)n4)n3c2)CC1,IC50,7.58,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,VVZXIPYMKVAZOT-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL353644,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(C(=O)OCc1ccccc1)C(C)C,IC50,6.02,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,XLHLDCVJLJQLIL-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL355556,,O=C1OCc2c(cc3n(c2=O)Cc2cc4ccccc4nc2-3)C1(O)CO,IC50,5.14,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,RFHJILZUQZQPSJ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1821797,EUPHODENDRIANE A,CC1=C[C@@H]2[C@H](C1=O)[C@H](O)C(C)=C[C@H]1[C@@H]3C(C)(C)[C@]3(OC(=O)C(C)C)[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@]21O,IC50,4.22,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,TUYMOSZNDXCMQM-GLPNJXFDSA-N,72.0,Anticancer activity,SRB
CHEMBL111998,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.49,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,MUZZKZIHYIHBGE-SFTDATJTSA-N,,Unspecified,Unspecified
CHEMBL260577,,NC(c1ccc(Cl)cc1)C1CCN(c2ccnc3[nH]ccc23)CC1,IC50,5.46,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,PRPNDHHOYWARPB-UHFFFAOYSA-N,,Growth inhibition,SRB
CHEMBL98350,LY-294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,IC50,5.09,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,CZQHHVNHHHRRDU-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL104264,,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,IC50,4.82,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,,Growth inhibition,SRB
CHEMBL4865974,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(CCc7c[nH]c8ccccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.26,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,MFELGXXVSHQQHD-CTRMNHBPSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4877575,,O=C1C[C@H]2O[C@@H](CI)[C@@H](O)[C@H]2O1,IC50,5.12,CHEMBL4836842,Antiproliferative activity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,CZOPNPBGJUPGBD-LCZOEFHHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3622407,,Cl.O=C(CNc1ccc(Cl)cc1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,5.91,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,XZKBTOISYXIPED-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL515133,,O=C1NC(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.51,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,MYVFKQAHICRDPT-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL489463,,CCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.35,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,GMBQUBWBOHICIN-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL453903,,CC(C)(C)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.07,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,YHJMEBQVHJJZMS-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL454889,,O=C1NN(c2ccc([N+](=O)[O-])cc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.32,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,LSJRAXQSPRWLFJ-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1807802,,COCCC(=O)N1CCCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@@H]1C)CC(C)(C)CC3=O,IC50,7.1,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RBWHSVCFANTGQI-OALUTQOASA-N,,Antiproliferative activity,Unspecified
CHEMBL1779531,,Cc1c2c(n3c1CCCN1CCC[C@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WQTXERXALASGRT-SFHVURJKSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807804,,Cc1c2c(n3c1CCN(C(=O)[C@H](C)N)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.1,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,JSSUIPOIXFFFQU-NJAFHUGGSA-N,,Antiproliferative activity,Unspecified
CHEMBL176381,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(Br)ccc2O1,IC50,4.27,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,IQMRTGYHVNXAEP-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL373788,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(F)ccc2O1,IC50,4.52,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KTDZECNPAAWQKH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL510164,,Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1,IC50,5.96,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,XXLAEKOWCYJOKK-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL494921,,c1cc(-c2nc(N3CCOCC3)c3sccc3n2)c2cn[nH]c2c1,IC50,5.08,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,GXJBABITGPOFCK-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL3780933,,Nc1nc(OCc2cccc(CNC(=O)N(CCCl)N=O)c2)c2nc[nH]c2n1,IC50,4.3,CHEMBL3783554,Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay,SF126,GVMAIDVNRQTZES-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL1164468,,O=C(OCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.35,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,KKMQNWAUGKFRNL-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1779538,,Cc1c2c(n3c1CCCN1C[C@H](O)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,6.17,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,IRRAGNCOBFDJHT-QZTJIDSGSA-N,,Antiproliferative activity,luminescence
CHEMBL1779539,,Cc1c2c(n3c1CCCN1C[C@@H](F)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.02,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,RWRRZRNJYYDDSN-FUHWJXTLSA-N,,Antiproliferative activity,luminescence
CHEMBL3426486,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(CO)CCC[C@@]4(C)C2=CC[C@@H]1C3,IC50,4.69,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,OPSDBQPQYGWZJL-UYUBTLJZSA-N,24.0,Cytotoxicity,MTT
CHEMBL478507,,Oc1ccc(CN(Cc2ccc(C(F)(F)F)cc2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.0,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,JZARXLRJMQKPON-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4758691,,C#CCOc1ccc(/C=C/C(=O)c2ccccc2C)cc1OC,IC50,5.68,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,XFLIJBVWDOJQLX-PKNBQFBNSA-N,72.0,Cytotoxicity,RRA
CHEMBL4758544,,C=CCOc1ccc(C=O)cc1OC,IC50,5.12,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,DGWCHURQYFMBFC-UHFFFAOYSA-N,72.0,Cytotoxicity,RRA
CHEMBL3621992,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(C(=O)/C=C/c2ccccc2)cc1,IC50,6.43,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,IZAYQOKSONRKCE-SFQUDFHCSA-N,72.0,Cytotoxicity,MTT
CHEMBL2417820,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.6,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YJGBMSZABXWLMO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417818,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.4,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CCPJHMRMRYWHNJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1823651,,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(F)cc2c1,IC50,6.41,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,QFMBYPBOVSGXGC-UHFFFAOYSA-N,1.0,Unspecified,ELISA
CHEMBL2402943,,CC(C)=CCC[C@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,IC50,4.6,CHEMBL2405050,Cytotoxicity against human A172 cells assessed as growth inhibition after 48 hrs by MTT assay,A-172,HTNVFUBCWIYPJN-HSZRJFAPSA-N,48.0,Cytotoxicity,MTT
CHEMBL3092021,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O[Si](C)(C)C(C)(C)C)cc2)c(OC)c1,IC50,4.72,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,PRLFQHHCWWXLCB-UHFFFAOYSA-N,120.0,Cytotoxicity,methylene blue staining
CHEMBL388881,,c1cn(-c2ccc(OC[C@H]3CCCN3Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,6.6,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,LJMQPVKSZNDSKH-LJQANCHMSA-N,,Unspecified,Unspecified
CHEMBL232826,,c1cn(-c2ccc(O[C@@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.77,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-HXUWFJFHSA-N,,Unspecified,Unspecified
CHEMBL3975545,,Cc1[nH]c2c(c1-c1nnc(-c3ccccc3)o1)Cc1ccccc1-2,IC50,7.22,CHEMBL3878557,Antiproliferative activity against human T98G cells after 72 hrs by XTT assay,T98G,ASVQGQLIXGMQDH-UHFFFAOYSA-N,72.0,Antiproliferative activity,XTT
CHEMBL111249,,O=C1c2nccc(Cl)c2C(=O)c2c(-c3ccccc3[N+](=O)[O-])ccnc21,IC50,5.7,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,HYARGZOCQYEIQS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL107092,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1,IC50,9.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,GZYLUVFSBIJQAU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL355569,,CCN(CCc1c2c(nc3cc4c(cc13)OCO4)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC)C(=O)OCc1ccccc1,IC50,5.55,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,SNJYBAJACUNLGR-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1630325,,C=C1C(=O)O[C@@H]2C3=C[C@H]4OO[C@]3(CC[C@@H]12)C(C)(C)C4=O,IC50,5.59,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NMXXTJXRQIYUIO-IGRCHAIXSA-N,72.0,Cytotoxicity,MTT
CHEMBL1641650,,CC(=O)O[C@@H]1C=C[C@H](OCCCOc2cc(O)c3c(=O)c(-c4ccc(O)cc4)coc3c2)O[C@H]1C,IC50,4.78,CHEMBL1647062,Cytotoxicity against human T98G cells after 72 hrs by SRB assay,T98G,PDZLLRLDZPDGCT-HRCLSFSHSA-N,72.0,Cytotoxicity,SRB
CHEMBL432949,,O=C1OCc2c(cc3n(c2=O)Cc2cc4ccccc4nc2-3)C1(O)CCO,IC50,5.35,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,CCBXXGSAGQNXHX-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL103577,,Cc1cnc2c(c1)C(=O)c1cccnc1C2=O,IC50,6.6,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,XVXWDZYWGRHSJR-UHFFFAOYSA-N,,Cytotoxicity,using SRB
CHEMBL3092927,,C=CCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,5.3,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,UPLYWSQTJNMGKG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL392695,S-TRITYL-L-CYSTEINE,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,IC50,5.56,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DLMYFMLKORXJPO-FQEVSTJZSA-N,,Growth inhibition,Unspecified
CHEMBL446473,PHENYLBUTYL ISOTHIOCYANATE,S=C=NCCCCc1ccccc1,IC50,4.46,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,CCBQOLFAKKAMLD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL513097,PLAKORTIDE M,CC/C=C/[C@H](CC)C/C=C/[C@@]1(CC)C[C@H](CC)[C@H](CC(=O)O)OO1,IC50,5.75,CHEMBL982259,Cytotoxicity against human SF295 cells,SF295,APFBSUUYUMZERZ-ACISTPACSA-N,,Cytotoxicity,Unspecified
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,7.66,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,QXRSDHAAWVKZLJ-PVYNADRNSA-N,,Growth inhibition,Unspecified
CHEMBL446125,FASCAPLYSIN A,CC1=C(CC/C(C)=C/CC/C(C)=C/CCC(CC(=O)O)C(=O)[O-])C(C)(C)CCC1.O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,IC50,5.28,CHEMBL1000757,Antitumor activity against human SNB75 cells,SNB-75,LORHTOVIKVOXSY-YOEDIAEGSA-N,,Unspecified,Unspecified
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.8,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL571623,,Cc1cc([N+](=O)[O-])ccc1NC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.73,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QQRVFKSGDWMEIS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL571407,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccccc1[N+](=O)[O-],IC50,5.75,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AZERFNFOCUWMHL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1910998,,Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.89,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,WFRUFWRKGZIARP-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL1911114,,COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O,IC50,6.23,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,JMCCNBLPWHIWCV-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL476113,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](C)NC1=O,IC50,5.22,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,RGRWKFDNYSQFBZ-JRBASJLZSA-N,,Cytotoxicity,Unspecified
CHEMBL565420,,C[C@@H]1CC[C@H]2[C@H](CBr)CO[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,IC50,4.79,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,ICJKLGDDPGNBBS-BXPKWHOZSA-N,,Anticancer activity,sulforhodamine B
CHEMBL569090,,C[C@H]1[C@@H](CCSCC[C@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CCC([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@]3(C)CCC4[C@H](C)CC[C@@H]1[C@]42OO3,IC50,5.26,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,SONOEGJPRKBJAA-HDHWBIKTSA-N,,Anticancer activity,sulforhodamine B
CHEMBL2180727,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,IC50,7.16,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,FNYGWXSATBUBER-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL421,SULFASALAZINE,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.52,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,NCEXYHBECQHGNR-QZQOTICOSA-N,0.25,Unspecified,Unspecified
CHEMBL1630582,,C/C(=N\NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,9.0,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,QJEQNMXYYQUOAY-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037449,,C/C(=N/NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.37,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,MXWJIUNQTNDDFG-YVLHZVERSA-N,48.0,Cytotoxicity,MTT
CHEMBL1630581,,C/C(=N\NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.59,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,DIAIPLSVPPGTLG-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037436,,C/C(=N\NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.75,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VCKFVZSNSWYSKQ-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL1081853,,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)sc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.04,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,ACASJCMNZMOGPH-AWEZNQCLSA-N,1.0,Unspecified,ELISA
CHEMBL49378,,CCOC(=O)[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)NC(=O)CCCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,IC50,4.68,CHEMBL805826,The compound was tested for cytotoxicity against SF-126 (human) Glioma cell lines,SF126,IDHGEFGDZPCYJX-GDLZYMKVSA-N,,Cytotoxicity,Unspecified
CHEMBL2098107,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ccccc2[nH]1,IC50,6.48,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,YGUDSHJNJUBIHP-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL5199446,,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1nc2ccccc2[nH]1,IC50,5.19,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,HQTLILQUYCGKIQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5201756,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2c(Cl)ccc(Cl)c2c1=O,IC50,5.04,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,ANMPGAUFPGVOHG-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL3092918,,COc1ccccc1-c1cnc(OCCCc2ccccc2)n1C,IC50,5.52,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,IJRQFMLSTLUNTK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093026,,Cn1c2cnc1OCCCCCCCCOc1cc(F)ccc1-2,IC50,4.16,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CFNQXEGOPRAOTL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL125191,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(N(CCCl)CCCl)cc13,IC50,7.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,CDSDBTYEKSPYEZ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL523263,,CN(C)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.1,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,GFUQYTODWIEYAX-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL455132,,O=C1NN(c2ccccc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.34,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WGKFUFBYBCYABN-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL3933347,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCCC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.8,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LGGXLUJMVMVVOQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL84,TOPOTECAN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,IC50,6.8,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,UCFGDBYHRUNTLO-QHCPKHFHSA-N,48.0,Antiproliferative activity,MTT
CHEMBL428725,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CF)nn3)nccc12,IC50,6.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,HUZFIDHFHZMOAP-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238265,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ncc(F)c12,IC50,6.21,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ABWXAJAMZIXGLW-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392758,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)nccc12,IC50,6.82,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DLNPHXOJDBJBBK-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL393585,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ccc(F)cc12,IC50,5.44,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,PAQRKQUUKFOMSK-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238074,,C[C@@H]1CN(S(=O)(=O)c2c[nH]c3ncccc23)CCN1C(=O)c1ccccc1,IC50,4.89,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,QGODFPZTUSIJQW-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL393400,,CC1CN(C(=O)c2cnc3ccccc3n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.27,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ANOLRYSIPZVGCW-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL236997,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.07,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ICLFAMDXSMSQGX-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL3588942,,CCCC(=O)Oc1ccc(/C=C/COC(C)=O)cc1OC,IC50,4.98,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,HOQXDJJQJVPBRZ-FNORWQNLSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3588939,,COc1cc(/C=C/COC(C)=O)ccc1OC(C)=O,IC50,5.97,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,KCODNVFFXXYJPA-SNAWJCMRSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL4099562,,O=C(Nc1ccncc1)Nc1ccc(-c2cc(N3CC4CCC(C3)O4)c3nccn3n2)cc1,IC50,4.93,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,AMGONPXTTMZQRC-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4089423,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nn2ccnc12,IC50,5.58,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,AAXLFXKVJQWRCB-NRFANRHFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4077736,,CCc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4ccncc4)cc3)nn12,IC50,5.29,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,OECGDPJSTMHVTP-KRWDZBQOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3290928,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OXESTPIQGJVUCC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290917,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.6,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,NORQIYMCKYRXOJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3612309,,COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.28,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SETOUQDIHCNCHQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612318,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1C#N,IC50,5.08,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,CYWXKRWCESQIOB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612322,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3n2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.32,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GCCYGPNWMFOFLT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1241832,,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc(-c2ccc3ccccc3c2)n[nH]1,IC50,6.0,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,XOXCTLAKMCIWCF-CVKSISIWSA-N,72.0,Cytotoxicity,SRB
CHEMBL4864941,,CC12CC3CC(C)(C1)CC(NCc1ccc(C(=O)NO)cc1)(C3)C2,IC50,4.34,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,ZGUUWDMEHPPEGH-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL1782902,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CO)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.68,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VYEHKJZEGTZXEK-AZIXLERZSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,4.71,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,OWPMENVYXDJDOW-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2380760,,NS(=O)(=O)c1cccc2c1C(=O)c1cccc(O)c1C2=O,IC50,6.8,CHEMBL2383235,Cytotoxicity against human U87 cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,CQBHSRLUQDYPBU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL223615,,COc1ccc(CCNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PQRVHILYLCVPLT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL221320,,Cc1cc(N2CCNC(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NQPBHEDOJDMNSV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2381456,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccccc7C#N)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.82,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,XOGYFHSVBPTAAE-RROBCMOASA-N,48.0,Cytotoxicity,SRB
CHEMBL2381455,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(CC#N)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.89,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,VQCWBWUZOOXFSK-ICIQEZEZSA-N,48.0,Cytotoxicity,SRB
CHEMBL456075,CASEARLUCIN A,C=C/C(C)=C/C[C@]1(C)[C@H]2C[C@H](OC(=O)C(C)CC)C=C3[C@H](OC(C)=O)O[C@H](OC(C)=O)[C@@]32[C@H](O)C[C@@H]1C,IC50,5.85,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,FGGPIWICAGRSLN-UQSIVEBGSA-N,,Cytotoxicity,Unspecified
CHEMBL554,LAPATINIB,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,4.02,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,BCFGMOOMADDAQU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1189501,,CN1CCOc2cccc3nc(O)c(nc23)-c2cccc3c(O)n(nc23)CC1,IC50,7.11,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,VHQSTBKAAYHLRM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4852923,,C(=C/c1nc2ccccn2c1Sc1ccccc1)\c1ccccc1,IC50,4.23,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,QQUXYMHDLHUXOU-CCEZHUSRSA-N,48.0,Anticancer activity,MTT
CHEMBL4852797,,N#Cc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.18,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,PMQSQPJUDIFZFL-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4864675,,COc1cc(C(=O)c2cn(-c3ccc(C)cc3)cc2-c2ccsc2)cc(OC)c1OC,IC50,7.71,CHEMBL4838790,Cytotoxicity against human U-87MG cells assessed as cell growth inhibition measured after 48 hrs by MTS colorimetric assay,U-87MG ATCC,IPVNWYTUTMCVEH-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS colorimetric
CHEMBL2165013,,COc1ccc(Nc2ncc(CN3CCNCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.7,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KEDQOULNSHVTKP-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165034,,COc1ccc(Nc2ncc(CN3CCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.21,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LOXQLWVHDSHBPP-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL106369,,COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1,IC50,7.58,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,LKDCAIVJHAMVHC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL229365,,O=C1C(=O)c2c(nc3cnccn23)-c2ncccc21,IC50,7.04,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,SQKMJSZLUCXAHB-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL229723,,O=C1c2cnncc2C(=O)c2nc3cc(OC(F)(F)F)ccc3nc21,IC50,7.01,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,BGEMJGUECGHJCV-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL317476,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1,IC50,8.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XRUMZMCHUHDEQQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL7064,,O=C1c2ccccc2-c2n[nH]c3cccc1c23,IC50,4.77,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,ACPOUJIDANTYHO-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5191468,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1ccc(F)cc1,IC50,6.27,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,BCNMJLRKWYKBBZ-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL606259,,CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.84,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,CPWFSOCJQNZDPU-LVIOGHJBSA-N,,Cytotoxicity,Unspecified
CHEMBL5436017,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCCC(=O)NO)CC1)C2,IC50,4.37,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,BNAJKXYRVNGASQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5425203,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)CC1)C2,IC50,5.24,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,DRKZKGNONHNGTB-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1777854,,CCC1=C(C)/C(=C/c2ccc(C(=O)NC(=N)N)cc2)CCC1(C)C,IC50,5.18,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,XSSNKBMVZGXBCU-FOWTUZBSSA-N,72.0,Anticancer activity,Unspecified
CHEMBL5412356,,O=C(C#Cc1ccccc1)Nc1cc(-c2nccs2)ccc1F,IC50,5.93,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,OFHSPEKSWQTWLL-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5430775,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCC1,IC50,6.81,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VJPUQDMXGSSMSV-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5402707,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCc1ccc(C(F)(F)F)cc1,IC50,6.77,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,KVBZBOFHPSXVJH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5436721,,O=C(C#Cc1ccccc1)Nc1cccc(-c2ncc[nH]2)c1,IC50,6.91,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XAQWDQFCIKPFCH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5428972,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)/C=C/c1ccc(Cl)cc1,IC50,5.0,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,KKBBKKLTSASRPU-BJMVGYQFSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5439553,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(OC)c1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BQYVIYBBGCUYOJ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL361946,,CC1(c2ccccc2)CC(=O)C(C2CC(c3ccc(-c4ccc(Br)cc4)cc3)Cc3ccccc32)=C(O)O1,IC50,5.87,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,BOKGXPIFERMENI-UHFFFAOYSA-N,72.0,Unspecified,Unspecified
CHEMBL3216760,,CN(C)CCNCCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.Cl.Cl,IC50,6.22,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,HCNOLYNOZAOMMO-UHFFFAOYSA-N,48.0,Unspecified,MTT
CHEMBL261907,DIHYDRODEHYDRODICONIFERY ALCOHOL,COc1cc([C@H]2Oc3c(OC)cc(CCCO)cc3[C@@H]2CO)ccc1O,IC50,4.87,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,SBLZVJIHPWRSQQ-HNAYVOBHSA-N,,Anticancer activity,SRB
CHEMBL1760596,,COc1cc(C(=O)CCO)cc(OC)c1O,IC50,4.61,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,UHOAHNLBCNGCHE-UHFFFAOYSA-N,,Anticancer activity,SRB
CHEMBL485875,,COc1cc(C(=O)CCO)ccc1O,IC50,4.55,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,NXCPMSUBVRGTSE-UHFFFAOYSA-N,,Anticancer activity,SRB
CHEMBL1289102,,COc1ccc(-c2cc(C(=O)N/N=C(\C)c3ccc(OC)c(OC)c3)[nH]n2)cc1,IC50,6.22,CHEMBL1291285,Cytotoxicity against human U87MG cells after 48 hrs by sulforhodamine B assay,U-87MG ATCC,GMFUWEBOUKIKRP-LPYMAVHISA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL5563604,,CCCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.85,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZCJXMLPKKDIHSJ-CQSZACIVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL385415,,Oc1nc2cccc3c2nc1-c1cccc2c(O)n(nc12)CCN1CC[C@@H](C1)O3,IC50,7.57,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,XKBVYQGZLBOXHF-LBPRGKRZSA-N,,Unspecified,Unspecified
CHEMBL1778208,,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.1,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,SRLFTYLZJAKYNU-AWEZNQCLSA-N,,Antiproliferative activity,luminescence
CHEMBL1779532,,Cc1c2c(n3c1CCCN1CCCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.54,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,VNNXUBVMSLWQDG-LJQANCHMSA-N,,Antiproliferative activity,luminescence
CHEMBL4080072,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1Cl)CC(C)(C)O2,IC50,4.06,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,DEMWNIWYAZPRNO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1652081,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccc(O)cc3)[nH]c21,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QNKQRHGAMGCRIT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1098852,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccccc3)nn2)[C@H]1Br,IC50,5.81,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JSNJUKIDLLBRQT-PGRDOPGGSA-N,72.0,Cytotoxicity,MTT
CHEMBL4088848,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)nc3ccccc32)c(OC)c1,IC50,4.79,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DNMHJEOHMSRAAL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4072335,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.03,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MJSOEWYWKXULFD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL103667,DORAMAPIMOD,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,IC50,4.48,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,4.64,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ULDXWLCXEDXJGE-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL333669,,Cc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.22,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,XQDQFRGZXXSQCO-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL463602,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C[C@H]3[C@](C)(O)CC[C@@H]12,IC50,4.99,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FAESSFVRXUTLPW-FMRSBHEDSA-N,72.0,Cytotoxicity,MTT
CHEMBL1360494,,COc1cc(OC)c(C(c2cc3c(cc2O)OCO3)N2CCOCC2)c(OC)c1,IC50,4.87,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CURGVCDXVHAOOH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1450405,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCC2)cc1,IC50,4.65,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,TUODYFDDFYVYBP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4764456,,Oc1c(C(Nc2ccccn2)c2c(Cl)cccc2Cl)ccc2cccnc12,IC50,5.16,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,WOPDKGYYANFDPZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1760593,(-)-ISOLARICIRESINOL,COc1cc([C@@H]2c3cc(O)c(OC)cc3C[C@H](CO)[C@H]2CO)ccc1O,IC50,4.64,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,OGFXBIXJCWAUCH-WAWZGNHOSA-N,,Anticancer activity,SRB
CHEMBL3793126,,Brc1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCOCC1,IC50,4.64,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,RWEPXLQRLRYFSK-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3794277,,CON(C)CCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.44,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,VRBJHYXYYJVWFK-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3792414,,CCN(CC)CCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.77,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,BORYBNQNXCBXDX-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL554997,,Cc1c(CO)c(CO)c2n1-c1ccccc1C2,IC50,4.71,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,PLJQHKWMUDHDEF-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL3794215,,CONCCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.55,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,DEKITJMQIIOWLZ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL597378,,COc1cc(/C=C/c2cc(O)c(CCC(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,6.4,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,SDPGTYZDUFQIRL-HLULBIOLSA-N,44.0,Cytotoxicity,MTT
CHEMBL1081029,,N[C@H](CNc1ncc(-c2ccc3c(c2)CNC3=O)s1)Cc1ccc(C(F)(F)F)cc1,IC50,5.22,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,UFEUMFPFVBUZRR-INIZCTEOSA-N,1.0,Unspecified,ELISA
CHEMBL590061,,FC(F)(F)c1ccc(CNc2nonc2NCc2ccc(C(F)(F)F)cc2)cc1,IC50,4.69,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,MWVJBONVTITVIC-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL591033,,O=C(Nc1nonc1NC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1,IC50,4.85,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,OHBCJOHNVMVQIG-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL140730,,COc1ccc(-c2cc3c(N(C)C)cccc3c(N3CCN(C)CC3)n2)cc1,IC50,4.97,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,CUXVREHOPMDBBI-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5277445,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,5.9,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,PVCHFDQWRQFBTJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL553205,ROLLOAMIDE A,CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2CC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,6.14,CHEMBL1055507,Antiproliferative activity against human U87MG cells after 3 days by MTS assay,U-87MG ATCC,LVEJXBHPAHVYAJ-ZTTRGGFUSA-N,72.0,Antiproliferative activity,MTS
CHEMBL5410875,,O=C1NC(O)(c2ccc(Cl)cc2)C(c2ccc(Cl)cc2)=C1c1ccc(Cl)cc1,IC50,6.03,CHEMBL5333084,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth by CCK-8 assay,U-87MG ATCC,QVGDWGHPYVXRFO-UHFFFAOYSA-N,,Antiproliferative activity,CCK-8
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261844,Cytotoxicity against human LN-229 cells measured after 8 days,LN-229,GVJYOLRRZZUUOE-AATRIKPKSA-N,192.0,Cytotoxicity,Unspecified
CHEMBL111300,,O=C1c2nccc(O)c2C(=O)c2c(-c3ccccc3[N+](=O)[O-])ccnc21,IC50,6.1,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,SQGQTACESPGMNK-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1224362,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,MAWLSILLWAABOI-CNHRZFDUSA-N,72.0,Cytotoxicity,MTS
CHEMBL594568,,CC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.89,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,OIKLWYPNJDWKNL-DQSYDGHTSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL595647,,CNc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12,IC50,4.65,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,CSUBNOHVQCLNET-MVWRLGRASA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL595667,,CN(C)c1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12.Cl,IC50,4.47,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,VGFLJNZLWXAPCR-ZVSWTSNUSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL107154,,C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,9.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZPSNELIJNCRWKW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL391846,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2cccc(F)c12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WCWCDFCBGJVWBT-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240688,,CC1CN(C(=O)c2cccs2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.34,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OUYKEJFBGBJLIL-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL85641,,Cn1c(=O)c(-c2ccc(O)cc2)cc2c(O)cc(O)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,PUEMVFSBPADQCN-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL411515,,Clc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,7.19,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,YLRSPXDEXXKFBG-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL449964,,Clc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,IC50,7.29,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,SYJAQTIUQWZRLK-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL3780761,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.07,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OJSDVUBZLAMEFI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1081105,,N[C@H](CCc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,IC50,5.42,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,HZEDOBNROFBZAQ-HXUWFJFHSA-N,1.0,Unspecified,ELISA
CHEMBL1081295,,Nc1cc2cc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1,IC50,6.05,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,XLMDNKMMDBSPSJ-SFHVURJKSA-N,1.0,Unspecified,ELISA
CHEMBL1081829,,N[C@H](CNc1ncc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.14,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,JEJKZRXWJBUNLT-INIZCTEOSA-N,1.0,Unspecified,ELISA
CHEMBL574976,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC1CC1)C(=O)C(O)=C3C(C)C)/C(=C/NC1CC1)C(=O)C(O)=C2C(C)C,IC50,4.49,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,USMHSUMBECSGPI-GACBQCINSA-N,48.0,Anticancer activity,MTT
CHEMBL3774448,,O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1,IC50,6.7,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,ZFGAUFCQRUSRCF-XFFZJAGNSA-N,96.0,Growth inhibition,MTT
CHEMBL3765479,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(C)cc2)cc(OC)c1OC,IC50,5.69,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,XVQGQUSOBZXZFW-CPNJWEJPSA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL3763772,,COc1ccc(/C(=C\c2cc(OC)c(OC)c(OC)c2)C(=O)N2CCC=CC2=O)cc1,IC50,6.07,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,GXAWBZCBBVCHHX-CPNJWEJPSA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL3805290,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5ccccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.34,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FVACZTPWZHJRTQ-RIWGJCQISA-N,72.0,Antiproliferative activity,MTT
CHEMBL3785656,,COc1cc(/C=C/C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.74,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-PXQSDCCFSA-N,,Cytotoxicity,SRB
CHEMBL917,FLOXURIDINE,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,IC50,5.25,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793573,,CC(C)(C)c1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,6.47,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,MYGBVGRQGYOQBF-ARFHVFGLSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1699,MEMANTINE HYDROCHLORIDE,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl,IC50,4.63,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,LDDHMLJTFXJGPI-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL3793447,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc([N+](=O)[O-])cc1,IC50,6.4,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,QCIKSNAZLKDOMN-YNEHKIRRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793774,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cncc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.97,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,XPGBBZUSOYAGMV-GRUVHVDGSA-N,48.0,Antiproliferative activity,MTT
CHEMBL119393,,COc1cnc2c3c(nccc13)-c1c(N(C)C)ccnc1C2=O,IC50,5.52,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,JJXIXCZCTTWZLB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,8.0,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N,72.0,Anticancer activity,CCK8 reagent
CHEMBL4873475,,O=C(NCCc1c[nH]c2ccccc12)c1ccccc1Nc1ccc(C(F)(F)F)cc1,IC50,4.45,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,KTWQLMKUUDQDDZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL2372256,,CSCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)CCCCCNC(=O)CC[C@H](NC(=O)COCCOCCOCCN)C(=O)NCCCC[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(C)C)C(N)=O,IC50,7.97,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,RNOUTIRQWZWSHX-RMCMQRDFSA-N,,Unspecified,Unspecified
CHEMBL357518,,Cc1ccc2c(N3CCN(C)CC3)nc(-c3ccc(Cl)cc3)cc2c1,IC50,5.39,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,BGNUPPHAVDLYFT-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL242533,,O=C(/C=C/c1cccc(C(=O)c2cc3ccccc3[nH]2)c1)NO,IC50,6.0,CHEMBL895813,Cytotoxicity against human U87MG cells,U-87MG ATCC,YONXIFHNDNWCKF-CMDGGOBGSA-N,,Cytotoxicity,Unspecified
CHEMBL4639932,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cn3)cc2)n1,IC50,4.34,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GBMNARGJHFJMLX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4648861,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ncccc3Cl)cc2)n1,IC50,4.34,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDGSCYNTEHZLRR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1224135,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.54,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,ZFPAEAGOILUCEX-MHANECDQSA-N,72.0,Cytotoxicity,MTS
CHEMBL1165328,,COc1cc(C(=O)OC2CCCC(OC(=O)c3ccc(O)c(OC)c3)C2)ccc1O,IC50,4.14,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,JUFXEAUUKULHLY-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1165327,,COc1cc(C(=O)O[C@H]2CCCC[C@H]2OC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.12,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CJJVDYUOTKHCBA-HDICACEKSA-N,24.0,Anticancer activity,MTT
CHEMBL1164467,,O=C(OCCCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.51,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CNLXSCDIMLYWSJ-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1164100,,O=C(OCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.62,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,QYFNSLNMLBHCHL-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163758,,COc1cc(C(=O)OCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.04,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,IXUAYZKUQBDYPL-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL471988,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(Cl)cc3)cc1OC2(C)C,EC50,5.47,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,IRTQKPRGPXHPGU-WOJBJXKFSA-N,18.0,Cytotoxicity,Unspecified
CHEMBL471123,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(F)cc3)cc1OC2(C)C,EC50,5.48,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,GXMKPONJLTZWSW-WOJBJXKFSA-N,18.0,Cytotoxicity,Unspecified
CHEMBL471297,,CCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.49,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,FWCLETPIGPWXKI-FGZHOGPDSA-N,18.0,Cytotoxicity,Unspecified
CHEMBL513924,,CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1,IC50,6.1,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,UPQKAJYEZWCPJY-HNNXBMFYSA-N,,Antiproliferative activity,Unspecified
CHEMBL522031,,OCCN1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1,IC50,6.1,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,PFNYDAIJXABZEY-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL447062,LANTALUCRATIN A,C=C(C)C1CC2=C(O1)c1cccc(OC)c1C(=O)C2=O,IC50,5.33,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ICDFLJCHILFMDR-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL348667,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1,IC50,8.74,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,KQHWUFNWNPCEGY-UGKGYDQZSA-N,,Unspecified,Unspecified
CHEMBL1087801,,Oc1ccc(CN(Cc2cccc(C(F)(F)F)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.24,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,MNSWKXBKBFUHHI-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL477958,,Oc1ccc(CN(Cc2ccccc2C(F)(F)F)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.68,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,LOMOLCXMSWGBDB-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1242367,,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,IC50,4.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,YVXCDLCJCIDFHE-DKXQDJALSA-N,,Growth inhibition,Unspecified
CHEMBL1081263,,N[C@H](CNc1ncc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.37,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,RUQPVADMLMMXDR-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL1081852,,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)oc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.3,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,NIKDKNHGEBMTNT-AWEZNQCLSA-N,1.0,Unspecified,ELISA
CHEMBL454888,,Cc1ccc(N2NC(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.42,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,DJMAZMQCAGJMQH-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL497812,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)OC(C)C,IC50,4.28,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,ANDHAMDHAMHCNK-BRAPJGFWSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL85761,,CC(=O)Oc1ccc(-c2cc3c(OC(C)=O)cc(OC(C)=O)cc3n(C)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,FPPHNMULMXCJGO-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL78535,ANCRIVIROC,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,9.22,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZGDKVKUWTCGYOA-URGPHPNLSA-N,,Unspecified,Unspecified
CHEMBL4088257,,Cc1nc(C)c(/C=C/C(=O)N2CCC=CC2=O)nc1C,IC50,5.06,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LAYWHPVNALSHFB-BQYQJAHWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3823726,,O=C1C(O)=C(C(NCc2ccccc2)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.76,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WOHVVTQDLLOQNU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823458,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(C)ccc1O.Cl,IC50,5.26,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBWIHNBOQUVPNA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3618244,,COc1ccc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.35,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,DEOGGEOLSMKCSC-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL314002,,COc1ccc(-c2cc3c(OC)ccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,KXHHAFDFPJBSKE-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL445564,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC#N)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,UWUBRPDSQCUZOQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5171674,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCOCC2)cc1)OCc1cccnc1,IC50,6.05,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,ZEVISJFSMWKSMN-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5180838,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3COC3)CC2)cc1)OCc1cccnc1,IC50,6.31,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WHZPXXBWOIWRBY-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,5.36,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,INVTYAOGFAGBOE-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5177034,,COCCN1CCN(c2ccc(C(F)(F)F)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.07,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,CNCYHYVBWHVTRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL3116223,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.15,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DTHZTZLQTJVRSH-YYADALCUSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116239,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.0,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OXQHEWOTAZXICR-HIXSDJFHSA-N,72.0,Cytotoxicity,MTT
CHEMBL395498,,O=C(CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2)NCc1ccc(C(F)(F)F)cc1,IC50,5.75,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,SFGIHMAJHAGGRH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL396273,,CCOC(=O)CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2,IC50,5.92,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,QKBJVYOXPPHUJY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1779543,,Cc1c2c(n3c1CCCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,5.81,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,RPEZFJINCXMCIT-LJQANCHMSA-N,,Antiproliferative activity,luminescence
CHEMBL85691,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCc3nnn[nH]3)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,VFDUYXFWEKLFIY-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4092858,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.19,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LDPSTPXLWVVSEJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL298669,,Nc1nc(S)c2ncn([C@H]3S[C@@H](CO)[C@H](O)[C@@H]3O)c2n1,IC50,4.21,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,MLMHTQZFUSSXMA-GIMIYPNGSA-N,,Cytotoxicity,Unspecified
CHEMBL228133,,Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1,IC50,5.72,CHEMBL919353,Inhibition of GSK3-beta phosphorylation in U87MG cells by ELISA,U-87MG ATCC,HPWBHQIUIBFTQC-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL3985009,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5ccnc5C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.4,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OUVJFIJCTWGJEX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1779536,,Cc1c2c(n3c1CCCN1CC[C@H](CNc4cc-3ccc4C(N)=O)C1)CC(C)(C)CC2=O,EC50,6.38,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,HIBZKCZRHCXVEZ-QGZVFWFLSA-N,,Antiproliferative activity,luminescence
CHEMBL1813656,,COc1ccc(/C=C(NC=O)/C(=C/c2ccc(OC)cc2)NC=O)cc1,IC50,6.16,CHEMBL1816300,Cytotoxicity against human SF295 cells,SF295,ZRAIRHSUKMHHQT-YZLQMOBTSA-N,,Cytotoxicity,Unspecified
CHEMBL121911,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(NCc2ccccc2)cc13,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,JPFZPGSRDXAQRE-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL332240,,CN(C)c1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,YJPSFNBCJFAVCP-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL451169,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCC(C)=O)NC(=O)[C@H]2CCCCN2C1=O,IC50,7.14,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,SLNRKQPBCJPWHD-DVORCMKRSA-N,3.0,Unspecified,Unspecified
CHEMBL1269013,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(Br)cc1,EC50,4.9,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KFHJWWYSIYEQTP-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4061960,,Cc1cccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)c1,EC50,5.48,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,WVUKPAXSYYBWGE-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL575179,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCO)C(=O)C(O)=C3C(C)C)/C(=C/NCCCO)C(=O)C(O)=C2C(C)C,IC50,4.92,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,IUQOLNRSKATKPJ-MPKYGIEOSA-N,48.0,Anticancer activity,MTT
CHEMBL3780556,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.19,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JGYPLELRFFNBJT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3781197,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.8,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SUBPIGJEMSEJIK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3780813,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.5,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KUQGSEZEDTXRKC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3780676,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.28,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HBQMROYUNHRFSB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3780337,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.97,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HSMHBKPGNYWETC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL518421,LARICIRESINOL,COc1cc(C[C@H]2CO[C@H](c3ccc(O)c(OC)c3)[C@H]2CO)ccc1O,IC50,4.93,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,MHXCIKYXNYCMHY-AUSJPIAWSA-N,,Anticancer activity,SRB
CHEMBL258765,FASCAPLYSIN CHLORIDE,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,5.41,CHEMBL1000754,Antitumor activity against human SF295 cells,SF295,PWUOOJVYZQILBG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL470052,,O=C1c2ccc(Br)cc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,5.42,CHEMBL1000757,Antitumor activity against human SNB75 cells,SNB-75,OCNFGKRSWOZYBV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL573336,,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)ccc1O,IC50,4.6,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,QLJNETOQFQXTLI-JKUDBEEXSA-N,,Anticancer activity,SRB
CHEMBL442020,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(NCCCl)cc13,IC50,8.22,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,DNYPVNJKBKBXEJ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL267616,,COc1ccc(CC2CCc3nc(N)nc(N)c3C2)cc1OC,IC50,6.6,CHEMBL801267,Compound was tested for the growth inhibition of SF-295 CNS tumor cell line,SF295,XVXBYTNVUPDKPO-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4280638,,C#CCOc1ccc(-c2noc(-c3nnn(-c4cccc(/C(C)=N/O)c4)c3N)n2)cc1,IC50,5.48,CHEMBL5227635,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by XTT assay,U-87MG ATCC,IGQKYFPXTAJJLB-DHRITJCHSA-N,,Antiproliferative activity,XTT
CHEMBL2088450,,CC(C)(C)c1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,4.95,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QXRQXPBVPSBMGN-FDAWAROLSA-N,72.0,Cytotoxicity,MTT
CHEMBL2088449,,Cc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,5.3,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ICIKDUZNAHFGKF-LQKURTRISA-N,72.0,Cytotoxicity,MTT
CHEMBL2088444,,N#Cc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.01,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GTULBBSHIUDCMY-MUFRIFMGSA-N,72.0,Cytotoxicity,MTT
CHEMBL1096171,,CCCCCCCCCCCC(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.09,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,IRFFYKLEZMTNDZ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL118845,,CN(C)c1cc(Cl)nc2c1-c1nccc3ccnc(c13)C2=O,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,XFCAQNNNTPNSHA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL109640,,O=C1c2nc(O)ccc2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,7.4,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,AOLNSOSEKLYMGN-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL167656,,O=C(Nc1ccccc1)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.56,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,SGZFZFJELKXJQX-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL255273,PLAKORTIDE N,CC/C=C/[C@H](CC)C/C(=C/[C@@]1(CC)C[C@H](CC)[C@H](CC(=O)O)OO1)CC,IC50,6.52,CHEMBL982259,Cytotoxicity against human SF295 cells,SF295,HGRUNRAUYWALHI-XICUHNIJSA-N,,Cytotoxicity,Unspecified
CHEMBL352708,,CNC(=S)N(C)CCNc1c2ccccc2nc2ccccc12,IC50,5.74,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,LZXUHHGAOZIYPO-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL611449,Acridinylthiourea derivative and platinum conjugate,,IC50,6.12,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,,24.0,Unspecified,Unspecified
CHEMBL505354,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.5,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,ZUXYTKOTAAEJOQ-NPVSZXFSSA-N,,Cytotoxicity,Unspecified
CHEMBL364880,,CC1(c2ccccc2)CC(=O)C(C(CC(=O)c2ccc(-c3ccc(Br)cc3)cc2)c2ccccc2)=C(O)O1,IC50,5.17,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,LHCOZKWTLBDTFM-UHFFFAOYSA-N,72.0,Unspecified,Unspecified
CHEMBL608104,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12,IC50,5.12,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,ZAKWVBZLRDHTMB-MVWRLGRASA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL3942320,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(C)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.47,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LZTXLXNESZHMGZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3914319,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCCCC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.5,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGGJCBAGAPLUTL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3915419,,CCN(CC)Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1,IC50,5.31,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CFNRSEZJUZDEPX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3985191,,COc1ncc(-c2ccc3nccc(-c4ccc(C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,4.17,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MAMRHDZUBGCTFM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1963575,,C/C(=C\CN1CCC(Cc2ccccc2)CC1)c1ccc2ccccc2c1,IC50,4.22,CHEMBL3877506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay,U-87MG ATCC,MIAFBZYKYDZOOH-FYJGNVAPSA-N,24.0,Cytotoxicity,MTS
CHEMBL5408037,,CCC1=C(C)/C(=C/c2ccc(C3=NOB(c4ccccc4)N3)cc2)CCC1(C)C,IC50,4.22,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,IPRHEPMPQFDJAX-HEHNFIMWSA-N,72.0,Anticancer activity,Unspecified
CHEMBL3414623,,Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12,IC50,5.23,CHEMBL5676190,Antiproliferative activity against human T98G cells after 10 days,T98G,PNYRDVBFYVDJJI-UHFFFAOYSA-N,240.0,Antiproliferative activity,Unspecified
CHEMBL3809493,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(Cl)cc4Cl)n3)ccc21,IC50,4.43,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,HHUHKGMXFBBNPB-WSDLNYQXSA-N,48.0,Cytotoxicity,MTT
CHEMBL535,SUNITINIB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,4.22,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,WINHZLLDWRZWRT-ATVHPVEESA-N,48.0,Cytotoxicity,MTT
CHEMBL1643030,,OCc1c(CO)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.63,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,AZPVOZPYNPBHHA-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL4873418,,CC1CCN(CCCN2/C(=C/c3cc(/C=C/c4ccc(N(C)C)cc4)[n+](C)c4ccccc34)Sc3ccccc32)CC1.[I-],IC50,4.83,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,QXZRPPRUYIDRQX-UHFFFAOYSA-M,48.0,Antiproliferative activity,MTT
CHEMBL4283509,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)([O-])Oc1ccc[n+](Cc2ccccc2)c1)c1ccccc1,IC50,5.58,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,FGHKFVXFDAGVOZ-ISJGIBHGSA-N,48.0,Unspecified,MTT
CHEMBL4281560,,C[N+]1(C)CCC(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)CC1,IC50,5.17,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,VCGBTSXCGBGKNS-XUVXKRRUSA-N,48.0,Unspecified,MTT
CHEMBL4286859,,CCOC(=O)C[n+]1cccc2cc(OP(=O)([O-])OC[C@H]3O[C@@H](n4cc(F)c(=O)[nH]c4=O)C[C@@H]3OC(=O)c3ccccc3)ccc21,IC50,6.28,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,PTGXRXANBUIEOI-ISJGIBHGSA-N,48.0,Unspecified,MTT
CHEMBL4278613,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccc4ncccc4c3)O2)cc1F,IC50,4.97,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,GEUOSZWLJLGCAR-ARFHVFGLSA-N,48.0,Unspecified,MTT
CHEMBL2311028,PLERIXAFOR OCTAHYDROCHLORIDE,Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,IC50,6.16,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,UEUPDYPUTTUXLJ-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL1802333,,Fc1cnc(Cl)nc1NCc1ccc(CNc2ccnc(NCCN3CCOCC3)n2)cc1,IC50,9.1,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,GYIWMFHGPQGUIL-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL2037441,,C/C(=N/NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.17,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VHVSCHSQNUUXNS-BOPFTXTBSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037438,,C/C(=N\NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-VCHYOVAHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2035437,,O=C1SC(=Cc2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(Br)cc1,IC50,5.14,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,CLVMUFNPZQJGKR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL259778,,Cn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.46,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,CBLUYKNIXJXUAT-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL530333,,COc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.19,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,RWWHHCTYSWQXOA-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL523939,,CCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.92,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,PFNRWTLIQMEHPQ-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL524101,,O=C1NNC(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.3,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WTDZQIBHGGRTSN-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL460702,BMS-777607,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,IC50,6.8,CHEMBL963606,Antiproliferative activity against Met-driven human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,VNBRGSXVFBYQNN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL153117,,COC(=O)[C@@]12CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)C1=C(C(C)C)C(=O)C2=O,IC50,4.13,CHEMBL916479,Cytotoxicity against human U87-Mg cells after 72 hrs by MTT assay,U-87MG ATCC,SQNAVENFPQWCIW-YHXGQZGQSA-N,72.0,Cytotoxicity,MTT
CHEMBL2333166,WITHAMETELIN L,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3CC=C4CC=CC(=O)[C@]4(C)[C@H]3C[C@@H](O)[C@]12C,IC50,6.24,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,IZNYGGIUGIZTBU-MCMIQRFLSA-N,72.0,Cytotoxicity,MTS
CHEMBL399623,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.62,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,OHVJEOXDVIFIPO-KLVPPCHUSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL235552,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=C(O)C(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,SVLBCFOVBXXWGQ-PGUJVLSBSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL441133,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=C[C@@H](O)C[C@H](O)[C@]4(C)[C@H]3CC[C@]12C,IC50,4.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,YCACVYNVSOIKQK-HQCBQJEKSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL672,FENOFIBRATE,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,IC50,4.13,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,YMTINGFKWWXKFG-UHFFFAOYSA-N,120.0,Antiproliferative activity,MTT
CHEMBL269671,ARTEMISININ,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,4.79,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BLUAFEHZUWYNDE-NNWCWBAJSA-N,,Anticancer activity,sulforhodamine B
CHEMBL2385190,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.14,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XUQSXACLGZWVAU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2417830,,COc1ncc(-c2ccn3nc(N)nc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.75,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NCYIPUPGKOLGPL-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417827,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.67,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YQNNUPLNGSZSSB-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3290912,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.77,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RGVRGSUCXNJFEX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290925,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.65,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DBLRBWBNPSEDCB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290909,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.53,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HCMHGGVUBAQHQZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290903,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.84,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CIPWVHJQNZNVAN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL461455,PHENYLHEXYL ISOSELENOCYANATE,[Se]=C=NCCCCCCc1ccccc1,IC50,4.64,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,XPNZXCHCPXLBOM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL1096221,,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN(C(=O)OCc3ccc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c([N+](=O)[O-])c3)[C@H]1[C@H]2C,IC50,4.68,CHEMBL1105585,Cytotoxicity against human U87 cells assessed as viability in presence of beta glucuronidase,U-87MG ATCC,SWQHSMHFXZXJJZ-CTDLUEAJSA-N,,Cytotoxicity,Unspecified
CHEMBL85726,,COc1ccc(-c2cc3c(OC)cc(OC)c4c3n(c2=O)CCC4=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,IDBLOWQDUQJYDQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1822052,,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,7.36,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,NCRYSHBHDZWERB-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL1823655,,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1,IC50,6.62,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,TWAIYMKBHKNSRO-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL461242,PHENYLHEXYL ISOTHIOCYANATE,S=C=NCCCCCCc1ccccc1,IC50,4.58,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,VJNWEQGIPZMBMA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL94990,,N[C@H](C(=O)O)c1ccc(C(=O)O)cc1,IC50,4.82,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,VTMJKPGFERYGJF-ZETCQYMHSA-N,0.25,Unspecified,Unspecified
CHEMBL504590,,CC(C)C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,5.06,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,JFMPKUDKNYENDN-JCXJWVNZSA-N,,Cytotoxicity,Unspecified
CHEMBL4786701,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCCN(C)CC1,IC50,5.16,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,HKHJHRUYPCHLAP-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4764241,,COc1cc(N(C)CCN(C)C)ccc1Nc1cc(-n2c(SC)nnc2-c2ccc(F)cc2)ccn1,IC50,4.72,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,SYDRWCHBDRZZIX-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL331140,,CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.04,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KFNRGFZWGOCXDB-QVTSOHHYSA-N,,Unspecified,Unspecified
CHEMBL4792536,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccc(F)c(F)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YMNSSLGTRPIRCK-VAWYXSNFSA-N,72.0,Cytotoxicity,MTT
CHEMBL261406,,C[C@@]12CCC[C@H]1[C@@H]1CCc3cc(O)ccc3[C@H]1CC2,IC50,4.66,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,HJKVPZJVBHWFCQ-BDXSIMOUSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL323172,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1,IC50,9.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,YZDKZEBRKKYLLA-QCWLDUFUSA-N,,Unspecified,Unspecified
CHEMBL106299,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1,IC50,7.64,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,CHLLENYTSNHZGS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL106247,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1,IC50,8.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZVCMZXYHBQKEGX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL141699,,Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.05,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QVDCSAIULQECDK-VXKWHMMOSA-N,,Unspecified,Unspecified
CHEMBL111383,,O=C1c2nccc(Br)c2-c2nc3ccccc3c3ccnc1c23,IC50,6.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,ASOVTXPXTGIJGF-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL314461,,COc1ccc2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,AJLACADSVJJPJH-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL311795,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.3,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,HMBFXHIQISYDKM-RXVVDRJESA-N,,Unspecified,Unspecified
CHEMBL112938,,Nc1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,6.52,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,XSXOEAKXDLVRHU-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL262185,,CC(C)NC(=O)OCc1cnc2c(c1)C(=O)c1cccnc1C2=O,IC50,7.0,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,KXKUQHADQCKIQT-UHFFFAOYSA-N,,Cytotoxicity,using SRB
CHEMBL327101,MERIDINE,O=C1c2nccc(O)c2-c2nc3ccccc3c3ccnc1c23,IC50,7.0,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,QSJNAFJALFWFMT-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1807794,,Cc1c2c(n3c1CCCN(CCO)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.73,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,HGNIKZYVUYNHHF-ROUUACIJSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807796,,CC(=O)N1CCCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@@H]1C)CC(C)(C)CC3=O,IC50,7.54,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,MMJUEHBYHKCNKW-IRXDYDNUSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807810,,Cc1c2c(n3c1CCN(C(=O)[C@@H]1CCCN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.22,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KRHCYUXPGWYNDE-LZNRXBQRSA-N,,Antiproliferative activity,Unspecified
CHEMBL235658,,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL5227813,Antiproliferative activity against human A-172 cells assessed as cell growth inhibition,A-172,ODYAQBDIXCVKAE-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL111359,,Nc1ccnc2c1C(=O)c1c(-c3ccccc3[N+](=O)[O-])ccnc1C2=O,IC50,5.57,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,CJSJGUVEESPREB-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL355355,,COCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.08,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,FNSKSIHLYYLLCL-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5418077,,C[C@H]1[C@@H](OCCCN=C=S)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,5.13,CHEMBL5355864,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,U-87MG ATCC,MLDQCUOFTGHGFK-YRPRCUQKSA-N,24.0,Antiproliferative activity,MTT
CHEMBL3220497,,COc1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)ccc1N1CCOCC1,EC50,7.64,CHEMBL3226845,Inhibition of JNK in human U87MG cells overexpressing EGFR V3 mutant assessed as inhibition of c-jun phosphorylation after 6 hrs by ELISA,U-87MG ATCC,VWMWJCYJXWZIIP-UHFFFAOYSA-N,6.0,Unspecified,ELISA
CHEMBL4798177,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C,IC50,5.55,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,XLUPXFVZMAQDMF-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL2313430,,CCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,5.34,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,SFOKZRCSHDMJIN-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL1668772,TETRANGOMYCIN,C[C@]1(O)CC(=O)c2c(ccc3c2C(=O)c2cccc(O)c2C3=O)C1,IC50,4.92,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,UGEKKXLEYACFTD-LJQANCHMSA-N,72.0,Cytotoxicity,MTS
CHEMBL4088600,,OCc1cc2nc(N3CCOCC3)nc(N3CCOCC3)c2s1,IC50,4.76,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,GLFPUHMSENBNSW-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL502620,ACLARUBICIN,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,IC50,6.86,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,USZYSDMBJDPRIF-SVEJIMAYSA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL3290918,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HRQBMMWXFQEHJT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290914,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.84,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FUGCLUZTVAAXJZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290906,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.81,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,LWLZJKLPPDVLAK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290897,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.55,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VGRKYDDEIPUXGN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL517080,WITHAFERIN A,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,IC50,5.96,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,DBRXOUCRJQVYJQ-CKNDUULBSA-N,72.0,Cytotoxicity,MTS
CHEMBL211146,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(Cl)ccc2O1,IC50,4.7,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,IKNQZHCMDQZSRM-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL377467,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(Cl)ccc2O1,IC50,4.6,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YTCPAIDEHJAZKD-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2041938,,O=[N+]([O-])c1ccc(NC(=S)NC2CCOc3ccc(Cl)cc32)cc1,IC50,4.92,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SQWYPEJSOVZQSZ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1164920,ORIDONIN,C=C1C(=O)[C@]23[C@H](O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O,IC50,4.85,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SDHTXBWLVGWJFT-XKCURVIJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3114420,,CC1(C)CC(Nc2cccc([N+](=O)[O-])c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.82,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,FTSMYZOOTBACTI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3114580,,CC(=O)OC[C@H]1OC(n2cc(CNC3=C(Br)C(=O)c4ccccc4C3=O)nn2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.55,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,QTTGRWDUISDAAB-ZZSHGKAPSA-N,72.0,Cytotoxicity,MTT
CHEMBL111490,,COc1ccnc2c1C(=O)c1c(-c3ccccc3[N+](=O)[O-])ccnc1C2=O,IC50,8.05,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,LTRFHRPVICTOEZ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL5427348,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2cccc(c2)CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.24,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YXYFFJSLHXKPMN-NQAOGTSWSA-N,48.0,Unspecified,CCK-8
CHEMBL5421388,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2cccc(c2)CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,4.93,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,CNKSUTIROBOIQG-RZAATYBRSA-N,48.0,Unspecified,CCK-8
CHEMBL5420985,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CC1,IC50,7.29,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XPNXLSWGWUOGGX-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL3774830,,O=C1NC(=S)S/C1=C\c1ccc2c(c1)CCO2,IC50,5.25,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,DMARRXYRWLAEFB-POHAHGRESA-N,96.0,Growth inhibition,MTT
CHEMBL3775393,,O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1,IC50,6.25,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,TWNKLQGDXMYCCB-WTKPLQERSA-N,96.0,Growth inhibition,MTT
CHEMBL424062,,CCOC(=O)c1cnc2c(c1)C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.1,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,DXQRWLHHNFKEIY-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1956940,,CC1(C)C=C2[C@H]3CC[C@@H]4[C@@]5(C)[C@@H](O)C[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C)CC1,IC50,5.88,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,KDVPRLJVCKYSQH-VTNDHLKMSA-N,24.0,Cytotoxicity,MTS
CHEMBL486400,HEDERAGENIN,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.44,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,PGOYMURMZNDHNS-MYPRUECHSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430030,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.59,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GROQHEZXWUJYNW-ITUQRZNASA-N,72.0,Cytotoxicity,MTT
CHEMBL2435994,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.25,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RUUVFPINVYGROZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5625099,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc1OC,IC50,5.36,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,WIQORLYRHMAZDT-ACCUITESSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3092917,,COc1ccc(C)cc1-c1cnc(OCCCCc2ccccc2)n1C,IC50,4.36,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QEHBKBVTBLVVFM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3091478,,C=CCCCCOc1ncc(-c2ccc(Cl)cc2OC)n1C,IC50,4.17,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CYEGDZWVJCBGKM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093020,,C=CCCCCOc1ccccc1-c1cnc(OCCC=C)n1C,IC50,4.54,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,LLGUTQDLVOAKNI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL449662,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc([N+](=O)[O-])c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.17,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,DTONGMYGEYJMOI-ALMBTRMVSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL1914730,,COCCN(C)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.25,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FUCFMCKCHUSEOG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4649419,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccccc1F)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.34,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,CNFOIYQXNYBPAV-CDGBYUCFSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4780138,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc3c(c2)OCO3)c(C#N)c(=O)[nH]1,IC50,4.47,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,HQDOZLBOPMIXJO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4779518,,COc1cccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)c1,IC50,4.39,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KKPNBRPRPDPLGU-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4755715,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)cc1,IC50,4.45,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KUFVWOZIJULUNL-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4754798,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccc(OC)cc4)n3)s2)cc1,IC50,5.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,BGDAILDJTKTVIH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2441792,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccccc4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.47,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NHSFILSFIDLRNH-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL5413645,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(N)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,PXQGWUYSXHQDIU-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5432897,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.98,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,OBOCKVNQRVNBRB-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5428612,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)c([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,6.24,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,FIZYZDVSEWXTLH-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5399985,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)c(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,5.62,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YPWHWQRROPQOSJ-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5433188,,COc1ccc(OC)c(COc2cc(NC(=O)OCCOC(=O)Nc3ccc(NS(C)(=O)=O)c(OCc4cc(OC)ccc4OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.64,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YXAGTWTXTAUDDC-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL593102,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)/C(=N/O)CC[C@@H]12,IC50,5.03,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,UMLKYOVSAWJPRN-GHMDYAQKSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.88,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,QFJCIRLUMZQUOT-HPLJOQBZSA-N,,Growth inhibition,Unspecified
CHEMBL401930,,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IC50,4.12,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ZWVZORIKUNOTCS-OAQYLSRUSA-N,,Growth inhibition,Unspecified
CHEMBL2385191,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ZVBZTMFYJLZTIL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL233032,,c1cn(-c2ccc(OC3CCCN(Cc4ccc5c(c4)OCO5)C3)nn2)cn1,IC50,7.28,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,QYDFDUCNHWMTCI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL388205,,c1cn(-c2ccc(OC3CCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.38,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WZGVPRAMPUCENN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL232827,,c1cn(-c2ccc(O[C@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,8.05,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-FQEVSTJZSA-N,,Unspecified,Unspecified
CHEMBL2417826,,CNC(=O)CNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.14,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,QTECVRYSLYWJJR-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5647204,,CNC(=O)c1ccsc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1C(F)(F)F,IC50,4.72,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,MKBIQORJBNIRLJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5639183,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CCN3CCOCC3)cc2)ncc1C(F)(F)F,IC50,5.08,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,BOBPOIDIKAENTO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL368347,(+)-SECOISOLARICIRESINOL,COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.73,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,PUETUDUXMCLALY-HOTGVXAUSA-N,,Anticancer activity,SRB
CHEMBL1643045,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.47,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,QLPYMGMVXHHGBU-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL1643054,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.43,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RAXFEHNXHDODMX-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL1643055,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.64,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,JNCBRJVOHSEOEE-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL3621416,,CCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,5.24,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,CKJGDRTWQYHBIU-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL3621997,,CC(C)c1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.79,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MZRQTEJEOVDTGI-WOJGMQOQSA-N,72.0,Cytotoxicity,MTT
CHEMBL5208456,,c1c(CN2CCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.0,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,YKQMGFLWYMLIGV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2088460,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4ccccc4F)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.41,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QJAWHITZMMIWOZ-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL3113684,,Oc1ccccc1/C=N/Nc1cnc2ccccc2n1,IC50,5.64,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,NLKMOIDNHNAMNW-RQZCQDPDSA-N,,Cytotoxicity,MTT
CHEMBL307261,ARTENIMOL,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.27,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BJDCWCLMFKKGEE-ISOSDAIHSA-N,,Anticancer activity,sulforhodamine B
CHEMBL2037340,,CC(=NNC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL589653,,O=C(Nc1nonc1NC(=O)c1ccc(F)cc1)c1ccc(F)cc1,IC50,5.22,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,FCKWSGYBASHDGM-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL4103455,,Cc1cc(=O)n(-c2ccc(Cl)cc2Cl)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.03,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HIHRRZMJJHACOC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4098102,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1C#N)CC(C)(C)O2,IC50,4.17,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,SHACTFQJZVRJCP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4103408,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1[N+](=O)[O-])CC(C)(C)O2,IC50,4.66,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,OPURGIRJJYDWKL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4095651,,COc1ccccc1NC(=O)NC1CC(C)(C)Oc2ccc(NC(=O)OC(C)(C)C)cc21,IC50,4.41,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,OYCICINCMXZKDR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4571168,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC(C=O)C(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.51,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,XCSPRISAUMCZTK-FPEHZDRDSA-N,48.0,Cytotoxicity,MTT
CHEMBL1652066,,C=C1C(CCC(C)C)=C(OC2(CCC(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,4.99,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QGMKFDWGONDNEK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652069,,CCCC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.64,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YLXBHRSUAARBCT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652073,,CC1=C(OC2(C)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DXQUZSASIDQOJP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4447630,,CC1(C)O[C@@H]2O[C@@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@H]3OC(C)(C)O[C@H]3[C@@H]2O1,IC50,6.64,CHEMBL4407644,Anticancer activity against human SF295 cells by MTT assay,SF295,GYARFLWMYFKNBZ-ADFNPOGKSA-N,,Anticancer activity,MTT
CHEMBL2152332,,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.23,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,BDUHCSBCVGXTJM-IZLXSDGUSA-N,24.0,Cytotoxicity,MTT
CHEMBL4090785,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.26,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,WQEJHLGNLCVSNT-LRYQAZMXSA-N,24.0,Cytotoxicity,MTT
CHEMBL1604428,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1OC,IC50,4.61,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IVAFIHXRSKJQPF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4752105,,CN(C)c1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1,IC50,4.61,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IWOZRLGQTHWMKK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL600752,,Cc1cc(C)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c(C)c1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,JEXROXHHDBQUAA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4066684,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,6.12,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OBFGRWOUNPRHNH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4084417,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc([N+](=O)[O-])c1)CC(C)(C)O2,IC50,5.16,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,GZAYOKRLLIKITK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4060881,,COc1ccc(NC(=O)NC2CC(C)(C)Oc3ccc(NC(=O)OC(C)(C)C)cc32)cc1,IC50,4.31,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CUDQHCMXHDSLLN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4094692,,CC1(C)CC(NC(=O)Nc2cccc(C#N)c2)c2ccccc2O1,IC50,4.5,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,PHNOCAJDMIWLQZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1669589,CORNUSALTERIN A,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.76,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,XQBDRFMUTUDWCI-SXQODDTDSA-N,,Cytotoxicity,SRB
CHEMBL1669592,CORNUSALTERIN D,C=C(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.75,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,SPMYJZJNYRWSFW-ICRZDDGFSA-N,,Cytotoxicity,SRB
CHEMBL4472807,,O=C(/C=C/c1ccc(-n2cnc3ccccc32)cc1)c1cccc(O)c1,IC50,4.97,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,OFWLIONWWZAJBY-JLHYYAGUSA-N,72.0,Cytotoxicity,MTT
CHEMBL4464788,,O=C(/C=C/c1ccc(-c2cccnc2)cc1)c1cccc(O)c1,IC50,4.96,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,STIQSWSUIPGZMK-DHZHZOJOSA-N,72.0,Cytotoxicity,MTT
CHEMBL4483086,,COC(=O)c1cccc(/C=C/C(=O)c2cccc(O)c2)c1,IC50,4.71,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,VMGKJSSPDGSNLN-CMDGGOBGSA-N,72.0,Cytotoxicity,MTT
CHEMBL1824706,,N=C(N)NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCNC(=O)CCCC(=O)Nc2ccc(C3=NN=C(c4ccccn4)[C@@H]4CCC[C@@H](OCC[19F])CC[C@@H]34)nc2)NC1=O,IC50,6.71,CHEMBL1828410,Displacement of [125]I-echistatin from alphaVbeta3 integrin expressed in human U87MG cells by competitive binding assay,U-87MG ATCC,IJBAFUUBLIYJHQ-CZFZYNMESA-N,,Unspecified,competitive binding
CHEMBL1081296,,N[C@H](CNc1ncc(-c2ccc3cncnc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,5.89,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,UKXIKQXJARSCKC-KRWDZBQOSA-N,1.0,Unspecified,ELISA
CHEMBL3410525,,Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(C)cc3)C2=O)cc1,IC50,5.32,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,GIPGGNDYQHJDEB-AYKLPDECSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410524,,O=C1/C(=C/c2ccccc2)CS(=O)(=O)C/C1=C\c1ccccc1,IC50,5.29,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IYAJZHOOMHWDGK-JYFOCSDGSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410529,,N#Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(C#N)cc3)C2=O)cc1,IC50,5.87,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,XGNJMOWMCZCOSF-LQGKIZFRSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410538,,CCOC(=O)C1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C(=C/c2ccc([N+](=O)[O-])cc2)C1,IC50,5.61,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,OTVIWKDZSAWVIQ-JYFOCSDGSA-N,48.0,Cytotoxicity,resazurin
CHEMBL348877,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CNC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.15,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,YUYPWAMLWZVHAE-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410540,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CSC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.94,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,JFBLEOXWBXYUCR-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL1643041,,CCNC(=O)OCc1c(COC(=O)NCC)c2n(c1C)Cc1ccccc1C2,IC50,4.86,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RTMHDNWDEYRLSD-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL5268484,,C/C=C/Cn1cc(-c2cc(OC)c(C(=O)N3CCOCC3)cc2OC)c2cc(C)[nH]c2c1=O,IC50,5.3,CHEMBL5262595,Cytotoxicity against human T98G cells measured after 3 days,T98G,FWTDDBIMDSVPTR-AATRIKPKSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL5574581,,COc1ccc(-c2snnc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,6.72,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,OCKCVMKASHLWDW-UHFFFAOYSA-N,72.0,Antiproliferative activity,Alamar Blue
CHEMBL5562675,,CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.69,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UTAMAXPWOHAKSY-SNVBAGLBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5561771,,Cc1ccc(S(=O)(=O)N[C@H](CCC(N)=O)C(=O)O)cc1,IC50,4.7,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YDNYEJZZJXFADP-SNVBAGLBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1683552,,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@@H](CN4CC(C)CC(C)C4)OC)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C,IC50,10.0,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,FVFOJNUMEBZYQA-IMUPSJILSA-N,,Antiproliferative activity,Unspecified
CHEMBL1668106,DEOXYFLINDISSONE,CC(C)=C[C@H]1C[C@@H]([C@@H]2CC[C@]3(C)C4=CCC5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)CO1,IC50,5.29,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WAGHSYJXJAHWPX-XZXIZOHXSA-N,,Cytotoxicity,SRB
CHEMBL5431418,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N(C)C)CC2)n1,IC50,5.96,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,PWNNFZVPGJMZEG-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL2398330,,COc1ccc(C(=O)Nc2ccc(N(C)S(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.5,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,LNDXEXUTQMQCLA-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4788798,,CCS(=O)(=O)N(C)c1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.09,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,FIQDGCIYCNETRN-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1956924,,CO[C@@H]1O[C@@]2(CO)CC[C@@]13CC[C@]1(C)[C@H](C[C@@H](O)[C@@H]4[C@@]5(C)CC[C@H](O)[C@](C)(CO)[C@@H]5CC[C@]41C)[C@@H]3[C@]2(C)O,IC50,5.48,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,MECPBJHFIZSOAJ-IZSUBYBESA-N,24.0,Cytotoxicity,MTS
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,7.01,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JSKUWFIZUALZLX-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1914729,,COCCNc1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.27,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CCTIPTYZBUJCCE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914733,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCC4CCCNC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.57,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,NMRMRRLTZFLVMO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914947,,O=S(=O)(Nc1cc(-c2ccc3ncc(-c4ccncc4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.62,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,URZNQWWEAQTUIM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3335770,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cc(F)c(F)c(F)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.04,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,DAMPDFDFNFIDMJ-QFIPXVFZSA-N,72.0,Cytotoxicity,WST8
CHEMBL584746,,CC1(C)OC2c3ccccc3C(=O)C(=O)C2C1Nc1ccc(Cl)c(Cl)c1,IC50,5.31,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QVEMLFNIOZASOI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL561201,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C[C@H]3[C@](C)(OC(C)=O)CC[C@@H]12,IC50,5.51,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NEBROCOVJBQSTF-IUPKNAOTSA-N,72.0,Cytotoxicity,MTT
CHEMBL343482,,CN1CCN(c2nc(-c3ccccc3)cc3ccccc23)CC1,IC50,4.73,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,IWNXRLLJQNKLRQ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2012805,,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CS)NC1=O,IC50,5.22,CHEMBL2016103,Antiviral activity against Human immunodeficiency virus type 1 SF162 pseudovirus expressing envelope glycoprotein 160 infected in human U87 cells after 48 hrs by luminometric analysis,U-87MG ATCC,OAGGTYVPCYVCMS-POFDKVPJSA-N,48.0,Antiviral activity,Unspecified
CHEMBL509514,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5Cl)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.0,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ALGAIOAAAOKMBW-GVGYXHIPSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL4094631,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(C(F)(F)F)c1)CC(C)(C)O2,IC50,4.68,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ISDJDFNLNBGKFY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3774518,,O=C(Nc1cc(-c2cccnc2)nc(NCCCN2CCOCC2)n1)c1cc(Br)cc(C(F)(F)F)c1,IC50,5.82,CHEMBL3777262,Cytotoxicity against human SNB75 cells after 24 hrs by SRB assay,SNB-75,SWGHSHOUMNMZNI-UHFFFAOYSA-N,24.0,Cytotoxicity,SRB
CHEMBL4466566,,CC(C)[C@@H]1CC[C@]2(C)C1=CC[C@]1(C)[C@H]3CC[C@@]4(C)O[C@H]([C@H]4O)[C@]3(C)[C@@H](O)C[C@H]12,IC50,4.79,CHEMBL4393484,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,NLVZPTYDJZNGCY-OVZDKSCUSA-N,48.0,Cytotoxicity,MTT
CHEMBL238100,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ccccc12,IC50,6.37,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,XZADTAXOFGSUFI-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL3262851,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3Cl)cc2F)ccn1,IC50,5.92,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASXICJDAFDMINP-AMVVHIIESA-N,72.0,Cytotoxicity,MTT
CHEMBL3262853,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(Cl)cc3Cl)cc2F)ccn1,IC50,5.63,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RXRDEPGMDFYQTQ-AMVVHIIESA-N,72.0,Cytotoxicity,MTT
CHEMBL333225,,CN(C)CCNc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,QJOCISBWQLZIJK-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL121878,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(Cl)cc13,IC50,6.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,RDOBSVYAIZUPAY-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1976714,,CC1=CC2=C(C=O)C(=O)[C@](C)(O)[C@@H](O)C2=CO1,IC50,4.55,CHEMBL3107274,Cytotoxicity against human SF295 cells by colorimetric method,SF295,QVMUHZHZYCDMAI-RYUDHWBXSA-N,,Cytotoxicity,colorimetric
CHEMBL1366503,,COc1ccc(CC(=O)NCc2ccccc2)cc1,EC50,5.5,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,AODURBKQPXZTLP-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3104959,,CC(=O)O[C@H]1C2=COC(C)=CC2=C(C=O)C(=O)[C@]1(C)OC(C)=O,IC50,4.58,CHEMBL3107274,Cytotoxicity against human SF295 cells by colorimetric method,SF295,QVXVIOCTOACBNT-HOTGVXAUSA-N,,Cytotoxicity,colorimetric
CHEMBL3093021,,C=CCCCCOc1ccc(C)cc1-c1cnc(OCCC=C)n1C,IC50,4.03,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DWYSYKYKDCSKNC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL4175621,,O=C1c2ccccc2C(=O)c2c(-c3cccc4c3OCO4)coc21,IC50,5.43,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CBLDQKDCGPUTCM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5410443,,COc1ccc(SC2=CC(=O)c3cccc(O)c3C2=O)cc1,IC50,4.78,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,OVZPYFOIGDYLFC-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL3121278,,CCOc1ccc(Nc2nc(-c3c(C)nc4sccn34)cs2)cc1,EC50,7.52,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,GFBWFHBEQJJBIU-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121273,,COc1ccc(Cl)cc1C(=O)N1CC(=O)Nc2ccccc21,EC50,6.19,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,GHDXFDQEPFAWSR-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL4438947,,O=C(/C=C/c1ccc(B(O)O)cc1)c1ccccc1,IC50,4.49,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,GJEUTIGMSWDODK-DHZHZOJOSA-N,72.0,Cytotoxicity,MTT
CHEMBL4520670,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)c1,IC50,4.94,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IRTWUJOEIWQCHP-FNORWQNLSA-N,72.0,Cytotoxicity,MTT
CHEMBL5565051,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,IC50,5.4,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DRGUAWBWMQFXCR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5566977,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNC(=O)CN(C)Cc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.29,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMROOFNFVYWIQS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL98745,NARCICLASINE,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,IC50,7.01,CHEMBL998497,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,LZAZURSABQIKGB-AEKGRLRDSA-N,,Antiproliferative activity,MTT
CHEMBL1802329,,CCOCCN1CCN(C(=O)c2cnc(NCc3ccc(CNc4ncc(F)cn4)cc3)nc2C(F)(F)F)CC1,IC50,8.27,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,HKDAUWBQNJQYOP-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL2418954,,CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1,EC50,7.3,CHEMBL2423270,Inhibition of PI3 kinase in human U87MG cells assessed as inhibition of AKT phosphorylation at ser473,U-87MG ATCC,TVUPSIBSWDXJGQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4545456,,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,EC50,6.28,CHEMBL4387158,Antiproliferative activity against human T98G assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,T98G,KMRYRPPWJDYHAL-QGZVFWFLSA-N,120.0,Antiproliferative activity,CyQuantGR dye-based fluorescence
CHEMBL2064814,,CC(=O)O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@]2(C)CC[C@H]([C@](C)(O)CCCC(C)(C)O)[C@@H]12,IC50,4.46,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,NHBPWNBEBHAAIP-ADZWRMKASA-N,48.0,Antiproliferative activity,MTT
CHEMBL342647,,Oc1nc(-c2ccc3c(c2)OCO3)cc2ccccc12,IC50,5.57,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,REBBEBMIHXXSMZ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL124546,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(Br)cc13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,IEMDEAMHQYKMCM-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL122076,,Nc1ccc2nc3c4c(nccc4c2c1Br)-c1ncccc1C3=O,IC50,7.1,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,VRNDCSQPEDETKM-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1807791,,Cc1c2c(n3c1CCNC[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.4,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,BDFNVHFLLPLTRV-ZBFHGGJFSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807792,,Cc1c2c(n3c1CCCN(C)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.88,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,XXAWNLULHYRRBI-IRXDYDNUSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807793,,Cc1c2c(n3c1CCN(C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.31,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,UYHYKUQARKBKHF-WBVHZDCISA-N,,Antiproliferative activity,Unspecified
CHEMBL1807807,,Cc1c2c(n3c1CCN(C(=O)C(C)(C)N)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.41,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RXKNSFZSSAIGRV-AEFFLSMTSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807808,,Cc1c2c(n3c1CCN(C(=O)C1(N)CC1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.07,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RENRGENBCMHTBB-AEFFLSMTSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807811,,Cc1c2c(n3c1CCN(C(=O)[C@H]1CCCN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.57,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KRHCYUXPGWYNDE-ZWCUEREDSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807812,,Cc1c2c(n3c1CCN(C(=O)[C@H](C)O)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WGTWKBHDMIJGNZ-NJAFHUGGSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807813,,Cc1c2c(n3c1CCN(C(=O)[C@@H](O)C(C)C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.12,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZRAYVGSXRWTSBW-QZXAKIBKSA-N,,Antiproliferative activity,Unspecified
CHEMBL340160,ASCIDIDEMIN,O=C1c2cccnc2-c2nccc3c2c1nc1ccccc13,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,BTAIBIXHXSXUFN-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2024160,,Oc1ccc2[nH]cc(C(c3ccc(C(c4c[nH]c5ccc(O)cc45)c4c[nH]c5ccc(O)cc45)cc3)c3c[nH]c4ccc(O)cc34)c2c1,IC50,5.56,CHEMBL2027285,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,JDESIJRAHSFINB-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1956190,,Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cn1cc(NC(=O)CC[S+](C)C)cc1-c1nc2cc(C(=O)Nc3ccc(N(CCCl)CCCl)cc3)ccc2[nH]1,IC50,6.15,CHEMBL1958537,Growth inhibition of human SF295 cells,SF295,FGDAMRJAQQORJV-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL1949931,,C=C1CCC(=O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.3,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KZCDZBRUJRDWLZ-RVYHWVNWSA-N,72.0,Antiproliferative activity,MTS
CHEMBL2430031,,CC[C@H]1O[C@@H](O[C@H]2CO[C@@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,IC50,5.23,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YVZJSSFXXNLBHY-LNBDOPGKSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430029,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,5.65,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YMUVECXYJPPWBW-ZQPXAOBSSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430032,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.54,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LKXSEJWOAPOCIO-SIOYIREESA-N,72.0,Cytotoxicity,MTT
CHEMBL565966,SCHISANTHERIN A,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1O)OCO3)C[C@H](C)[C@](C)(O)[C@H]2OC(=O)c1ccccc1,IC50,4.0,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VJGNXZQPNWMFAQ-SSEZWIOCSA-N,72.0,Cytotoxicity,MTT
CHEMBL2313858,,CCCCCCCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.16,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VOPUILLVARXVAT-LUXASXKVSA-N,72.0,Cytotoxicity,MTT
CHEMBL5279512,,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,4.88,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,HLTROIQLCAEASX-HLKALLPASA-N,4.0,Cytotoxicity,MTS
CHEMBL3578214,,Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1,IC50,7.13,CHEMBL3580215,Anticancer activity against human U87 cells assessed as cell growth inhibition after 20 to 70 hrs by Real-time RTCA iCELLgence system,U-87MG ATCC,VMTZCKPMAFGPEN-UHFFFAOYSA-N,70.0,Anticancer activity,Unspecified
CHEMBL141075,,CN1CCN(c2nc(-c3ccccc3)cc3c(N(C)C)cccc23)CC1,IC50,5.02,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,LVIPDHQIBOMSFK-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL1928601,,COc1c2c(c(OC)c3ccccc13)[C@H]1Oc3ccccc3[C@H]1CO2,IC50,4.65,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,ADFKBBNAHGKEAQ-BEFAXECRSA-N,72.0,Unspecified,MTT
CHEMBL2037140,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.54,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,JJWCPJDPEMMMMR-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037141,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.13,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,SLNLXKMQVSYVRR-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037440,,C/C(=N\NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PTOHINKLMXPSKL-LICLKQGHSA-N,48.0,Cytotoxicity,MTT
CHEMBL2037342,,CC(=NNC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.19,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NRNNRLWHLIPYQW-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL534423,,CC(=NNC(S)=Nc1ccccc1Cl)c1ccccn1,IC50,8.96,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,DIAIPLSVPPGTLG-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL1725990,,CC(=NNC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,7.51,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,QJEQNMXYYQUOAY-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL478110,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(Cl)cc1,IC50,5.88,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SDMKQOWHXHPBLL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL569228,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)NCCCN3CCN(CCCNC(=O)CC[C@H]4O[C@@H]5O[C@]6(C)CC[C@H]7[C@H](C)CCC([C@H]4C)[C@@]57OO6)CC3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,6.34,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,JVHGAAKZMCRLRS-APGVTMGHSA-N,,Anticancer activity,sulforhodamine B
CHEMBL4458861,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1C,IC50,6.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,GMHBADQJCABDJH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4590434,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1OC,IC50,5.79,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,JIORUMFDOIOVJQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL603675,,CC(C)(C)c1ccc(CC2(N)CCN(c3ccnc4[nH]ncc34)CC2)cc1,IC50,8.19,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,ZSPYHLIIAPFXSZ-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL4438250,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1F,IC50,6.16,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,WXNYEPSDUHRGAY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4560662,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2O)nn1,IC50,5.12,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,LZPJQBTUNHVIHV-HOINCJJXSA-N,72.0,Cytotoxicity,SRB
CHEMBL2164700,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,6.39,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FNEBMMOEXCTUNT-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2165020,,COc1ccc(Nc2ncc(CC3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.27,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IMXXTFKFHMPFMA-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165019,,COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.34,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,UZUPOMTXPRNVLO-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL493083,,Cc1cc2nc(-c3cccc(O)c3)nc(N3CCOCC3)c2s1,IC50,6.0,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,IAAWZHBLOYYROY-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL4126709,,Nc1n[nH]c2nc3cc(Cl)ccc3cc12,IC50,4.23,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,SAPWXFJDVCRSKW-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4127746,,Nc1n[nH]c2nc3c(ccc4ccccc43)cc12,IC50,4.26,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,KPDJPPWWQTYBRP-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL448558,LANTALUCRATIN B,C=C(C)C1CC2=C(O1)c1cccc(O)c1C(=O)C2=O,IC50,5.72,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,WKLGYQWVPPIRFC-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL493290,,COCCN(C)Cc1cc2nc(-c3cccc(O)c3)nc(N3CCOCC3)c2s1,IC50,6.38,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,HAUSIZJQROQUOS-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL447293,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5C)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.02,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,GRYDWYKJDXLYKW-MHTDFPPDSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL4763301,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)C2=C[C@@]3(C(=O)N(C)c4ccccc43)C(=O)N21,IC50,5.14,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,PLQBGVIHNRFEKK-FGTQWKHKSA-N,,Antiproliferative activity,SRB
CHEMBL4166594,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1,IC50,6.6,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,IEDGFXCUFJCEAP-UHFFFAOYSA-N,96.0,Cytotoxicity,MTT
CHEMBL514351,,Cc1ccc(NCc2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,5.0,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,HIRRHXZKTMZOHN-PKNBQFBNSA-N,72.0,Cytotoxicity,alamar-blue cell viability
CHEMBL4529472,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(OC)cc43)S2)cc1,EC50,6.17,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SXHQACGBIOZRKH-ZIADKAODSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4440176,,CCOP(=O)(OCC)C(N(OC(C)c1nccn1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,INXHFCOUUUGHJG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4871838,,O=S(=O)(Nc1cc(-c2ccc3nncc(-c4cnc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1,IC50,6.58,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JDQJRYKTFFQLMZ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL3780278,,O=c1oc2ccc(-c3cnc4ccccc4c3)cc2c2c1[nH]c(=O)n2-c1ccccc1,IC50,4.45,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LVSBOXRWFDUGKX-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3780267,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccncc5)cc4c32)cc1,IC50,4.44,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ALCXWEWOCSHWQS-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3780660,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cccnc5)cc4c32)cc1,IC50,4.59,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LSNCVXRDSDKEFL-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3781715,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccncc5)cc4c32)cc1,IC50,4.54,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GBZAAXXFXRMRAP-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3764611,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccccc2F)nn1,IC50,4.32,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RKLRFKNYTRWJAM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3763427,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc([N+](=O)[O-])cc2)nn1,IC50,4.48,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RBTLETQAAVLDLV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4437426,,CO/C1=C\CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@@H]2C[C@H](OCc3cn(C[C@@H]4O[C@H](O)[C@@H](O)[C@H](O)[C@H]4O)nn3)O[C@@H]12,IC50,4.9,CHEMBL4432289,Cytotoxicity against human U87 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay,U-87MG ATCC,KUMDGGQDLPKBIB-ASWBBHMMSA-N,72.0,Cytotoxicity,sulforhodamine B
CHEMBL4760262,,Cc1nn(C)c(Oc2cccc(F)c2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.01,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LYZWYIFVGJYHFM-UHBFCERESA-N,72.0,Antiproliferative activity,MTT
CHEMBL4751883,,Cc1nn(C)c(Oc2ccc(Br)cc2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.82,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GWDBAGVHQLBYBE-UHBFCERESA-N,72.0,Antiproliferative activity,MTT
CHEMBL4756515,,Cc1nn(C)c(Oc2ccc(Cl)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.42,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VTCBPYADQWPZMH-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4593656,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(CNc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(N)nc2=O)C1(F)F,IC50,5.34,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,YOROBEOGIMLFGN-YFYJLLRASA-N,72.0,Cytotoxicity,SRB
CHEMBL43612,JUGLONE,O=C1C=CC(=O)c2c(O)cccc21,IC50,5.13,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,KQPYUDDGWXQXHS-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,6.44,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N,132.0,Antiproliferative activity,CCK8
CHEMBL1782898,,CCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.0,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZUNBZSJIGSBNJN-GVQBMFDGSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782907,,CCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.75,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,GPLLOVYREUOHFC-ULBKPHCJSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782897,,CCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.62,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,PKYDWSNOPPOHAE-ULBKPHCJSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL5267325,,CCOC(=O)[C@H]1[C@@H](NO)[C@@H]2c3ccccc3OC(C)(C)[C@H]2[C@H](O)[C@]12C(=O)Nc1ccc(F)cc12,IC50,4.38,CHEMBL5235657,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,IVDOKEMXWIICJE-XNZMQEADSA-N,48.0,Anticancer activity,MTT
CHEMBL5289048,,COc1ccc(/C(C)=C/CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,7.69,CHEMBL5225165,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,PTGWAAKNSYOHMB-WOJGMQOQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5560649,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DMOOGJIRMQGHML-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5555620,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.47,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FRCYUJLTCPHQMY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4285772,,CC[N+](CC)(CC)CCCCCCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,6.96,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,JPHZPBLJNRODIE-LTRPLHCISA-M,72.0,Antiproliferative activity,MTS
CHEMBL4176771,,COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.55,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,YLPQMLSKPUQHLB-QGZVFWFLSA-N,96.0,Cytotoxicity,MTT
CHEMBL4166144,,COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.92,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,FEHPMLVVSQNYOF-UHFFFAOYSA-N,96.0,Cytotoxicity,MTT
CHEMBL3793543,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCSCC1,IC50,4.6,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,USUALIZBISSRTB-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3793099,,CN1CCN(CCCCCCN2c3ccccc3Sc3cccnc32)CC1,IC50,4.8,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,FKGCIKNEJVJXTO-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3792772,,O=[N+]([O-])CCCCCCN1c2ccc(F)cc2Sc2cccnc21,IC50,4.5,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,PCSDEWNPQINATA-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3291068,,CCC1=C[C@@H]2CN(C1)C[C@H](CN1CCC[C@H]1C(=O)N[C@H](C(=O)OC)[C@@H](C)CC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.4,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,MCGMYWJVQYWGBF-WDOZCWQQSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4204920,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,6.02,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HFSWCNDZVPIIOF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3609553,,Cc1ccc([Se]C2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.02,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,CUAJPFMTSQUMCC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3400565,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(C=O)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.92,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,UBXMGYCFGXRKKK-KYOITVBSSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3426484,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(C=O)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.36,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,QUHOWUGRZVTLAK-CBFGRJNTSA-N,24.0,Cytotoxicity,MTT
CHEMBL3810407,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(F)cc4)n3)ccc21,IC50,4.79,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,DGVVXRGLEZWRQX-OEAKJJBVSA-N,48.0,Cytotoxicity,MTT
CHEMBL3808776,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(C(F)(F)F)cc4)n3)ccc21,IC50,4.59,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,OEYIHBVDTVJSJG-OEAKJJBVSA-N,48.0,Cytotoxicity,MTT
CHEMBL169169,,CCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.86,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,GBYYUYBZZWBZIP-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4292222,,O=C(COc1ccc(/C=C/C(=O)c2ccc(F)cc2)cc1)Nc1ccc2c(c1)COC2=O,IC50,5.22,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SAESZHBCOSRELJ-KGVSQERTSA-N,48.0,Cytotoxicity,MTT
CHEMBL4286698,,Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1,IC50,6.04,CHEMBL4276487,Growth inhibition of human T98G cells after 72 hrs by ATPlite based assay,T98G,UGDKPWVVBKHRDK-UHFFFAOYSA-N,72.0,Growth inhibition,ATPlite based
CHEMBL424549,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(Cc1ccccc1)C(=O)OCc1ccccc1,IC50,5.93,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,BXUCUCJMGQGAGS-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL168489,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(CCOC(C)=O)C(=O)OCc1ccccc1,IC50,4.73,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,FKFWJXGEBAKAOB-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4295010,,O=C(/C=C/c1ccc(Oc2cc(=O)oc3ccccc23)cc1)/C=C/c1cccnc1,IC50,4.43,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,FDNNBTZTUHPFMX-MKICQXMISA-N,48.0,Antiproliferative activity,MTT
CHEMBL4451749,,COc1cc(/C=C/C(=O)Nc2cccc(OCC3CCNCC3)c2)ccc1O.Cl,IC50,4.51,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NHIRLIGCPAUYLZ-WVLIHFOGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4453750,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.67,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BKHJEJHQMSABBI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3113706,,O=[N+]([O-])c1ccc(O)c(/C=N/Nc2cnc3ccccc3n2)c1,IC50,5.68,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,PPXNOINSRNIZRH-CAOOACKPSA-N,,Cytotoxicity,MTT
CHEMBL2436000,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5C)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.69,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LKJFGAFEPSNWPJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385188,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.92,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QABSXSLQFVTLTK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385202,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NCZHZMPXMHJOKE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385206,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Br)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.8,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QVRRVDVQZFLJPI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385176,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.83,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YRIRNSUDWILAQP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385198,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.9,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YXHJZCCPKMMPDW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392824,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)cc1,IC50,6.03,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ACLUFQYNCIXYPM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392942,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.04,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HJPZKRAXGGLLCM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4060213,,CCCCNc1nc(SC)nc2c1ccn2Cc1ccc(F)cc1,IC50,4.68,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,FQVMTUKCTPYSEC-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL2297275,,COc1cc(OC)c2c(NCc3ccccc3)cc(-c3ccccc3)nc2c1,IC50,5.15,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,ZCOHSLDTKONWKK-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL2297272,,COc1cc(OC)c2c(N3CCN(C)CC3)cc(-c3ccccc3)nc2c1,IC50,5.76,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,PLIQXFGTHSMWHJ-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL2297268,,CCCCNc1cc(-c2ccccc2)nc2cc(OC)cc(OC)c12,IC50,5.41,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,PDUABDJEEBIIKK-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL3781720,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccccc5)cc4c32)cc1,IC50,4.5,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LITPROVKGQYSLW-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1230020,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,IC50,4.29,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,YZDJQTHVDDOVHR-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2165052,,Cc1nc(N)nc(-c2cccnc2Nc2cccc(O)c2)n1,IC50,7.22,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,ITUBWSOGJQVWCJ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2375552,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C2CCCCC2)nn1,IC50,5.5,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,DNRCXULLPXOXGG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2375476,,CCC(C)(O)c1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,IC50,5.38,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ZFNUJYXVCGAIRX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262845,,Cn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3)cc2F)ccn1,IC50,4.44,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GPPWMADCPAEKSN-DHRITJCHSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262860,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)cc3)cc2F)ccn1,IC50,5.11,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VUTCCEJQYPCNLA-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL3262865,,Cc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)cc(C)c1O,IC50,5.11,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HSWWIQFCGIMTQE-FJEPWZHXSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262866,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cc(C(C)(C)C)cc(C(C)(C)C)c3O)cc2F)ccn1,IC50,6.28,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GTNVXSUZBLAROW-ODNPBWNPSA-N,72.0,Cytotoxicity,MTT
CHEMBL3263122,,COc1ccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c(OC)c1OC,IC50,5.12,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FXSLJSRWXCSNNE-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL3263125,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc4c(c3)OCO4)cc2F)ccn1,IC50,6.14,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JUKOZSDIACGIFL-IPPBACCNSA-N,72.0,Cytotoxicity,MTT
CHEMBL2348724,,Nc1n[nH]c(=O)c2ccccc12,IC50,5.22,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,IUBSMBJKUKVEMK-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL3986488,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1nnc(-c2ccccc2)c1I,IC50,5.55,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,UXBPRHGBARQXMO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3911886,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1nncc1-c1ccccc1,IC50,5.55,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,CCTAXCDYRZFLMW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3901778,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nncc1-c1ccccc1)O2,IC50,5.11,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,GPKASGONNYIPKG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3952951,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3=CCCCC3)nn1)O2,IC50,5.63,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,WOWMAWBIEUQPCI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3806140,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.94,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,MJCYXBGMYBXSHF-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793270,,BrCCCCCCN1c2ccc(Br)cc2Sc2cccnc21,IC50,5.05,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZFSLTURYGVDXIY-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3793661,,CC(=O)N1CCN(CCCCCCN2c3ccccc3Sc3cccnc32)CC1,IC50,4.68,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZXKPHFCJOIZGBZ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3092925,,C=CCCCCOc1ncc(-c2cc(C(C)C)ccc2OC)n1C,IC50,5.22,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,XXAGNOIZVPRFLM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092928,,C=CCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.41,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,VOLSTGCHRLWGMM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092933,,C=CCCCCCOc1ncc(-c2ccccc2OCCCCC=C)n1C,IC50,4.2,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DMTIIWJTCDCVEM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093016,,C=CCCCCOc1cc2ccccc2cc1-c1cnc(OCCC=C)n1C,IC50,4.5,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,RUEBIOFSSXTYMQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL180127,SALUBRINAL,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,IC50,4.29,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,LCOIAYJMPKXARU-VAWYXSNFSA-N,,Growth inhibition,Unspecified
CHEMBL3416185,,COc1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2cc1OC,IC50,5.3,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QXZWVYUEPCJXSN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3414588,,COc1cc2nc(-c3ccc(OC)c(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.72,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RRSGTZKCGTZSHE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL305942,FAGARIDINE,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1O,IC50,5.95,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,RSCIYYHIBVZXDI-UHFFFAOYSA-O,,Cytotoxicity,Unspecified
CHEMBL3121274,,COc1cc(OC)cc(C(=O)Nc2ccc(I)cn2)c1,EC50,5.88,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KPZBBEOAWINKFP-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3262847,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(Cl)cc3)cc2F)ccn1,IC50,5.86,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JFZSKKWSBXCPGI-WKULSOCRSA-N,72.0,Cytotoxicity,MTT
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],EC50,6.41,CHEMBL4810919,Cytotoxicity against human U-87MG cells assessed as reduction in total cell count measured after 96 hrs by Hoechst staining analysis,U-87MG ATCC,QTRZVIIDNJPRSU-UHFFFAOYSA-N,96.0,Cytotoxicity,Unspecified
CHEMBL2381447,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc8c(c7)OCO8)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.75,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,LLYHHQGLZTYOIO-FEOXQYHVSA-N,48.0,Cytotoxicity,SRB
CHEMBL4854987,,COc1cc(C(=O)c2cn(-c3ccc(F)cc3)cc2-c2ccncc2)cc(OC)c1OC,IC50,7.41,CHEMBL4838790,Cytotoxicity against human U-87MG cells assessed as cell growth inhibition measured after 48 hrs by MTS colorimetric assay,U-87MG ATCC,HSFUMBZPJRQQBQ-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS colorimetric
CHEMBL1760588,BERBIKONOL,COc1ccc([C@H](O)[C@@H](CO)Oc2c(OC)cc([C@@H]3Oc4c(OC)cc(CCCO)cc4[C@H]3CO)cc2OC)cc1OC,IC50,4.71,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ABIOAIYWIAGXDZ-JZQDODDWSA-N,,Anticancer activity,SRB
CHEMBL1760589,FICUSESQUILIGNAN A,COc1cc([C@@H](O)[C@H](CO)Oc2ccc([C@@H]3OC[C@@H]4[C@H]3CO[C@H]4c3cc(OC)c(O)c(OC)c3)cc2OC)ccc1O,IC50,5.02,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,PFZFCRCFYYFTPE-RWMYVIIASA-N,,Anticancer activity,SRB
CHEMBL1760594,,COc1cc([C@@H]2c3c(cc(OC)c(O)c3OC)C[C@H](CO)[C@H]2CO)cc(OC)c1O,IC50,4.58,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ZDVZKBOFCHOPLM-LBTNJELSSA-N,,Anticancer activity,SRB
CHEMBL455365,,COc1cc([C@H]2c3c(cc(OC)c(O)c3OC)C[C@@H](CO)[C@@H]2CO)cc(OC)c1O,IC50,5.15,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ZDVZKBOFCHOPLM-SUNYJGFJSA-N,,Anticancer activity,SRB
CHEMBL1760597,,COc1ccc(CC(=O)O)cc1,IC50,4.55,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,NRPFNQUDKRYCNX-UHFFFAOYSA-N,,Anticancer activity,SRB
CHEMBL2392951,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)cc1,IC50,5.96,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MRZXKRZICOTLCN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4080532,,Cc1cc(=O)n(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.72,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YAHBWSUTJNPKIT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4093275,,Cc1cc(=O)n(-c2ccccc2F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.2,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUJPISNEJSVWCB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5592590,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N[C@H]1CCNC1)C3,IC50,5.29,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PREHDGJVTUBHPV-NSHDSACASA-N,72.0,Antiproliferative activity,MTT
CHEMBL5555258,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N1CCC(N2CCCCC2)CC1)C3,IC50,5.55,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DOVUGJIPCTTWJH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4575746,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.37,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VLELOJUMXNTMDJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4441090,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.27,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CGCPUDDQPHXYNV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4098763,,CSc1nc(NCCc2ccc(Cl)cc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.34,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,WIHTVIAVTFAFHD-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3621994,,Cc1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.34,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZNUCWZNVXLGUSK-SFQUDFHCSA-N,72.0,Cytotoxicity,MTT
CHEMBL441441,ALPHA-LAPACHONE,CC1(C)CCC2=C(O1)C(=O)c1ccccc1C2=O,IC50,4.73,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PJWHOPKRRBUSDH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652071,,CCCC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.64,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CQUTYTUJYIFOMU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652075,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3cccc(F)c3)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PKEVBAAYDGBCRS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652077,,Cc1ccccc1-c1nc2ccc3c(c2[nH]1)C(=O)c1ccccc1C3=O,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QVXHINYXGZQZKJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL604471,,Cc1ccc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)cc1,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MRHQJLSJDVEZQP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5624986,,COc1cc(C(=O)/C=C/c2ccccc2C(=O)N2CCN(Cc3ccccc3)C23COC3)cc(OC)c1OC,IC50,5.26,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OBBXIDOCUKVRIY-BUHFOSPRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624576,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccccc1,IC50,5.3,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KMYZPKBNYTUWMF-DTQAZKPQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624739,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccncc1,IC50,5.28,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,PJEYCULHRXACRW-DHZHZOJOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630408,,N#Cc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1,IC50,5.2,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BGUVZKJVWHVYIX-XNTDXEJSSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1822055,,Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,6.38,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,FPJNXVCSICMXRJ-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL1822056,,O=S(=O)(Nc1cc(-c2ccc3nccn3n2)cnc1Cl)c1ccc(F)cc1,IC50,7.3,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,WEIYGNUYMJRNTA-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL550986,,COc1ccc(-c2c(CO)c(CO)c3n2-c2ccc(OC)cc2C3)cc1,IC50,4.61,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,OKKFIOJHAIELBA-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL561917,,CNC(=O)OCc1c(COC(=O)NC)c(-c2ccc(OC)cc2)n2c1Cc1ccccc1-2,IC50,4.46,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,FHWSLEBLQJUACW-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL552053,,COc1ccc(-c2c(CO)c(CO)c3n2-c2ccccc2C3)cc1,IC50,4.34,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,SCNHIBOGDBGMJE-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4059832,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.93,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QQUWBQJOOWMYGO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4071208,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.91,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OZCQMOAWZCBZGN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3335759,,Cn1cc(-c2cnc(N3CCO[C@H](Cn4nc(-c5ccc(OCc6ccccc6)cc5)ccc4=O)C3)nc2)cn1,IC50,5.12,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RBIQCGFCXSOQEO-MHZLTWQESA-N,72.0,Cytotoxicity,WST8
CHEMBL3335763,,O=c1ccc(-c2cccc(C(F)(F)F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.6,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,BTGRTFFNHLVSJR-DEOSSOPVSA-N,72.0,Cytotoxicity,WST8
CHEMBL3359304,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.85,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,GHKZTZQXOVCKSZ-LWXWOMNKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3359315,,CC(C)(CCC[C@@](C)(OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C)OC(=O)CCl,IC50,4.72,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,QHPAQYVVVUEVBN-BVLXKVINSA-N,48.0,Antiproliferative activity,MTT
CHEMBL404024,,CC(C#N)c1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,IC50,6.86,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,JPILNANJKLSYFG-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL53424,,Nc1nc(=O)n([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)cc1F,IC50,4.08,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,QDVOFRWTPUEFTR-TYQACLPBSA-N,,Cytotoxicity,Unspecified
CHEMBL3808886,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4cccs4)n3)ccc21,IC50,5.14,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SUZJMSQJZBKXBA-DEDYPNTBSA-N,48.0,Cytotoxicity,MTT
CHEMBL2165021,,COc1ccc(Nc2nccnc2-c2cc(N)nc(C)n2)cn1,IC50,6.23,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IFEHHBCJSIHKDR-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165268,,Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ccc23)n1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LVUPFSONRUTLLF-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL3905411,,CCCCNC(=S)NNc1nncc2ccccc12,IC50,8.2,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,NKPUKLSVXYDTLL-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL1380839,,CCN=C(S)NNc1nncc2ccccc12,IC50,9.4,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LNBNLTRDQFABLX-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3906533,,CCOC(=O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,9.48,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,FZXFZHFLUJFRGT-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3116221,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.32,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PQNPOENKAKBBNV-NJNXFGOHSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116444,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.82,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RSJQQGAPVMIJRS-HPNDGRJYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3116446,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZXTQQNYRMCOIST-XTCLZLMSSA-N,72.0,Cytotoxicity,MTT
CHEMBL3121281,,Cc1c(C(=O)OC(C)C)[nH]c2c1C(=O)CC(c1cccs1)C2,EC50,6.62,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,SGRJCCAQTQWZDV-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121279,,Cc1nc2ncccn2c1-c1csc(Nc2ccc(Cl)cc2)n1,EC50,5.61,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,NAIFKGCRLXUVSL-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL1521217,,O=C(Cc1ccc(-c2ccccc2)cc1)NCc1ccccc1,EC50,6.36,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,HFZXKRVFJQSEJD-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL4070665,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2Cl)ccc1OCCCN1CCc2ccccc21,IC50,4.7,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BPZIZFSBNOIBGP-YRNVUSSQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3319516,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCN(C)CC3)[C@@H]2C[C@@H]1O,IC50,4.64,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,AJVKCEKWRIWUFN-KKKYIMSDSA-N,72.0,Anticancer activity,MTT
CHEMBL4468684,,C=CC[C@H]1C[C@]2([C@H](C)Cc3cc(O)c(OC)cc3F)OCOC2=CC1=O,IC50,5.02,CHEMBL4326187,Antiproliferative activity against taxane-resistant human SF295 cells after 72 hrs by CellTiter 96 aqueous nonradioactive cell proliferation assay,SF295,NBQLFTNZXOUHIO-MTJIALIYSA-N,72.0,Antiproliferative activity,CellTiter 96 aqueous nonradioactive cell proliferation
CHEMBL4634658,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(OC)ccc1C4=O,EC50,7.68,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,RSXKWDSDUVYSQA-UMGCSLAASA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL5272213,,COc1cc(Nc2ccc3nnc(-c4ccco4)n3c2)cc(OC)c1OC,IC50,4.37,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,KXLLUBZULSSKMD-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL3339340,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.32,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RUEPFGSLNFJPIU-FADJLKOXSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339342,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.99,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,IRZYUTJCYKVYJW-GOJREDGKSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3415678,,CCCOc1ccc2c3cc[n+](CC)c(C)c3n(CCC)c2c1.[Br-],IC50,4.66,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,ZCEJWAQQAGRUKR-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL4240179,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCOCC3)CC1)c1ccccc1S2,EC50,4.7,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,DCOREAZQNUSYDA-UHFFFAOYSA-N,,Unspecified,Fura-2 AM dye-based
CHEMBL4248942,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCCC3)CC1)c1ccccc1S2,IC50,5.66,CHEMBL4232384,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,DALKPQZIEUGGGK-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3609552,,CC1(C)OC2=C(CC1[Se]c1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.68,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,DNWGOVCPCLJUDO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4757485,,C=C(CC)C(=O)c1ccc(OCC(=O)NC2CCN(S(=O)(=O)c3ccc(OC)cc3)CC2)c(Cl)c1Cl,IC50,6.62,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,IDBBJXCKCAYMLL-UHFFFAOYSA-N,,Cytotoxicity,CellTiter Glo luminescent
CHEMBL3343363,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.8,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RJMBEUADUJYIEH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343378,,COc1ccc(-n2nnc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)c2C(F)(F)F)cc1,IC50,5.62,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WUTYCVPPFZPUPA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343387,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.67,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHOMYTXWOSNFKJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343389,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZKBOLDIUXTTCC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2313857,,CCCCCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.23,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,LDAMDKYTTMERSL-FGFRBZMOSA-N,72.0,Cytotoxicity,MTT
CHEMBL4295220,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1cccnc1)c1ccccc1,IC50,5.89,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,BODLNGDCJGRVNV-RCCFBDPRSA-N,48.0,Unspecified,MTT
CHEMBL4291354,,CCOC(=O)C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,5.8,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,WHXVUFUYVAMPKN-PWRODBHTSA-N,48.0,Unspecified,MTT
CHEMBL4293736,,CCCCCCCCCC[n+]1cccc(O)c1,IC50,4.25,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,NVKKMFKXRUVDJJ-UHFFFAOYSA-O,48.0,Unspecified,MTT
CHEMBL3318026,,COc1cc(-c2cnc3ccc(NC(=O)NC(C)(C)C)nc3c2)ccc1O,IC50,5.01,CHEMBL3367509,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZCHJWXKREFTWSX-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4521917,,CCOP(=O)(OCC)C(N(OC(C)c1n(C)cc[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VSIKVCAIEJWCGB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290908,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.96,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PUWBEDGMRHQJNX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL197603,,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,4.66,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ZMNWFTYYYCSSTF-SOAUALDESA-N,,Growth inhibition,Unspecified
CHEMBL3971437,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.1,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,ZNXUSLMSNLSJII-YDVZNJOFSA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL5291091,,CCN1CCN(CCC(=O)Nc2cccc(-n3cc(-c4ccncc4)c(-c4ccc(Cl)c(OC)c4)n3)c2)CC1,IC50,6.41,CHEMBL5231164,Anticancer activity against human SNB-75 cells assessed as cell growth proliferation,SNB-75,KYADEHTYBROPGP-UHFFFAOYSA-N,,Anticancer activity,Unspecified
CHEMBL217092,SARACATINIB,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,4.12,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,OUKYUETWWIPKQR-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2392819,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.96,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VODLZXJWEDNALT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5274027,,CN1CCN(c2ccc3nc(-c4ccc(OCCCN5C(=O)c6cccc7cccc(c67)C5=O)cc4)[nH]c3c2)CC1,IC50,6.96,CHEMBL5245068,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B reagent assay,SNB-75,KNRGNAFDDSPVOF-UHFFFAOYSA-N,48.0,Cytotoxicity,sulforhodamine B reagent
CHEMBL2407686,,C=CCNC(=O)/C1=C(\C(=O)OC)Cc2c([nH]c3ccccc23)[C@@](C(=O)OC)(c2cc3c(cc2OC)N(C)[C@H]2[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]32[C@@H]54)C[C@@H]2C=C(CC)CN1C2,IC50,5.52,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BSQAKIMWPONUOF-HAIPHDKGSA-N,72.0,Cytotoxicity,resazurin
CHEMBL3092022,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(OC(C)=O)cc2)c(OC)c1,IC50,5.16,CHEMBL3096270,Cytotoxicity against p53-knockdown human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,GMAGLVPSKNBQKR-UHFFFAOYSA-N,120.0,Cytotoxicity,methylene blue staining
CHEMBL3393272,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nc2nccn12,IC50,5.85,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,DYHJJLYLVDGULB-UHFFFAOYSA-N,,Unspecified,crystal violet staining-based
CHEMBL3343407,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](O)[C@H]2O1,IC50,4.84,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-MSXRDDOVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2385196,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.07,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,VDRLWKQXYDMXJW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385186,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.87,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,UNUOJJJJMNFSAC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385193,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.98,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PAGRSZZWQKPHIC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL515325,MAPPAIN,CC(C)=CCC/C(C)=C/Cc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc(O)c1O,EC50,5.27,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,GJZKDVGLDGLPMB-ZVBRSKEYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL376007,SCHWEINFURTHIN F,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,6.62,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,BUFNPAYKUGAAAO-HLULBIOLSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4248529,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(CC#N)nc3n2)cc1CO,IC50,7.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,LNGGLFWITGYQKY-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4240170,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C)nc3n2)cc1CO,IC50,7.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,UGJRAKREIVRFDR-ZDUSSCGKSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4250280,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)C)nc3n2)cc1CO,IC50,7.47,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,OYHFLRHRRAMMKF-HNNXBMFYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL3354442,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,6.66,CHEMBL3376032,Cytotoxicity against human SF295 cells assessed as growth inhibition after 72 hrs by MTT assay,SF295,LVHKHLZPRPTQJG-BNLDXBMISA-N,72.0,Cytotoxicity,MTT
CHEMBL2064825,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](OC(C)=O)[C@@H]4[C@@H]([C@](C)(O)CCCC(C)(C)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,IC50,4.38,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZEZRUSOHKTZTBL-CNRRHNSPSA-N,48.0,Antiproliferative activity,MTT
CHEMBL477989,SB590885,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1,IC50,4.06,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MLSAQOINCGAULQ-QFMPWRQOSA-N,,Growth inhibition,Unspecified
CHEMBL1208572,SALINOMYCIN,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C,IC50,4.41,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,,Antiproliferative activity,MTT
CHEMBL3116070,,C=CCn1c(C)nc2ccc(Nc3nc(Nc4ccc(F)cc4)nc4ccccc34)cc21,IC50,5.12,CHEMBL3118244,Cytotoxicity against human SNB75 cells after 48 hrs by SRB assay,SNB-75,NVBPDZFQQPGTRB-UHFFFAOYSA-N,48.0,Cytotoxicity,SRB
CHEMBL3409956,,C/C(=N\O)c1cc(-c2ccc(O)cc2)ccc1O,IC50,4.46,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,JFJKNDANYYIWDV-OQLLNIDSSA-N,96.0,Antiproliferative activity,Unspecified
CHEMBL480420,,O/N=C/c1cc(-c2ccc(O)cc2)ccc1O,IC50,4.34,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,INQGQXOIWVULMW-RIYZIHGNSA-N,96.0,Antiproliferative activity,Unspecified
CHEMBL1914725,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccccc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.9,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DBCYFWOTALWDQJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1256616,NIMUSTINE HYDROCHLORIDE,Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1.Cl,IC50,6.14,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KPMKNHGAPDCYLP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL447565,ALPHA-HEDERIN,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IC50,4.76,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KEOITPILCOILGM-LLJOFIFVSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430035,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.36,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,FRALZQPZQJMQEK-MKSLBANYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430033,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.46,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ANZUJNAJUBXIKU-WFXPECHOSA-N,72.0,Cytotoxicity,MTT
CHEMBL3353044,,O=C(c1ccccc1)N1CCN(C(=O)c2ccc3c4c(cccc24)CC3)CC1,IC50,4.88,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,CVPZIQHWFMJXFX-UHFFFAOYSA-N,48.0,Antiviral activity,cell-based luciferase reporter gene
CHEMBL3353049,,COc1cnc(Cl)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,4.78,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,OITFVXLQFVGROH-UHFFFAOYSA-N,48.0,Antiviral activity,luciferase reporter gene
CHEMBL3609558,,CCCC[Se]C1CC2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.48,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,TXTHGEBIRWTCGO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5632812,,N#Cc1cncc(Cl)n1,IC50,4.74,CHEMBL5625423,Cytotoxicity against human LN-229 cells assessed as reduction in cell growth incubated for 72 hrs by Celltiter-Glo assay,LN-229,CZPOFSDHJNNWQL-UHFFFAOYSA-N,72.0,Cytotoxicity,Celltiter-Glo
CHEMBL5619899,,CC(C)CCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.08,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,PVDOVVCNMDJUMN-XIFFEERXSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619811,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@H]1CCCO1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.67,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,MJHSFRDACBYUCG-HEIROHQZSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618400,,CCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.79,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,ZSGFENIVWPHHNA-DHUJRADRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL4063136,,CSc1nc(NCCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.88,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,ROJDRHKTFQFHCV-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3954520,,O=C1C(Cl)=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,5.53,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DDPYCCFALDEDQC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3805422,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(Cl)cc2)cc(OC)c1OC,IC50,5.49,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XXVFADRKOFZSGV-YPKPFQOOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793866,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCC(N2CCCC2)CC1,IC50,4.85,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,MCLOERVVCNFRGV-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4095304,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PKYAUFYPURMQOL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4584494,,C=C(c1ccc2c(c1)c1ccccc1n2C)c1cc(C)nc2ccccc12,IC50,8.72,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QFMFGYHKBRNDLH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4517935,,C=C(c1ccc2c(ccn2C)c1)c1cc(C#N)nc2ccccc12,IC50,8.26,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,IGADDWJYYPETJI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4100335,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccccc4O)cc3n2)C[C@H](C)O1,IC50,5.0,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,IPJAFJNXEKNDFO-GASCZTMLSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4083106,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=[N+]3C(=C(c4ccccc4)c4ccc(Cl)n4[B-]3(F)F)C=C2)nn1,IC50,5.71,CHEMBL4046412,Cytotoxicity against human SF295 cells after 24 hrs in absence of GSH-OEt by MTT assay,SF295,CWTATMITRQBWAX-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4283745,,CCCCCCCCCc1ccc(OP(=O)(O)OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)cc1,IC50,5.17,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,KPQPXTTWNSJLOS-UPRLRBBYSA-N,48.0,Unspecified,MTT
CHEMBL5193570,,O=C(Cc1ccc(NC(=O)c2cc3c(F)cc(F)cc3[nH]2)cc1)NC12CC3CC(CC(C3)C1)C2,IC50,5.31,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,WSMNNVPMLSBLSH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5192764,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2c(Cl)c(Cl)ccc2c1=O,IC50,5.09,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,REUDJZPVCYIQID-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5170486,,CCCCN(C)Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.24,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,BBFCAELXDZIWJB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3915508,,N#Cc1ccc(Nc2nncc3ccccc23)cc1,IC50,9.49,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LYKFUIDYYBNHOA-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3113705,,COc1ccc(/C=N/Nc2cnc3ccccc3n2)c(O)c1,IC50,4.8,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,AMYCQSIRLSVLNG-GIJQJNRQSA-N,,Cytotoxicity,MTT
CHEMBL3410526,,O=C1/C(=C/c2ccc(O)cc2)CS(=O)(=O)C/C1=C\c1ccc(O)cc1,IC50,5.17,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,XPAZXXUGNRNCAJ-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410532,,O=C1/C(=C/c2ccc(O)cc2)CS(=O)(=O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.66,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,WGBPZGIYBGZHKX-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL14762,SELICICLIB,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,IC50,4.14,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,,Growth inhibition,Unspecified
CHEMBL3951052,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(CCO)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.67,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PVMLGIUZPIXOHY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1236962,OMIPALISIB,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.27,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CGBJSGAELGCMKE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4543075,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2[N+](=O)[O-])cc(OC)c1OC,IC50,7.46,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,RTVPWMWCWOVESQ-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS
CHEMBL2417837,,COc1ncc(-c2ccc3nc(NC(=O)C4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.31,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,UEKVQZJSGBXJFO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417831,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.16,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NVAPPQYBNBVKDJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2441789,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.51,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,YGSBVQPQFQEYSR-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL2441800,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,6.21,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NCAOISCQJZUYIU-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL4583587,,CC1(C)C(/C=C/C2=C(SCCC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21.[Cl-],IC50,7.68,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,COFRJLZYSZMKJW-QLSQMBKKSA-N,72.0,Cytotoxicity,AlamarBlue
CHEMBL4541564,,CC1(C)C(/C=C/C2=C(SCCC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)/C(=C/C=C3/N(CCCCS(=O)(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)O)c2ccccc21.[Cl-],IC50,7.68,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,VPIHYTGLXWIJEG-NOOGLOLCSA-N,72.0,Cytotoxicity,AlamarBlue
CHEMBL495641,SIARESINOLIC ACID,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@@H]1O,IC50,4.36,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KFALHTDSQSJCFC-LLICELPBSA-N,72.0,Cytotoxicity,MTT
CHEMBL168,OLEANOLIC_ACID,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.73,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,MIJYXULNPSFWEK-GTOFXWBISA-N,72.0,Cytotoxicity,MTT
CHEMBL3401524,,NC(=O)c1cc(OC(F)(F)F)cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1,IC50,5.82,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OOHISYGGXDTPAM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,4.05,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,UBPYILGKFZZVDX-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL393929,,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,IC50,5.86,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,XOLMRFUGOINFDQ-YBEGLDIGSA-N,,Growth inhibition,Unspecified
CHEMBL1353474,,Cc1cc(C)c(S(=O)(=O)NCc2ccncc2)c(C)c1,EC50,5.38,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LGKQKELVYYSUHI-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL4278178,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(OC)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.84,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VCGDLHPPHXFKLT-GRCRCFNVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4294165,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc([N+](=O)[O-])cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.91,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UWJVPWYWBPTVLU-UVHRBFQASA-N,72.0,Antiproliferative activity,MTT
CHEMBL2381459,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cc(OC)c(OC)c(OC)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.57,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,ARINPQLYYUMHKA-IVDBYKEZSA-N,48.0,Cytotoxicity,SRB
CHEMBL4569743,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CI)cc1C2=O,IC50,4.84,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,BEJHJNFDBJSEOG-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3622410,,O=C(NC1(C(=O)NCc2ccc(Cl)cc2)CSC2=C1C(=O)c1ccccc1C2=O)c1ccc(Cl)cc1,IC50,6.5,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,FJKLNTLROKNEJY-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3622409,,Cl.O=C(CN1CCCCC1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,6.29,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,UPJLJSZLZARAQV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4075562,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZIEWBFVEFQUEHS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4286339,,CCn1c2ccccc2c2cc(C(=O)c3cccc4ncccc34)ccc21,EC50,6.74,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,PVXVLICZYVCCKQ-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4281189,,CCn1c2ccccc2c2cc(C(=O)N3CCCc4ccccc43)ccc21,EC50,6.12,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,FCYOAJHMZOQTGU-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4276667,,Cc1ccc(C(=O)n2c3ccccc3c3ccccc32)c2ccccc12,EC50,6.02,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,LKFUAUSEGXTMHZ-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL3339344,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.38,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JZEBTBLTIZKIAL-FADJLKOXSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339352,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(S(C)(=O)=O)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.17,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YTSHUBILDJXKTF-HPNXWYHWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5564960,,CCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.79,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JKULNQJWKJXVEF-LLVKDONJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5560959,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NC(C)C)C(=O)O)cc1,IC50,4.69,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VKLSUDCNBZVPTF-CYBMUJFWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343409,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](O)[P@@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,4.79,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-MDBOQZRESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343415,,Cc1ccc(S(=O)(=O)O[C@H]2[C@H]3OC(C)(C)O[C@H]3[C@@H]([C@H]3COC(C)(C)O3)O[P@]2(=O)c2ccccc2)cc1,IC50,5.03,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,BGQCWCIRJUFYEA-PCCBZKKBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343641,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc([N+](=O)[O-])c([N+](=O)[O-])c3)[C@H]2O1,IC50,5.16,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,JDPPBAVDMURBSO-AHJGHJDGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343645,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](NCc1ccccc1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.29,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SFTOZIBEPGKZDW-RSERMMFASA-N,72.0,Antiproliferative activity,MTT
CHEMBL5619176,,CC(C)CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.77,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,QPVQMCCXYZJJHQ-YTTGMZPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618638,,CCCCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.92,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,CHENBVQGLCJZOL-KDXMTYKHSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5620079,,CCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.22,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,WMHNKAPHRPPRMJ-QNGWXLTQSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619209,,CC(C)CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.69,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,PWLTUGNQRLCODH-YTTGMZPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL3410541,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)C[S+]([O-])C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.75,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IJIZQHZXBYFAJE-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3823627,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)/C=C/[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,6.21,CHEMBL3825128,Antiproliferative activity against human SF295 cells after 48 to 72 hrs by Alamar blue assay,SF295,AIIZZRMMCAVMCU-SEFLVTODSA-N,72.0,Antiproliferative activity,Alamar blue
CHEMBL332828,,Nc1cccc2c1nc1c3c(nccc32)-c2ncccc2C1=O,IC50,6.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,XDPPYVAWMGNABF-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4172942,,C=C(c1ccc(OC(F)F)c(N)c1)c1cc(OC)c(OC)c(OC)c1,IC50,9.22,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,CNNMSQTUVDFJKI-UHFFFAOYSA-N,72.0,Antiproliferative activity,resazurin-based fluorescence
CHEMBL4284890,,c1cc(-c2cnco2)nc(-c2cnc(-c3cccc(-c4cccc(-c5ncc(-c6cccc(-c7cnco7)n6)o5)n4)n3)o2)c1,IC50,6.61,CHEMBL4261146,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,LMVRDHUJKDYIMS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4089146,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2)ccc1OCCCN1CCCc2ccccc21,IC50,4.79,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MYDFZQPERCVXKB-OQLLNIDSSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4205819,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(OC)cc4)c3=O)cc2)ccn1,IC50,5.09,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XFDZUVJMQQXSSX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4209961,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.74,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RHJNVFIPNGUCGL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2407563,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NC(C)(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.6,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WZZDEXUAXZLSNU-YQMZIVQWSA-N,72.0,Cytotoxicity,resazurin
CHEMBL2064799,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@@H]4[C@@H]([C@](C)(O)CCCC(C)(C)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,IC50,4.49,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,BOZXDFXOMFAOOW-ADZWRMKASA-N,48.0,Antiproliferative activity,MTT
CHEMBL2397980,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(NC(C)(C)C(=O)O)c2)c(OC)c1,IC50,7.05,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,RINOCMDJPRBIMQ-MDZDMXLPSA-N,96.0,Cytotoxicity,sulforhodamine B
CHEMBL59976,,O=C1C2=C(OCC=C2)C(=O)c2ccccc21,IC50,5.64,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,NMAATQFODBZYJW-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL3358286,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(S(=O)(=O)c3ccccc3)c2)n1,IC50,6.12,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,IOYMOANGBJUQON-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357869,,COc1ncc(Nc2ncc(C3(O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.75,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,LDEKSEIDMAEWQY-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL3357863,,COc1ncc(Nc2ncccc2-c2nc(C)nc(N)n2)cc1F,IC50,7.38,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,MSQQWMIPDSCJOT-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL408851,ACETYLBAKUCHIOL,C=C[C@@](C)(/C=C/c1ccc(OC(C)=O)cc1)CCC=C(C)C,IC50,5.1,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,KLWKVZWSRSGVHJ-UPTIQUDWSA-N,48.0,Cytotoxicity,sulpharhodamine B
CHEMBL1085588,,Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,IC50,4.06,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZWKJWVSEDISQIS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5201895,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@@]3(O)OC2,IC50,6.05,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ATISONUWEZVDGA-IEJGXSRGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4438521,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.97,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,WTILQCQZUFSWFT-ZIGMMIRASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4543609,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.89,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,YXQDTYWWQFSZQC-WWMJZJIFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4466655,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.13,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,GWPIZLOXKPAPCU-RXQFCVLDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3824027,,CC(C)(C)OC(=O)NCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.58,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SXKNYMHGZVLVMI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3822533,,CCCCCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,5.77,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XZAKQUHBBCBSGG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823665,,Cl.O=C1C(O)=C(C(NCc2ccccc2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.94,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FZCPDAWKNGSOMB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823211,,Cl.O=C1C(O)=C(C(NCc2ccccc2)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.97,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SNHYFEXPAPEPCS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823380,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(Br)ccc1O.Cl,IC50,4.67,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NBADPCNUKCZVFE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823588,,Cc1ccc(O)c(C(NCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)c1.Cl,IC50,4.84,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,OPFQPAJXVJXPBM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3806194,,O=C(Nc1ccc(Nc2ccc(OC3CCNCC3)cc2)cc1)c1cccc(-n2nc(C(=O)Nc3ccc(Nc4ccc(OC5CCNCC5)cc4)cc3)c3c2C(=O)NCC3)c1,IC50,4.47,CHEMBL3807045,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method,U-87MG ATCC,IJMDBRMQQXOTSY-UHFFFAOYSA-N,72.0,Cytotoxicity,Z2 coulter counter
CHEMBL3343410,,CC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,IC50,5.31,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,YDBHENJAGLBQMF-ZAHCLZMSSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343412,,CC(=O)O[C@H]1[C@H]2OC(C)(C)O[C@H]2[C@@H]([C@H]2COC(C)(C)O2)O[P@]1(=O)c1ccccc1,IC50,5.86,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,HMNHGADPRMRMRU-RKBDPEJBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343642,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc(N)cc3)[C@H]2O1,IC50,5.21,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,VOQLGBUZFMSHHR-VVRVBYJRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343647,,CC(=O)N[C@@H]1[C@H]2OC(C)(C)O[C@H]2[C@@H]([C@H]2COC(C)(C)O2)O[P@@]1(=O)c1ccccc1,IC50,6.19,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,ZNQDHAKESODAIJ-VOLRFWRVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3600437,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(C)cc4)c3)cn2n1,IC50,6.17,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FBUYWHIWCGFGGE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4228946,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,RGNZNWVPZKJPFW-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL5436930,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(S(=O)(=O)c3cccc(/C=C/C(=O)NO)c3)CC1)C2,IC50,5.2,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PLVJFQLTLNVOKN-VOTSOKGWSA-N,,Cytotoxicity,MTT
CHEMBL5431792,,Cc1ccc(COc2ccc(-c3ncc[nH]3)cc2NC(=O)C#Cc2ccccc2)cc1,IC50,7.36,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RRRDSGXKQKNURJ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5400122,,CN(C)c1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,6.33,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,QIIJRYSAAUQNMF-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL3804852,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(F)cc2)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BHLSJTFSALJROM-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805548,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.89,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,UVDZSUIHYBIZLL-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL3818299,,CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,5.92,CHEMBL3820289,Antiproliferative activity against human U87MG cells expressing wild type p53 after 48 hrs by MTS assay,U-87MG ATCC,QXHBVJGLCMIHJL-UIOOFZCWSA-N,48.0,Antiproliferative activity,MTS
CHEMBL3819071,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C)C(=O)OC,IC50,7.82,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,OJGVAQYHHAIMOZ-RTFZILSDSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL3819001,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)NC,IC50,8.01,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,NUROBXGZWIJWJT-OICBGKIFSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL3813842,PAXALISIB,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,EC50,6.13,CHEMBL3816998,Antiproliferative activity against human U87 cells after 4 days by CellTitre-Glo assay,U-87MG ATCC,LGWACEZVCMBSKW-UHFFFAOYSA-N,96.0,Antiproliferative activity,CellTitre-Glo
CHEMBL3947656,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CC(N)=O,IC50,7.58,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,VNZGFEKDXRDFKR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL141064,,CN1CCN(c2nc(-c3ccc(Cl)cc3)cc3c(N(C)C)cccc23)CC1,IC50,5.14,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,MCQUMVWUMGSPRV-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3335761,,O=c1ccc(-c2cc(F)cc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.5,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,QDPRJEMEPAHBFN-DEOSSOPVSA-N,72.0,Cytotoxicity,WST8
CHEMBL3335764,,O=c1ccc(-c2cc(F)c(F)c(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.82,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,PAOJJIBFZZVKMH-NRFANRHFSA-N,72.0,Cytotoxicity,WST8
CHEMBL3927935,,[N-]=[N+]=NCC1CC2=C(O1)C(=O)c1ccccc1C2=O,IC50,6.46,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,AMDIHEAGTDRSSE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3904272,,C#Cc1cccc(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)c1,IC50,5.59,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GDWZPGDVJPMMQX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5433894,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3ccc(C(F)(F)F)cc3)cc2)CCC1(C)C,IC50,5.23,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,GAKUZJXPJNLERL-CAPFRKAQSA-N,72.0,Anticancer activity,Unspecified
CHEMBL5424731,,CCC1=C(C)/C(=C/c2ccc(-c3noc(-c4cccnc4)n3)cc2)CCC1(C)C,IC50,4.45,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,JAPQNNLEFMFBDO-HMMYKYKNSA-N,72.0,Anticancer activity,Unspecified
CHEMBL4633294,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[n+]3ccc4ccccc4c3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.6,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,NGTBGPGGABSUAM-LZFLYAGFSA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL260224,,CC(C)n1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.31,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,XYZISUWGALDUBA-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL5647372,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1C(F)(F)F,IC50,5.62,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,QUPSSTNMTKCKSQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5422876,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc2NS(C)(=O)=O)c1,IC50,5.63,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,QEXIPIGGYWEZII-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL3339341,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.21,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WYYQCNCNUUTYNA-GMEAVFFOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339343,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.86,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VNAIQSATTCBFAH-PNEAAFPUSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339345,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,KDDAHMJSDNKWMA-GMEAVFFOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339346,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.01,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WRKFZFVDYDEDIQ-GUBAARJWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339347,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.83,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,SFOBMADEYUECEF-NHXQZRDHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL325202,,O=C1c2cccnc2-c2nccc3ccnc1c23,IC50,6.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,PBFIHLLASGHCTR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220632,,Cc1cc(N2CCC[C@@H]2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KGCBJOGQMCNHQZ-QGZVFWFLSA-N,,Unspecified,Unspecified
CHEMBL220630,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccco1,IC50,7.2,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,IZHMORDLBSKBHC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223045,,CN(C)c1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.18,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MCCURRRMYPISPD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223788,,O=C(CC1CCCCN1c1cc(Cl)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.31,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BEVVGWOCTQZNGA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL316041,,C/N=N\N(C)C(C)=O,IC50,4.43,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,SQENJUQJJQSJMP-WAYWQWQTSA-N,,Cytotoxicity,MTT
CHEMBL4634849,,CCCNC(=O)c1ccc(Oc2nc(-c3c(C)noc3C)cnc2N)cc1,IC50,4.32,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YLQOKEHNPHRXAA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4647800,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCOCC3)cc2)n1,IC50,4.57,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ONWUZLTWJSDCTN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4638925,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cc(Cl)ccn4)cc3)n2)cn1,IC50,4.32,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BHDQFKWHUIWPRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL229728,,O=C1c2cnncc2C(=O)c2nc3cc4c(cc3nc21)OCO4,IC50,6.93,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,WOPAKMGWAKJGRN-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL5220033,,COc1ccc(CNc2cccnc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.1,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MRMBGKFJCKCWSE-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1951709,GYPENSAPOGENIN C,CC(C)=C1CC=C([C@H]2CC[C@]3(C)[C@@H]2CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)C1=O,IC50,6.24,CHEMBL1955142,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PTTPQVVXFQBCKP-WDKNXSKUSA-N,72.0,Cytotoxicity,MTT
CHEMBL4101265,,COc1ccc(C(=O)/C=C/c2ccc(OCCN3CCOCC3)c(OC)c2)cc1,IC50,5.15,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,OCKUBYMSWAAOSQ-YCRREMRBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3967244,,Oc1nc(-c2ccccc2)nc2sc3c(c12)CCCC3,IC50,4.74,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,CDFWRIZOSNAGCV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1643031,,OCc1c(CO)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.57,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,LPXDODBVOVEYLQ-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL313958,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)c2=S)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,FWXPNVLRLORRJY-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5404518,,COc1ccc(SC2=C(c3ccc(O)cc3O)C(=O)c3c(O)cccc3C2=O)cc1,IC50,4.95,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,KRDUKFLZZKMMPR-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL2398335,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Br)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.81,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,OVSPUTNOWQJAED-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5417589,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC(F)(F)F)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.6,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,ZHVKLCABOSDPPM-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5407384,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc([N+](=O)[O-])cc3)ccc2NS(C)(=O)=O)c1,IC50,5.92,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,VPEHTALTXOOVOZ-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5429683,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,7.19,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZTGOFTUXWMUHPM-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,5.74,CHEMBL5445015,"Affinity Phenotypic Cellular interaction: (CellTiter-Glo assay (Promega, cell proliferation assay using SF295 cell line, 72 h incubation)) EUB0000612a TTK",SF295,JFOAJUGFHDCBJJ-UHFFFAOYSA-N,72.0,Unspecified,CellTiter-Glo
CHEMBL51495,,CC(=O)O.CC(C)NCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CCO,IC50,5.45,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,UMUBOSFRVJIHCA-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1927613,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(CCN(C)C)c23)C1=O,IC50,6.89,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OXMVKWSROJASQD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1927615,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(C)c23)C1=O,IC50,5.94,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LZPAEFQRLQMXJF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5287665,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4c(Cl)cccc4Cl)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,UPBDCVTUDJDRJV-DBTHSLHSSA-N,,Antiproliferative activity,Unspecified
CHEMBL258838,,CN1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccccc12,IC50,6.87,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,PPQBKZIRDIWMOB-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL5087988,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)CCCC[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.72,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,ALSGWVXTKBXFEL-JPJFXSLNSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5422307,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)CC[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.75,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,LQYFBFLLULPDRN-ZMUWHQJZSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5428624,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,10.4,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,WOPQERLLNMDXCO-JBJZENLMSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL4743128,,Cc1nn(C)c(Oc2ccc(Br)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.27,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZKCZORFIEPVVRR-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL244238,,CCN(CC)CCOc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O,IC50,6.4,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,QAOJLLDMCMPLFS-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL1224278,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,AKVCSRSRJFVZDW-JNLDGDHFSA-N,72.0,Cytotoxicity,MTS
CHEMBL5428348,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(I)c3)ccc2NS(C)(=O)=O)c1,IC50,6.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,CSGPCUWSIHSOMM-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5406903,,COc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,5.08,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,RCRFQZPPCAAFGM-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5406623,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)c([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.58,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MQOCVRWDRMZBHE-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL561956,,COc1ccc(S(=O)(=O)c2cc(OC)c(OC)c(OC)c2)cc1,IC50,5.09,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NYEDBTDROUDIGI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3633269,,COc1cccc2c1C(=O)c1ccc3c(c1C2O)C(=O)C[C@](C)(O)C3,IC50,5.51,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,YRKOFHPWOUTOGA-GFOWMXPYSA-N,72.0,Cytotoxicity,MTS
CHEMBL488458,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc([N+](=O)[O-])cc2)C1=O,IC50,5.99,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,FFOLIJUFOTVDCR-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4063923,,OCc1cc2nc(N3CCOc4ccccc43)nc(N3CCOCC3)c2s1,IC50,4.67,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,FDJMFUPBFCVPKM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL1742001,,O=C(O)/C(=C\c1ccccc1)c1ccccc1,IC50,4.07,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,BIDDLDNGQCUOJQ-KAMYIIQDSA-N,48.0,Cytotoxicity,SRB
CHEMBL374300,,CS(=O)(=O)c1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.77,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HAUORGHEYRCDAG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL374486,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc([N+](=O)[O-])cc1,IC50,6.78,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZZZBJPZLGWDOGF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL219896,,Nc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,6.57,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,VARXOJXJKFRUFG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223043,,Cc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.64,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,RBGAQAAKQMYHIU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220269,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccccc1,IC50,7.6,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YDZKZOIFEBHVTR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL266768,,O=C(CC1CCCCN1c1cc(-n2ccnc2)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.46,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KDPIGDVECQEMIR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL222619,,COC(=O)N1CCN(c2cc(C)nc(-n3ccnc3)n2)CC1CC(=O)NCc1ccc2c(c1)OCO2,IC50,8.27,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BHPZTAGGZNBTOV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220511,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)[C@H](CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,7.47,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-QGZVFWFLSA-N,,Unspecified,Unspecified
CHEMBL4289867,,C=CCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,IC50,4.51,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,YQRFAPQVWGCSLL-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL3343386,,COc1ccc(-n2nnc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c2C(F)(F)F)cc1,IC50,5.55,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HAHHSTUUBWPNHV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343388,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QMNMYAYUSXNUSZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343395,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.85,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OPZFRGMIMMLJME-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3109413,,CC(=O)O[C@@]1(C)CCC(=O)[C@@H](C)CCC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.64,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,VLTIKKJYNDMBON-RWXMBLCBSA-N,24.0,Cytotoxicity,MTT
CHEMBL5288231,,c1ccc(-c2nc(CNc3nccc(N4CCCC4)n3)cs2)cc1,IC50,4.58,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SWTLLAOPNTXGEU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5275618,,c1ccc(-c2nc(CNc3nccc(N4CCCCC4)n3)cs2)cc1,IC50,5.08,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,AAVIEAVLIPLDKB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5273678,,CCN(CC)c1ccc2cc(-c3nc4cc(C5=NCCCN5)ccc4[nH]3)c(=O)oc2c1.Cl,IC50,4.01,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,QDCMGWUZNQPGQU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL3290926,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,KXSCVFRVUWUVDK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290924,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCC(C)CC4)ccc23)c(F)c1,IC50,5.94,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YIJZSESZNCHBPL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290929,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.8,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FVPKNPIIGGEJGZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL242557,,CC(C)N(CCOc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O)C(C)C,IC50,5.5,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,OBPYWCNNZZRYSP-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL396473,,CC(CN(C)C)Oc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O,IC50,5.76,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,ZTIIATLEWCTJQL-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL4449966,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)Cc4nccnc4C(C)(C)[C@@H]3CC[C@]12C,IC50,4.42,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,NFXWMPDHPCQECL-OJAFHGKASA-N,48.0,Cytotoxicity,MTT
CHEMBL4460972,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)C=C(O)C(=O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.34,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,HBMZZQPIQVFJBU-OSLPSIGMSA-N,48.0,Cytotoxicity,MTT
CHEMBL4562094,,Cc1ncc2c(n1)C(C)(C)[C@@H]1CC[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@@H]([C@@]5(C)CCCC(C)(C)O5)CC[C@]43C)[C@@]1(C)C2,IC50,4.06,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,TXNUXKLJONJFDC-ZSYGMLCOSA-N,48.0,Cytotoxicity,MTT
CHEMBL445938,,CC(CN(C)C)Oc1cc2oc3c(c2cc1Cl)C(=O)c1ccccc1C3=O,IC50,6.26,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,YZDUWZIPARTLNH-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL4082724,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.83,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QODZCSPDZVDCSD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL427062,,O=C(NCCc1ccc2c(c1)OCO2)[C@H]1CCCN1c1ccnc(-n2ccnc2)n1,IC50,9.32,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVOJJTOWUAGHLE-MRXNPFEDSA-N,,Unspecified,Unspecified
CHEMBL4068286,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.36,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZPDXQLPRRAIZEG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL385324,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)[C@@H](CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.62,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-KRWDZBQOSA-N,,Unspecified,Unspecified
CHEMBL3393280,,C=COC(=O)NCc1ccc(Nc2nc(Nc3ccccc3C(=O)NC)n3ccnc3n2)cc1,IC50,5.54,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,DIVBJWPQPWFSGQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,WST-1
CHEMBL3400568,,C#Cc1ccc2[nH]c3c(c2c1)C/C(C(=O)OC)=C\N1CC(CC)=CC(C1)C[C@]3(C(=O)OC)c1cc2c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]3(CC)C=CCN4CC[C@]21[C@@H]43,IC50,5.8,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,KBESTWONWPHFJI-YOGRKGKHSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL364713,NOSCAPINE,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,IC50,4.16,CHEMBL3599618,Antiproliferative activity against human LN229 cells assessed as decrease in colony formation,LN-229,AKNNEGZIBPJZJG-MSOLQXFVSA-N,,Antiproliferative activity,Unspecified
CHEMBL4279079,,CCn1c2ccccc2c2cc(C(=O)c3ccc(C)cc3)ccc21,EC50,6.0,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,XAOSAGCPDVOOIN-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4294001,,CCn1c2ccccc2c2cc(C(=O)c3ccc(Cl)cc3)ccc21,EC50,5.82,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,PVEHLRUSSIFJEZ-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL3416004,,COc1cc2nc(-c3cccc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.8,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UOBMKCYJPQWFNP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1224361,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.85,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,OPFARVHLHCUEBK-JEMCJYJNSA-N,72.0,Cytotoxicity,MTS
CHEMBL4289577,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,IC50,6.21,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IXULLLZCNUKGBJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2037063,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.76,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,RFIAIOOIVGYGRQ-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037071,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.53,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,DQAJBKDSVCOILV-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037072,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.58,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,HRUGBLPNQAMDNO-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037073,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.42,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,SKXROXLGGWJOMV-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL559398,,COc1cc(/C=C/c2cc(O)c(/C=C/c3cccc(O)c3)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.1,CHEMBL1053939,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,CSNGISUZVMQNJH-MLYJIWBTSA-N,44.0,Cytotoxicity,MTT
CHEMBL538653,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)[C@@]4(F)C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,IC50,5.65,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,KLWOZTZXVGZOOI-LNDZPLTESA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL488457,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc(Cl)cc2)C1=O,IC50,6.23,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,VMHZPMBRTFQLHS-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL489268,,CCN(CC)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.14,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,SEHVPBXORALIPC-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL379715,,CC1(C)CC(NC(=O)Nc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.47,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,JEGXVJSJPRRLJM-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL367287,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(F)ccc2O1,IC50,4.31,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,HROJXDDLVYXAHT-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL1076555,,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,IC50,4.97,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ZFGXZJKLOFCECI-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL3410534,,Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc([N+](=O)[O-])cc3)C2=O)cc1,IC50,5.86,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,VRIPMQKPFGIJOH-ODPUSEOTSA-N,48.0,Cytotoxicity,resazurin
CHEMBL4287953,,CCCCCCCCCC[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.4,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,CEVBXTPFVCEMSL-UPRLRBBYSA-N,48.0,Unspecified,MTT
CHEMBL4279183,,CCCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,IC50,4.53,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,PESSYBNCGCYSIU-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4278116,,COc1ccc(COc2ccc(C(c3oc(C)cc(=O)c3O)c3oc(C)cc(=O)c3O)cc2)cc1,IC50,5.28,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,IRETWYAUKXXMAV-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL3116220,,COc1cc(N2C(=O)NC(=O)/C(=C\Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)C2=O)c(OC)cc1Cl,IC50,5.55,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CYVPZDFIJGYWLQ-BSYVCWPDSA-N,72.0,Cytotoxicity,MTT
CHEMBL1165533,,O=C(OCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.42,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,MLDOJAWEIYORFI-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1165527,,O=C(OCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.96,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,GVNLJMMUFRRTAY-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL1163780,,COc1cc(C(=O)OCCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.52,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,SAFCXUZYFBMWGZ-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL3310591,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc1C(N)=O,IC50,5.54,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DEQPTLVHBFFNGH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1097311,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.89,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WBEBANORPCGJMO-YXAZKUIBSA-N,48.0,Cytotoxicity,MTT
CHEMBL233031,,c1cn(-c2ccc(NC3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,8.0,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,KYDUFQIZMRXXFB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL115716,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,GLPXKCDPFDUVQT-GOTSBHOMSA-N,,Unspecified,Unspecified
CHEMBL113154,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,QCDDKNCWCRNPEP-OALUTQOASA-N,,Unspecified,Unspecified
CHEMBL3612314,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCN(C)CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.36,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GADNWLMJPUJMIN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612319,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)C1CC1,IC50,5.78,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMNHIBFNIBQIEX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL325276,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,8.92,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,SWRITPDTBCAFCK-OALUTQOASA-N,,Unspecified,Unspecified
CHEMBL302389,,COc1ccc(C2C(OC(C)=O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-],IC50,6.84,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,QGJLKHPPBNNBCA-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3747513,CB-5083,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,IC50,7.12,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RDALZZCKQFLGJP-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5414874,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(Cl)c1,IC50,7.46,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VQSRULQBCHLBDH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL2205662,,Cc1ccc(N(CCn2nnc3c(C(N)=O)ncn3c2=O)CCn2nnc3c(C(N)=O)ncn3c2=O)cc1,IC50,4.95,CHEMBL4423100,Antiproliferative activity against human T98G cells after 5 days by CyQuantGR dye-based fluorescence assay,T98G,SRFTZNAYQBILPX-UHFFFAOYSA-N,120.0,Antiproliferative activity,CyQuantGR dye-based fluorescence
CHEMBL4071720,,O=C(CCCc1ccc(-c2cccnc2F)cc1)Nc1ccc(O)cc1,EC50,5.85,CHEMBL4423086,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by AlamarBlue assay,U-87MG ATCC,ULZGONBLGFFMKX-UHFFFAOYSA-N,72.0,Antiproliferative activity,AlamarBlue
CHEMBL4469689,,O=C1C=C(N[C@@H](Cc2ccccc2)C(=O)O)C(=O)c2ccccc21,IC50,5.7,CHEMBL4423116,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NKLMFCNSZRLCJX-INIZCTEOSA-N,72.0,Cytotoxicity,MTT
CHEMBL3942123,,COc1ccc(/N=C/c2c(O)ccc3c2oc2cc(Cl)c(O)c(Cl)c23)cc1,IC50,4.6,CHEMBL4423113,Antiproliferative activity against human U87MG cells after 24 hrs by WST-1 assay,U-87MG ATCC,UWXKHLVNEQUSFY-NUGSKGIGSA-N,24.0,Antiproliferative activity,WST-1
CHEMBL4169540,,N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NC(c2ccccc2)c2ccccc2)c1,IC50,6.94,CHEMBL4145085,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QKCFDPUKGKJIML-NRFANRHFSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3824051,,Cc1ccc(O)c(C(NCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)c1,IC50,5.07,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VFYYHNQZUSDYNE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823432,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,5.02,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CNSGWJRTENMKET-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL15221,,Cc1ccc2[nH]c3nnc(N)c-3cc2c1,IC50,4.21,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,RKOSJFGLKQAHTK-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4091786,,O=C1/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)CSC/C1=C\c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.68,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VPIODVANGKMJSC-KAVGSWPWSA-N,72.0,Cytotoxicity,MTT
CHEMBL259804,,O=c1[nH]c(-c2cccc([N+](=O)[O-])c2)nc2sc3c(c12)CCCC3,IC50,5.08,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,PGKKSSRLXTZLGF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL506862,,COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,IC50,6.0,CHEMBL3882890,Cytotoxicity against human A172 cells after 3 days by InCell analyser assay,A-172,GYHFAWCGOCYIPE-UHFFFAOYSA-N,72.0,Cytotoxicity,InCell analyser
CHEMBL3604102,,COc1ccc(OC2=CC(=O)c3cccc(O)c3C2=O)cc1,IC50,4.9,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,VTTOUOKMZWJFAL-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL254849,,COc1ccc(CS(=O)(=O)/C=C/c2c(OC)cc(OC)cc2OC)cc1,IC50,7.4,CHEMBL926537,Antitumor activity against human U87 cells by trypan blue exclusion assay,U-87MG ATCC,PKJIMDZRAFWKBI-MDZDMXLPSA-N,,Unspecified,trypan blue exclusion
CHEMBL5573600,,N#CC1=C(N)Oc2c(cc(Cl)c3cccnc23)C1c1ccc(Cl)c(Cl)c1,IC50,5.38,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,MBGZHUPYZCKGHI-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5575161,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(F)cc1,IC50,5.1,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,JVHAXSCWKMOCIX-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL4102138,,C=C(c1ccc(OC)c(O)c1)c1cc(C)nc2ccccc12,IC50,8.82,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,UOHMIDHLKVSHEV-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL3115965,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccc(C)c(C)c4)nn3)[C@@H]2CC1,IC50,4.92,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,FALDXBZLBIZXRG-IMPNOVIYSA-N,,Cytotoxicity,colorimetric sulphorhodamine B
CHEMBL3314669,,O=C1/C(=C/c2ccc(F)cc2)CS(=O)(=O)C/C1=C\c1ccc(F)cc1,IC50,5.66,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,DDCLVAVYBCIVNX-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410536,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CC2(C/C1=C\c1ccc([N+](=O)[O-])cc1)OCCO2,IC50,4.81,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,SQPUICXPDUIQQG-JYFOCSDGSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410537,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CC(O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.33,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,BCDOATJLGCTQBE-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410539,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)COC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.3,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IDGWXKSDMBOSHH-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL4251185,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C4CCOCC4)nc3n2)cc1CO,IC50,7.03,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,SSTJSROOZICEBQ-INIZCTEOSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.97,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,BIWGYFZAEWGBAL-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL472940,,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,IC50,4.0,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RFAXLXKIAKIUDT-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL558642,GSK-650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,IC50,5.05,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WVSBGSNVCDAMCF-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2385178,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(C)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.71,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NFGUCNQIGLKFJZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1081628,,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.35,CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,BRTIFMBVAUCZIX-HNNXBMFYSA-N,1.0,Unspecified,ELISA
CHEMBL2407564,,CCC1=C[C@@H]2CN(C1)C[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.15,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,QLRSUTPMRJVBOB-LGOXCPFQSA-N,72.0,Cytotoxicity,resazurin
CHEMBL2407571,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NC(C)(C)C)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.1,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,NCXVCMMXIPFTAI-WUFFRZSXSA-N,72.0,Cytotoxicity,resazurin
CHEMBL2407569,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NC(C)C)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.7,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,PZERHFHXOGNCIS-AIURUJAXSA-N,72.0,Cytotoxicity,resazurin
CHEMBL2407567,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)OC)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.82,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WVLGMGBTBSCBCV-GFCHHHBMSA-N,72.0,Cytotoxicity,resazurin
CHEMBL4293238,,CCCCCCC[N+]1(CCCC)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,4.92,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,LZAUXCIOLOABFJ-IQIXNTFZSA-M,48.0,Antiproliferative activity,MTT
CHEMBL4288767,,CCCCCCCCCCCC[N+]1(CCCC)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,4.71,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NAMAPGGJMXSNRB-NHYSMLRKSA-M,48.0,Antiproliferative activity,MTT
CHEMBL4279750,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3scnc3C)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.02,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,IDTUYXNRINXUIJ-SQIWNDBBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4467819,,COc1ccc(C2CC(c3cccs3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(Cl)cc43)S2)cc1,EC50,5.24,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,JCVDHJINKKLSQI-DQRAZIAOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4284568,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccc2ncccc2c1)c1ccccc1,IC50,6.06,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,DYQOTLNYCHIRDN-BHDDXSALSA-N,48.0,Unspecified,MTT
CHEMBL4280046,,C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.23,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,JGMWIVXPWUUSHK-IPMKNSEASA-N,48.0,Unspecified,MTT
CHEMBL4282076,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccccc3)O2)cc1F,IC50,4.47,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SNJLCEROIWROPY-YNEHKIRRSA-N,48.0,Unspecified,MTT
CHEMBL50,QUERCETIN,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,4.64,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,REFJWTPEDVJJIY-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL221895,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccs1,EC50,6.66,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KJGVNCPJDOKDLP-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL2407628,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.14,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,MVGQVUFEKIVQTO-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL4087882,,CN1CCN(CCOC(=O)N(c2cccc(Br)c2)c2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,5.28,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,ZPYFGEVWAWJEIR-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue
CHEMBL400211,,CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,4.76,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,ZSKSRKTYCCBGOO-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue
CHEMBL110185,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3Br)CC2)CC1,IC50,5.89,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,DOECUUJDDMDCMT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5282379,,Cc1ccc(F)c(NS(=O)(=O)/C=C/c2ccc(OCc3ccc(C(=O)NCCO[C@@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)cc3)cc2)c1,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,PNNXMIZIJXWEIU-PKNYZBDWSA-N,,Antiproliferative activity,Unspecified
CHEMBL5286086,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccc(Cl)cc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MFAAXNUFCCVXRZ-KFFRJZQJSA-N,,Antiproliferative activity,Unspecified
CHEMBL5618120,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1cn(C)c2ccccc12)c1cn(C)c2ccccc12,IC50,4.23,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,QAWJNXINUKRMKP-NDEPHWFRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618865,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(F)cccc12)c1c[nH]c2c(F)cccc12,IC50,4.83,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,GVYYFFSSLUXDQY-SANMLTNESA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5620245,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(Br)cccc12)c1c[nH]c2c(Br)cccc12,IC50,5.13,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,FNKHUIDOILEMJD-SANMLTNESA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619755,,CC(C)OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,HGFHWYQDTQWKRH-PMERELPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619566,,CCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.66,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,WPLFAFAPIXAWJP-HKBQPEDESA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619171,,CCCCCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.26,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,MTPKQHRIZWOKLZ-KDXMTYKHSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618234,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cc(Br)ccc12)c1c[nH]c2cc(Br)ccc12,IC50,5.18,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,IEVQQZKXBRVHGN-NDEPHWFRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5620250,,COCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.71,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,PPNXYNNTAAQBNK-HKBQPEDESA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL3426485,,C=C1C(=O)[C@@]23CC[C@@H]4[C@](C)(CO)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,4.89,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,HCZYQWZXOMCLRO-JBCQCRMPSA-N,24.0,Cytotoxicity,MTT
CHEMBL3426487,,C=C1C(=O)[C@@]23CC[C@@H]4C(C)(C)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.42,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,DGKNOMBMBJXZGO-DMSXTEQDSA-N,24.0,Cytotoxicity,MTT
CHEMBL3121288,,COc1ccc(Cl)cc1NS(=O)(=O)c1ccc(N2CCCC2=O)cc1,EC50,6.29,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RIIDUZTZWJNBAF-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3121283,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccccc1)C2,EC50,6.96,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,JKCCBJPERVOVSS-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL3334513,,O=c1ccc(-c2ccc(F)c(Cl)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.92,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,YTJGVIJQWQWUQU-QFIPXVFZSA-N,72.0,Cytotoxicity,WST8
CHEMBL3335785,,CN1CCN(c2ccc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cccc(C#N)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.8,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RSHVSHQCLHTDJZ-SANMLTNESA-N,72.0,Cytotoxicity,WST8
CHEMBL3818586,,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C,IC50,7.61,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,DMOPRYXQRGZSPH-GMAHTHKFSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL5218457,,CCOC(=O)c1c(NC(=O)CC#N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,6.21,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,BPQSRLLFHGSCEN-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL3343377,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RXQZRDTUYYDUIN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343384,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5Cl)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BHCGVCIDYXFAEL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343399,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.86,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NSBBTNXMJRENKO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL496089,,CC1(C)CC(NC(=S)Nc2ccccc2Cl)c2cc(Br)ccc2O1,IC50,5.1,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,TUBPYFDYIFDFBD-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL513524,,COc1cccc(NC(=S)NC2CC(C)(C)Oc3ccc(Br)cc32)c1,IC50,4.06,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,TVXILMSSFSASBV-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2041935,,O=[N+]([O-])c1cccc(NC(=S)NCc2cccc(Cl)c2)c1,IC50,4.21,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,GWMKLBRGUPIGNQ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL4068289,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(F)c1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,URLZKXFVTNTQAR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4094715,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(Br)c1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CBFYQYIFVNRVRR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4076935,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)O,IC50,4.34,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,HWONCQFYVPJQAU-JVHWHSFSSA-N,24.0,Cytotoxicity,MTT
CHEMBL4077042,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCOCC3)c(OC)c2)cc1,IC50,5.15,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,ALFHQRBQXLUACD-ONNFQVAWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4084821,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CC(C)OC(C)C3)c(OC)c2)cc1,IC50,5.25,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,XWLRUOAWOQYIMG-WUXMJOGZSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4069958,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H](N)CC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.91,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PNHQDLHJACAPEL-GYVXDGDLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3799200,,O=c1c(Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(N[C@@H](c2ccccc2)C(O)(c2ccccc2)c2ccccc2)c1=O,IC50,4.22,CHEMBL3801363,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,SBQCJYMLXBPBIH-LJAQVGFWSA-N,,Cytotoxicity,MTT
CHEMBL4225819,,COc1ncc(-c2cc3c(C)nc(N)nc3n(C)c2=O)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.02,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,BKGXQRKGPFGJOA-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL3794099,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(I)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.42,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QIKJEQMDFNCEEL-MQUPRSIOSA-N,72.0,Cytotoxicity,MTS
CHEMBL3794354,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.36,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,OZQXINIQLALHEN-NZCVOGEZSA-N,72.0,Cytotoxicity,MTS
CHEMBL4103684,,CSc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)cc1,EC50,5.41,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,YGKNAFRUJDSMIE-XBXARRHUSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4059707,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(N2CCCC2)cc1,EC50,4.45,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,RMHUSSMRBNFSBA-VQHVLOKHSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3612194,,COc1ncc(-c2ccc3nc(NC4CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.82,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,BFHXGYPDVYFMJA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612311,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.31,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FMBGGQZXHUMWCJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4782575,,CC(=O)c1c(C)c2cnc(Nc3ccc(C(=O)N4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.42,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,OSBNRKPPJHLDGI-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL3914323,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@@H](n2cc(C[Se]c3ccccc3)nn2)[C@@H]1Br,IC50,5.82,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,IPDKQWJEDZNPSV-XXBNENTESA-N,72.0,Cytotoxicity,MTT
CHEMBL5084959,,NC(=O)C1CCN(C(=O)c2ccc(CSc3nc4cccnc4n3Cc3ccccc3)cc2)CC1,IC50,4.22,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,PDIMNUOJFYPJNS-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL574956,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C2C(C)C,IC50,4.53,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,CKTQBCPTHBKRDI-GDKVXFNHSA-N,48.0,Anticancer activity,MTT
CHEMBL3416181,,COc1cc2nc(-c3cc(O)cc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.74,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZEETVDFZYSVSGW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL258925,,CCCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.07,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,WFNPIJHYLBLJEH-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL2392952,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(Cl)cc5Cl)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.98,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WTRKXSWNJPFRGC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392823,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LALAFGCPFSXPPR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392958,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.01,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NDHAEGOOGOUGQD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392818,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BYGPPINXSJTQLN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392948,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.16,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YSIIKSBQGZWJKP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4162270,,C=C(c1ccc(OC)c(F)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.1,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,VOVPNYONAIMJOD-UHFFFAOYSA-N,72.0,Antiproliferative activity,resazurin-based fluorescence
CHEMBL3400562,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(I)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,5.52,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,BKSFWWGISUGTFD-FHJQSJRSSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3400569,,C#Cc1ccc2[nH]c3c(c2c1)C/C(C(=O)OC)=C(/C(=O)NC(C)C)N1CC(CC)=CC(C1)C[C@]3(C(=O)OC)c1cc2c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]3(CC)C=CCN4CC[C@]21[C@@H]43,IC50,5.7,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,QUDGKSCVTLGFEM-NYYDPSAMSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3963403,,Fc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,IC50,9.24,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RZJRJEDTYIELCA-AGFWYPDZSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3927914,,COc1ccc(NC(=S)NNc2nncc3ccccc23)cc1,IC50,8.14,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,MJDGWMQMQUKVMK-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL118655,,COc1cnc2c3c(nccc13)-c1ncccc1C2=O,IC50,6.52,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,JOBZJDOSNDFONB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3601923,,COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.27,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVAOMSDQXISTTH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601924,,COc1ncc(-c2ccc3nc(NC(=O)NCCN(C)C)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.01,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KYFUXWQWFUDCNB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601926,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.25,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DIJARPLLNQUOIO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3600440,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.13,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SCGUAQOLNATAPZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3600442,,COc1ncc(-c2ccc3nc(NC(=O)N(C)C)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.75,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NQQQYVBBWRJZAK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4446669,,O=C(/C=C/c1ccc(-c2ccncc2)cc1)c1cccc(O)c1,IC50,4.95,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,GHKWSAXLDYCGJD-RMKNXTFCSA-N,72.0,Cytotoxicity,MTT
CHEMBL4577143,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.51,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,WQJDLXODDONTGE-MDWZMJQESA-N,72.0,Cytotoxicity,MTT
CHEMBL424928,,O=C(CC1CN(Cc2ccco2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.24,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZARLWMXTKBWNAF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4239931,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(C(N)=O)nc3n2)cc1CO,IC50,6.09,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,AUEZWXLCYWYYPN-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL436535,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(F)cc1,IC50,8.52,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PFQCCCKWAOJRHG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL432219,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3)c1C2,IC50,4.68,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,RWKBPANRHRUTJW-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4586974,,Cc1c(C)c2c(c(C)c1CCCCCCN)CCC(C)(COc1ccc(/C=C3\CC(=O)NC3=O)cc1)O2,IC50,5.06,CHEMBL4380121,Antiproliferative activity against human U87 cells in 10% FCS by crystal violet staining based assay,U-87MG ATCC,KCRDVAXWHFTBNS-JJIBRWJFSA-N,,Antiproliferative activity,crystal violet staining based
CHEMBL244240,,CC(CN(C)C)Oc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O,IC50,6.77,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,JTKGQAOAZSNXIC-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL2017974,BUPARLISIB,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,IC50,5.79,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CWHUFRVAEUJCEF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL390312,,O=C1C(=O)c2c(nc3ccc(Cl)cn23)-c2ncccc21,IC50,6.91,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,XQLDSZMTBZNFBP-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL392123,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N/O)[C@@H]4[C@@H](O)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.64,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,BUFTXAANMISQCF-DUTFGLQASA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL3634878,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)nc2c(C)cc(C)nc21,Ki,6.84,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,SGOGIXZBMCSNBW-UHFFFAOYSA-N,1.5,Unspecified,competition radioligand binding
CHEMBL3634877,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)nc2c(C)cc(C)cc21,Ki,6.4,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,SJPVZIDWKSNHDB-UHFFFAOYSA-N,1.5,Unspecified,competition radioligand binding
CHEMBL3609554,,COc1ccc([Se]C2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.3,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SGRWXWKASKMUOL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3612196,,O=C(Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1)NC1CC1,IC50,5.76,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,WFCYKYWPNDNUOI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2062865,,C/C=C(\C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.12,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,NPUVRWFJDAPMIA-BDPKFFACSA-N,72.0,Antiproliferative activity,cyquant
CHEMBL237677,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3cc[nH]n3)nccc12,IC50,6.85,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BGBYYLQBZCCHMG-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238113,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cccn3)nccc12,IC50,6.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,KVIXYBWOZQTNIY-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392576,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)nccc12,IC50,6.8,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ARHPJYQUPRCXQA-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL391847,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(F)ccc(F)c12,IC50,6.43,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,MHLUAQVEUDGLSM-CYBMUJFWSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240063,,C[C@@H]1CN(C(=O)c2cccc(Cl)c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.08,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RHSZSOYHPUMCPO-CYBMUJFWSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL239204,,C[C@@H]1CN(C(=O)c2ccccn2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.48,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,SVTUHBOSNIGMNL-CYBMUJFWSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL2012582,,COc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,EC50,6.18,CHEMBL3412560,Inhibition of IL6 secretion in LPS/IL-1beta-stimulated human U87 cells compound pretreated for 30 mins before stimulation measured after 24 hrs by ELISA,U-87MG ATCC,IWMCPJZTADUIFX-UHFFFAOYSA-N,0.5,Unspecified,ELISA
CHEMBL462949,,C=C1C(=O)O[C@H]2[C@H]1C[C@H](O)/C(C)=C/CC[C@@]1(C)O[C@@H]21,IC50,4.6,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RZUCCKARTVHQBW-MPFAERRBSA-N,72.0,Anticancer activity,MTT
CHEMBL3337791,,O=C(CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)OCc1ccccc1,IC50,5.0,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,LVTJBMIJDJGFJV-PXLJZGITSA-N,,Cytotoxicity,MTT
CHEMBL4276776,,COc1cc(/C=C/c2ccc(OCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc(OC)c1.[I-],IC50,6.07,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,PKZQPSOKNDPKAZ-ANVLNOONSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4288118,,C(=C/c1ccc(OCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,5.85,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,TVAJSTLSCVCRRZ-PGCQSHBKSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4277119,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.9,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NIHUEMNHVRWWIR-RAKOKPLXSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4281638,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(Br)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.72,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CVBXBPXINGAATK-UVHRBFQASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4281536,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccccn3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.58,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,OFWLZTVJYKXFDY-VKWKXTMMSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4280439,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCC)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.3,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BDKSMEQWIKWOSA-PFRVYOCJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4282880,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(COc4ccc([N+](=O)[O-])cc4)nn3)CC[C@@H]12,IC50,5.87,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,XXUFVBQJPSKENX-CJRDBDCPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4539915,,CC(=O)Oc1ccc(-c2cnc3cc(C)c(C)cc3n2)cc1O,IC50,4.37,CHEMBL4342568,Antiangiogenic activity in human U87cells after 24 hrs by MTT assay,U-87MG ATCC,HRZBIKZMLQFWBP-UHFFFAOYSA-N,24.0,Unspecified,MTT
CHEMBL4277691,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,FSJLTXIAYGJAJT-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4083202,,C=CC[C@H]1C[C@]2([C@@H](C)Cc3ccc(OC)c(OC)c3)OCOC2=CC1=O,IC50,6.6,CHEMBL4053635,Antiproliferative activity against human SF295 cells after 72 hrs by CellTiter96 AQueous nonradioactive cell proliferation assay,SF295,BHTLRQBVGVBCSE-WDUKFBBWSA-N,72.0,Antiproliferative activity,CellTiter96 AQueous nonradioactive cell proliferation
CHEMBL3597212,,COc1ccc2c(Sc3cc(OC)c(OC)c(OC)c3)c(-c3ccccc3)[nH]c2c1,IC50,7.82,CHEMBL3599943,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTS conversion assay,T98G,JOWLYQJNJNGREB-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS conversion
CHEMBL4282477,,CC1(C)[C@@H](OC(N)=O)C=C[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,8.24,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,LGQRKPYKYDALST-ZDQYYBRASA-N,72.0,Cytotoxicity,MTS
CHEMBL2035489,,COc1ccc2[se]n(CCn3[se]c4ccc(OC)cc4c3=O)c(=O)c2c1,IC50,5.79,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,MZMQMEKKARSJNG-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1644111,TRANS-PHYTOL,C/C(=C\CO)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,IC50,5.1,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,BOTWFXYSPFMFNR-PYDDKJGSSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL4085110,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZWBDBKSODBXWAG-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4129767,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.54,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,USJQDXYIXWEYAI-LWCHGPQXSA-N,72.0,Cytotoxicity,MTT
CHEMBL4126612,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(OC(F)(F)F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.71,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,WGAVTWUAWXWHSK-LWCHGPQXSA-N,72.0,Cytotoxicity,MTT
CHEMBL3912723,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccc(Cl)cc1,IC50,8.89,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,VXXXFNQITZZUER-OQKWZONESA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3893698,,CCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,IC50,8.46,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,HZSSTZXPAUWYIN-GHRIWEEISA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL2088451,,FC(F)(F)c1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.32,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WFRXYTZMMUQYIJ-IBBHUPRXSA-N,72.0,Cytotoxicity,MTT
CHEMBL4086663,,C=C(c1ccc(OC)cc1)c1cc(C#N)nc2ccccc12,IC50,9.0,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,NXQPEOJBNVLIDQ-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4074142,,COc1ccc(C(=O)c2cc(C)nc3ccccc23)cc1,IC50,7.6,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,YJPJWRJEDPGCAM-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL2441804,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1,IC50,5.77,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,XGEXNJLMBQAOEX-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL5641814,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2OC)ncc1C(F)(F)F,IC50,4.78,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GFFVSBZSQJUZJY-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1097764,LUDARTIN,C=C1C(=O)O[C@H]2[C@H]1CCC(C)=C1C[C@H]3O[C@@]3(C)[C@@H]12,IC50,5.2,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,QXJYIGSXUBOSID-JZEMPJKHSA-N,,Cytotoxicity,colorimetric sulphorhodamine B
CHEMBL3337790,,O=C(C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1)OCc1ccccc1,IC50,4.17,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,MDAGTEMXGXPCCE-SVWSIEHRSA-N,,Cytotoxicity,MTT
CHEMBL4066913,,C=C(c1ccc(OC)cc1)c1nc2ccccc2nc1C,IC50,6.16,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,ITIITPSWAMLPJU-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL411729,CYTOCHALASIN B,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,IC50,5.63,CHEMBL2019566,Cytotoxicity against human XF498 cells after 48 hrs by SRB assay,XF 498,GBOGMAARMMDZGR-TYHYBEHESA-N,48.0,Cytotoxicity,SRB
CHEMBL2435976,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(C)cc5)n4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.62,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NJOWRKQMWSBOGC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435969,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.1,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGMYZLMRKMRCLC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2035491,,O=c1c2cc(O)ccc2[se]n1CCn1[se]c2ccc(O)cc2c1=O,IC50,5.18,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OZRKFNKYXQVVSD-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2034987,,O=c1c2cc(F)ccc2[se]n1CCn1[se]c2ccc(F)cc2c1=O,IC50,5.16,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,FRYLJQGCOCBGLG-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2037336,,CC(=NNC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.3,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PMHTWYVKIPHSFS-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2165270,,Cc1nc(N)cc(-c2cccnc2Nc2cccc(O)c2)n1,IC50,6.52,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OFOLNFFDYMUPIF-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165053,,Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ncc23)n1,IC50,6.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,YCLSLKKTHSFLGB-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL603669,,COc1cc(CCc2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.54,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,QMPBVDJIRSEKGB-YCVRVPNXSA-N,44.0,Cytotoxicity,MTT
CHEMBL1822929,,COc1ccc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c2c1OC,Ki,8.3,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,VLNYVUQPQVEPDW-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1822931,,COc1ccc2cc(C(=O)NCC(F)c3ccccc3)c(=O)[nH]c2c1OC,Ki,7.66,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,RTTGKYVLNXUSQE-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1822933,,CCCCOc1c(OC)c([N+](=O)[O-])cc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.85,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,LIFKXJIIMHZEDS-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1822936,,CCCCOc1c(OC)ccc2cc(C(=O)NCCCF)c(=O)[nH]c12,Ki,7.24,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,JFSQXIGNGMVQLG-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL5091566,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.37,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,BZQJKEMXKXEHFN-WFVGHVPHSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5090018,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CCC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.92,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,BDWTWOVMVWJZNR-SUNMMQDUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5089977,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CCCCC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.6,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,XNZFUNKIEWOVAE-MCLIRCHUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5089631,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccccc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.67,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,CKQLOINPQOUXOW-MCLIRCHUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4764838,,COC(=O)c1ccc(-c2cccc([C@H]3N(C(=O)OC(C)(C)C)CC[C@]34C(=O)Nc3ccccc34)c2)cc1S(C)(=O)=O,IC50,5.12,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,CSIIUZYJPVSIJG-MXBOTTGLSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL84852,,CCOC(=O)N(C)/N=N\C,IC50,4.7,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,GESXCZVUZIBFRC-SREVYHEPSA-N,,Cytotoxicity,MTT
CHEMBL333433,,COc1ccnc2c1C(=O)c1nccc3ccnc-2c13,IC50,5.4,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,CGMJZZIYLGQIJU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3976938,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5cccn5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.79,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MGJLRASXFUHARL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1801706,,CCN(CC)CCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.Cl,IC50,6.22,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,WGDYDYRTFNYLSX-UHFFFAOYSA-N,48.0,Unspecified,MTT
CHEMBL3800138,,COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,VEXIODYWKRBZER-UHFFFAOYSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL4642386,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)CCC(=O)n1cc(/C=C/c2cccnc2)c2ccccc21,IC50,6.12,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JALDPRKSINWMRJ-LCPPQYOVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3621410,,CCCCCCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.49,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,NKUUIVLNNUOSEA-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.71,CHEMBL3625311,Cytotoxicity against human U87 cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,BPEGJWRSRHCHSN-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL483847,,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,IC50,4.42,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WEVYNIUIFUYDGI-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2381451,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(I)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.36,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,UQIMIZMWCGHEED-WKZPCIAFSA-N,48.0,Cytotoxicity,SRB
CHEMBL4088635,,C[C@H]1COCCN1c1cc(-c2ccc3[nH]ccc3c2)nn2c(C3CCN(Cc4cccnc4)CC3)cnc12,IC50,5.1,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,YTASBTNTVMGSHW-NRFANRHFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2095003,,CC(C)(C)c1cc(C(c2ccccn2)N2CCOCC2)cc(C(C)(C)C)c1O,IC50,4.31,CHEMBL4390251,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Cell Titer-Glo luminescent assay,U-87MG ATCC,FHIRILMXIWNDLT-UHFFFAOYSA-N,72.0,Antiproliferative activity,Cell Titer-Glo luminescent
CHEMBL4072236,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.96,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BMCXPSDQXSBAHT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3763919,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc(Cl)cc2)nn1,IC50,4.61,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SMEYPLCWRNXDCK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3609562,,CC1(C)OC2=C(CC1Sc1cccc(Cl)c1)C(=O)C(=O)c1ccccc12,IC50,5.96,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,VDJREMNYXGITNM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL18155,,Nc1nc(N)c2nc(CNc3ccc(C(=O)NC(CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1,IC50,9.29,CHEMBL801266,Compound was evaluated for in vitro activity against SF-295 CNS cell lines (Human tumor cells ),SF295,NYQPLPNEESYGNO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4453479,,C=CC(=O)NC(c1ccccc1)C(C(=O)/C=C/c1cccc(O)c1)C(=O)/C=C/c1cccc(O)c1,IC50,6.42,CHEMBL4364468,Cytotoxicity against human U87MG Cells 48 hrs by MTS assay,U-87MG ATCC,SZHWVJARXUAHDW-YXLFCKQPSA-N,48.0,Cytotoxicity,MTS
CHEMBL4290621,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccc([N+](=O)[O-])c3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.0,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,GSYMDOHZLCQWSN-YTEMWHBBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL229614,,C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.92,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-QKKBWIMNSA-N,48.0,Unspecified,Unspecified
CHEMBL379849,,O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F,IC50,5.85,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NIVYQYSNRUIFIF-KAVGSWPWSA-N,72.0,Cytotoxicity,MTT
CHEMBL4068246,,O=C(O)CCC(=O)OCCOc1c(S(=O)(=O)c2ccccc2)no[n+]1[O-],IC50,4.49,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VIIYJQVYKOHPLH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4072672,,COc1cc(/C=C/C(=O)c2ccc(Br)cc2)ccc1OCCCCN1CCCCC1,IC50,5.4,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,ZXNZWXWTGKDQCQ-NTUHNPAUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2206908,,Cc1nc(N)nc(-c2cc(CN3CCOCC3)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,8.28,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,GNMXQROCYSRVEQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206904,,COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.2,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,BHEMPSVJQFJQIN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3310592,,COc1c(NS(=O)(=O)C2CC2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc1C(N)=O,IC50,5.08,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CPMLWFNIQIZNKF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL323280,,O=C1c2nccc([N+](=O)[O-])c2-c2nc3ccccc3c3ccnc1c23,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,YKRRMKBNPLZPKR-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2385205,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NZTZNGJHLDGDDB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385179,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C)ccc5C)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,AZZAXSOMHADXBU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL140827,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,9.52,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,CAZKDDQXONGRTE-ROUUACIJSA-N,,Unspecified,Unspecified
CHEMBL3410530,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(OC)c([N+](=O)[O-])c3)C2=O)cc1[N+](=O)[O-],IC50,5.94,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,UPRAHZCTKDUQPW-BGPOSVGRSA-N,48.0,Cytotoxicity,resazurin
CHEMBL1097302,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.83,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MJXFAVYMJZHYAK-IVEJOGDBSA-N,48.0,Cytotoxicity,MTT
CHEMBL1097300,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.74,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,JLKUKOUXEVPGQG-MYEUQPDOSA-N,48.0,Cytotoxicity,MTT
CHEMBL1097299,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCCCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.05,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,VGRCLALCXBLFSZ-JGFHVXTRSA-N,48.0,Cytotoxicity,MTT
CHEMBL601719,CRIZOTINIB,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,IC50,4.16,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,KTEIFNKAUNYNJU-GFCCVEGCSA-N,,Growth inhibition,Unspecified
CHEMBL191334,NUTLIN-3,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.17,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,BDUHCSBCVGXTJM-WUFINQPMSA-N,,Growth inhibition,Unspecified
CHEMBL4063172,,COc1cc(/C=C/C(=O)c2ccccc2OC)ccc1OCCCN1CC(C)OC(C)C1,IC50,5.3,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QUGACEDDVWEABX-ZRDIBKRKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4093183,,C=C(c1ccc(OC)cc1)c1nc(C)nc2ccccc12,IC50,7.4,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,LHIIXZMSXRDIET-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4064087,,CC(O)c1cc2nc(N3C[C@@H](C)O[C@@H](C)C3)nc(N3CCOCC3)c2s1,IC50,5.48,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,KPYIICUHFXSFAD-FUNVUKJBSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL393220,ATORVASTATIN CALCIUM,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],IC50,5.09,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,FQCKMBLVYCEXJB-MNSAWQCASA-L,72.0,Cytotoxicity,MTT
CHEMBL4080590,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nnc1Cl,IC50,5.77,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,BJYZYCDBIWVFEN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3597223,,COc1cc(Sc2c(-c3ccccc3)[nH]c3c(Cl)c(Cl)ccc23)cc(OC)c1OC,IC50,7.79,CHEMBL3599943,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTS conversion assay,T98G,NGOSBFUXHJANRG-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS conversion
CHEMBL1782905,,CCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.68,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,RFEUBQAKWNFXQN-LVEBQJTPSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1807801,,Cc1c2c(n3c1CCN(C(=O)CO)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.33,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZNHZHSANEXQZND-WBVHZDCISA-N,,Antiproliferative activity,Unspecified
CHEMBL278315,GELDANAMYCIN,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,7.05,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,QTQAWLPCGQOSGP-KSRBKZBZSA-N,,Antiproliferative activity,Unspecified
CHEMBL237830,,c1ccc(NCc2ccc(CNc3ccccn3)cc2)nc1,IC50,8.74,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,KBVFRXIGQQRMEF-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL4641878,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(C)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.55,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,DRCZVSOYNQERJP-PXCOWHNISA-N,96.0,Antiproliferative activity,MTT
CHEMBL1807798,,Cc1c2c(n3c1CCCN(C(=O)CN)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.32,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RGXUGCVLZOLOQG-IRXDYDNUSA-N,,Antiproliferative activity,Unspecified
CHEMBL1807799,,Cc1c2c(n3c1CCN(C(=O)CN)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.42,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,QRUWUQGHACTCGO-WBVHZDCISA-N,,Antiproliferative activity,Unspecified
CHEMBL3400563,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(Br)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,5.52,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,AXCLHNCUQVHTDE-LUJDZOJYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3400564,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(C=O)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.64,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,XRDWUWZIBPDAJW-OXPDPLDSSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL3415682,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CC(C)C)c(C)c21.[Br-],IC50,5.42,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,OJSRECCJWPQHDA-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL3114423,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1Sc1ccccc1,IC50,5.04,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,CSKHKZLUBWGDKA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3114589,,COc1ccc(NC2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)cc1,IC50,6.13,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SGUSEXOKZCOCFX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3114586,,CC1(C)CC(Nc2ccc(Br)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.2,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,LVDWHNNSPPTBKQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2375477,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(-c2ccccc2)nn1,IC50,5.46,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SKZPRPFMFVHUMQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1567256,,O=C(Cc1ccc(Br)cc1)NCc1ccccc1,EC50,5.63,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KXFWFGCNDQHKRZ-UHFFFAOYSA-N,48.0,Unspecified,ELISA
CHEMBL4097578,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nnc1Cl,IC50,4.88,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,NVINUJFUNDNKJI-UHFFFAOYSA-N,,Cytotoxicity,WST1
CHEMBL117185,,C=C/C(C)=C/C[C@@]1(C)[C@@H](C)C[C@@H](O)C23C(=C[C@@H](OC(=O)C(C)C)C[C@@H]21)[C@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.0,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,PASSAFHUDJPXAL-UUCYYRGWSA-N,,Cytotoxicity,Unspecified
CHEMBL4284792,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccs3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.68,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SVOFEUHLLHYNRJ-JLXBFWJWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2407568,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NCc1ccccc1)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BERPIXVXUHXNAJ-GIBQAPQMSA-N,72.0,Cytotoxicity,resazurin
CHEMBL4284998,,c1cc(-c2ncc(-c3ccc(-c4cnco4)cn3)o2)nc(-c2ncc(-c3ccc(-c4cnco4)cn3)o2)c1,IC50,6.36,CHEMBL4261146,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,FZMULGSCSMOHRS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL5280101,,O=S(=O)(NC1CCCCC1)c1ccc2c(c1)C(=NO)c1cc(S(=O)(=O)NC3CCCCC3)ccc1-2,IC50,5.38,CHEMBL5250701,Induction of ferroptosis in human LN-229 cells assessed as GPX4 degradation,LN-229,JLCFMMIWBSZOIS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5269497,,Clc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.63,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,YUWNKSTXMKZSEK-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL4097171,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.05,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,URZMEUOWWYWJBV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3617078,,CCCc1cc(=O)n2nc(NCc3c(F)cc(Cl)cc3F)c(C#N)c2[nH]1,IC50,5.28,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,SFUVDTPAOHEGCQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5267195,,COc1cc(C(=O)c2cn(-c3ncccn3)cc2-c2ccco2)cc(OC)c1OC,IC50,8.0,CHEMBL5238348,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth incubated for 48 hrs by trypan blue exclusion assay,U-87MG ATCC,IXBOSJOTMWEKPZ-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue exclusion
CHEMBL4206106,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@H](c2ccc(O)cc2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.51,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,AMGHFASSLAHWBX-PBBNMVCDSA-N,24.0,Cytotoxicity,CCK8
CHEMBL4756703,,CO[C@@]1(C)N(C[C@H](O)c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,4.77,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,NSKGPNPTDFLIQO-RDPSFJRHSA-N,,Antiproliferative activity,SRB
CHEMBL5179292,,Br.Fc1ccc2c(c1)c(-c1nc(-c3c[nH]c4ncccc34)cs1)cn2CCCCN1CCOCC1,EC50,5.44,CHEMBL5122041,Cytotoxicity against human U-87 MG cells overexpressing GLS-1,U-87MG ATCC,OFXKPOFBKPYJJU-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5205920,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1cccc(C(F)(F)F)c1,IC50,5.75,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,KEZRNSQBXOWDMI-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL4238900,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCC3)CC1)c1ccccc1S2,EC50,5.21,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,CVFJHVCUQHZUDA-UHFFFAOYSA-N,,Unspecified,Fura-2 AM dye-based
CHEMBL4576165,,CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2n1,IC50,4.34,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,AWJAAKKEYXUCFY-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4127998,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(C(F)(F)F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.82,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HVEMXAGNWZKCPE-LWCHGPQXSA-N,72.0,Cytotoxicity,MTT
CHEMBL4286032,,Cc1cc(=O)c(O)c(C(c2ccc(OCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,IC50,5.34,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,NRCFTXZTBUYJRR-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4102004,,CCc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,5.08,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VTCYYHFNVWXODK-KRWDZBQOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL168888,,CC(C)NC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.28,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,RZTDQABOCFQUFV-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4760781,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(Nc2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.43,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,YIKYKYFYFWNCSE-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL5433580,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2ccccc2CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.94,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,VMIUNURGDIYHPA-NQAOGTSWSA-N,48.0,Unspecified,CCK-8
CHEMBL5395996,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2ccccc2CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,5.55,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,CJDQEJPOCUIGOI-RZAATYBRSA-N,48.0,Unspecified,CCK-8
CHEMBL5558244,,O=C(Nc1ccc(Oc2ccnc(C(=O)NCCCCNC(=O)C3CC4C=CC3C4)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,4.2,CHEMBL5503291,Antiproliferative activity against human U87 cells assessed as inhibition of cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QPMWUPDBRJFZLI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3401519,,NC(=O)c1cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)ccc1OCc1ccc(F)cc1,IC50,5.4,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WYNDFDUHWUEWJF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3780566,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BKMYJTORXVRSOY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3339360,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.54,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DQVUCDBOFDTXMU-LALXJTNGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339371,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.29,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JFZPAVVJZJMWAJ-UUKRNIFRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL373546,,C/N=C/N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,7.48,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HDWZRGPJHTWCSK-ZVHZXABRSA-N,,Unspecified,Unspecified
CHEMBL373868,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(C(F)(F)F)cc1,IC50,6.82,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GMACZBIWIXUAPQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220123,,Cc1cc(N2CCN(Cc3ccccc3)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.6,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DVUZLCFDNOGYKM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3327006,,COc1ncc(-c2cnc3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(C#N)cc1,IC50,5.61,CHEMBL3380580,Antiproliferative activity against human U87MG cells after 4 days by CellTiter-Glo assay,U-87MG ATCC,JFSMZTDNJFICOR-UHFFFAOYSA-N,96.0,Antiproliferative activity,CellTiter-Glo
CHEMBL1234354,PF-04691502,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,IC50,6.28,CHEMBL3380580,Antiproliferative activity against human U87MG cells after 4 days by CellTiter-Glo assay,U-87MG ATCC,XDLYKKIQACFMJG-WKILWMFISA-N,96.0,Antiproliferative activity,CellTiter-Glo
CHEMBL169,URSOLIC ACID,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.32,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,WCGUUGGRBIKTOS-GPOJBZKASA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4864509,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7cccc8[nH]ccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.33,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,RFNPZBPEUSTEIE-JDMHCBMBSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL3353045,,O=C(COc1cccc2ccccc12)N1CCN(C(=O)c2ccccc2)CC1,IC50,4.27,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,XLZDOLVDLGNPEM-UHFFFAOYSA-N,48.0,Antiviral activity,cell-based luciferase reporter gene
CHEMBL1779533,,Cc1c2c(n3c1CCCN1CCOC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.52,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,WCKJSDUJHUSOFY-SFHVURJKSA-N,,Antiproliferative activity,luminescence
CHEMBL4441865,,COc1cc(/C=N/Nc2nc(-c3ccc(Br)cc3)cs2)cc(Br)c1OC,IC50,4.55,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,NKCFNFYCVRRXDU-ZVBGSRNCSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4550807,,COc1ccccc1-c1csc(N/N=C/c2ccc(F)c(F)c2)n1,IC50,4.39,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,CEWAJXHLDDWARA-AWQFTUOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2435965,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5)n4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.95,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OKJTTYWLYKAMBD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435975,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccccc5)n4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RBUJKCIMCCHILL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435985,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.89,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZFWMISSSYWICDR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435998,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.0,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NGTAHWHMGVUEDB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3588941,,CCCC(=O)OC/C=C/c1ccc(OC(C)=O)c(OC)c1,IC50,4.73,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UHANZZHYVNKKSW-FNORWQNLSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3588938,,CCCCCCCCCCCCCCCCCCCCOC(=O)/C=C/c1ccc(O)c(OC)c1,IC50,5.28,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UBNJQWYYWIBSGN-ZNTNEXAZSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL2435997,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5F)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.21,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZEXVKTFRFYFERV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2375474,,CCCCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,IC50,5.56,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,GQBURWAEKZKSAW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL452911,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.73,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,QUBNLZCADIYAFW-RITZIESXSA-N,72.0,Cytotoxicity,MTT
CHEMBL444982,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.8,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,HZLWUYJLOIAQFC-HRDZKRTASA-N,72.0,Cytotoxicity,MTT
CHEMBL2430037,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,4.53,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GSOMSXJOAJCAIV-YFNOCVKUSA-N,72.0,Cytotoxicity,MTT
CHEMBL4763389,,Cc1nn(C)c(Oc2ccc(Cl)cc2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.73,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DYSYRTYGHNZWOO-UHBFCERESA-N,72.0,Antiproliferative activity,MTT
CHEMBL4791408,,Cc1nn(C)c(Oc2ccccc2Br)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.66,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CUYOGGLYAOKVHD-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4762880,,Cc1nn(C)c(Oc2cccc(C(F)(F)F)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.63,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UZFLECKMFSQDKV-DLCNMLRHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4779312,,Cc1nn(C)c(Oc2ccc(OC(F)(F)F)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.02,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JQMSUSQEEABTHG-DLCNMLRHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4791226,,Cc1cccc(C(C(=O)NC2CCCCC2)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CQTVFFHTFZUWRM-FOCLMDBBSA-N,72.0,Cytotoxicity,MTT
CHEMBL223385,,O=C(CC1CN(C(=O)Oc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.85,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,CNWNPKTZNBJRTQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220156,,O=C(CC1CN(S(=O)(=O)c2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.57,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,UXEWUEZKRXQCGG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223791,,O=C(CC1CN(C(=O)NCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.02,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,TXDBPIRWDGSMJW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3577925,,O=S(=O)(Nc1cc(-c2cc3c(-c4ccncc4)ncnc3s2)cnc1Cl)c1ccc(F)cc1F,IC50,5.35,CHEMBL3579772,Cytotoxicity against human U87MG cells harboring PTEN deletion mutant assessed as growth inhibition after 4 days by CellTiter-Glo luminescent cell viability assay,U-87MG ATCC,OGUIPHCQISNMKY-UHFFFAOYSA-N,96.0,Cytotoxicity,CellTiter-Glo luminescent cell viability
CHEMBL5184425,,CO[C@@H]1O[C@H](COC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)[C@H]2OC(C)(C)O[C@@H]12,IC50,6.8,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,AMDWNEOUUQNSLQ-HDWZVLIESA-N,,Cytotoxicity,MTT
CHEMBL1652065,,CC(C)CC1=C(OC2(CC(C)C)C(=O)C(=O)C3=C(CCCC3)C2=O)C(=O)C2=C(CCCC2)C1=O,IC50,4.97,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AWUWZGUYHOFDNO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL307794,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc4c(cc3nc2-1)OCO4,IC50,6.96,CHEMBL5109659,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,RPFYDENHBPRCTN-NRFANRHFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4082189,,CC(=O)OC[C@H]1O[C@@H](S[C@@H]2CC(=O)[C@@H]3OC[C@H]2O3)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,4.19,CHEMBL4611186,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 14 hrs by CCK8 assay,U-87MG ATCC,ILWHSILTMOSREC-OJWHBJTBSA-N,14.0,Antiproliferative activity,CCK8
CHEMBL1096181,,NCCCCCCCCCCCC(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.11,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,MVUALRSRYHHUKP-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL5272157,,CC1(C)CC(=O)C2=C(C1)OC(N)=C(C#N)C21C(=O)N(CCCCCCCCCCBr)c2ccccc21,IC50,5.6,CHEMBL5226671,Antiproliferative activity against human U87 cells,U-87MG ATCC,UJDUXBISCYQNNZ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4643992,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(C(F)(F)F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.76,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RCKSXRJGPINTBA-AAKZOTGXSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4644332,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccccc1F)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.49,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,IDURRGUUHPZZPT-CDGBYUCFSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4646810,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)NCCCC)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.32,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,SIARFVBTBUCVJS-ZDBMLTPASA-N,96.0,Antiproliferative activity,MTT
CHEMBL4647700,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(CC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.84,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,BAQCFXXHSYBPQT-HILUMYNGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4633299,,Cc1cc(C)c(CNC(=O)c2cc(C)n(-c3cccc(NC(=O)CCCCCCC(=O)NO)c3)c2C)c(=O)[nH]1,IC50,4.7,CHEMBL4616189,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter-Glo Luminescent cell viability assay,U-87MG ATCC,HQAHZUWVVKNTRB-UHFFFAOYSA-N,72.0,Cytotoxicity,CellTiter-Glo Luminescent cell viability
CHEMBL5291398,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4cccc(Cl)c4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,XXJNRYISGDIFRB-IZNAELAISA-N,,Antiproliferative activity,Unspecified
CHEMBL4647017,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(C(F)(F)F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.6,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ROMCDQXUNLGMJO-AAKZOTGXSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1822054,,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,7.89,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,FHOXICOTPQTJOQ-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL1822059,,O=S(=O)(Nc1cc(-c2ccc3nccn3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.24,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,DNCWCPDSMUNNAM-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL1822060,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2[nH]1,IC50,6.47,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,VMOWYZQEUZXDFM-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL4239569,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(C#N)nc3n2)cc1CO,IC50,6.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,YORDELGQXBGIHM-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4246481,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(CC(OC)OC)nc3n2)cc1CO,IC50,7.05,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,QENAZHNQLZMAPO-HNNXBMFYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4246121,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C4=CCOCC4)nc3n2)cc1CO,IC50,7.07,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,PQSRXIWKDZAALQ-INIZCTEOSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL425148,MATAIRESINOL,COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.63,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,MATGKVZWFZHCLI-LSDHHAIUSA-N,,Anticancer activity,SRB
CHEMBL4103284,,COc1cc(/C=C/C(=O)c2ccccc2O)ccc1OCCCN1CCCCC1,IC50,5.54,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HZCOSEZBEUQJPH-ZRDIBKRKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3262849,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3)cc2F)ccn1,IC50,5.64,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASBJBQZTHWZUNT-WKULSOCRSA-N,72.0,Cytotoxicity,MTT
CHEMBL3335768,,O=c1ccc(-c2cc(F)c(F)c(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCN(CCO)CC4)c3)cn2)CCO1,IC50,5.39,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,INWKTLVUGKCAMW-QHCPKHFHSA-N,72.0,Cytotoxicity,WST8
CHEMBL3335769,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cccc(F)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RDWKECAQTMHRSL-VWLOTQADSA-N,72.0,Cytotoxicity,WST8
CHEMBL1822211,,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,IC50,7.0,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,SMTOUMSBNIEJMF-UHFFFAOYSA-N,2.0,Unspecified,alphascreen
CHEMBL3343381,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CODZLYDUWWEMOC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343391,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.55,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHQYABUNYJJQNG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3262856,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)c(Br)c3)cc2F)ccn1,IC50,4.91,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVWVQRDRTYXJEJ-IPPBACCNSA-N,72.0,Cytotoxicity,MTT
CHEMBL3263195,,COC(=O)CCC[C@@H]1[C@H]2CCCN3CCC[C@H](CN1Cc1ccc(Cl)cc1)[C@@H]23,IC50,4.9,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,DBHCSAFZYROWFD-LPOZWGFCSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1795857,,CCCCc1ccc(C#Cc2ccc(S(=O)(=O)N[C@H](Cc3ccc(OCc4ccccc4)cc3)C(=O)NO)s2)cc1,IC50,7.92,CHEMBL1799656,Antiinvasive activity against human U87MG cells after 24 hrs by Matrigel basement membrane transwell assay,U-87MG ATCC,VZNWQFCLBMVARX-SSEXGKCCSA-N,24.0,Unspecified,Matrigel basement membrane transwell
CHEMBL4101008,,Cc1ccccc1-n1nc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)cc2)c(C)cc1=O,IC50,5.49,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LUCCIHRGBDBWOV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4068211,,CN1CCN(CCOC(=O)N(Cc2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,4.73,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,ONIFAJAFWHMUOA-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL4060917,,CSc1nc(N(C(=O)OC(Cc2ccccc2)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.17,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,YZYCFZMIKGBFFD-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL411043,,ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1,IC50,5.31,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,SEFWYTXTKMMUEF-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue
CHEMBL5620269,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.77,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LSCFMIBDVFNSCU-NDEPHWFRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL1169766,,COc1ccc(/C=C/[C@](C)(/C=C/c2ccc(O)cc2)CCC=C(C)C)cc1,IC50,4.66,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,YUBDDAFYPBAOLK-NSDNEPAYSA-N,48.0,Cytotoxicity,sulpharhodamine B
CHEMBL355004,,CCOCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.95,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,KFVUDTYOUWJVII-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5436787,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N(C)C)CC2)n1,IC50,5.69,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,JXCSRHVITGYTRY-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5397031,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.13,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,DWMRSQUGHUXVSZ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5433632,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCCCC1,IC50,6.84,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,QKZIZOZKBBOCAH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL4098035,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccccn4)cc3n2)C[C@H](C)O1,IC50,5.35,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,DSQSNLIGWUDVSQ-GASCZTMLSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4634930,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(O)ccc1C4=O,EC50,7.29,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,SRBWZZOBDMCFHB-XIQYBZFWSA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL4633528,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(OC)c1O)C4=O,EC50,8.4,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,IEVSIHHPTPATHO-UOGOAWDKSA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL1351,CARBOPLATIN,,IC50,4.87,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,,,Cytotoxicity,Unspecified
CHEMBL3793044,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCOCC1,IC50,4.51,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,UIEKSGGZBSOENC-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL3793499,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccnc1,IC50,6.18,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,UAQPYWINZIRBDY-QJPTWQEYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3792839,,O=C(CCCC[C@@H]1CCSS1)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,6.48,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,AVEZQSILLDDILW-YXCITZCRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3793670,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1,IC50,6.28,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,WINHOLWWINLHRE-YNEHKIRRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3792429,,CC(=O)Oc1ccccc1C(=O)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,5.45,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,XKWCELKXOXBVSR-RRFJBIMHSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3764541,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(SC)cc2)cc(OC)c1OC,IC50,5.69,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,BSTXCPVIBADBRU-CPNJWEJPSA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL3765252,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(F)cc2)cc(OC)c1OC,IC50,5.71,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,RHGMRAZDADDXKT-LDADJPATSA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL352630,,COCC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.16,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,PUVLMZIGKJSEMS-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5572684,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CNC1)C3,IC50,5.54,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DQLTZXUTRHYPJH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5569200,,N[C@H]1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,6.16,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DKTKUPGWANWPSS-NSHDSACASA-N,72.0,Antiproliferative activity,MTT
CHEMBL5589615,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CCCNC1)C3,IC50,5.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DJAPPFABCGXIHD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4090663,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(Br)C2=O)nc1C,IC50,5.37,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QDSGKXLBOWDWHE-VOTSOKGWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4090082,,COc1cc(/C=C/C(=O)c2ccccc2)ccc1OCCCN1CCCc2ccccc21,IC50,4.7,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,VFOXCQNDDNLOKR-JQIJEIRASA-N,48.0,Antiproliferative activity,MTT
CHEMBL4100526,,CSc1nc(N2CCOCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.69,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,QGGIXKZOWARZOR-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4091022,,CSc1nc(NCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,5.15,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,RENHBYHXMSFCBW-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4084146,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ISLMUWZWOABKBN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3735270,,OC[C@H]1O[C@@H](Sc2c(F)c(F)c(/C3=C4\C=CC(=N4)C(c4c(F)c(F)c(F)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(F)c(F)c5F)=C5/C=CC3=N5)C=C4)c(F)c2F)[C@H](O)[C@@H](O)[C@@H]1O,EC50,8.0,CHEMBL3737968,Photocytotoxicity against human U87 cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,U-87MG ATCC,AYDRZTACVIBHHJ-ZBFLLVCBSA-N,24.0,Cytotoxicity,irradiation at 16 J/cm2 measured at 24 hrs by WST-8
CHEMBL4092999,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.92,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XDRRPCJJHJGRKX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1164287,,COc1cc(C(=O)OCc2ccccc2COC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.19,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CYTQDYWRDYAMTP-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL331163,,CN(C)c1ccnc2c1-c1nccc3ccnc(c13)C2=O,IC50,5.7,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,BLYPRRAUYLWDOD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL113436,,Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.7,CHEMBL815087,Compound was tested for inhibiting HIV (ADA) entry into cells; Range is 0.2-2.0 nM,U-87MG ATCC,DTKUANPECHGGBY-UNMCSNQZSA-N,,Unspecified,Unspecified
CHEMBL3805762,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4ccc5ccc(=O)oc5c4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.36,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YXTSDYROYUUFHX-ZYDPEMPTSA-N,72.0,Antiproliferative activity,MTT
CHEMBL85702,,CCOP(=O)(OCC)N(C)/N=N\C,IC50,4.85,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,BARCMKNJTPZIIK-FPLPWBNLSA-N,,Cytotoxicity,MTT
CHEMBL3793372,,COc1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,6.41,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,FQPVJRDHGMKKQS-BFHYXJOUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3780698,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.32,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KXTZGBPADOSZJP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3780522,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.88,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GUOHTHYECWTYKK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL85734,,Oc1ccc(-c2cc3c(O)cc(O)cc3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,WWGWIVQHGAYORR-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL339527,,Nc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,QVCFIRMNSMMTLK-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3337794,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.58,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,CUPKWSGZEKNROE-ODZSYRHHSA-N,,Cytotoxicity,MTT
CHEMBL442870,PHENETHYLISOSELENOCYANATE,[Se]=C=NCCc1ccccc1,IC50,4.62,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,CNMSUIBHTZHSEK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL115487,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,HMVJROBJYQFKLV-GOTSBHOMSA-N,,Unspecified,Unspecified
CHEMBL1170448,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,6.51,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,BAYGQIFIHYGSEE-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL1170261,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,6.19,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,MACTYDWFDZZTGD-FQEVSTJZSA-N,1.0,Unspecified,ELISA
CHEMBL1096067,,CCCCC(C#CC(=O)OC)O/C=C/C(=O)OC,IC50,5.31,CHEMBL4378598,Antiproliferative activity against human U87 cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UTONHELWURZURG-MDZDMXLPSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL5175707,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CCF)CC2)cc1)OCc1cccnc1,IC50,6.39,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YLGCHBUJABEZPI-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5199657,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3CCC3)CC2)cc1)OCc1cccnc1,IC50,6.21,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,KOYLPNACSINQDI-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL4468971,,CC(=O)C(=NNc1ccccc1C#N)C(C)=O,IC50,4.06,CHEMBL4317180,Cytotoxicity against human LN229 cells assessed as reduction in cell proliferation measured after 48 hrs by trypan blue dye-based cell counting analysis,LN-229,FDMUFIZTSWLKSP-UHFFFAOYSA-N,48.0,Cytotoxicity,Trypan Blue
CHEMBL3609559,,CC1(C)OC2=C(CC1SCc1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.41,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,RJMWHRTZXBLHNQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3609561,,Cc1ccc(SC2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.22,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,VKFXKHDQMRJCPP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL50001,,COC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,VSEDGUQFBMASFM-YEFHWUCQSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL496557,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(N)=O,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,GZTMFRUGZMZCRD-CFBAGHHKSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL524628,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N(C)C,IC50,4.7,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,LQDIKDAVLUSQPN-YHHVCGRHSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL478414,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.71,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,MXEIEIPFARBHKD-JQZXIOIQSA-N,,Cytotoxicity,Unspecified
CHEMBL326020,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.7,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,KFQDPQKXTSWQOC-SFTDATJTSA-N,,Unspecified,Unspecified
CHEMBL4090537,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IHLDUYHYMVUCMO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4279607,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(C(F)(F)F)cc5Cl)c4=O)cc3F)ccnc21,IC50,4.99,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PSHVAMXWEGRSSC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1097304,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.81,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PVRNBHHCMFPGTE-FBXQPAQYSA-N,48.0,Cytotoxicity,MTT
CHEMBL5565786,,NCCN(CCN)C(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.8,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,FCTNJSDNGJBGKT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5590209,,N#CC1(C(=O)Nc2ccc3c(c2)OCO3)CC2c3ccccc3C1c1ccccc12,IC50,4.34,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,KKZYSGCIMXPESB-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4238656,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)(C)C)nc3n2)cc1CO,IC50,8.49,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,DZLWBRXUDBZZHQ-HNNXBMFYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4239712,,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)(C)C)nc3n2)c1,IC50,7.49,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,VUWOZURKZJVAEV-HNNXBMFYSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL4572589,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.58,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,PVIFYSUWLTVVKK-MDWZMJQESA-N,72.0,Cytotoxicity,MTT
CHEMBL2385175,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.77,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NQSBULPZCGDNAY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385174,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.84,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ADAZJHGJWPAJRZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4162596,,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc(C/C=C(\C)CCC=C(C)C)c1O,EC50,5.16,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,MRXGJOGASBBDTM-FVFOHYRDSA-N,72.0,Antiproliferative activity,MTS
CHEMBL223046,VEDELIANIN,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)[C@H](O)C[C@@]2(C)O3)cc1O,EC50,7.52,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,OYMAGMAEFPAAGU-HKYLTJPLSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4535709,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CI)cc1C2=O,IC50,4.98,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,KAKKQFWHQUGART-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4452206,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.75,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,IHULAANGIJWQQE-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL117784,,COc1ccnc2c1-c1nccc3ccnc(c13)C2=O,IC50,7.0,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,WCRIHVQLNYDYHQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL87769,,CNC(=O)N(C)/N=N\CCCl,IC50,4.57,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,CJLYVUNRUJYSGI-HJWRWDBZSA-N,,Cytotoxicity,MTT
CHEMBL2435973,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C(F)(F)F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JIRWVSFHXIEANN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3109415,,CC(=O)O[C@@]1(C)CCC(=O)/C(C)=C/CC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.43,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,JNFYTEVLFJWCJH-VUWNFVCTSA-N,24.0,Cytotoxicity,MTT
CHEMBL354150,,CC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.4,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,WOJJOSHDTGRKES-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL119037,,COc1ccc2c(n1)C(=O)c1nccc3ccnc-2c13,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,NXHFYTNPRXAFAC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3805637,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.99,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KFRVRWSQDNDVJA-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805375,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.74,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CXYFPWNKXDCDRW-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL1823630,,N[C@H](CNc1nnc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.52,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,ULPHTBRVXJBSIQ-HNNXBMFYSA-N,1.0,Unspecified,ELISA
CHEMBL3965975,,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,4.99,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,PBPCGYFTVDKXDD-OWBOGJPASA-N,1.0,Antiviral activity,viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24
CHEMBL3927147,,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCNC(=O)c1ccc(B(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,5.0,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,PLFZZOMKOTYLDB-SHAJCIBYSA-N,1.0,Antiviral activity,viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24
CHEMBL2172488,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncn4C)cn23)n1,IC50,6.56,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CTXUPZKYBBQLJM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172482,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnccc4C)cn23)n1,IC50,7.31,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,NECBLBSHQGQKDS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2385200,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C)ccc5C)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.61,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YECWSUXGTFLMNH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385177,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.98,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SLONUMXPVJUXEW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4639291,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[n+]3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,4.95,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,AHEFQKUDCFDRAD-XARMMMSZSA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL4642711,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.89,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,ACEHQLUTLAXHMS-ZTDYFSAPSA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL4285411,,CCCCCCCCCCCC[N+]1(C)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,5.12,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,ZOLGSVKCRDIUOJ-NCHIOQGESA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL375920,,Cc1cccn2c3c(nc12)-c1ncccc1C(=O)C3=O,IC50,7.07,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,VPBRLYVYYCPCCW-UHFFFAOYSA-N,48.0,Anticancer activity,SRB
CHEMBL4752354,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccc(Cl)cc2)n1,IC50,5.47,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,RHKHXSMWHHAZLL-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3092922,,C=CCCCCOc1ncc(-c2cc(C(F)(F)F)ccc2OC)n1C,IC50,4.06,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,FVRGXLUIRGUICK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL2392949,,COc1cccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)c1,IC50,5.79,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HUJQXBZJKIRBCV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3104250,,C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O,IC50,5.94,CHEMBL3107689,Growth inhibition of human U87 cells after 96 hrs by ATPlite luminescence assay,U-87MG ATCC,NKUDGJUBIVEDTF-FYJGNVAPSA-N,96.0,Growth inhibition,ATPlite luminescence
CHEMBL1911002,,FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,6.38,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,PJLRZCKJQYTSNY-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL2417828,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.69,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,GTKPTDFLYGQQPV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417824,,CCOC(=O)CNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.1,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WNQIPKTTWSVBJF-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417836,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(C2CC2)cc1,IC50,5.43,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YFSUSZAVLPDOCY-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL337820,,Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,10.0,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,KUOUHUKIBBTXEV-PXNSSMCTSA-N,,Unspecified,Unspecified
CHEMBL2206919,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(C)c(NS(C)(=O)=O)c2)n1,IC50,7.02,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,RBXKFGUMEZSADC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL481608,,C=CCN(C)Cc1ccc(-c2ccc(C(=O)c3ccc(Br)cc3)cc2)cc1.Cl,IC50,4.75,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,MCMDJJBPNGLKKM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5394493,,COc1cccc(-c2ccc(F)c(NC(=O)C#Cc3ccccc3)c2)c1,IC50,4.93,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XIGSSELZIPMFEM-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5415803,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cc(OC)c(OC)c(OC)c1,IC50,6.91,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WCOJKQVBIGKRIH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5423427,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(F)cc1,IC50,7.47,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VFWLIXHERZWZAJ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL3889534,,Cl.FC(F)(F)c1cccc(-c2c[nH]c(C3CCN(c4ncnc5[nH]ncc45)CC3)n2)c1,IC50,4.84,CHEMBL3881188,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation after 72 hrs by Alamar Blue assay,U-87MG ATCC,KBPOPQFIGUANJS-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar Blue
CHEMBL5430183,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,8.96,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,BVLMGTBJGDNQCI-MNVSKPNQSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5394654,,C=CCc1c(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c(c1O)O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.34,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WMKPMYWSMDYVJC-IZTRPBQQSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL411344,SCHWEINFURTHIN H,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)C(O)C3)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.18,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,RFLJGOACFXZRHJ-ZHIKFPNPSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5413968,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(C)ccc32)cc1,IC50,4.68,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,KBDSJUFIJNFEOV-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5396858,,CC(=O)n1cc(Cc2cc(C)c(O)c(C)c2)c2ccccc21,IC50,4.23,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WIWKDKJEINZEAT-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL2163603,,CC(C)CN(Cc1cc(O)c2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccncc1,IC50,4.04,CHEMBL2169673,Cytotoxicity against human LN229 cells transfected with V6R incubated for 3 days under normoxic condition by SRB assay,LN-229,NJOAQZNAGFIDRV-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL237859,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3nccs3)nccc12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ZCBXKVDZSCIMDK-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL393332,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ncon3)nccc12,IC50,5.91,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,QSZNZPLBLSGDFR-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL393331,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ccnc(N)n3)nccc12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BBKIJJQQYXXNIU-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238115,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)nccc12,IC50,7.27,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WELZLTSZYGTAHI-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL429087,,COc1cc2c(S(=O)(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c2cn1,IC50,5.04,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LHMWTBKZSSXQOL-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240477,,CC1CN(C(=O)c2ccc3[nH]ccc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.34,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CJYOAVILJRQDKM-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238103,,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12,IC50,7.58,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DBPMWRYLTBNCCE-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL337301,,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,IC50,8.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OKGPFTLYBPQBIX-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL442078,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ncccc12,IC50,7.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CCGWWGUXCYXFJW-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL2206909,,Cc1nc(N)nc(-c2cc(CN3CCOCC3)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,8.41,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,ZMAXXRHYLSDAIN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206918,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,7.75,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,QNTWFBRDSGVBHE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1042,CHOLECALCIFEROL,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.53,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QYSXJUFSXHHAJI-YRZJJWOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL1949933,,C=C1CC[C@@H](N)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.91,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KBTODVOGUWIIOU-YHJXBONMSA-N,72.0,Antiproliferative activity,MTS
CHEMBL1949934,,C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.41,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QYSXJUFSXHHAJI-YHJXBONMSA-N,72.0,Antiproliferative activity,MTS
CHEMBL1949935,,C=C1CC[C@H](N)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.91,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KBTODVOGUWIIOU-YRZJJWOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL2172634,,Cc1nc(Nc2cnn(C3CCOC3)c2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.84,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,BODKINCAIVHOBM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172625,,Cc1nc(N)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.68,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,PQQNUIZZMSTORP-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL388708,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2F)n1,IC50,7.04,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,FDGPPDMWCPBMSY-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL2163598,,COc1cc(CN(C(C)C)S(=O)(=O)c2ccccn2)cc2c1OC(C)(C)C=C2,IC50,4.16,CHEMBL2166125,Cytotoxicity against human LN229 cells transfected with V6R incubated for 14 days under normoxic condition by clonogenecity assay,LN-229,LREPTZOCUMWFMS-UHFFFAOYSA-N,336.0,Cytotoxicity,clonogenecity
CHEMBL4450512,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(C[Se]c3ccc(F)cc3)nn2)[C@H]1Br,IC50,5.83,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OAOAYCGZHNXPAB-WMZHIEFXSA-N,72.0,Cytotoxicity,MTT
CHEMBL454935,,CC(C)(O)c1cn(C2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)nn1,IC50,5.55,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,KQPBRFALEYFWBN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1927618,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCN(C)C)c23)C1=O,IC50,6.43,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NLQVIEPODYFPBE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL428676,AMONAFIDE,CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O,IC50,5.55,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UPALIKSFLSVKIS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL475845,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](CS(=O)(=O)O)C(C)=O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,7.9,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,YWMWRRNNRCIAAJ-WGPXQLEISA-N,3.0,Unspecified,Unspecified
CHEMBL515145,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,8.46,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,PCZVRCIZMAPKOI-HMHHHFJXSA-N,3.0,Unspecified,Unspecified
CHEMBL3290920,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.82,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RVPSNYLJUHSZDC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1170446,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,6.04,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,XDBJHHAFLGPGOE-FQEVSTJZSA-N,1.0,Unspecified,ELISA
CHEMBL259265,,c1ccc2c(c1)N(c1ncnc3[nH]ccc13)CC21CCNCC1,IC50,7.02,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,OMUNCTQJLGEHQC-UHFFFAOYSA-N,2.0,Unspecified,ELISA
CHEMBL1914727,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccncc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,8.43,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LHLRTOZIMJUPET-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914719,,CN(C)c1ccnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,6.65,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTHFARGKBRIFCM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914721,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCC(O)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.82,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LGDWBXISXWXDQF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914742,,CC(C)N1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1,IC50,7.77,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,MVPHPMFJESRQLE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL376632,,Cc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.54,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LBCGUKCXRVUULK-QGZVFWFLSA-N,,Unspecified,Unspecified
CHEMBL442041,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YCVKPMKXQJEDIS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL376237,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(Cl)cc1,IC50,8.24,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QSGAUBIKGYULKQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223839,,COc1ccccc1CNC(=O)CC1CCCCN1c1ccnc(-n2ccnc2)n1,IC50,6.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MQLMLAGRRODONI-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL374681,,COc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,9.1,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,RWQHNEZMEIPWJF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223840,,O=C(CC1CCCCN1c1cc(C(F)(F)F)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,6.75,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JDDBNIXQWYFIPL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220824,,Cc1cc(N2CCN(C(=O)C(C)C)[C@@H](CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,6.52,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-FQEVSTJZSA-N,,Unspecified,Unspecified
CHEMBL1369953,,Nc1[nH]nc2nc3ccccc3cc12,IC50,5.11,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,KEVOFPICRVTBPL-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL3612310,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,6.41,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YWFOHQFLGQVFIB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612315,,COc1ncc(-c2ccc3nc(NC(=O)NCCN(C)C)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.99,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,MMPNESYYANFTSJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612321,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,6.28,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GQEYRORRZYLMJY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL270638,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1,IC50,7.35,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,HFNJWNHCEQNJQQ-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL4644076,,Cc1c(C(=O)N/N=C\c2c(O)cccc2F)oc2cccc(O)c12,IC50,5.03,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,LLUZEJOXOPCQPJ-UWVJOHFNSA-N,,Antiproliferative activity,Unspecified
CHEMBL2385201,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.31,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JUNYZZIFXGBUIR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL52910,,CC(=O)O.COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,4.92,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,SIUALZNIFSJUSF-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL110757,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1,IC50,9.05,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XXBAQSKVZOMDJH-GKPLWNPISA-N,,Unspecified,Unspecified
CHEMBL3093014,,C=CCCCCOc1cc2ccccc2cc1-c1cnc(OCCCCC=C)n1C,IC50,4.4,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,UCNOEJJVPVJYSN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3818951,,CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)[C@@H](C)CC,IC50,7.93,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,DSKXIRKCUGRZJR-MQQADFIWSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL493090,,CN1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.1,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,XXHROJHHXVCFML-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL2435959,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5F)n4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.11,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VHCBNYHCIPMGJM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435971,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,4.9,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XQLJHWGHYTTZRD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5274151,,c1ccc(-c2nc(CNc3nccc(N4CCC4)n3)cs2)cc1,IC50,4.67,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,LUXJFZBHVLTCOX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3394092,,ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1,IC50,4.76,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,TWWILBWAYDXBCM-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL4090317,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,5.59,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,PHZNEXIQOLYTSB-UHFFFAOYSA-N,72.0,Cytotoxicity,trypan blue
CHEMBL1652070,,CCCC1=C(OC2(CCC)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.93,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZYYHKDCWWXNTTA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3622411,,Cl.O=C(CN1CCCCC1)NC1(C(=O)NCc2ccc(Cl)cc2)CSC2=C1C(=O)c1ccccc1C2=O,IC50,6.21,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,JEUNFIVMHNCMAB-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL7492,PIRITREXIM,COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1,IC50,7.32,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,VJXSSYDSOJBUAV-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4794622,,CCOC(=O)[C@@H](N)CCCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.98,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QAQOLDHIHQCYBL-IKGHOSPCSA-N,72.0,Antiproliferative activity,SRB
CHEMBL7063,,COc1cc(CC2CCc3nc(N)nc(N)c3C2)cc(OC)c1OC,IC50,6.6,CHEMBL801267,Compound was tested for the growth inhibition of SF-295 CNS tumor cell line,SF295,CEJLKULOOMMHNK-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2172637,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,6.79,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,OEQWYIZFUDGMEW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4579634,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CCC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,DZUFXUWCLMAHIK-VOUBRIMZSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5424990,,COc1ccc(OC)c(COc2cc(NC(=O)OCCOCCOCCOC(=O)Nc3ccc(NS(C)(=O)=O)c(OCc4cc(OC)ccc4OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.26,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,JBISAMZWMJFIRT-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4444630,,COc1cc2c(cc1OC)[C@H](O)[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,IC50,5.85,CHEMBL4337234,Cytotoxicity against human SF295 cells assessed as inhibition of cell viability after 69 hrs by MTT assay,SF295,ZAVWGRCRKSHIMO-OALUTQOASA-N,69.0,Cytotoxicity,MTT
CHEMBL4757761,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(-c2cc(F)c(CO)c(S(C)(=O)=O)c2)c1,IC50,5.11,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HYQGRYRHNUHTJF-PDDLMNHVSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL5399967,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3ccccc32)cc1,IC50,5.14,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,FBLPWEPWFONTID-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5420275,,COc1ccc2c(Cc3cc(C)c(O)c(C)c3)cn(S(=O)(=O)c3ccc(C)cc3)c2c1,IC50,4.98,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WZZXMLBYQHQMME-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5413828,,Cc1cc(Cc2cn(Cc3ccc(Cl)cc3)c3ccccc23)cc(C)c1O,IC50,4.06,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,NHPSRZJEKIXTMN-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5417863,,Cc1cc(Cc2cn(C(=O)c3ccc(Cl)cc3)c3ccccc23)cc(C)c1O,IC50,4.38,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,OVKXLAMBGQHZFS-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5397688,,Cc1cc(Cc2cn(S(=O)(=O)c3ccc([N+](=O)[O-])c(Cl)c3)c3ccccc23)cc(C)c1O,IC50,5.45,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,ACOUUHGFPHAQCN-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL110786,,Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1,IC50,7.42,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KXMNHKYDYLLZNM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4467693,,CCOP(=O)(OCC)C(N(OC(C)n1cc[n+](C)c1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,BEBGZMBAAKJZSE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5182819,,COc1cccc(-c2nn(-c3ccccc3)cc2-c2ccnc(NCCCNC(=O)Nc3ccc(F)cc3)c2)c1,IC50,5.38,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,BBDDFAGBJKUSTL-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL178,DAUNORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.55,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,STQGQHZAVUOBTE-VGBVRHCVSA-N,24.0,Unspecified,compound washout and further incubation for 48 hrs in presence of serum by MTT
CHEMBL4475868,,CCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCC)c4ccccc4C3(C)C)=C2SCCC(=O)Nc2ccn([C@H]3C[C@H](O)[C@@H](CO)O3)c(=O)n2)C(C)(C)c2ccccc21.[Cl-],IC50,5.47,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,CBUCLPBNOVAOCL-XRHWIWAFSA-N,72.0,Cytotoxicity,AlamarBlue
CHEMBL4569800,,O=C(CCS)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.96,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,MODDLRRNEHNQAD-BDODKLCJSA-N,72.0,Cytotoxicity,AlamarBlue
CHEMBL4475048,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CCl)cc1C2=O,IC50,5.1,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,GZUAONCDQFICIN-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4553726,,[N-]=[N+]=NCCOc1cccc2c1C(=O)c1c(OCCN=[N+]=[N-])cc(NC(=O)CCl)cc1C2=O,IC50,5.32,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,OGZTZYVYGUMFAU-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4450413,,O=C(CI)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,4.86,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZFPGMRDWBXYKGL-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4455664,,[N-]=[N+]=NCCOc1cccc2c1C(=O)c1c(OCCN=[N+]=[N-])cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.86,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,YFVWLTXYBCBCPX-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4561562,,C=CC(=O)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,5.01,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,MIQLGXGHNNEPKZ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4453643,,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cn(Cc2ccc(F)cc2)nn1,IC50,7.38,CHEMBL4343297,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,UPCFUUCRTSFTAE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2381452,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccccc7CO)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,WXSHMRMCDVUCEU-RROBCMOASA-N,48.0,Cytotoxicity,SRB
CHEMBL5590516,,Cc1c(I)c(C)n2c1C=C1C=C(I)C(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,7.3,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,KTSLYWMADUYWFD-UHFFFAOYSA-N,1.0,Growth inhibition,compound washout and light irradiation measured after 72 hrs by MTT
CHEMBL5569643,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCC(=O)NCCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.31,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,QFMUFYJYPWNLNA-RJEGBZFXSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL1988478,,CC1=CC(=O)c2cccc(O)c2C1=O,IC50,5.62,CHEMBL5514332,Cytotoxicity against human U87 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis,U-87MG ATCC,ZMOIGGHUSNHCAB-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL4174909,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1,IC50,6.39,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,DVLVYFPEVHXTKT-GOSISDBHSA-N,96.0,Cytotoxicity,MTT
CHEMBL223515,,O=C(CC1CCCCN1c1nccc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.28,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BVJMSWZNRPVGLJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL219792,,CC(=O)N1CCN(c2cc(C)nc(-n3ccnc3)n2)CC1CC(=O)NCc1ccc2c(c1)OCO2,IC50,8.07,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PRXHAUDSZIOYDL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220122,,Cc1cc(N2CCN(C)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LIAQATNNEGXRGJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4871213,,O=S(=O)(Nc1cc(-c2ccc3nncc(-n4ccnc4)c3c2)cnc1Cl)c1ccccc1,IC50,4.78,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QKUMTMOJNZWMQU-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL3823820,,CC(C)(C)OC(=O)NCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.8,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HWJQKFLZTSDONP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3822799,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.48,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GJXMVBYYKCTZSU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823544,,CCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.72,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZRHUOQGBOBKJOJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3822502,,CCCCCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.64,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MRMKOFUCDNSWBG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823118,,O=C1C(O)=C(C(NCCCCl)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.54,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBCISFONTTYOSV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3823494,,O=C1C(O)=C(C(NCc2ccccc2)c2ccccn2)C(=O)c2ccccc21,IC50,5.89,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BMZQEWMGLOSUOR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3415685,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CC(C)C)c(C)c21.[Br-],IC50,6.16,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,PAUADKIMJMOVMB-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL83405,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,TYXOBSPYAFYWGB-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL2062868,,C/C=C(\C)C(=O)O[C@H]1C[C@@H](C)[C@]2(OC)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.09,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,CIBBPLMBWXKCDP-RRPNGBMBSA-N,72.0,Antiproliferative activity,cyquant
CHEMBL298391,,Cc1cn([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)c(=O)[nH]c1=O,IC50,4.17,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,CKHFVQVATAWGSH-AZRUVXNYSA-N,,Cytotoxicity,Unspecified
CHEMBL475216,,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,IC50,4.79,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZYVVXIHSTYIMGL-GSLJADNHSA-N,3.0,Unspecified,Unspecified
CHEMBL514318,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,7.67,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZRUGSOVQAHAWHC-GSLJADNHSA-N,3.0,Unspecified,Unspecified
CHEMBL4280053,,COc1cc(Sc2c[nH]c3c(-c4cccs4)cccc23)cc(OC)c1OC,IC50,6.68,CHEMBL4271597,Growth inhibition of human T98G cells after 48 hrs by MTS assay,T98G,HHIQFCHFPXQBND-UHFFFAOYSA-N,48.0,Growth inhibition,MTS
CHEMBL2237321,,O=C(O)/C(=C\c1ccc(Cl)cc1)c1ccccc1,IC50,4.47,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,VRWKAXRIXMCDDY-UVTDQMKNSA-N,48.0,Cytotoxicity,SRB
CHEMBL5289050,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](Cc3ccccn3)c(C)c21.[Br-],IC50,6.7,CHEMBL5242229,Antiproliferative activity against human T98G cells incubated for 72 hrs by MTT assay,T98G,MYLAXHVFTIRMMF-UHFFFAOYSA-M,72.0,Antiproliferative activity,MTT
CHEMBL260541,,CCCCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,6.74,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,PNAPCIDZFSMMAU-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL261876,,CCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.77,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,KGHAPBUPHIFEAH-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL406853,,CCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.47,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,IMMFHDPBBANZQP-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL4075470,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.99,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UVSFRKXOKUPOTQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4089464,,Cc1cc(=O)n(-c2cccc(Br)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.25,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DRXUGBRWMOFPNF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3618236,,Cc1nc(N)nc(-c2c(Nc3ccc4cccnc4c3)nc3ccccn23)n1,IC50,7.75,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,HEVFJNSHEIITJA-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL4076153,,COc1cc(COC(C)C)c(Br)c(Br)c1OCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,4.95,CHEMBL4026219,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AWKZWYURJDYGJQ-VVHMCBODSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4069584,,CCC(CN1CCN(C)CC1)OC(=O)N(c1cccc(Br)c1)c1nc(SC)nc2c1cnn2CC(C)c1ccccc1,IC50,5.11,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,VIWJZMBDSOVKQF-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL1836680,,CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,4.79,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,JSXXDWHFXXQDDJ-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL2397802,,ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1,IC50,4.85,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,FCRZBVJEMPDRTR-UHFFFAOYSA-N,72.0,Cytotoxicity,trypan blue
CHEMBL4084444,,COc1ccc(C(=CC#N)c2cc(C)nc3ccccc23)cc1,IC50,9.6,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,FLNFVWURPNUCNM-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL3186037,,CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.42,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,DGRJOOOHPBSAHD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3357147,,C/C=C(/C)C(=O)O[C@H]1[C@H](O)[C@]2(COC(C)=O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)OC)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,IC50,5.08,CHEMBL3385800,Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay,U-87MG ATCC,RGTNKIXWAOWJPX-IJNATDAXSA-N,72.0,Unspecified,sulforhodamine B
CHEMBL5220644,,N#CCC(=O)Nc1sc(C(=O)Nc2ccc(Cl)cc2)c(-c2ccccc2)c1C#N,IC50,6.07,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,OXRZSZLXOGIFDP-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5191222,,O=C(O)C=Cc1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,IC50,6.28,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,QAWBIEIZDDIEMW-UHFFFAOYSA-N,24.0,Antiproliferative activity,incubating in drug-free medium for 48 hrs and measured by SRB
CHEMBL3612197,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.86,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMPJGKNDCOTNMA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612199,,CNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.91,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JJPRVXVDVQMCOL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3612313,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.12,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UNUKYNBFUYDMTJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3618242,,COc1ccc(Nc2nc3ccc(N4CCN(C(=O)N(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.47,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,WXJHQJVEUDYPFR-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL221208,,CCc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.28,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BXVNHBCLUUHXBC-GOSISDBHSA-N,,Unspecified,Unspecified
CHEMBL223634,,O=C(CC1CN(Cc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,IQVGYCFOQODFLE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL387348,,COc1ccc(CCNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,8.46,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KRNSTVMZJJNREA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220121,,COc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,8.82,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,XBKKUUPXEKAGJX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3735275,,CN1CC2C3=N/C(=C(/c4c(F)c(F)c(S[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(F)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)=C5/C=CC(=N5)C3c3c(F)c(F)c(F)c(F)c3F)C=C4)C2C1,EC50,9.3,CHEMBL3737970,Photocytotoxicity against human T98G cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,T98G,XLZXJTFDRJWXSX-SCIACSNLSA-N,24.0,Cytotoxicity,irradiation at 16 J/cm2 measured at 24 hrs by WST-8
CHEMBL3780662,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,IJTYJQYEMJCTLU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL38957,,CC(=O)Nc1ccc2[nH]c(C(=O)Nc3ccc4[nH]c(C(=O)N5CC(CCl)c6c5cc(O)c5ccccc65)cc4c3)cc2c1,IC50,8.58,CHEMBL798840,"Cytotoxicity against NCI tumor panel, SF-295 CNS cancer cell line",SF295,BIIZHPQOVMNVIQ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL269538,HARMINE,COc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,5.14,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,BXNJHAXVSOCGBA-UHFFFAOYSA-N,96.0,Growth inhibition,MTT
CHEMBL4559783,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCCC4)CC3)cc2)ncc1Cl,IC50,6.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,DBZXJKBZMWSTGM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4454063,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccccn4)CC3)cc2)ncc1Cl,IC50,5.6,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,RZMMXURVEVVUGK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4593471,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.97,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UVKDLRXKOGRONZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4476739,,Cc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)sc2c1,IC50,4.48,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,HAXZZJQOXVLTTC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4545225,,CC1(C)CCC[C@@](C)(O)[C@H]2CC[C@]3(C)[C@@H]2[C@@H](C[C@@H]2[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.12,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,IWMOSQKFCLANLM-ZVHMLHRNSA-N,48.0,Cytotoxicity,MTT
CHEMBL489014,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.05,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,ZGORCAMFPVLITP-ZVHMLHRNSA-N,48.0,Cytotoxicity,MTT
CHEMBL2018715,,CC1=C(C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,IC50,4.91,CHEMBL2019566,Cytotoxicity against human XF498 cells after 48 hrs by SRB assay,XF 498,SEJHGGVKMSZDDH-ZQLHMVIYSA-N,48.0,Cytotoxicity,SRB
CHEMBL4474426,,CC(C)=CCc1cccc2[nH]c3c(c12)C[C@@H]1CC[C@@]2(O)[C@@]45O[C@@H]4[C@H](O)[C@@H](C(C)(C)O)O[C@H]5CC[C@]2(C)[C@@]31C,IC50,4.79,CHEMBL4334155,Cytotoxicity against human LN229 cells after 48 hrs by CCK8 assay,LN-229,RQTDORUGVRDBLB-WQRLADHGSA-N,48.0,Cytotoxicity,CCK8
CHEMBL2441127,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=CC(=O)c3ccccc3C2=O)nn1,IC50,5.89,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FCMCLALNSGOKIL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3612198,,O=C(NCCN1CCOCC1)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.62,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DTDHIXBPCHJAML-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4072336,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5cccc(F)c5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.73,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CZQQNZKELSIAMN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4081754,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.88,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VBLNZCDXYXXGTG-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3310590,,NC(=O)c1cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc(NS(=O)(=O)c2ccc(F)cc2)c1Cl,IC50,4.75,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OLBXVIGQZSYVGL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3337798,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.45,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,WGLWHAXXSHABCO-BJKOEGOMSA-N,,Cytotoxicity,MTT
CHEMBL4748065,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)c2cc3c([nH]c4ccccc43)c(=O)n21,IC50,4.37,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,SURJBUWWTULNRV-OTOIZHKDSA-N,,Antiproliferative activity,SRB
CHEMBL4758385,,CO[C@@]1(C)N(C[C@@H](O)c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,4.54,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,NSKGPNPTDFLIQO-YKSBVNFPSA-N,,Antiproliferative activity,SRB
CHEMBL4783568,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl,IC50,5.89,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,HKMFURWCSXCSMM-XSFVSMFZSA-N,48.0,Cytotoxicity,MTT
CHEMBL244033,,CC(CN(C)C)Oc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O,IC50,6.92,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WIBDGWKPTCDNFX-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL4444824,,CC(C)COc1cccc2c1C(=O)c1c(OCC(C)C)cc(NC(=O)CCl)cc1C2=O,IC50,4.95,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,MOOQOLLQRXEKKT-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4539926,,[N-]=[N+]=NCC(=O)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,4.6,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,DNKTWHCBXNDZRJ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL5286232,,CC(=O)C(C(C)=O)=C1SC=C(n2c(CC#N)nc3ccccc32)N1c1ccccc1,IC50,6.6,CHEMBL5245308,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,HBYFKBKJBFIPJY-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3290911,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,URGMUHQGYAUFID-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290922,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.85,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,UBHHPJNVXBNFSL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290913,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.53,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,IXQJSKIPBZCEJF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4641170,,Nc1nc2cc(-c3nn(C[C@H]4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-SNVBAGLBSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL4648575,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3Cl)cc2)n1,IC50,4.22,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BGKCFKWVLYAQNL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4643724,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cc(Cl)ccn3)cc2)n1,IC50,4.15,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVCQDSDKCMAUKH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4646357,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4)cc3)n2)cn1,IC50,4.75,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PYIBJGHLGTVZLN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4646392,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cn4)cc3)n2)cn1,IC50,4.65,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OQAJFASGBAFYQH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4636924,,Cc1c(C(=O)N/N=C\c2ccc(O)c(O)c2O)oc2cccc(O)c12,IC50,5.22,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,LDELKHXVFGCHDM-WSVATBPTSA-N,,Antiproliferative activity,Unspecified
CHEMBL595755,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C)CC[C@@H]12,IC50,5.03,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,QSDRFCWATFIFOD-HDCQOPJRSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL576322,,CC(C)OC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.36,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DAWQESFNBIZODU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL516585,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc([N+](=O)[O-])cc1,IC50,6.09,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XOXKVAOVWLVYET-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4453837,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.71,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,MZUFKJUBPJEFAS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4441965,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.9,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XAOHZUNBVXUMQM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4551259,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UEPIUPUOHWLWEO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4525662,,Cc1cc(C)n2c1C(c1ccc(OCc3cn(C4C5=C(OC4(C)C)c4ccccc4C(=O)C5=O)nn3)cc1)=C1C=CC=[N+]1[B-]2(F)F,IC50,6.47,CHEMBL4407636,Anticancer activity against human SF295 cells,SF295,NIABHJXOXNBEBS-UHFFFAOYSA-N,,Anticancer activity,Unspecified
CHEMBL5618644,,CCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.09,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LWAKRXJTSPCTEM-UMSFTDKQSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618247,,CCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.12,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LJBFWTUMACMVTG-XIFFEERXSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619638,,CCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.97,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,IORSARDCFLNDGU-UMSFTDKQSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL3339349,,COc1ccc(/C=N/NC(=O)Cc2ccc(Oc3ccnc4cc(OCCCN5CCOCC5)c(OC)cc34)c(F)c2)cc1,IC50,5.58,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CZJIPNAZFHAYCU-HPNXWYHWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5419197,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCOCC3)CC2)n1,IC50,6.22,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,HGOVTMLLXZBSHZ-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5429899,,COc1ccc([C@H]2[C@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1OCCCC(=O)NO,IC50,5.36,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,JICILFJSGOUHAX-RCDICMHDSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4473391,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,5.8,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BUXHFMLQFQVHDW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3400566,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(C)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.96,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,UEQSALAYTBZOKG-LGAKBANOSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL2164701,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,5.46,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VPBPTPYEZGRHBG-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL5195582,,CC(C)=CC[C@@H](OC(=O)/C=C/C(=O)N1CCc2ccccc2C1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.16,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,RILGTTMDSJEPTB-UWHSVAFCSA-N,48.0,Anticancer activity,MTT
CHEMBL2058276,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)OC(Cc2cn(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCN3C(=O)C=CC3=O)nn2)c2ccc(O[C@@H]3O[C@H](CC(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c([N+](=O)[O-])c2)[C@H](O)[C@H](C)O1,IC50,6.07,CHEMBL2061955,Antiproliferative activity against human U87MG cells after 48 hrs by XTT assay in presence of beta glucuronidase,U-87MG ATCC,KQTGOPFGQCCEMM-MSAOKDIJSA-N,48.0,Antiproliferative activity,XTT
CHEMBL3426225,,CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21,IC50,6.13,CHEMBL3430071,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,BNRXMSGHPVYSDK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5407500,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,6.0,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,VSXIQVSRTXSVGU-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5394592,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(Cl)cc(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,7.01,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,NKVCJWYRWCQWSL-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2172479,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cnco4)cn23)nc(C)n1,IC50,6.46,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,XSGOPXVWIFLLDO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172476,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccccn23)nc(C)n1,IC50,6.03,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,UVYODFKMMWFOEC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5558842,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.99,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,OWSARESXAAVFSL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5560076,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,OQYAYTWFLPMJAY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL595421,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)/C(=N/NS(=O)(=O)c3ccc(C)cc3)CC[C@@H]12,IC50,4.56,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,GAYYAIPFTSBIDH-BMFAISMBSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL604882,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](NC(C)C)CC[C@@H]12,IC50,4.31,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,PTAIDWOXJBPQKX-HIFDQRORSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL4291607,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccccc1)c1ccccc1,IC50,6.1,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,TVSGTBVPVITRGR-IPMKNSEASA-N,48.0,Unspecified,MTT
CHEMBL4289446,,C[N+](C)(CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1)Cc1ccccc1,IC50,6.21,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,OWFIZODXJXOTEE-RBZQAINGSA-N,48.0,Unspecified,MTT
CHEMBL4286524,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3cccnc3)O2)cc1F,IC50,4.4,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,RRRLTAROEKGADT-QJPTWQEYSA-N,48.0,Unspecified,MTT
CHEMBL5566237,,Cc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1,IC50,5.21,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,IXNNWKMEEPNZAG-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5423780,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C#N)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.1,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,JPLZYVWUANYAPB-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL553871,,COc1ccc(Sc2cc(OC)c(OC)c(OC)c2)cc1,IC50,7.52,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WQRZZYOXMWAVJV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL561955,,COc1ccc([S+]([O-])c2cc(OC)c(OC)c(OC)c2)cc1,IC50,5.84,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HTDALNILKMJESX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL343264,,COc1ccc(-c2cc3cc(C)ccc3c(N3CCN(C)CC3)n2)cc1,IC50,5.13,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,ONMCQORMNSLXRV-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4085248,,O=C(Nc1ccc(-c2cc(N3CCOCC3)c3nccn3n2)cc1)Nc1cccnc1,IC50,4.7,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,PELFYEIYHAVUKB-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5559557,,C[C@H](NC1=CC(=O)c2ccccc2C1=O)C(=O)O,IC50,5.59,CHEMBL5514115,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,LXNTYZVDQSHAMO-ZETCQYMHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5557274,,CC(C)=CCC1=C(NCCCCN(CCCN)Cc2ccccc2)C(=O)c2ccccc2C1=O,IC50,5.37,CHEMBL5514220,Cytotoxicity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RNYIVYZOEUFKBP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL221630,DEHYDROISO-ALPHA-LAPACHONE,C=C(C)C1CC2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.58,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ZDMOREUAQLXRCQ-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL510369,,C=C(C)C1CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.47,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,JXIGNVDGTOKIJS-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL124551,,O=C1c2cccnc2-c2nccc3c2c1nc1c([N+](=O)[O-])cccc13,IC50,8.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,GYNPAJQTGVMZOH-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5420233,,CCc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,5.73,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,SONNMBQXZLPXFI-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5408307,,CCOc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,5.42,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,GTTIKNCVGNBXMI-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1774418,CASEARUPESTRIN B,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](OC(=O)/C=C\C=C\CCCCC)[C@H](O)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.1,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WGHDGSZCVSIZQE-WWRGVMLBSA-N,72.0,Cytotoxicity,MTT
CHEMBL523379,,CN1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1,IC50,6.0,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,OKWPNODGKOTLAT-UHFFFAOYSA-N,96.0,Antiproliferative activity,alamar blue
CHEMBL2165022,,COc1ccc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.41,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,FPDKFSHCGOROGZ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL1615182,,N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,6.72,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,FEBJYEFFVIDUNF-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL220559,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)Nc1nc2ccccc2[nH]1,IC50,7.96,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KKOHDWOUQQFWIP-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223005,,CN(Cc1ccccc1)C(=O)CC1CCCCN1c1ccnc(-n2ccnc2)n1,IC50,6.05,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KVYHMAVXYYJCLV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5569396,,CCOC(=O)C1=C(CCl)NC(=O)NC1c1ccc(S(N)(=O)=O)cc1,IC50,4.0,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,QSFWINATQNXDQX-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL3353048,,O=C(c1ccccc1)N1CC2CN(C(=O)c3ccc4c5c(cccc35)CC4)CC2C1,IC50,4.0,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,YGRNBIZGACQZHP-UHFFFAOYSA-N,48.0,Antiviral activity,luciferase reporter gene
CHEMBL170758,,CCC(CC)n1c(C)cc2c3c(N)nc(N)nc3ccc21,IC50,8.68,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,YBHNZQJIFKDDHM-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL38761,,O=[Se](=O)(CCCl)c1ccccc1,IC50,5.22,CHEMBL873122,"In vitro cytotoxicity was determined against SF-295, U251, SNB19 human CNS tumor cell line using NCI screen",SF295,AONQHFVNYDVVAC-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL2172490,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)on1,IC50,8.15,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,INKMULYTOXUNTN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5624452,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc(OC)c1OC,IC50,5.68,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,JVDABCHLQNLAEA-SDNWHVSQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630874,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1OC,IC50,5.43,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OHJFXZQUSCOORH-GXDHUFHOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624511,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)o2)cc(OC)c1OC,IC50,4.83,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,HOPXJXBUIFQLHV-PKNBQFBNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624808,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)s1)c1ccncc1,IC50,5.17,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,YVLPLKQDLFBCCM-SOFGYWHQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630088,,COc1cc(/C=C/C(=O)c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc(OC)c1OC,IC50,5.43,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,FLFDMHULUNZTIB-NTEUORMPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2165007,,COc1ccc(Nc2ncc(Cc3ccc(S(C)(=O)=O)cc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.96,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,AXVUBWYMDBEDQM-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL594118,,CCC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.06,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,DWIATUOXMDFPNE-ARSFUWKMSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL5618867,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(/C=C/C(=O)NO)cc2)ccc1O,IC50,5.27,CHEMBL5614768,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,VNSNXSBINKRROS-KZHHGSSRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5559224,,CCOC(=O)C(NC1=C(Cl)C(=O)c2ccccc2C1=O)C(C)=O,IC50,4.72,CHEMBL5514202,Cytotoxicity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by resazurin assay,U-87MG ATCC,VJLKDEPOPCQNHD-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin
CHEMBL5566563,,N#CC1(C(=O)NCCC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.3,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,RZJZAWPSUBSTEJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4645988,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,6.28,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GEEOCEZSANXNQQ-SEYXRHQNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4646521,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)c3cccc(Cn4nnc5c4C(=O)c4ccccc4C5=O)c3)nn2)c1,IC50,6.37,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,BYONMJRCXBUVGH-NXVVXOECSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4648258,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,6.21,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,DVDXIQZRWHQODS-WYMLVPIESA-N,72.0,Antiproliferative activity,MTT
CHEMBL4644554,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)c3cccc(Cn4nnc5c4C(=O)c4ccccc4C5=O)c3)nn2)c1,IC50,6.43,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,WEWGBNLINSIYFL-BMRADRMJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4634071,,C(=N/Nc1cnc2ccccc2n1)\c1ccccn1,IC50,5.41,CHEMBL4604072,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,SF295,JXPKKVRUTJZIMP-RQZCQDPDSA-N,72.0,Cytotoxicity,MTT
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,6.05,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL2165736,,CCNC(=O)Nc1ccc(S(=O)(=O)Oc2ccccc2CC)cc1,IC50,6.12,CHEMBL4723429,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SF295,BEQRKSLOFGBOPF-UHFFFAOYSA-N,48.0,Antiproliferative activity,sulforhodamine B
CHEMBL4799617,,C#CCOc1ccc(/C=C/C(=O)c2ccc(OC)c(OC)c2)cc1OC,IC50,5.54,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,QSJSOTLGLXQWOT-RMKNXTFCSA-N,72.0,Cytotoxicity,RRA
CHEMBL3319515,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCCCC3)[C@@H]2C[C@@H]1O,IC50,4.77,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RHKZDVNMLMFSCO-SVNMQMHNSA-N,72.0,Anticancer activity,MTT
CHEMBL2397805,,Clc1ccccc1CNc1ncnc2c1cnn2CC(Cl)c1ccc(Br)cc1,IC50,4.83,CHEMBL4423083,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,PYGLWXFBTJNWSQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4534087,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.44,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RBWIXWWPRYTMCH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4472885,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AYSPBJARTFATSL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL113042,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1,IC50,9.1,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,NIQFKQNWLGIKCV-PMACEKPBSA-N,,Unspecified,Unspecified
CHEMBL3310805,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC4CC4)sc3n2)cc1C(N)=O,IC50,4.38,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGIZKCFSSHOEIA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4872845,,CC12CC3CC(C)(C1)CC(NS(=O)(=O)c1cccc(/C=C/C(=O)NO)c1)(C3)C2,IC50,5.66,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,AYRVIZARUCAIDJ-VOTSOKGWSA-N,1.0,Antiproliferative activity,MTT
CHEMBL3357875,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C,IC50,7.31,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZVLPCWDGIPHSSN-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL2013119,RIGOSERTIB SODIUM,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+],IC50,7.1,CHEMBL2015273,Cytotoxicity against human U87 cells after 96 hrs by trypan blue exclusion assay,U-87MG ATCC,VLQLUZFVFXYXQE-USRGLUTNSA-M,96.0,Cytotoxicity,trypan blue exclusion
CHEMBL1760169,,Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1,IC50,6.46,CHEMBL1763013,Antiproliferative activity against human U87MG harboring PTEN gene mutation/amplification at 1 uM after 72 hrs by Ambit assay in presence of 10% serum,U-87MG ATCC,XPLCDRVACNNQQT-UHFFFAOYSA-N,72.0,Antiproliferative activity,Ambit
CHEMBL4755317,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.15,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,WCOXMLFEWOILDZ-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL142703,VILDAGLIPTIN,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,IC50,4.1,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,,Unspecified,fluorescence based
CHEMBL1422,SITAGLIPTIN,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,IC50,4.07,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,MFFMDFFZMYYVKS-SECBINFHSA-N,,Unspecified,fluorescence based
CHEMBL5180424,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN1CCN(CC1)C(=O)CCCCCC(=O)N1CCN(CC1)CC2=C,IC50,4.36,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,VLAUTMRUYKPPJW-HRHHFINDSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL5195533,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN(CC)CCCCCCN(CC)CC2=C,IC50,4.41,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,DCDFXXOJMPMSLZ-DSNGMDLFSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL5174980,,CCCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.38,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,PLCQLVRNMKSZQY-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5196611,,COCCN1CCN(c2ccc(F)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.54,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,UFJYPJJOQSPYBA-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5180109,,COCCN1CCN(c2ccc(Cl)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.0,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,MQQSWRJWBQGBGD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5183886,,COCCN1CCN(c2cc(C)ccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.28,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YRVYXPGVIJBXNM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL405384,,NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.22,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,CUQIEUIMKDNKMI-UHFFFAOYSA-N,,Growth inhibition,SRB
CHEMBL260000,,NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.35,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,KCWPSUKJCKZEAO-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL220213,,O=C(CC1CCCCN1c1cccc(-n2ccnc2)c1)NCc1ccc2c(c1)OCO2,IC50,7.11,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YJJUDDTUAPFIMD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220932,,O=C(CC1COCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MQSBSZNNVXQJSJ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL374552,,O=C(CC1CCCCN1c1cc(-n2ccnc2)ncn1)NCc1ccc2c(c1)OCO2,IC50,8.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,XLIZPIPYSZBNFC-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL374132,,CC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HJZJKRIOLQAAGX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL223838,,CN(C)c1cccc2c(S(=O)(=O)N3CCN(c4ccnc(-n5ccnc5)n4)C(CC(=O)NCc4ccc5c(c4)OCO5)C3)cccc12,IC50,8.96,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PGJNLWRKGQTXCD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL376713,,O=C(CC1CN(C(=O)COCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HPYBQXBLGMGFEK-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL390905,,CC(C)N(CCOc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O)C(C)C,IC50,6.04,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TZWKRWADOOFEEP-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL3609557,,CC1(C)OC2=C(CC1[Se]c1cccc(C(F)(F)F)c1)C(=O)C(=O)c1ccccc12,IC50,5.66,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ATCYVHURVWBFGU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL392510,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=CC(=O)C(O)=C[C@]4(C)[C@H]3CC[C@]12C,IC50,5.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,AGHDZMKTPDANEA-HBEGYKGVSA-N,48.0,Cytotoxicity,MTT dye reduction
CHEMBL3588944,,COc1cc(/C=C/COC(=O)C(C)C)ccc1OC(=O)C(C)C,IC50,4.53,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,RWETVSSIRIMMBD-VOTSOKGWSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3588943,,CC[C@H](C)C(=O)OC/C=C/c1ccc(OC(C)=O)c(OC)c1,IC50,4.82,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,ZLACIACJCLRKRE-SYTKJHMZSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3785785,,COc1cc(/C=C\C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.71,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-IEXSKJOKSA-N,,Cytotoxicity,SRB
CHEMBL443508,PHENYLBUTYL ISOSELENOCYANATE,[Se]=C=NCCCCc1ccccc1,IC50,4.57,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,NMPQIJIERCLTOG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL1643111,INDIOSIDE E,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.61,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,DQYACEDUQHWXQZ-QBHYPGBSSA-N,4.0,Cytotoxicity,MTT
CHEMBL1630324,,C=C1C(=O)O[C@@H]2C3=C[C@@H]4OO[C@@]3(CC[C@@H]12)C(C)(C)C4=O,IC50,5.59,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NMXXTJXRQIYUIO-UBOXLASSSA-N,72.0,Cytotoxicity,MTT
CHEMBL228363,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc(OC)c1OC,IC50,8.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QASRNVZBHIVOPA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5176963,,CCCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.56,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SWJIJEHBWVAUTG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5188413,,C#CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,8.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OZIYMFFXZNGZRQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4649244,,C=C1/C=C/C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)O[C@@H]([C@H](C)C[C@@H](C)CCC)[C@H](OC)C(=O)N1,IC50,6.92,CHEMBL4611999,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs under hypoxia condition by MTT assay,U-87MG ATCC,KRASFEIPFGADRT-RHDNYFDQSA-N,48.0,Cytotoxicity,MTT
CHEMBL2325741,CAPIVASERTIB,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1,IC50,4.3,CHEMBL4830056,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,U-87MG ATCC,JDUBGYFRJFOXQC-KRWDZBQOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4854960,,C[C@H]1[C@@H](O[C@@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]5[C@@H]4C[C@H](O)[C@@H]3C2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.38,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,ZIINWKOITYBTBX-QFXSOFMZSA-N,72.0,Anticancer activity,CCK8 reagent
CHEMBL233236,,c1cn(-c2ccc(OCC3CCCCN3Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,7.0,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,OGIDTPKJWIUESB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3921710,,CCCCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,IC50,8.34,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,GYWJHWLJQBKSEF-XDJHFCHBSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3970399,,O=S(=O)(Nc1nccs1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.19,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,CBTHRMSBBQSAPG-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL179581,,COc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1OC,IC50,4.84,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,AWEISDLYLCJIFV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL385334,,O=C(CC1CN(C(=O)c2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QUWWIESFFMGIEG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL376733,,O=C(C[C@H]1CCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZOBAVNWRXCJDMM-MRXNPFEDSA-N,,Unspecified,Unspecified
CHEMBL387349,,COc1cccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)c1,IC50,8.43,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JWXNMIUXCQSJPN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL455534,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5C)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.71,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,XYMUPCSZALEVRH-GEYQZXRLSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL346383,,Cc1ccc(-c2cc3ccccc3c(O)n2)cc1,IC50,5.15,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,GNXMJRCVKBVQMQ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5397184,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)C(C)C,IC50,4.84,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YLEVETUZPGFSKX-FOXFXTFKSA-N,48.0,Unspecified,CCK-8
CHEMBL5427057,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,4.89,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,BZNXRRBWLFGHLA-RZAATYBRSA-N,48.0,Unspecified,CCK-8
CHEMBL4279728,,O=C(COc1cccc(C(=O)/C=C/c2ccccc2)c1)Nc1ccc2c(c1)COC2=O,IC50,5.4,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,JUMOSJFJWDXNTR-FMIVXFBMSA-N,48.0,Cytotoxicity,MTT
CHEMBL393719,,O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2ncccc12,IC50,6.28,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,YOOZSXQWGPLESR-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL391722,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)nccc12,IC50,7.57,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WELZLTSZYGTAHI-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238109,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)ccc(F)c12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,AVJXMYYTKYQQKC-OAHLLOKOSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238107,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(C#N)cc(F)cc12,IC50,5.0,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BWYCZDBEUMMMLW-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL238574,,CC[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,4.8,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,YTXBGWLKIPICDW-MRXNPFEDSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL240064,,C[C@@H]1CN(C(=O)c2cnccn2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.04,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,JEICIUQZOHOSQV-GFCCVEGCSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392147,,CC1CN(C(=O)c2ccc3occc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.0,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,VAUYARZNYJPRLX-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL5647104,,CNC(=O)c1cc(-c2ccccc2)sc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.63,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,ALAFOINLMDDMOW-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5639490,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1Br,IC50,4.52,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,CYWYRDRLCGNGDO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3088349,,CCN(CC)c1ncnc2sc(Nc3ccc(Cl)cc3)nc12,IC50,5.47,CHEMBL3090176,Antiproliferative activity against human T98G cells after 48 hrs by SRB assay,T98G,LCWHOXGVDBIAJN-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL4646906,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)CCC(=O)n1cc(/C=C/c2cccnc2)c2ccccc21,IC50,5.79,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,NEWUWRCUPSARDJ-XGRKLIJNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4634290,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)CCC(=O)n3cc(/C=C/c4cccnc4)c4ccccc43)nn2)c1,IC50,6.05,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YHMDJSKBHCHCHZ-HWWDBJQCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4536105,,COc1ncc(-c2cc(OCCCCCCC(=O)NO)c3ncnc(C)c3c2)cc1F,IC50,5.5,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,BQKQDMVFQZHPJZ-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4548558,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CNC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,XZYKRDKKCJVLNQ-SPJFXFQZSA-N,48.0,Antiproliferative activity,SRB
CHEMBL553,ERLOTINIB,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,4.5,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,AAKJLRGGTJKAMG-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3415473,,O=S(=O)(Cc1ccccc1)N1Cc2ccccc2[C@@H]1c1c[nH]c2ccccc12,IC50,5.02,CHEMBL3420474,Cytotoxicity against human T98G cells assessed as growth inhibition after 4 days by XTT assay,T98G,WCZRIPJXOMUAPT-HSZRJFAPSA-N,96.0,Cytotoxicity,XTT
CHEMBL3343369,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXSOMTVQGIJIAW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343371,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.82,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AGSRPEMWMIUSDW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343390,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.1,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KKEHZDMMOKHTMG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL399680,BUFALIN,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,EC50,7.85,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QEEBRPGZBVVINN-BMPKRDENSA-N,72.0,Cytotoxicity,MTS
CHEMBL470256,LANTALUCRATIN C,C=C(C)C1CC2=C(O1)c1ccc(O)cc1C(=O)C2=O,IC50,5.14,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,RFNIZIGETMKYEI-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL487397,LANTALUCRATIN E,C=C(C)C(O)CC1=C(OC)C(=O)c2c(OC)ccc(O)c2C1=O,IC50,5.16,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,IGQHQXQDGDLBTH-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL4161307,,COc1ccc(-n2cc(-c3ccc(Cl)cc3)c3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.37,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,ONQQNMNDBOIKLW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5559858,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.24,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ATJCPWGWLOZRGF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1643034,,COc1ccc(-c2c(CO)c(CO)c3n2Cc2ccccc2C3)cc1,IC50,4.98,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RKZDLGRDWVDWQR-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL1643051,,Cc1c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c2n1Cc1ccccc1C2,IC50,4.58,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,MOJIYIRNBVHOJS-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL1643058,,COc1ccc(-c2c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c3n2Cc2ccccc2C3)cc1,IC50,4.68,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,GJWLYONOXCRYMT-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar blue
CHEMBL297453,EPIGALOCATECHIN GALLATE,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.82,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,WMBWREPUVVBILR-WIYYLYMNSA-N,48.0,Cytotoxicity,MTT
CHEMBL443114,SOLAMARGINE,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.5,CHEMBL1772719,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,MBWUSSKCCUMJHO-ZGXDEBHDSA-N,,Cytotoxicity,MTT
CHEMBL4517078,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1C(=O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.49,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,JEDMOEWELHTQOB-IIHYJMCISA-N,48.0,Cytotoxicity,MTT
CHEMBL4585866,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)Cc5cnc(N)nc5C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.08,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,ZPMAIMHOUQQFQD-IUZFIUEISA-N,48.0,Cytotoxicity,MTT
CHEMBL4582822,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC(C#N)=C(O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.38,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,OPEANCHMAFTYCL-OSRQYFBDSA-N,48.0,Cytotoxicity,MTT
CHEMBL4580671,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)Cc5cn[nH]c5C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.58,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,HKYOUQDPYNJOOO-OSRQYFBDSA-N,48.0,Cytotoxicity,MTT
CHEMBL2417821,,COc1ncc(-c2ccc3nc(NCC(=O)O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.01,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OWPOAPSRFIECAC-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417835,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.8,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SWNBKCKYZFXETO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417833,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.74,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,QBNYBMSPQYXIKK-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4214671,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,5.95,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZIHXGTPYCJAFNA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4207763,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)c(Cl)c4)c3=O)cc2)ccn1,IC50,5.45,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DBIJPVPCWQXIGH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3927439,,c1ccc(-c2nnc(-c3c[nH]c4c3Cc3ccccc3-4)o2)cc1,IC50,6.3,CHEMBL3878557,Antiproliferative activity against human T98G cells after 72 hrs by XTT assay,T98G,JKVNVOZGQYTLOK-UHFFFAOYSA-N,72.0,Antiproliferative activity,XTT
CHEMBL2164712,,Cc1nccc2c3ccc(OCC4CCCCC4)cc3n(CC3CCCCC3)c12,IC50,4.5,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,PHTXDKLUFFBKQI-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164711,,Cc1nccc2c3ccc(OCc4ccc(F)cc4)cc3n(Cc3ccc(F)cc3)c12,IC50,4.85,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DCRLKBATTHCECA-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL14355,,Cc1nccc2c1[nH]c1cc(OCCO)ccc12,IC50,4.28,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,ANFGSACSROQTSO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL4292872,,CCn1c2ccc(C(=O)c3ccc(C)c4ccccc34)cc2c2ccc(OC)cc21,EC50,5.58,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,FLOPIVXDSYCUEZ-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL3937796,,CNC(=O)CCN1C(C)c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S1(=O)=O,IC50,7.15,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,CDNKQZRLGOBBHA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5086537,,CC1Oc2ccc(S(=O)(=O)Nc3ccc(CCC(=O)O)cc3)cc2NC1=O,IC50,4.32,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,DXWAOBZLNDDYFW-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5076259,,Cc1ccc(CNC(=O)Cn2c(CO)cnc2SCC(=O)Nc2ccc3c(c2)OCO3)cc1,IC50,4.42,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,MLPJLGQFCCOREW-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5630510,,O=C(/C=C/c1cccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)c1)c1ccccc1,IC50,5.51,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,PTKJRAVLHGNQKU-CCEZHUSRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630226,,O=C(/C=C/c1cccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)c1)c1ccncc1,IC50,5.14,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RYTDMJFCMVKMGD-MDZDMXLPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624827,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)c(OC)c1OC,IC50,5.46,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GZFYOLNOQMFVEC-RVDMUPIBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5083629,,O=C(Nc1ccccc1)Oc1cc(OC(=O)Nc2ccccc2)c2c(c1)N(C(c1ccc(F)cc1)c1cccc(Cl)c1O)CC2,IC50,4.07,CHEMBL5031400,Cytotoxicity effect against human LN-229 cells assessed as cell growth inhibition incubated for 48 hrs by trypan blue exclusion assay,LN-229,NBSJTAILDXZBAL-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue exclusion
CHEMBL3805521,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc(OC)c1OC,IC50,5.63,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NSJGQQBFMNXEJU-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL4633273,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCN(C)CC3)cc2)n1,IC50,4.67,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LROSTRBOAUSAAK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4648432,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)n3)cc2)n1,IC50,4.19,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDFAOWZCJOIKMO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4644226,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)c4)cc3)n2)cn1,IC50,4.66,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WEOGGUARIACEDQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3319514,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCCC3)[C@@H]2C[C@@H]1O,IC50,4.82,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,JYDLHDBFEPZUPQ-BGPVHYFNSA-N,72.0,Anticancer activity,MTT
CHEMBL367333,,CC(C)NC(=S)NC1CC(C)(C)Oc2ccc(Cl)cc21,IC50,4.04,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KUYZXQYDFLUTKL-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL176290,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(Br)ccc2O1,IC50,4.42,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,ZSFAFBUNKYKVAS-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL177950,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(F)ccc2O1,IC50,4.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BFDJNFIUFOYSPC-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL360709,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,RHEPHFNLNYPAFY-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL596383,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(Br)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YWRHTJZCWMLTRN-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL5405084,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.28,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WIPDZZDNGWPJCA-NQAOGTSWSA-N,48.0,Unspecified,CCK-8
CHEMBL5423251,,CC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O)C(C)C,IC50,5.04,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GTNCABRKYIQBGL-BDXNKPMSSA-N,48.0,Unspecified,CCK-8
CHEMBL3290902,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.93,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FSTYDHPHNAHVOZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290932,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,BWVHLLZOTCLDJN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290898,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.87,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JBJZYGZTNVVXMN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290933,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.7,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,GAOHMJDLFNCXGF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3290900,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.67,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,XKTCLUMXLWSCMM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3544960,AT-13148,NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,IC50,5.96,CHEMBL3881297,Inhibition of PKB in human U87MG cells assessed as reduction in Gsk3beta Ser9 phosphorylation incubated for 1 hr by time-resolved fluorescence based assay,U-87MG ATCC,IIRWNGPLJQXWFJ-KRWDZBQOSA-N,1.0,Unspecified,time-resolved fluorescence based
CHEMBL3588945,,CCCC(=O)OC/C=C/c1ccc(OC(=O)CCC)c(OC)c1,IC50,4.76,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PEENEBPZOQREGJ-RMKNXTFCSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3087010,,O=C1c2c(Cl)cccc2-n2c1nc1ccccc1c2=O,IC50,4.71,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,SXBMVQSPFHEBPB-UHFFFAOYSA-N,6.0,Unspecified,Unspecified
CHEMBL306946,TRYPTANTHRIN,O=C1c2ccccc2-n2c1nc1ccccc1c2=O,IC50,5.3,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,VQQVWGVXDIPORV-UHFFFAOYSA-N,6.0,Unspecified,Unspecified
CHEMBL3806016,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(Br)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.41,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,CHXKOYXTKFWSCN-RIWGJCQISA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805597,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Br)cccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.67,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NENOXQQCEZKXHZ-IUFQJPFESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3806061,,Cc1cc(=O)oc2cc(OCc3cn(CC(=O)O[C@H]4CC[C@@]5(C)C(=CC[C@@H]6[C@@H]5CC[C@]5(C)C(=O)CC[C@@H]65)C4)nn3)ccc12,IC50,4.32,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YJLIRGNRJJEWAG-OIZIHFBPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4592660,,CCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCC)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21.[Cl-],IC50,5.15,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,MRQQUMFCWVKRHK-UHFFFAOYSA-M,72.0,Cytotoxicity,AlamarBlue
CHEMBL4442218,,Nc1ccn([C@@H]2O[C@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1,IC50,4.9,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,YYCQJCLXZOMYAD-LTYCNYMDSA-N,72.0,Cytotoxicity,SRB
CHEMBL4473696,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Cl)cc1,IC50,4.6,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,FNPDVQLGCRLOSL-NLDKGBHCSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL2165038,,Cc1nc(-c2cccnc2Nc2cccc3[nH]ccc23)c2[nH]cnc2n1,IC50,6.14,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OBMONDJKDAOWHR-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL1762782,,Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,7.77,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,MOYOOFRKRSCAKY-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4779845,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCC5(CCNC5)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.14,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,RLSTVRSFIFFZGV-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4791259,,CC(=O)c1c(C)c2cnc(Nc3ccc4c(n3)CCNC4)nc2n2cc(C(C)C)nc12,IC50,5.43,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,HKKFFWNWVBAQRC-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL5435725,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(C)c1,IC50,6.53,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,YKOKZQZLXVBCQH-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL229477,,C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,8.17,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-PIGZYNQJSA-N,48.0,Unspecified,Unspecified
CHEMBL4164754,,CCOC(=O)Cc1c(-c2ccc(OC)c(OC)c2)c2c(n1-c1ccc(Br)cc1)C(=O)c1ccccc1C2=O,IC50,5.19,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,WSTFOHKWMJBNKP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL228992,,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,IC50,9.77,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-XIKOKIGWSA-N,48.0,Unspecified,Unspecified
CHEMBL2165271,,Cc1nc(N)cc(-c2cccnc2Nc2cccc3[nH]ncc23)n1,IC50,6.09,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WHJXPQMHEGTMAA-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4517739,,Cc1nc(=O)c2c(-c3ccccc3)c(C(=O)c3ccccc3)[nH]c2[nH]1,IC50,7.11,CHEMBL4818316,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,JAQDZDAZCCSBAX-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL3805856,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.37,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BQCOUJYYNSPSCH-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3806062,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc(OC)c1OC,IC50,4.9,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KVQBDMFCRQLCRE-YPKPFQOOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805111,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(F)cc2)cc(OC)c1OC,IC50,5.32,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,IPFWJHPHVYDGLP-YPKPFQOOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4591115,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.99,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,OVYRDRDOTZHHTI-CPLYJULGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4459552,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.64,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,SNPLUKLYEATAGX-JGKBFTOSSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5173983,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12C=CCC(C)(C)[C@H]1[C@H](O)[C@@]3(O)OC2,IC50,5.94,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZLITUQOOIXADIY-KLSHHCPLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5219349,,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1C#N,IC50,5.3,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,JBKRLZPXWNTYBD-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL72165,,O=C1c2cc(Br)ccc2-n2c1nc1ccccc1c2=O,IC50,5.5,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,INPHXCCBDRGBRF-UHFFFAOYSA-N,6.0,Unspecified,Unspecified
CHEMBL312537,,Cc1ccc2c(c1)C(=O)c1nc3ccccc3c(=O)n1-2,IC50,4.66,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,DSZRZFCUYHAAAE-UHFFFAOYSA-N,6.0,Unspecified,Unspecified
CHEMBL5087558,,CC(C)(C)NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1,EC50,4.98,CHEMBL5167608,Antiproliferative activity against human T98G cells assessed as reduction in cell viability measured after 1 to 7 days by resazurin dye based fluorimetric analysis,T98G,YCFFONJEHNSECY-UHFFFAOYSA-N,168.0,Antiproliferative activity,Resazurin
CHEMBL3926164,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.82,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,LFDNGBFUZSXYRZ-KQNUSQPASA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL4291410,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(CCCCC)nn3)CC[C@@H]12,IC50,5.24,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QNQRAZPKMAHRCI-OMHGRDNWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4279674,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(C(C)=O)nn3)CC[C@@H]12,IC50,5.21,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QJGCJLOTFNHKGA-BWKWREGDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4279410,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(OC)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.75,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RHBCULMKUXUPLC-QFGYYXCTSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4290751,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(COc4ccc(-c5ccccc5)cc4)nn3)CC[C@@H]12,IC50,6.0,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,MPVPEFOUWMRSHU-ZIMZEJNUSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4294566,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(=O)/C=C/c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.36,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZSWWBNCHZRUSOY-LSWJKHNWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3898261,,Nc1nc(OCc2ccccc2)c2ncn(CCNC(=O)N(CCCl)N=O)c2n1,IC50,4.28,CHEMBL3879641,Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability measured after 24 hrs by CCK8 assay,SF126,WFIOEKMZVNMZTQ-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL3916732,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1nncc1-c1ccccc1,IC50,5.62,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,NJIVJKVAHNLXIJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3980519,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(-c3ccccc3)nn1)O2,IC50,5.49,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,LTAVIWBELVODLJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3983586,,Cc1ccc(C(/C=C/c2ccc(F)cc2)=N\Nc2nncc3ccccc23)cc1,IC50,9.26,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IGXWHXJCDUCSBX-GNVALWJASA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3974626,,COc1ccc(N2C(=O)CS/C2=N/Nc2nncc3ccccc23)cc1,IC50,8.62,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,WRXMYALXQGBBNT-RELWKKBWSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3937949,,O=C(O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,9.36,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,FGBWIPBEKQBXCP-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL5437683,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(/C=C/C(=O)NO)cc3)CC1)C2,IC50,5.75,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YDGCPLJSOWXJQC-BQYQJAHWSA-N,,Cytotoxicity,MTT
CHEMBL5425578,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCC(=O)NO)CC1)C2,IC50,5.1,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,OSKOJXVSKYGIAD-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5439573,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCCCC(=O)NO)CC1)C2,IC50,4.54,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PXASOYWUFJQDQD-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL502,DONEPEZIL,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,IC50,4.33,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ADEBPBSSDYVVLD-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5420815,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(F)c1,IC50,7.55,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZERJPDQJQQFZDN-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5402810,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1,IC50,7.72,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZHMBNIOIPWBHET-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5427428,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(C(F)(F)F)c1,IC50,7.3,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,USYCACRSMUSOQU-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5428726,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1F,IC50,7.9,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,NLKWPAPHRJUWLZ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL4289759,,CCn1c2ccccc2c2cc(C(=O)c3ccc(F)cc3)ccc21,EC50,5.1,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,BCOJHFLANMVQSY-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4294230,,CCn1c2ccccc2c2cc(C(=O)c3cccc4cccnc34)ccc21,EC50,5.06,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,GPGKTWSQCNBODD-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL4084427,,CSc1nc(N(C(=O)OC(C)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.35,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,DAIZESMIDQCQRX-UHFFFAOYSA-N,48.0,Cytotoxicity,trypan blue
CHEMBL165,RESVERATROL,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,IC50,4.7,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,48.0,Cytotoxicity,MTT
CHEMBL4278554,,COc1cc(Sc2c[nH]c3cc(-c4ccsc4)ccc23)cc(OC)c1OC,IC50,7.58,CHEMBL4271597,Growth inhibition of human T98G cells after 48 hrs by MTS assay,T98G,YIPMYOQVBMPGMW-UHFFFAOYSA-N,48.0,Growth inhibition,MTS
CHEMBL4580864,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1COC(=O)[C@H](C)O,IC50,4.8,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,FKBITCOIJAFLNT-SPJFXFQZSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5083440,,COc1ccc(N2C(=O)C[C@H](C(=O)NC3CCCCC3)[C@H]2c2ccc(F)cc2)cc1,IC50,4.11,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,SODMCALIAXWOMI-JTHBVZDNSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5091005,,Cc1ccc([C@H](O)CNC(=O)c2cccc(C)c2C)cc1,IC50,4.17,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,PTDPRGPUURVUJA-QGZVFWFLSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5405263,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C)c3)ccc2NS(C)(=O)=O)c1,IC50,6.38,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZWVFOQDPNKJXIG-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5563057,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(Cl)c(Cl)c1,IC50,5.7,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,AGJXRCUZJGTRGD-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL597211,,CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1,IC50,8.24,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,SNNUMARRAFQOGY-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL599448,,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,IC50,8.14,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,WPDHASUWSYKMLT-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL597600,,NC1(C(=O)NCc2ccc(Cl)cc2F)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.7,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,PEMLYVADBMMTQF-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL1782904,,CCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.64,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,SLMAQIZSYXKRPJ-QQJYNPJZSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782909,,CCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.24,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,FVBXFAPFRUROQX-ALMBTRMVSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL4447924,,COc1c(-c2ccccc2)cc(OC)c2c1oc1cc(O)c(OCC=C(C)C)cc12,IC50,4.99,CHEMBL4344200,Cytotoxicity against human U87 cells after 24 hrs by SRB method,U-87MG ATCC,AMGZEEWYBXDHSG-UHFFFAOYSA-N,24.0,Cytotoxicity,SRB
CHEMBL448455,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.16,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,NBOAYFKMDBWDLM-GVQBMFDGSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL4073713,,CSc1nc(N2CCCCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,WCTJLMVSZAACPV-UHFFFAOYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4754687,,CCS(=O)(=O)Nc1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.31,CHEMBL4713864,Antiproliferative activity against human T98G cells overexpressing AR assessed as reduction in cell viability incubated for 48 hrs by MTT assay,T98G,FBNFIWKETUMPPR-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL141838,,Cc1ccc2c(O)nc(-c3ccc(Cl)cc3)cc2c1,IC50,4.95,CHEMBL822900,Tested for in vitro cytotoxicity against XF498 (human CNS) tumor cell line using sulforhodamine B (SRB) assay,XF 498,DNQYHWBDJNQUHG-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL4127432,,COc1ccc2nc3[nH]nc(N)c3cc2c1,IC50,4.03,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,XYBJZZAKAVVXDR-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL1782900,,CCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.85,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,UKUWMCDJZBBMPC-VQCLQPKNSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782911,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CO)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.82,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VRYBKUIEJIKFNC-QWIYEXKTSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL106406,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1,IC50,8.05,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,CPELYVWCRNINCS-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4128893,,C[C@H]1[C@H](NCc2ccc(OC(F)(F)F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.75,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,DTMVQUYLGYAQDU-ZMJFZODZSA-N,72.0,Cytotoxicity,MTT
CHEMBL4126483,,C[C@H]1[C@H](Nc2ccc(SC(F)(F)F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.55,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZWIOXSUVMPVWTH-SZMJOESGSA-N,72.0,Cytotoxicity,MTT
CHEMBL4789230,,Cn1c2ccccc2c2cc(C(=O)NCCc3ccccc3)[nH]c(=O)c21,IC50,4.96,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,BHVGVCZSTYUCEH-UHFFFAOYSA-N,,Antiproliferative activity,SRB
CHEMBL141081,,Oc1nc(-c2ccccc2)cc2ccccc12,IC50,5.86,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,VZYRBVZOGGKAKY-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5597580,,O=C(O)[C@@H]1[C@H](C(=O)n2ccc3ccccc32)[C@H]2CC[C@@H]1O2,IC50,4.7,CHEMBL5587087,Synergistic antiproliferative activity against human U-87 MG cells in presence of TMZ,U-87MG ATCC,KZVHQCVKMCBKRP-RQJABVFESA-N,,Antiproliferative activity,Unspecified
CHEMBL4278233,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccccc2)c1=O,IC50,5.9,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WSCIHXKETKCFDO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4280004,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,IC50,5.87,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CQCVNKBXWWKFDO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4639420,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(O)c1O)C4=O,EC50,7.35,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,KPDKPRCLDGTNFK-UUNAQHPASA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL4287656,,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1.[I-],IC50,5.28,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZQOOZRXNZQVSIV-RRABGKBLSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4790971,,C#CCOc1ccc(/C=C/C(=O)c2ccc(-n3ccnc3)cc2)cc1OC,IC50,5.85,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,VNMNPXUSEUDRAE-ONNFQVAWSA-N,72.0,Cytotoxicity,RRA
CHEMBL150607,,Cc1c(CNc2ccc(C(=O)NC(CCCNC(=O)c3ccccc3C(=O)O)C(=O)O)cc2)cnc2nc(N)nc(N)c12,IC50,9.23,CHEMBL801266,Compound was evaluated for in vitro activity against SF-295 CNS cell lines (Human tumor cells ),SF295,IAVQJNSRTDVUJY-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4545128,,Fc1ccc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)cc1F,IC50,4.4,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,XLNLIDYPMSLHDI-DNTJNYDQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4434923,,Fc1ccc(/C=N/Nc2nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cs2)cc1F,IC50,4.53,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,CYNOGIKKPGIECM-OAHLVZFQSA-N,48.0,Antiproliferative activity,MTT
CHEMBL254578,,O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N\Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1,IC50,4.12,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,KFRKRECSIYXARE-HMAPJEAMSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1928598,,COc1ccc2c(c1)O[C@@H]1C3=C(OC[C@H]21)C(=O)c1ccccc1C3=O,IC50,4.75,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,XSQMOHMPRQZEHK-KUHUBIRLSA-N,72.0,Unspecified,MTT
CHEMBL4483778,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.82,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HIHLTQCSRFBDDQ-QDJGCMBGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5428709,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C(C)C)c(O)c(C(C)C)c3)c3ccccc32)cc1,IC50,4.12,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,MMMLVOMCRQVEDO-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL3883573,,O=c1c2nc3ccccc3nc2cc(-c2ccccc2)n1-c1ccccc1,IC50,4.67,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AKDIWALMSBBMRJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3883472,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1,IC50,5.48,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HEPDGKDHKDFTDK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5408043,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N3CCOCC3)CC2)n1,IC50,5.91,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,BRNCLSYLICSNRO-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4474362,,Cc1cn([C@H]2C[C@H](O)[C@@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,4.87,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,ILQANIFPCKZLGQ-ZQLWZKNSSA-N,72.0,Cytotoxicity,SRB
CHEMBL5429070,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(N(C)C)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.72,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,SIZXPYCVVXWDOK-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL1098875,,O=C1c2cc(F)ccc2-n2c1nc1ccccc1c2=O,IC50,7.22,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,UXBGZQXHNVNPFT-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL5630349,,C#CCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.25,CHEMBL5621066,"Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-azido-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)butanamide by MTT assay",U-87MG ATCC,IJDJQTVSYXXWMT-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5624941,,[N-]=[N+]=NCCCC(=O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,IC50,5.25,CHEMBL5621068,Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(prop-2-yn-1-yl)picolinamide by MTT assay,U-87MG ATCC,IQDAUQZEUZNBJF-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5624529,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCN=[N+]=[N-])C(C)(C)C)cc1,IC50,4.79,CHEMBL5621068,Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(prop-2-yn-1-yl)picolinamide by MTT assay,U-87MG ATCC,ZTMPPRFQBBGAOO-ZFGGDYGUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4582766,,CC(C)COc1cccc2c1C(=O)c1c(OCC(C)C)cc(NC(=O)CBr)cc1C2=O,IC50,4.78,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZCSFDYYGXDRTEM-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL1372036,,O=C(Nc1ccc(Cl)c([N+](=O)[O-])c1)Nc1nc2ccccc2s1,IC50,5.64,CHEMBL5506204,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 6 days by RealTime-Glow MT cell viability assay,LN-229,JOTYYZZVRLAFOZ-UHFFFAOYSA-N,144.0,Antiproliferative activity,RealTime-Glow MT cell viability
CHEMBL4072504,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2)ccc1OCCCCN1CCCCC1,IC50,5.1,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QNUPDLGIOKVKMM-NTUHNPAUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4096453,,COc1cc(/C=C/C(=O)c2ccc(C)cc2)ccc1OCCCN1CC(C)OC(C)C1,IC50,5.38,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RTOXDVTXDWFPKT-XYOKQWHBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4064878,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc([N+](=O)[O-])cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,RYIXKARLZZLQDP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4066710,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.47,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SKFNRSXADVNTQX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4104755,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.26,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VYGQKAWFMNCRKR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4102463,,Cc1cc(=O)n(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.49,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JEMUEMMIHBANKW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4078189,,Cc1ccccc1-n1nc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)c(F)c2)c(C)cc1=O,IC50,5.58,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZAUITWXGIQXSFV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4078622,,Cc1cc(=O)n(-c2ccc(F)c(Cl)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,4.9,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XQQSOOFPTZZWTH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL211045,,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,6.98,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,BDUHCSBCVGXTJM-UHFFFAOYSA-N,0.1666666666666666,Unspecified,quantitative sandwich immuno
CHEMBL3983169,,O=C1C2=C(OC(Cn3cc(C[Se]c4ccccc4)nn3)C2)C(=O)c2ccccc21,IC50,6.01,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GDSDFDXWWZQUBO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3895357,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1Nc1cccc(-c2cn(C[Se]c3ccccc3)nn2)c1,IC50,5.97,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,LKZVCKKXFFRUOZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3936130,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nnc(-c3ccccc3)c1I)O2,IC50,5.43,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,CBEHSQUYTWTCBE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4556971,,C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)[C@@H]1O,IC50,5.42,CHEMBL4416282,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by SRB assay,U-87MG ATCC,JZQFWTNEUBVJCY-JDMXSVICSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4218338,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.56,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,LVGLBFQVAZMOBH-ONOMSOESSA-N,24.0,Cytotoxicity,CCK8
CHEMBL4468114,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QUDBXQWWBJDDOH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5173319,,CC(C)(C)[Si](O[C@H]1[C@H](O)C[C@](O)(CO)C[C@H]1O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)(c1ccccc1)c1ccccc1,IC50,4.97,CHEMBL5141031,Cytotoxicity against human LN-229 cells assessed as cell viability measured after 48 hrs by countess-II FL Hemocytometer method,LN-229,LVKKRKKKISMYSS-RDKVZNNQSA-N,48.0,Cytotoxicity,countess-II FL Hemocytometer
CHEMBL38434,BREQUINAR,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O,IC50,6.62,CHEMBL4723429,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SF295,PHEZJEYUWHETKO-UHFFFAOYSA-N,48.0,Antiproliferative activity,sulforhodamine B
CHEMBL3087009,,O=C1c2cc(F)ccc2-n2c1nc1ccc(F)cc1c2=O,IC50,7.21,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,PNIGSYVPVQBQOJ-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL2385204,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RIJAXDHUBFBQQH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5619848,,COC(=O)c1nn2c(NC(C)(C)C)nc3cc(Cl)ccc3c2c1C(=O)OC,IC50,5.58,CHEMBL5614908,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,CWWYOYQQBVCVDC-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5523403,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.87,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,AFJGGZNITGUTBL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2381461,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cc(C)cc(O)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.72,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,YEAGUSLHYRFJBW-BJMSDPACSA-N,48.0,Cytotoxicity,SRB
CHEMBL2381457,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(C#N)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.32,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,OKKOOEZHSOJKTD-BJMSDPACSA-N,48.0,Cytotoxicity,SRB
CHEMBL4287242,,CCCCCCCCCCCC[N+](C)(C)[C@H]1CC[C@H](O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)O[C@@H]1C.[I-],IC50,4.55,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,ASIORGZWKDNLSR-KHNSZOIESA-M,48.0,Antiproliferative activity,MTT
CHEMBL4577179,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.79,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,BFHHDNOGNZULGK-CKBBDEFZSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2088463,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(C#N)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.18,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OWIQELVAPAZAHH-VTNSRFBWSA-N,72.0,Cytotoxicity,MTT
CHEMBL2088459,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4ccc(Cl)cc4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.13,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ODVYHDCENWVMPV-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL2088443,,Fc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,5.05,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XEVSBQUGUYKTRS-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL2088442,,Fc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,4.9,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GZATWFXSLUADDR-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL2088439,,Clc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.22,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JVDTYHMYONBVAU-RWPZCVJISA-N,72.0,Cytotoxicity,MTT
CHEMBL314455,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccn2)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,VYPKYZTWZFRBOL-PNHLSOANSA-N,,Cytotoxicity,MTT
CHEMBL4450973,,COc1cc(/C=N/Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc(Br)c1OC,IC50,4.39,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,JTFPPLGYLNFXQV-PGGKNCGUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4475103,,COc1cc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)c(Br)c(Br)c1OC,IC50,4.56,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,YYMUAVBTOWHGMO-GZIVZEMBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4062301,,O=C(/C=C/c1ccc(S(F)(F)(F)(F)F)cc1)/C=C/c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.06,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NMHQTDFYUPBIBB-FACPPWRESA-N,72.0,Cytotoxicity,MTT
CHEMBL317644,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1,IC50,8.77,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,HSAKOKPUPOVOFH-RMLRFSFXSA-N,,Unspecified,Unspecified
CHEMBL3337793,,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.66,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,CTUZCHLJFUMBPX-IGMOWHQGSA-N,,Cytotoxicity,MTT
CHEMBL3337795,,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.24,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,IFVIVIXQVQVFAL-UZGNFBRWSA-N,,Cytotoxicity,MTT
CHEMBL3337797,,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.2,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,GNTQQMKQEBDBQY-XGTQTKKKSA-N,,Cytotoxicity,MTT
CHEMBL4564714,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CCl)cc1C2=O,IC50,5.28,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,XJEWVCSTXGINMO-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4454437,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.45,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZJQHBRAJUNHHDZ-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4476404,,C=CC(=O)Nc1cc(OCCC)c2c(c1)C(=O)c1cccc(OCCC)c1C2=O,IC50,4.6,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,NPDZGZCRKKKLTL-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL212242,,O=c1oc2c3c4c(cc2cc1-c1nc2ccccc2[nH]1)CCCN4CCC3,IC50,4.48,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,GPGSAESYFKTPBM-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL113072,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1,IC50,9.3,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,IICSHLLWAXMCEQ-ZEQRLZLVSA-N,,Unspecified,Unspecified
CHEMBL4085354,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCCCC3)c(OC)c2)cc1,IC50,5.2,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SIIHRNDOOSWZJP-NTUHNPAUSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3262846,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3)cc2F)ccn1,IC50,5.65,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VUZGCTWESWLKJB-LQKURTRISA-N,72.0,Cytotoxicity,MTT
CHEMBL120077,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,IC50,4.89,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,ZDNURMVOKAERHZ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4097280,,C[C@H]1COCCN1c1cc(-c2ccc3[nH]ccc3c2)nn2c(C3CCN(C(=O)c4cccnc4)CC3)cnc12,IC50,5.0,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JVOVVCAGNVWRQW-FQEVSTJZSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2361103,,Nc1nc2cc3c(cc2cc1C(=O)NCCc1c[nH]c2ccccc12)OCO3,IC50,4.34,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WNBZIJXYKUPXDE-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL5085922,,COc1cc2nc(N)c(C(=O)NCCc3c[nH]c4ccccc34)cc2c(Cl)c1OC,IC50,4.22,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,BCTNKASKUKYVNC-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL4525323,,c1ccc(CNCCN(CCNCc2ccccn2)Cc2ccc3ccccc3c2)nc1,IC50,5.2,CHEMBL4381289,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 48 hrs by cell titer-glo assay,LN-229,JQZJBHLTWMYVSN-UHFFFAOYSA-N,48.0,Antiproliferative activity,cell titer-glo
CHEMBL111845,,O=C1c2nccc(-c3ccccc3NC(=O)C(F)(F)F)c2C(=O)c2c([N+](=O)[O-])ccnc21,IC50,5.33,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,RFSJCVJLNACMNQ-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4225722,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.68,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,SMVKAKYSTNLAPJ-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4173811,,COc1cccc(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)c1O,IC50,4.31,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,ZJKYMNBOQCAOEE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4172390,,O=c1[nH]c(-c2ccc(Cl)cc2Cl)nc2sc3c(c12)CCCC3,IC50,4.05,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,YNFSDNHFYZXMKX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4072683,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCC#CCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.07,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CSOYPFGNCFIXJG-HKIQETCMSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4098675,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)c2ccccc2C(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.09,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZPXXFKDIYJIPRZ-BRAPIWAESA-N,72.0,Antiproliferative activity,MTT
CHEMBL4090941,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CNC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.76,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,IGHHYVSLRSHUME-SZZCUWPLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2172632,,Cc1nc(Nc2cccnn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.56,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,RHLKAAGLEWHOFV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1946507,,CC1C(C(C)(C)O)CCC1(C)/C=C/c1ccc(O)cc1,IC50,4.64,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,LCKVCMDFSAGHIF-PKNBQFBNSA-N,48.0,Cytotoxicity,sulpharhodamine B
CHEMBL112659,,Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.15,CHEMBL815093,Inhibition of the entry of HIV-1 reporter virus (JrF1) into U-87 cells,U-87MG ATCC,RYUYDSMTRQCJHP-VXKWHMMOSA-N,,Unspecified,Unspecified
CHEMBL4100714,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.66,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUNTWEBPNIIEQN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4103060,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Br)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.93,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YXFZCAIVOGPFBI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4074866,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5C(F)(F)F)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.75,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XUNIDUGFADGDTL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4099282,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.82,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JGSPNDOPABPAES-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4782175,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc(N3CCOCC3)n2)c1,IC50,5.66,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NWBPDMCNTURELD-KPKJPENVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL3426483,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(CO)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.36,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,HCZYQWZXOMCLRO-CBFGRJNTSA-N,24.0,Cytotoxicity,MTT
CHEMBL3426505,,C=C1C(=O)[C@@]23CC[C@@H]4C(C)(C)CCC[C@@]4(C)[C@@H]2[C@@H](O)C[C@@H]1C3,IC50,5.5,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,CNFJKVOXPKJCBT-SPBSJPQISA-N,24.0,Cytotoxicity,MTT
CHEMBL4593477,,COc1cc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)c(Br)c(Br)c1OC,IC50,4.71,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,MGVARTUZLPAUJN-HCGXMYGOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL237675,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CN(C)C)nn3)nccc12,IC50,5.96,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,VLWKVXAOJONEGL-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL392281,,Cc1ccc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)C(C)C2)cc1,IC50,4.91,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,NHMZZPYSOHOZKU-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL391499,,C[C@@H]1CN(C(=O)c2csc(Br)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.38,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RMNCEFNERVTQJN-SNVBAGLBSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL399421,,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12,IC50,8.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,XGLVOQFSQKQWHL-CQSZACIVSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL4453821,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCC4)CC3)cc2)ncc1Cl,IC50,6.7,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KJYKPTQKFIDZFU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3137331,DEFACTINIB,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,IC50,4.99,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,FWLMVFUGMHIOAA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4554455,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1C(F)(F)F,IC50,7.22,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,UXDPRPCEEZGHNQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL432537,,O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1ccccc1c2=O,IC50,7.4,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,UFMQJYHLIUACCG-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL3884639,,CCOC(=O)c1nc2ccccc2nc1C#CC1CC1,IC50,5.21,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CMGQXFJIDHHBGP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2172631,,Cc1nc(Nc2cccnc2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,5.19,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,MQFYWBFKHIRBIQ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL242770,,CC(COc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O)N(C)C,IC50,5.33,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,HTJRAEYDZNBECV-UHFFFAOYSA-N,,Cytotoxicity,SRB
CHEMBL388880,,c1cn(-c2ccc(OC3CCCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,7.11,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HGPUMTWTRGEZDO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL232818,,c1cn(-c2ccc(OCCN(Cc3ccc4c(c3)OCO4)Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,5.82,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WPWUABDSYBUYSZ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2170087,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.51,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-KGLIPLIRSA-N,2.0,Unspecified,Unspecified
CHEMBL2170085,,COc1ncc(Nc2ncc([C@H](N3CCN(S(C)(=O)=O)CC3)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.36,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,BTHPXDNRFHNRDI-KRWDZBQOSA-N,2.0,Unspecified,Unspecified
CHEMBL3806219,,Cc1ccc(OCc2cn(CC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@@H]5[C@@H]4CC[C@]4(C)C(=O)CC[C@@H]54)C3)nn2)cc1,IC50,4.73,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YLGXDGNAZDDRHG-AXOMYGEFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805633,,C[C@]12CC[C@H](OC(=O)Cn3cc(CNc4ccc(Br)cc4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.06,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JJMCMOFPGYOSRJ-SUAVODKESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805391,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(Cl)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.32,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MVQRUVBPPCEYAE-RIWGJCQISA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805540,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(F)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.04,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BQFMWMDYXURCKR-RIWGJCQISA-N,72.0,Antiproliferative activity,MTT
CHEMBL4793459,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccccc2F)cc1,IC50,5.4,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,DSFJPTWEJDCCKX-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL4796569,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1,IC50,5.54,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,OHHJTGRTQJGKLY-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL5569751,,N#CC1(C(=O)NCCc2ccccc2F)CC2c3ccccc3C1c1ccccc12,IC50,4.31,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,DJZIVJNHSWIMMC-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL1914743,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.7,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YKIWXNATSYCOKT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914710,,O=S(=O)(Nc1cc(-c2ccc3ncccc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.42,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LBMKYGFVNPHLPV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914728,,CN(C)c1ccc(-c2ccnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc23)cc1,IC50,7.21,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DCKNELOICLMUKN-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914738,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.89,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CITYVTFEGMZZGV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4528589,,COc1cccc(N2C(=N)S/C(=C\c3ccc(-c4ccc5c(c4)C(=O)NC5=O)o3)C2=O)c1,IC50,5.0,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,HCJVVFVIICAVRF-BILQUMLASA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL5431799,,COc1cccc(SC2=CC(=O)c3cccc(O)c3C2=O)c1,IC50,5.09,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,FKUQPQABTSLCJZ-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL4853279,,Cc1nc(=O)c2c(-c3cccc(Cl)c3)c(C(=O)c3ccccc3)[nH]c2[nH]1,IC50,6.05,CHEMBL4818316,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,GUTOAQSFSWJYTL-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1782901,,CCCCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.21,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,JINCHVNCWHGGGU-QGWJVEIISA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL5436814,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,9.15,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,GFNOBLJAGYIDLB-YQCPNUQPSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5402604,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(-c4ccccc4)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.16,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,NHMQMQATMQEBKF-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5408579,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(/C=C/CC(=O)NO)c1,IC50,5.67,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,LTQYHLRYCLMQNY-XYXUZSOXSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4793994,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(O)c1,IC50,6.84,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VQAFFPQTZLYJDR-GOSISDBHSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5523580,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.94,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZSIDGHXLTCSENF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5620297,,CCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.8,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,NAOYDIWOTBXUJD-XIFFEERXSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619669,,CCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.9,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,XNIOOABZUIRVKL-BHVANESWSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL4633648,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NCCCC)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.76,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RMWJGKGUCUHVCC-ZDBMLTPASA-N,96.0,Antiproliferative activity,MTT
CHEMBL4641992,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NC(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.26,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LEICXSSFNVJEDD-VACPRRTESA-N,96.0,Antiproliferative activity,MTT
CHEMBL4643037,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1cccnc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.57,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LDBJWVCPZNVIIN-MVNQOXTESA-N,96.0,Antiproliferative activity,MTT
CHEMBL5417192,,COc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,USJUPOQTPOFLDF-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5422395,,COCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,8.06,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BGMYFXWMIMLVCJ-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5410189,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1F,IC50,7.99,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RQFGVNXBMRSDGL-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL4093415,,CSc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.35,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,SMUJMXAEMNIVGX-RMKNXTFCSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5433226,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(F)ccc32)cc1,IC50,4.37,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,MIXJLSRSFQOQPD-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL2170090,,COc1ncc(Nc2ncc(C(C)(C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,DZRQGNOLDZNGKA-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2170089,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-KBPBESRZSA-N,2.0,Unspecified,Unspecified
CHEMBL2170084,,COc1ncc(Nc2ncc([C@@H](N3CCN(S(C)(=O)=O)CC3)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.75,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,BTHPXDNRFHNRDI-QGZVFWFLSA-N,2.0,Unspecified,Unspecified
CHEMBL2164698,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,5.7,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LIQPIULRQPRNHC-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2165015,,COC(=O)N1CCN(Cc2cnc(Nc3ccc(OC)nc3)c(-c3nc(C)nc(N)n3)c2)CC1,IC50,7.21,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,AXHJCTAXCZSLFA-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165029,,COc1ccc(Nc2ncc(N3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.08,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,UMNVNHUOVNNHPM-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL3780259,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.8,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JNSHVPBNGLECKZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2037144,,COc1ccc(-c2c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c3sc4ccccc4n23)cc1,IC50,4.22,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,XCFLJAUWJKYJSW-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2165009,,COc1ccc(Nc2ncc(CN3CCCCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.85,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,XDLCZYNDGPSHBI-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165031,,COc1ccc(Nc2ncc(N3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.06,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HJMSDMFCCDZFIX-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4476614,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCS(C)(=O)=O)CC3)cc2)ncc1Cl,IC50,6.04,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZOHDSYSNYVEESE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL5425232,,O=C1C=C(Sc2ccc(O)cc2)C(=O)c2c(O)cccc21,IC50,5.19,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,YBKODABFAUCIHI-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL3765584,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc(F)c2)nn1,IC50,5.69,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KTNZWURAXJUMHW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3763753,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc(F)cc2)nn1,IC50,4.42,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OQWFEEXCSSYPKS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4789504,,CN(C)CCCNC(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,5.64,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,JVMVYUIDMDTZDE-GIJQJNRQSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4791748,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCCC2)cc1,IC50,5.84,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,DQHQFAXHHXUAPF-CAOOACKPSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL5399499,,C=C(C)C#C[C@]12O[C@H]1[C@@H]1OC(C)(C)[C@H](OC(C)=O)C[C@@]13O[C@H]3C2=O,IC50,5.17,CHEMBL5392808,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,UDLWCNHPUOUNNV-ZPUMPEKVSA-N,48.0,Antiproliferative activity,MTT
CHEMBL213746,,CCN(CC)c1ccc2c(C#N)c(-c3nc4ccccc4[nH]3)c(=O)oc2c1,IC50,4.37,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,BCLNKBPAGCVDED-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL374632,,CCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1,IC50,4.82,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,GOLORTLGFDVFDW-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5647606,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)ncc1C(F)(F)F,IC50,5.56,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VMWRMINOTAWTRV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5647080,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCN(CCO)CC3)cc2)ncc1C(F)(F)F,IC50,5.43,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,BJMQXXHLUKXBRQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5639507,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CS(=O)(=O)N3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.72,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,REDVNZHZAIDXGJ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4092171,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(C#N)cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ACNMHKXKDCWNAR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5220854,,COc1ccc(-c2ncccc2NCc2ccc(C)cc2)cc1OC,IC50,4.61,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,GLGSWJSMMONYGR-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4796914,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2c1CCC2,IC50,4.55,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PUJDQZLKNOZWLN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1485589,,COc1ccccc1C(c1cc2c(cc1O)OCO2)N1CCOCC1,IC50,4.56,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CSQQCASHAULUEU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4750094,,COc1cccc(C(Nc2ccccn2)c2ccc3cccnc3c2O)c1,IC50,4.92,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LRIKTDRCLNJXMA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2095087,,Cc1ccnc(NC(c2ccc3cccnc3c2O)c2c(F)cccc2Cl)c1,IC50,4.69,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CRIZOPXWFAJBPS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4762974,,Cc1ccnc(NC(c2ccc3cccnc3c2O)c2c(Cl)cccc2Cl)c1,IC50,5.14,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LNQAUBSYKUMDRN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4206850,,N[C@H]1CCN(C(=O)c2coc3c(O)c4c(c(O)c23)C(=O)c2ccccc2C4=O)C1,IC50,5.28,CHEMBL4480830,Cytotoxicity against human A172 cells after 72 hrs by MTT assay,A-172,HECFNGGMVTZBKE-VIFPVBQESA-N,72.0,Cytotoxicity,MTT
CHEMBL5563067,,CCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.49,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,RVTVYAMLKHQXSN-GFCCVEGCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5563434,,CCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.78,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,MZBKDEGDTCITBX-CQSZACIVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1645551,,Cc1nccc2c1[nH]c1cc(OCc3ccccn3)ccc12,IC50,4.7,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,RINQBMRYJCENBJ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164403,,Cc1c2c(cc[n+]1CCO)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,4.21,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XPIFHWUFLHRFRI-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164708,,Cc1nccc2c3ccc(O)cc3n(Cc3ccccc3)c12,IC50,4.09,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SZJTUBCBHRFAAE-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164705,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,6.22,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,BKJRAVOKCBMHTR-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2165003,,COc1ccc(Nc2ncc(CN3CCCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.19,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,ONJSIGPCPAOGNJ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165014,,COc1ccc(Nc2ncc(CN3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,QIBHHZDVUBRFRC-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165030,,COc1ccc(Nc2ncc(C3=CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.33,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IFIUXKIVTAKIHT-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL3945818,,O=C1C=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,6.01,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,MHCZNBSEGFJRMA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3966682,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(C[Se]c2ccccc2)nn1,IC50,5.88,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DRDCWILTIUDZCE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3932274,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C[Se]c2ccccc2)nn1,IC50,5.58,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GIGCBAVNNGPPQM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL517968,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1N=[N+]=[N-],IC50,5.52,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,KTBBERAINMFOJN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2164693,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,6.4,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,APZJDZWUWVRLPM-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164714,,CCCn1c2cc(OCc3ccccc3)ccc2c2ccnc(C)c21,IC50,4.47,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,GFKJHDTZPIORLX-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2164709,,Cc1nccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c12,IC50,4.44,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,RRSQKKMTIRLMGU-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2165027,,COCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,DLFVITASTHEQDC-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165025,,COc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,7.38,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,DYLZJJGYKQIVGK-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4074759,,c1cncc(CN2CCC(c3cnc4c(N5CCOCC5)cc(-c5ccc6[nH]ccc6c5)nn34)CC2)c1,IC50,5.29,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VHAOWCMAMJCCDO-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4074775,,Cc1cnc2c(N3CCOCC3)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,4.89,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JPPYZWTZMGTNMQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4093332,,Cc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,4.97,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,NSBZLJYTQXCINL-KRWDZBQOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5430557,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCCN1CCOCC1,IC50,7.86,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,YFRRKGINNPHMHR-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5425652,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1Cl,IC50,7.38,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WGOFDWAXBNRPKE-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5423222,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(Br)c1,IC50,7.39,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RVWHXDQOWSKLRN-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL4103646,,CN1C/C(=C\c2cc(F)c(F)cc2F)C(=O)/C(=C/c2cc(F)c(F)cc2F)C1,IC50,5.51,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,HICMTPXFJJCCDU-TUOIWHRTSA-N,72.0,Cytotoxicity,MTT
CHEMBL4070918,,O=C1/C(=C/c2ccc(F)c(F)c2)CSC/C1=C\c1ccc(F)c(F)c1,IC50,5.64,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GPWYCKFIDQFBEP-ACFHMISVSA-N,72.0,Cytotoxicity,MTT
CHEMBL4097794,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCc4ccccc43)c(OC)c2)cc1,IC50,4.82,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,YRRPPWAVUNXBTB-RIYZIHGNSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4062039,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCCc4ccccc43)c(OC)c2)cc1,IC50,4.74,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QVODHRCONKKYLI-MHWRWJLKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4527122,,CCCCCCNC(=S)NCc1ccc2c(c1)OCO2,IC50,4.06,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,IKBHNADYMMDTRR-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL4464767,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccc5c(c4)C(=O)NC5=O)s3)C2=O)cc1,IC50,5.0,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,SAJVLIRHXSJMQH-BILQUMLASA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL4579277,,Cc1cn([C@H]2C[C@H](n3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,4.97,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,WEBCKHJLVOSNNV-ZQLWZKNSSA-N,72.0,Cytotoxicity,SRB
CHEMBL4554315,,Cc1cn([C@H]2C[C@H](n3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,5.72,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BIUUUPZSQFCVTA-ZQLWZKNSSA-N,72.0,Cytotoxicity,SRB
CHEMBL4552928,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(COC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(NC(=O)OCc3ccccc3)nc2=O)C1(F)F,IC50,5.96,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,KGZWHTDZGKHYDI-BEYURWCVSA-N,72.0,Cytotoxicity,SRB
CHEMBL5558630,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.48,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,LKBCVMRXHSKDPT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5556281,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCCOc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,IC50,6.08,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SGMKJWDGNACVOF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4284204,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3cccs3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.89,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,DAXIRJXAMMBHLE-BERMCJJASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4288699,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(C(=O)OCc4ccc(OC)cc4)nn3)CC[C@@H]12,IC50,5.43,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NDHUIPQPANWQBE-YSBZXDJFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5423304,,O=C1c2nc3ccccc3c(=O)n2C2C=CC([N+](=O)O)=CC12,IC50,7.4,CHEMBL5386659,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 14 hrs by CCK8 assay,U-87MG ATCC,VHANRRAMCXJVLJ-UHFFFAOYSA-N,14.0,Antiproliferative activity,CCK8
CHEMBL601661,,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,IC50,7.19,CHEMBL5696731,Antiproliferative activity against human U-87MG cells assessed as cell growth inhibition incubated for 24 hrs by MTS assay,U-87MG ATCC,QLHHRYZMBGPBJG-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTS
CHEMBL1231795,,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1,EC50,6.3,CHEMBL5675724,Antiproliferative against human LN-229 cells after 5 days by Cell-Titer Glo assay,LN-229,QOECJCJVIMVJGX-UHFFFAOYSA-N,120.0,Antiproliferative activity,Cell-Titer Glo
CHEMBL223142,SCHWEINFURTHIN G,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)CC[C@@]2(C)O3)cc1O,IC50,8.1,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,CGJIPMVTBQUUQL-GEDZTWKOSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL3805245,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Cl)cccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.48,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SOABZRUKTCYMPO-IUFQJPFESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805659,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Cl)ccc(Cl)c54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,5.02,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BBWPOSLPFWUEKE-GBQDJQSCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805763,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cccc(Cl)c54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.68,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OKJZQJSPKHBPRJ-DCCPDJSOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4129272,,C=Cc1ccc(OC(=O)c2ccc(O)c(NC(C)=O)c2)cc1,IC50,4.99,CHEMBL4119405,Cytotoxicity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,GIZFCCIAJXWSKK-UHFFFAOYSA-N,72.0,Cytotoxicity,sulforhodamine B
CHEMBL178310,,COc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,6.3,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,MXYYHEJTMJMGSX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL361956,,COc1cc(OC)cc(-c2nc(O)c3c4c(sc3n2)CCCC4)c1,IC50,4.32,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,YXZRLJZTIHFJAM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4176356,,O=c1[nH]c(-c2ccc(F)cc2)nc2sc3c(c12)CCCC3,IC50,4.77,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,KAOOMLBGJNXBLA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5571295,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.84,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,IHVNOGSWEFFJSN-KHEAGTJRSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5568768,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.54,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,QTMBOQARWWEVKV-APYISGCASA-N,72.0,Cytotoxicity,CCK8
CHEMBL5569274,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.89,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,DHUBQULUTJZTLG-MMNKWBABSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5567441,,N#CC1(C(=O)NCCc2cccc(Cl)c2)CC2c3ccccc3C1c1ccccc12,IC50,4.44,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,VYZHXQPBFGSXFU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5574930,,N#CC1(C(=O)NCCS(=O)(=O)Nc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.89,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,ZUEUGFYUZCGAOG-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5592097,,Cc1c(Br)c(C)n2c1C=C1C=C(Br)C(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,6.52,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,ODEJCZKRNICMAE-UHFFFAOYSA-N,1.0,Growth inhibition,compound washout and light irradiation measured after 72 hrs by MTT
CHEMBL4515390,,CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1,IC50,6.22,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,SCJXQZZYGYLKJG-CQSZACIVSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4790355,,COc1cc(C(Nc2ccc(C)cn2)c2ccc3cccnc3c2O)cc(OC)c1O,IC50,5.13,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,MITSWHDEOSTHCR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL590899,,Oc1c(C(Nc2ccccn2)c2ccc(Cl)cc2)ccc2cccnc12,IC50,4.97,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RDIURRMJOIJGSL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2094875,,Oc1c(C(Nc2ccccn2)c2ccccc2Cl)ccc2cccnc12,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RGPCTXYEMALQFR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL589912,,Cc1ccnc(NC(c2ccccc2F)c2ccc3cccnc3c2O)c1,IC50,4.88,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LLJNUTJAVMTITA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL576209,,CCc1ccc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)cc1,IC50,5.05,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,BLRVDQSWWDLAAA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL589706,,Cc1ccnc(NC(c2ccc([N+](=O)[O-])cc2)c2ccc3cccnc3c2O)c1,IC50,5.47,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,WRUZNTSXJKBYPR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4074207,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(Cl)c1)CC(C)(C)O2,IC50,4.7,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,AWBDPWSULFCJEF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4064472,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(Cl)cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ORCGAZNEXCXRPF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4776190,,Oc1ccc2[nH]ncc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,4.06,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,TXEWFPSKHMOWRP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4099164,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.36,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,ZYPYAXPTWKNCLK-LPSCLBFBSA-N,24.0,Cytotoxicity,MTT
CHEMBL4750697,,C#CCOc1ccc(/C=C/C(=O)c2cccc(Br)c2)cc1OC,IC50,5.59,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KWVYUPDEBNSUDY-VQHVLOKHSA-N,72.0,Cytotoxicity,RRA
CHEMBL4291927,,C(=C/c1ccc(OCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.44,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZWMRQMMBBVUDPI-JGUILPGDSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4281382,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccccn3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.41,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QPAZZOMARVCHOR-YXLFCKQPSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4291595,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccc(/C=C/C(=O)/C=C/c4scnc4C)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.23,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BGPYOJIUFHLROC-USJAFLQSSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3804989,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4cc(=O)oc5ccccc45)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.4,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,TXOQAEYMEFQCKY-SFZGMJDZSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805490,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc(OC)c1OC,IC50,4.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,LRNGFHVVRARXBA-YPKPFQOOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1738758,ONVANSERTIB,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,6.64,CHEMBL5682227,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth incubated for 72 hrs by cell-titer glo assay,T98G,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,cell-titer glo
CHEMBL5086293,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(F)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.34,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GAFFZCCTWJWKRW-SMRIDXHDSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5079791,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C(C)(C)C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.52,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,QLFCJGYFBTYJGC-VZHCALMGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5080969,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.57,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,WCCOFLBJUFCACV-BDFBTMKGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5086100,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CCCCC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.67,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,DBJDUIQIYKJHPB-SMRIDXHDSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4211294,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.49,CHEMBL5048128,Cytotoxicity against human U-87 MG cells by sulforhodamine B assay,U-87MG ATCC,HWCVTYJVEWESOJ-XREWKEJESA-N,,Cytotoxicity,sulforhodamine B
CHEMBL3805190,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(O)cc2)cc(OC)c1OC,IC50,5.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OWRSMPKWHXEMRA-YPKPFQOOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5092573,,Cc1ccc(CN2C(=O)[C@](O)(CC(=O)c3ccc4c(c3)OCO4)c3cc(Br)ccc32)cc1,IC50,4.81,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,RJWAPLZQOHMKPF-VWLOTQADSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5418850,,COc1ccc2c(c1)c(Cc1cc(C)c(O)c(C)c1)cn2S(=O)(=O)c1ccc(C)cc1,IC50,4.55,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,UOBDDXCBKVNHNT-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5432847,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N3CCCC3)CC2)n1,IC50,5.7,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,WKWYSOWNDOKVBG-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1724189,,Nc1ccc(Cn2ccc3c4c(N)nc(N)nc4ccc32)cc1,IC50,4.68,CHEMBL5051747,Antiproliferative activity against human U-87 MG cells after 72 hrs by MTT assay,U-87MG ATCC,LNEWNMFMWDBAKM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3923330,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(C(C)C)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.33,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NVSHUXDGRVRGBX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3924412,,COc1ncc(-c2ccc3nccc(-c4ccc(CN(CCO)CCO)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.84,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WWQGZIBPCULVTA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3896400,,CCN(Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1)C1CCCCC1,IC50,5.84,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VDKDZMNKYPRJFD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3923855,,COc1ncc(-c2ccc3nccc(N4CCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.17,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SVNLAKNJHSGYGN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3982619,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccccc1,IC50,8.34,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,GSFCLBKGTQCVGV-HEHNFIMWSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3938794,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1,IC50,8.62,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RRPVAUYNDYHREV-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3896476,,S=C(NNc1nncc2ccccc12)Nc1ccc(Cl)cc1,IC50,8.08,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,PBFFTWJHTSVERV-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3908272,,O=S(=O)(Nc1ncccn1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.12,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,AUAMVGQDEAESMO-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3899216,,Cc1cc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)no1,IC50,8.36,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RTWIUHXCAFIOQK-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3934506,,O=C1C2=C(C(=O)c3ccccc31)[C@H](c1ccccc1)[C@@H](n1cc(C[Se]c3ccccc3)nn1)CO2,IC50,5.25,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,FOZGPHHONSZBQI-BJKOFHAPSA-N,72.0,Cytotoxicity,MTT
CHEMBL3974809,,CCCCCCc1cn(CC2CC3=C(O2)c2ccccc2C(=O)C3=O)nn1,IC50,5.57,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,ADVBYVIGGIGVIF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5591952,,N[C@H]1CC[C@H](NC(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)CC1,IC50,5.35,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,REIKLGHKTPRJRF-JOCQHMNTSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5571420,,N#CC1(C(=O)NCCC2CCN(Cc3ccccc3)CC2)CC2c3ccccc3C1c1ccccc12,IC50,4.94,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BFBLDTSWYZNMAD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL2037069,,OCc1c(CO)c2sc3ccccc3n2c1C1CC1,IC50,4.54,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,HWRJDZOMOKZHOF-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL2037076,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(OC)cc1,IC50,4.53,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,GKXKHQWSIYHBAH-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL5270282,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCNC(=O)c2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccn2)C(C)(C)C)cc1,IC50,4.69,CHEMBL5239980,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DQWLHVNWDUFZCJ-XUHBGXIGSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5273395,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)NC5CN6CCC5CC6)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.67,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RYQYIWQEMSPDMJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5282212,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccc6[nH]ncc6c5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.82,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ICRBTXCCGGMHJF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3884794,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1C,IC50,4.5,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ISEGQTIMVBKKSL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2298457,,N#CC1=C(N)Oc2c(c(=O)oc3ccccc23)C12C(=O)N(CCCCBr)c1ccccc12,IC50,4.11,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,JVTAAAJPZUCLIR-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL280986,,CC(C)=CCC[C@](C)(O)C1CC[C@]2(C)C1[C@H](O)CC1[C@@]3(C)CC[C@H](O)C(C)(C)C3CC[C@]12C,IC50,4.42,CHEMBL5233963,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation,U-87MG ATCC,PYXFVCFISTUSOO-NKYJHZBASA-N,,Antiproliferative activity,Unspecified
CHEMBL5268257,,O=C(CCCCCNC(=O)C1=CC2C(=O)C3C=CC=C(O)C3C(=O)C2C(O)=C1)NO,IC50,5.26,CHEMBL5231068,Cytotoxicity against human U87 cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ALJZJKPKINLHPS-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4285427,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccccc5)c4=O)cc3F)ccnc21,IC50,5.45,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RBQAQDXTXSPOKX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4291079,,CC[N+](CC)(CC)CCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.75,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,CAKFDDIAFHTZIJ-WPDLWGESSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4277852,,C(=C/c1ccc(OCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.42,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,SJAKUNBAYWZRAM-BTKVJIOYSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4282960,,CC1(C)[C@H]2OC(=O)O[C@H]2[C@@H](O)[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,6.21,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,CMWNDRSEHHSODA-XBJQJAEESA-N,72.0,Cytotoxicity,MTS
CHEMBL9941,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,6.24,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IKMOZUDCUBMIRL-FNORWQNLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4648447,,O=C(O)c1cccc(-n2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,4.67,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GSZLJYACJIRCIN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4645339,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)CCC(=O)n3cc(/C=C/c4cccnc4)c4ccccc43)nn2)c1,IC50,6.19,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LJDAZCPWCZBFKM-CJQREAPYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5561986,,NCCN(Cc1ccc2ccccc2c1)c1nc(C(=O)Nc2ccc(O)cc2)cs1,IC50,5.24,CHEMBL5520021,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UKTIJZJOHLGMQZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624701,,CCOc1ccc(Oc2ccc(C3=NN(C4=NC(=O)CS4)C(c4cc(O)c(O)c(Br)c4Br)C3)cc2)cc1,IC50,5.58,CHEMBL5620677,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,SSAVEPMIHHRFHV-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5279397,,CCCN(CCC)c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.79,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,OLEDTHPOZSTPSH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5564226,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,6.07,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SRWAGSNKUFDMAT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5559947,,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,6.11,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UNVKVCJYTQIHSW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4205768,,CCOC(=O)c1c(Nc2ccccc2)sc(C(=O)c2cnc3ccc(C)cn23)c1C,IC50,4.37,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,TVKXBGHYRKKAEJ-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL1760590,,COc1ccc(C[C@H]2CO[C@H](c3ccc(OC)c(OC)c3)[C@H]2CO)cc1OC,IC50,4.81,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,AYWPHVUFQNWITL-PNLZDCPESA-N,,Anticancer activity,SRB
CHEMBL402653,,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2cc(OC)c(O)c(OC)c2)cc(OC)c1O,IC50,5.05,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,KOWMJRJXZMEZLD-WRMVBYCNSA-N,,Anticancer activity,SRB
CHEMBL460862,(-)-PINORESINOL,COc1cc([C@@H]2OC[C@H]3[C@@H]2CO[C@H]3c2ccc(O)c(OC)c2)ccc1O,IC50,4.88,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,HGXBRUKMWQGOIE-FEBSWUBLSA-N,,Anticancer activity,SRB
CHEMBL4062698,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(Cl)C2=O)nc1C,IC50,5.46,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XAZAQCSIQYKFPW-VOTSOKGWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4534317,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.9,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DZMFLHMZKMFRGK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4079425,,CC(C)(C)c1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.49,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,HAVIMTMYFSHBCX-ZHACJKMWSA-N,72.0,Antiproliferative activity,SRB
CHEMBL1779544,,Cc1c2c(n3c1CCC(=O)N1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,5.96,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,CQXLACSOWMIHAJ-QGZVFWFLSA-N,,Antiproliferative activity,luminescence
CHEMBL4538916,,COc1cc(CNC(=O)Nc2ccc(Cl)cc2)ccc1O,IC50,4.03,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,CDCCZJXLORNRAE-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL2165023,,COc1ccc(Nc2ncc(Br)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.08,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,VBYCMVGPGAGETD-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165037,,Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2[nH]cnc2n1,IC50,6.47,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HMCXLHKQRBBRRQ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165269,,COc1ccc(Nc2ncccc2-c2nc(C)nc(N)n2)cn1,IC50,6.44,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,XZIRFISMMDAPDH-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4646493,,CCCCC#Cc1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n2ncnc(N)c12,IC50,6.0,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,JBNNQRWQYOANLE-MIGQKNRLSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4634224,,COc1ccc(-c2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)n3ncnc(N)c23)cc1,IC50,4.39,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,LDZMHIGRWXMUOC-DZUCGIPZSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL453902,,CCCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.02,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,FVSDHXRLSKXVSU-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL507815,,COc1ccc(N2NC(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.42,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WSGPGBRUDKIIGH-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4572210,BAY-771,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1,IC50,5.21,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,LZLNIHXKWZZQLE-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1836101,,Cc1ccc(CN2C(=O)S/C(=C\c3c4ccccc4nc4ccccc34)C2=O)cc1,IC50,5.11,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,XEBUFDRTTQXKLP-UCQKPKSFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2035438,,O=C1S/C(=C\c2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(Cl)cc1,IC50,5.24,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,GMCUOUPIWVXCTM-XKZIYDEJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5274651,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.13,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,WIUJEGJOHIUWMY-SUPJBSOFSA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL255863,NILOTINIB,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,4.02,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,HHZIURLSWUIHRB-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL3335766,,O=c1ccc(-c2cccc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCN(CCO)CC4)c3)cn2)CCO1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,KARZYTQDIOCJQW-SANMLTNESA-N,72.0,Cytotoxicity,WST8
CHEMBL3335782,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(-c5ccc(OCCN6CCOCC6)cc5)cn4)CCO3)n2)c1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,HJCJMGGMQIUHGY-LJAQVGFWSA-N,72.0,Cytotoxicity,WST8
CHEMBL5437234,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3nc4ccccc4s3)cc2)CCC1(C)C,IC50,4.64,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,VOGYFQFWXUTSHU-CAPFRKAQSA-N,72.0,Anticancer activity,Unspecified
CHEMBL5440659,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)CCC1(C)C,IC50,4.32,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,HJUVJJGIFNOFCE-CAPFRKAQSA-N,72.0,Anticancer activity,Unspecified
CHEMBL567015,DENDROGENIN A,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](NCCc4cnc[nH]4)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,6.13,CHEMBL1040901,Cytotoxicity against human U87 cells after 72 hrs by trypan blue exclusion assay,U-87MG ATCC,AVFNYTPENXWWCA-BULFVYHESA-N,72.0,Cytotoxicity,trypan blue exclusion
CHEMBL1097307,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.29,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,KMUMKXDYUNUHJP-QNKOPLAASA-N,48.0,Cytotoxicity,MTT
CHEMBL175918,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.82,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BTLAYFGMHXAALT-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL378033,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(F)ccc2O1,IC50,4.35,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,WVJAISADWKHYRO-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL213706,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(Cl)ccc2O1,IC50,4.48,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,XCNTZWMMYVKZPH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL209643,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(Br)ccc2O1,IC50,4.17,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,HLXNKMOLEFMIFG-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL425784,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(Br)ccc2O1,IC50,4.57,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,CLJQJCFKFTWBEI-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL497954,,CC1(C)CC(NC(=S)Nc2cccc(Cl)c2)c2cc(Br)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SBLLOSAMWVFIDV-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL467766,,COc1ccc(NC(=S)NC2CC(C)(C)Oc3ccc(Br)cc32)cc1,IC50,4.48,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BHQGZMYIJIWWDI-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL596384,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(F)ccc2O1,IC50,4.72,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,PKTSPJYSUTZTIX-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL595765,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(Cl)ccc2O1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,MYSINLZROQQGJK-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL593579,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(F)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,RPZWUSCLISWIAW-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3416200,,COc1cc(C(N)=O)cc(-c2nc(N3CCOCC3)c3cc(OC)c(OCCN4CCCC4)cc3n2)c1,IC50,5.61,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KHSQMICBWNABRT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3416183,,COc1cc2nc(-c3cc(C(N)=O)cc(C(F)(F)F)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.92,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZONBDBSYIRAYPB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3416006,,COc1cc(C(N)=O)cc(-c2nc(N3CCOCC3)c3cc(OC)c(OC)cc3n2)c1,IC50,6.0,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DPPWUQVKIGSRNI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5093530,,Nc1nc2cc3c(cc2cc1C(=O)NCCc1c[nH]c2ccccc12)OCCO3,IC50,4.35,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,ZQIJBTBWKOLWCH-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2144684,,COc1cc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(N)nc2cc1OC,IC50,4.62,CHEMBL5031820,Cytotoxicity against human A 172 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,A-172,QCHLGZWWWSKMPE-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL3805449,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,RHQMXZQEBQJNKG-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805690,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.88,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NFAMYNQBDJCOMF-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL1276127,INDIRUBIN,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O,IC50,4.9,CHEMBL5151556,Cytotoxicity against human U87 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay,U-87MG ATCC,CRDNMYFJWFXOCH-YPKPFQOOSA-N,24.0,Cytotoxicity,MTT
CHEMBL2180739,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,IC50,6.68,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,IMNXDWVLNJJERQ-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL4636438,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(OC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.36,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JDRUXFHAXKJOOG-FLRPPASCSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5632034,,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)ccc1F,IC50,6.17,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,LTAUUJCJWYELLU-HTAPYJJXSA-N,132.0,Antiproliferative activity,MTT
CHEMBL5633668,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc4c(n3)N(C)C(=O)OC4)cc2)CC1,IC50,7.35,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,PUYKVXYHYSNEOJ-INIZCTEOSA-N,132.0,Antiproliferative activity,MTT
CHEMBL5632655,,C=CC(=O)N1CCC(N(C)Cc2ccc([C@H](C)Nc3ncc4c(n3)N(CC)C(=O)OC4)cc2)CC1,IC50,7.87,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,DYROKBWIUGQINH-SFHVURJKSA-N,132.0,Antiproliferative activity,MTT
CHEMBL5633478,,C=CC(=O)N1CCN(C(CC2CC2)c2ccc([C@H](C)Nc3nc(F)cc(N4C(=O)OCC4(C)C)n3)cc2)CC1,IC50,9.3,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,NRKYICITCPBBEB-HSTJUUNISA-N,132.0,Antiproliferative activity,MTT
CHEMBL4747345,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCCC3)n2)cc1,IC50,5.35,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NEZOVFDTMRGNBQ-GIDUJCDVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4777552,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccc(Cl)cc3)nc(N3CCOCC3)n2)cc1)Nc1cccc(F)c1,IC50,5.36,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,UETFDSDTHZGWKZ-AWNIVKPZSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4786297,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCOCC2)cc1,IC50,6.26,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,VULCEIDDAZGSQP-GIDUJCDVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4293371,,COc1cccc(/C=C/C(=O)c2ccc(OCC(=O)Nc3ccc4c(c3)COC4=O)cc2)c1,IC50,5.24,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,KHRIHMMGXZXSCD-LFYBBSHMSA-N,48.0,Cytotoxicity,MTT
CHEMBL1592888,,Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@@H](CN1CCOCC1)CO3,IC50,5.09,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,HQVHOQAKMCMIIM-FQEVSTJZSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2165026,,COc1ccc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.06,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,JJRKQAAMIWSSRQ-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL5092199,,Cc1c(Cl)cccc1Nc1ccccc1C(=O)Nc1ccc2c(c1)OCO2,IC50,5.19,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,DWUXWNDVKZWHPM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4790321,,CC(C)(CO)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21,IC50,4.28,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,CEWOYNHYISZPFC-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL339505,,C#CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.4,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LWZDHLHMEOGKDZ-TXHRRWQRSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4787561,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCOCCO)C(=O)C=C(NCCOCCO)C1=O)OC,IC50,4.9,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,RYXFTCJGJZSPGQ-LWOLOBPDSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5413752,,COc1cc(COc2ccc3cc(CN(c4cc(-c5cc(OC6CCOCC6)c6ncnc(C)c6c5)cnc4OC)S(=O)(=O)c4ccc(F)cc4F)c(=O)oc3c2)c([N+](=O)[O-])cc1OC,IC50,5.49,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,SQZMHFUFHLUQNN-UHFFFAOYSA-N,72.0,Antiproliferative activity,CTG
CHEMBL2348735,,Nc1cc(-c2ccccc2)c(=O)[nH]n1,IC50,5.24,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,YJGAKEQOUFXKBO-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL4794124,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCC(O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.43,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,NXVPLORZKVVQMN-CFAHVTDHSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4794663,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3CCC(C(=O)O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.55,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LGYRVCYOCBKGHK-ULLGIGRLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4777808,,C#CCCN1CCC(NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,5.31,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WGKIKYFSLYDSHO-JBUWZVAHSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4778032,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(Cc4ccccc4)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.96,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WBRMZSFRWYMDJR-FSGHDYEQSA-N,72.0,Antiproliferative activity,SRB
CHEMBL126986,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.9,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,IKFQBKKOFWMKDO-HSHPMGMFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4789835,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCOCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.58,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,FWFGPTQFVAHBCB-GTZYIQDLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4866860,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNCc3ccccc3Br)c2C1=O,IC50,5.91,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NEIODWUCCZANRT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2035473,,Cc1ccc2[se]n(CCCCCn3[se]c4ccc(C)cc4c3=O)c(=O)c2c1,IC50,4.91,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XUNAXWKPYVSIFE-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4646929,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1cccc(C(F)(F)F)c1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.01,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZBSWWAZKCCWCKH-WQDDGORTSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4169901,,O=C1c2ccccc2C(=O)c2c(-c3ccc(Br)cc3)coc21,IC50,5.46,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,FQENAOMGHQFHAS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4173329,,COc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.3,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DWIJEFQDVDRKED-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4173738,,COc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1OC,IC50,5.43,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,OLEHVZCPKTVDTA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4166476,,O=C1c2ccccc2C(=O)c2c(-c3cccc4ccccc34)coc21,IC50,5.35,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CBWPQRWVKCXPAY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4634483,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(Cl)cc3)c12,IC50,4.49,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,IJSDNULBQHJOOO-MIGQKNRLSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4551060,,C=C(c1cc(C)nc(C)c1)c1ccc2c(ccn2C)c1,IC50,7.5,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,YKKUAOOAOPZZDC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL5439857,,COc1ccc(-c2ccc3[nH]c(=O)c4cnc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.39,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,GYQFVNINNLAMOS-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL2170098,,COc1cncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)c1,IC50,7.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,OHZHBEQIRGURAO-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2170095,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.21,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,XXVQUOSJLYEXMX-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2170093,,Cc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.36,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,NRNPLKNQEHSDHU-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2297269,,COc1cc(OC)c2c(-n3ccnc3)cc(-c3ccccc3)nc2c1,IC50,4.26,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,TZSRESUMYOIXEO-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL1834959,,O=C(O)c1cccc(C#Cc2ccc(S(=O)(=O)Nc3ccccn3)cc2)c1,IC50,4.12,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,FKSJWWYXAUHHOQ-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL1614646,SUSALIMOD,Cc1cccnc1NS(=O)(=O)c1ccc(C#Cc2ccc(O)c(C(=O)O)c2)cc1,IC50,4.16,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,WJLQPSZXCOYTHS-UHFFFAOYSA-N,0.25,Unspecified,Unspecified
CHEMBL3824119,,O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,IC50,6.35,CHEMBL3826434,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZWERENZUADIUDM-JMIUGGIZSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3823831,,CCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,6.0,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XLIDYKIFFYGVPE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5569551,,N#CC1(C(=O)NCCc2ccc3c(c2)OCO3)CC2c3ccccc3C1c1ccccc12,IC50,4.43,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,WFJXGLXEQPSKTB-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5565649,,N#CC1(C(=O)NCC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.23,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,ZMUBXGDBYBDURM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4763035,,C=C(CC)C(=O)c1ccc(OCC(=O)N2CCN(S(=O)(=O)c3ccc(OC)cc3)CC2)c(Cl)c1Cl,IC50,6.68,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,DWOGIRGYIBQNND-UHFFFAOYSA-N,,Cytotoxicity,CellTiter Glo luminescent
CHEMBL575828,GOSSYPOLONE,CC1=C(C2=C(C)C(=O)c3c(c(C=O)c(O)c(O)c3C(C)C)C2=O)C(=O)c2c(C=O)c(O)c(O)c(C(C)C)c2C1=O,IC50,4.58,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,YSPBCFMMSKAENM-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL598841,,CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]c(=O)[nH]c34)CC2)cc1,IC50,7.89,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,CENSOIHHGQYIKW-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL597793,,NC1(COCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,9.23,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,UFBYOZWKWYKBBZ-UHFFFAOYSA-N,,Unspecified,ELISA
CHEMBL4452076,,COc1cc(/C=C/C(=O)Nc2ccc(CC(=O)NN)cc2)ccc1O,IC50,4.31,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QWPLWKBEPSFENZ-WEVVVXLNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5269634,,CO[C@@H]1CC(=O)Nc2c(O)c3cc4c2[C@H]1[C@@H](/C=C/C=C/C[C@H](OC(=O)[C@@H](C)NC(=O)C1CCCCC1)[C@H](C)[C@@H](O)/C(C)=C\CC3)O4,IC50,5.15,CHEMBL5249012,Antiproliferative activity against human U-87 MG assessed as cell growth inhibition incubated for 48 hrs by Cell Counting Kit-8 assay,U-87MG ATCC,LBJSTKXSGJVGJM-VZRUPSOZSA-N,48.0,Antiproliferative activity,Cell Counting Kit-8
CHEMBL2152477,,COc1cccc2c1C(=O)c1ccc3c(c1C2=O)C(=O)C[C@](C)(O)C3,IC50,4.77,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,XZLGWJORNHETKI-HXUWFJFHSA-N,72.0,Cytotoxicity,MTS
CHEMBL504816,(L)-1-METHYLTRYPTOPHAN,Cn1cc(C[C@H](N)C(=O)O)c2ccccc21,IC50,4.25,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,ZADWXFSZEAPBJS-JTQLQIEISA-N,6.0,Unspecified,Unspecified
CHEMBL252316,,C=C1C(=O)[C@@]23CC[C@H]4[C@@](C)(CCC[C@]4(C)C(=O)O)[C@@H]2CC[C@@H]1C3,IC50,5.43,CHEMBL1112256,Cytotoxicity against human SF295 cells after 69 hrs by MTT assay,SF295,WQBNGXOJBVBQKP-YBDDNXDTSA-N,69.0,Cytotoxicity,MTT
CHEMBL4783328,,C1=C2CNCC3=Cc4c(ccc5ccccc45)OC23Oc2ccc3ccccc3c21,IC50,5.28,CHEMBL4688126,Anti-cancer activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by SRB method,SF295,FKUSUQUCJVZNII-UHFFFAOYSA-N,48.0,Growth inhibition,SRB
CHEMBL4857859,,CS(=O)(=O)c1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.11,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,IGHMKCXCLCQOOD-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4874832,,CSc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.57,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,QUOPXRYKTOYGSC-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4866877,,Cc1ccc(-c2nc3ccc(C)cn3c2Sc2ccccc2)cc1,IC50,4.09,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,ZZWGYALMBMIHRB-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4871031,,Clc1ccc(Sc2c(-c3ccccc3)nc3ccccn23)cc1,IC50,4.2,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,KRTIFEYECZHTLC-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL5219493,,COc1cc(OC)cc(-c2ncccc2NCc2ccc(Cl)cc2)c1,IC50,4.26,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MECMYKCKBJRKFQ-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5220680,,COc1cc(OC)cc(-c2ncccc2NCc2ccc(C)cc2)c1,IC50,4.44,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,IPVVCLCABITZJW-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5219066,,N#CCC(=O)Nc1sc(C(=O)Nc2ccccc2)c(-c2ccccc2)c1C#N,IC50,5.2,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,DNRFQOZSIMRZPZ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL106098,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.25,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,UIJWAUWNFOKGHC-XLVZBRSZSA-N,,Unspecified,Unspecified
CHEMBL4778502,,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,5.35,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ABGXDJDXYCHCQN-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL478316,,Cc1ccc(CN(Cc2ccc(O)c3ncccc23)Cc2ccc(O)c3ncccc23)cc1,IC50,7.15,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,JUTVCEPDUKZIQE-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5646546,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CCN3CCS(=O)(=O)CC3)cc2)ncc1C(F)(F)F,IC50,4.91,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,FBRXOXGYBUZPES-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL324884,,CN(C)c1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.22,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,SGLCYAHRUHJFMT-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL2011468,,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CC#CP(=O)(OCC)OCC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,IC50,7.44,CHEMBL2015748,Antiproliferative activity against human T98G cells assessed as decrease in cell number after 72 hrs by WST assay,T98G,HXQZYSIVVPUAQB-KBNXZVMKSA-N,72.0,Antiproliferative activity,WST
CHEMBL1970209,,C/C(=N/NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.59,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,DIAIPLSVPPGTLG-ZDLGFXPLSA-N,48.0,Cytotoxicity,MTT
CHEMBL5176707,,CC(C)=CC[C@@H](OC(=O)CCC(=O)N1CCCC1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.58,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,ORJHVQMCHBDMDR-LJQANCHMSA-N,48.0,Anticancer activity,MTT
CHEMBL466361,,COc1cc2cc3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,IC50,4.67,CHEMBL5258260,Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis,U-87MG ATCC,RTDRYYULUYRTAN-UHFFFAOYSA-N,24.0,Cytotoxicity,Unspecified
CHEMBL4072698,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(C2CCCCC2)cc1,EC50,5.02,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,DSDWNTNXGNKAAP-ZRDIBKRKSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5268015,,Cc1ccccc1NS(=O)(=O)/C=C/c1ccc(OCc2ccc(C(=O)NCCO[C@@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)cc2)cc1,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QQUTVICRJMPQSH-ZJXIGYLBSA-N,,Antiproliferative activity,Unspecified
CHEMBL5406487,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(NCc4ccc(C(=O)NO)cc4)cc3)CC1)C2,IC50,5.21,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RVROQBLQPGMOBQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5410787,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1F,IC50,6.94,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZBGGIVGWYMSCND-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL4776084,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCN3CCCC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.69,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,JESPMFITLIOJOF-KCXRSMJOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4795779,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(C(C)=O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.95,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WYDFMOGWHOXTHB-CBKZOCRPSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4787237,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCO)C(=O)C=C(NCCO)C1=O)OC,IC50,5.69,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,XBQQRQDTUFDEFJ-PVETWVJJSA-N,72.0,Antiproliferative activity,SRB
CHEMBL321336,,N#CC1=C(N)Oc2c(ccc3ccccc23)C1c1cccc([N+](=O)[O-])c1,IC50,7.17,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KLHQWXOILCCTOX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5203253,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc(OC)c1OC(C)C,IC50,7.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,XROQSPRUVSWIFG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL837,7-ETHYL-10-HYDROXYCAMPTOTHECIN,CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,IC50,7.52,CHEMBL3795470,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,FJHBVJOVLFPMQE-QFIPXVFZSA-N,72.0,Cytotoxicity,SRB
CHEMBL4226082,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.62,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VAWUMMRNRUYZAS-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4227076,,Cc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,4.82,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,HHBBCKXNKNEFRQ-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4227858,,CCC(=O)Nc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.82,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PFGIZSASYPLVGU-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4226683,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(C)(=O)=O,IC50,5.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,KUQHUGURFNQQJW-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL1956945,,CC(C)(O)[C@@H]1C[C@H]2[C@](C)(CC1=O)C[C@@H]1C[C@@]12C,IC50,5.94,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,ZUTBZJSJTAUXPB-SLFYDOTPSA-N,24.0,Cytotoxicity,MTS
CHEMBL5283175,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccncn5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.6,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,AMMUYGQQMQZGGU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5570148,,Cc1ccc(-n2cncc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,4.36,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,OTIGKMXGJJEDJY-UHFFFAOYSA-N,72.0,Antiproliferative activity,Alamar Blue
CHEMBL1086706,,COc1ccccc1C(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.09,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,CPGXMVQJYLPITP-UHFFFAOYSA-N,24.0,Cytotoxicity,MTT
CHEMBL254129,CYCLOPAMINE,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,IC50,4.81,CHEMBL1105585,Cytotoxicity against human U87 cells assessed as viability in presence of beta glucuronidase,U-87MG ATCC,QASFUMOKHFSJGL-LAFRSMQTSA-N,,Cytotoxicity,Unspecified
CHEMBL591985,,O=C(Nc1nonc1NC(=O)c1c(F)c(F)c(F)c(F)c1F)c1c(F)c(F)c(F)c(F)c1F,IC50,4.59,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,PTTHCDRNSSJOMO-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL602439,,COc1cccc(C(=O)Nc2nonc2NC(=O)c2cccc(OC)c2)c1,IC50,4.15,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,CLSVEQQHELQLAY-UHFFFAOYSA-N,48.0,Unspecified,Unspecified
CHEMBL4524968,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccc(C(C)(C)C)cc4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.72,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,VISWQCFQPPJSKS-ZVDSPYHHSA-M,,Antiproliferative activity,MTT
CHEMBL4875605,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNC(=O)c3ccccc3)c2C1=O,IC50,5.56,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GJZPHHMDWDCERL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4789753,,COc1ccccc1-c1csc2cnc(Nc3ccc(CP(=O)(OC)OC)cc3)nc12,IC50,5.77,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JHAPGQGRXCYODV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4784230,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3)nc12,IC50,6.19,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UKPLONCDDRXSLC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4564445,,COc1cc2c(cc1OC)[C@H](O)[C@@H]1c3c(cc4c(c3-2)OCO4)CC[N+]1(C)[O-],IC50,5.8,CHEMBL4337234,Cytotoxicity against human SF295 cells assessed as inhibition of cell viability after 69 hrs by MTT assay,SF295,XKKFNYKNDDHAQC-CHEUHSMRSA-N,69.0,Cytotoxicity,MTT
CHEMBL1171994,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,5.84,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,VOALQSCHGCHZEL-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL1171993,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,5.24,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,RFTXEPTYKFWMBQ-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL1165153,,COc1ccc(-c2nnn(CCCCCCCn3nnnc3-c3ccc(OC)c(OC)c3)n2)cc1OC,IC50,4.26,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LYQFYRDFHDRAHI-UHFFFAOYSA-N,24.0,Anticancer activity,MTT
CHEMBL453114,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(C2(O)CCCCC2)nn1,IC50,6.37,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,KHPUEYZUOUVPQB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5187816,,Cc1ccc(-c2cc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)n(-c3ccccc3)n2)cc1,IC50,5.98,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,PHZKISDSHJPMKB-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5083112,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Br)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.63,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,ZOLXXYHLNIAOLS-MCLIRCHUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5078218,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.91,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,FRDGYTCJYQGQAW-GTKRWHGSSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5081131,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.81,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LNWNGALQBKWVHJ-WFVGHVPHSA-N,96.0,Antiproliferative activity,MTT
CHEMBL1087195,,OC[C@H](NC[C@H]1NC[C@H](O)[C@@H]1O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,IC50,4.1,CHEMBL1104856,Cytotoxicity against human U87 cells after 72 hrs by colorimetric assay,U-87MG ATCC,RJPZKJUGELCBHP-YDZRNGNQSA-N,72.0,Cytotoxicity,colorimetric
CHEMBL4785811,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C)nc12,IC50,5.9,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,IWAMHIHVZUDZJR-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4098250,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.06,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VZHPPMUSJZGRBR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4583512,,COc1cc(/C=C/C(=O)Nc2ccccc2COc2ccc(OC3CCNCC3)cc2)ccc1O.Cl,IC50,4.85,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,ZYTOOBSCVFGQBC-FTPOTTDRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4537608,,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](OC(=O)CCN)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)OCc1ccccc1,IC50,5.62,CHEMBL4329226,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,UAMNSVVOLBKNJP-FUIGNZSISA-N,72.0,Cytotoxicity,MTT
CHEMBL4518892,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)c[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,SWPSBFJFCWSDLA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4559506,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.51,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,HWEPQWQOQSZLRC-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS
CHEMBL4872337,,CC12CC3CC(C)(C1)CC(NCc1ccc(/C=C/C(=O)NO)cc1)(C3)C2,IC50,5.73,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,JIHCJWRDPIDHTK-BQYQJAHWSA-N,1.0,Antiproliferative activity,MTT
CHEMBL4848719,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCC(=O)NO)(C3)C2,IC50,4.79,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,TYMNJEPTNOZUMD-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL3310804,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3n2)cc1C(N)=O,IC50,4.69,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KFJRXDCGDJWJQB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5197128,,CCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.37,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,GTYQBMHURMYYGD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5178580,,COCCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.4,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WMQFPBIGGMHBLW-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5193656,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CC3CC3)CC2)cc1)OCc1cccnc1,IC50,5.97,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,MYUNXMGJJWLYEZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5209544,,COCCN1CCN(c2cc(F)ccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.28,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,IRVYLZDWOWZXOO-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL1650631,,Oc1ccccc1-c1nc2ccccc2o1,EC50,4.28,CHEMBL5217394,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GHGZVWOTJDLREY-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4100244,,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NC(CCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1C[C@@H](O[C@@H]2C[C@@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(OC)cccc2C4=O)O[C@H](C)[C@H]1O,IC50,5.3,CHEMBL4015759,Cytotoxicity against human U87MG cells assessed as reduction in cell survival after 96 hrs by MTT assay,U-87MG ATCC,QIPAJWNWNVEIHL-SFFMQNFJSA-N,96.0,Cytotoxicity,MTT
CHEMBL3400561,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(I)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,5.3,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,VRKUVRJAEOSZFG-LUJDZOJYSA-N,72.0,Cytotoxicity,Unspecified
CHEMBL4786229,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3C(F)(F)F)nc12,IC50,5.68,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IGPMZLFRZABUAK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4742260,,COc1cccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)c1,IC50,4.22,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,SEOYEEBWNFIYKE-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4755770,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccccc2)n1,IC50,4.94,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NZYGXGIPGFEIFS-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4171347,,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)C[C@H](O)[C@@]2(C)O3)cc1O,EC50,7.3,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,ZNONRWMENUEMDO-ZWAQFZTDSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4174800,,CC(C)=CCC/C(C)=C/Cc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)[C@@H](O)C3)cc(O)c1O,EC50,6.6,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,LZMKRXSJEAADRC-QVLGIOJXSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3621411,,CCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.51,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,QTXHAQXFVJHSHE-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL3621409,,CCCCCCCCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.24,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,PSSICEWKMGRSPN-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL4169444,,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)NCC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1,IC50,6.69,CHEMBL4153991,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,LEOMYZQGJDWCFQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2035470,,Cc1ccc2[se]n(CCn3[se]c4ccc(C)cc4c3=O)c(=O)c2c1,IC50,4.75,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XTQXKDSAJRFHNT-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4555219,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(Cl)cc43)S2)cc1,EC50,6.42,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,LLFSKETWTCGGIS-DQSJHHFOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4173722,,Cc1ccc(S(=O)(=O)NCCN2c3nc4ccccc4cc3Sc3cc4ccccc4nc32)cc1,IC50,5.77,CHEMBL4140037,Cytotoxicity against human SNB75 cells assessed as cell growth inhibition after 48 hrs by SRB assay,SNB-75,HMIROELUYZRDFH-UHFFFAOYSA-N,48.0,Cytotoxicity,SRB
CHEMBL595878,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(C(N)=O)CC[C@@H]12,IC50,4.95,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,NOMXUKYQQHVOQD-GIVGKIPPSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL604895,,CCCC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.68,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,WNVNGNGYHALVBP-WFHKDSDPSA-N,,Antiproliferative activity,Brdu incorporation
CHEMBL3659991,,CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1,IC50,5.58,CHEMBL4220066,Antiproliferative activity against human T98G cells,T98G,ZBBDKEHQTOTGRO-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1615281,SLC-0111,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,IC50,4.24,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,YJQZNWPYLCNRLP-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL564618,,CNC(=O)OCc1c(COC(=O)NC)c(-c2ccc(OC)cc2)n2c1Cc1cc(OC)ccc1-2,IC50,4.42,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,MQLPOOFUYWVTRF-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL447807,BENZYLISOSELENOCYANATE,[Se]=C=NCc1ccccc1,IC50,4.37,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,NAOAAZDDXUNOGA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTS
CHEMBL4291994,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccc([N+](=O)[O-])c3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.1,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WFRWRDGTFGNABL-YXLFCKQPSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1088481,,Oc1ccc(CN(Cc2cccc(I)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.35,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,KAEVGKLVCMVJRS-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1086767,,O=C(O)C1CCC(CN(Cc2ccc(O)c3ncccc23)Cc2ccc(O)c3ncccc23)CC1,IC50,5.01,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,BUKNSOHSQVHWSQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL1170262,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,5.2,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,SUASCQMYTOBJHW-IBGZPJMESA-N,1.0,Unspecified,ELISA
CHEMBL4780040,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N(C)C)CC1,IC50,5.08,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,NWFALPFTUGPTOD-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4788364,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(CCCO)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.66,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,CRMFEXOOQMAPDO-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4092812,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(C)c(Cl)cc2OC)nnc1Cl,IC50,6.3,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,RJTWTALAEKYMLH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4207217,,O=C(c1sc(N2CCOCC2)nc1-c1ccc(Cl)cc1)c1cnc2ccc(Br)cn12,IC50,4.12,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,FWQWDAJDROZYTA-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL4212097,,O=C(c1sc(N2CCOCC2)nc1-c1ccc(Cl)cc1)c1cnc2ccccn12,IC50,4.09,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,UHRZOGNKLDKBRU-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL67279,TALABOSTAT,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,IC50,6.65,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,FKCMADOPPWWGNZ-YUMQZZPRSA-N,,Unspecified,fluorescence based
CHEMBL4777260,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,5.48,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,HTADFAXGWGDWNE-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL4750273,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C4CC4)c(=O)c3=O)cc2)ncc1Cl,IC50,5.14,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,NTYSXVNDTBLJBP-XSFVSMFZSA-N,48.0,Cytotoxicity,MTT
CHEMBL4636054,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(F)cc3F)c12,IC50,4.36,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,XCVFQTFAGIWYAN-MIGQKNRLSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4536640,,COc1cc(C(=O)c2cn(-c3ccc(N)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.62,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,HQVMRVMGUWOSRW-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS
CHEMBL4451152,,CCOP(=O)(OCC)C(N(OC(C)c1ncc[nH]1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,CNDVAMMAAGJGKC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4454246,,CCOP(=O)(OCC)C(N(OC(C)n1ccnc1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VEDYZZHYDWWOEK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4080000,,CN1CCN(CCOC(=O)N(c2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)CC1,IC50,5.09,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,CHHCUIHBACXKKX-UHFFFAOYSA-N,24.0,Cytotoxicity,trypan blue
CHEMBL4635291,,C#CCOc1ccc2c(c1O)C(=O)c1c3c(cc(O)c1C2=O)[C@@]12O[C@@]1([C@](C)(O)[C@@H](O)C(=O)OC)[C@H](C#C/C=C\C#C[C@H]2O)N3,EC50,8.55,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,CKFSRLNTPDHQJR-DNZMGCGRSA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL4648960,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(OCC(C)=O)c1O)C4=O,EC50,8.96,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,DSBNSMOLGAFZIH-KQGFGPPRSA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL1643,RIBAVIRIN,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,IC50,4.73,CHEMBL4682962,Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,SNB-75,IWUCXVSUMQZMFG-AFCXAGJDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4754468,,NC(=O)c1n[nH]nc1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,5.03,CHEMBL4682962,Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,SNB-75,IJUOARZYZPGODW-ZCIQCHDPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343397,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.66,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FKIGNRIKSXHZMX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343398,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.84,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FIORSHYNVPDAAK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5566709,,N#CC1(C(=O)NCCCc2ccc(Br)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.61,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,YZAAPYGRXYNYPH-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4084557,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5[nH]ccc45)cc3)c(C)cc2=O)cc1,IC50,5.08,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WYYAFOSCVKITNK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4087981,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.63,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OKOMFNJHGSKAPK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4448494,,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,IC50,6.68,CHEMBL4305840,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KGMVZSJAPXYTKH-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4463991,,COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(Cl)c(Cl)c4)ncnc3s2)cc1,IC50,5.36,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,TWKFKWDVEWKTRX-RUDMXATFSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4794252,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)cc1,IC50,4.32,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,ITGGBHPLLQUCNS-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4536320,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/OCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.18,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,OVQLAFDDLBGHAL-LBCQYTAVSA-N,24.0,Unspecified,compound washout and further incubation for 48 hrs in presence of serum by MTT
CHEMBL4562522,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccccn4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.8,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,JQEUEXIZZPTVBG-JJNZMVMZSA-M,,Antiproliferative activity,MTT
CHEMBL5281811,,CCOC(=O)[C@H]1[C@@H](NO)[C@@H]2c3ccccc3OC(C)(C)[C@H]2[C@H](O)[C@]12C(=O)Nc1ccc(Cl)cc12,IC50,4.43,CHEMBL5235657,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,XJVZAIYAAGLARK-XNZMQEADSA-N,48.0,Anticancer activity,MTT
CHEMBL3693786,CITARINOSTAT,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,IC50,5.04,CHEMBL5042627,Anti-proliferative activity against human U87G cells assessed as cell viability measured after 72 hrs by Cell-Titer assay,U-87MG ATCC,VLIUIBXPEDFJRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,Cell-Titer
CHEMBL3086870,,O=C1c2ccccc2-n2c1nc1ccc(F)cc1c2=O,IC50,6.3,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,DRHLXNRAFXVHOY-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL5196800,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12CCCC(C)(C)[C@H]1[C@H](O)[C@@]3(O)OC2,IC50,6.08,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,KOQSZWQYZSBQDS-KLSHHCPLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3823023,,O=C1C(O)=C(C(NCCCCl)c2ccccc2O)C(=O)c2ccccc21,IC50,4.76,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FXHSYGLMIOXGQO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4545330,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.99,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IZCIYUNGVIXYJY-RUDMXATFSA-N,72.0,Cytotoxicity,MTT
CHEMBL4443827,,COc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccccc3)sc2c1,IC50,4.39,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LISAUXBSYRKDOU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4460474,,COc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)sc2c1,IC50,4.67,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VSWARFMGPYOYCE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4567644,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccccc3s2)cc1,IC50,4.94,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GTYNRXNKGRRCHY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4575907,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccc(OC)c(F)c4)o3)C2=O)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,GKVFGTSDUJDABC-YNMBWQPYSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL3885383,,CCOC(=O)c1nc2ccccc2nc1C#CC1CCCC1,IC50,4.94,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BWLLEPXRBLMWQW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3410527,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(OC)cc3)C2=O)cc1,IC50,5.45,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,NXXRLIAVYCJUJL-JYFOCSDGSA-N,48.0,Cytotoxicity,resazurin
CHEMBL3410535,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CS(=O)(=O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,6.11,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,SSAMIOWVUGBIJK-KAVGSWPWSA-N,48.0,Cytotoxicity,resazurin
CHEMBL4750524,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,IC50,4.28,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,AVTGLIIZLJGQBA-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3578215,,Cc1ccc(-c2nn(CC(Cl)c3ccccc3)c3ncnc(N)c23)cc1,IC50,6.11,CHEMBL3580215,Anticancer activity against human U87 cells assessed as cell growth inhibition after 20 to 70 hrs by Real-time RTCA iCELLgence system,U-87MG ATCC,QQYAHZXECNNZDC-UHFFFAOYSA-N,70.0,Anticancer activity,Unspecified
CHEMBL3805533,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.33,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KPKQJAZKSIOCFD-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL4564763,,Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1,IC50,4.78,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,SGMFJEHTWHPKLD-LTYCNYMDSA-N,72.0,Cytotoxicity,SRB
CHEMBL4542902,,O=C(Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1)OCc1ccccc1,IC50,5.35,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BUSDOHDRRNDJLF-DJAIRROUSA-N,72.0,Cytotoxicity,SRB
CHEMBL4581890,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3ccc(NC(=O)c4ccccc4)nc3=O)C(F)(F)[C@@H]2OC(=O)c2ccccc2)nn1,IC50,5.47,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,ZKTZRHMWOIKMHZ-VNSBPBJWSA-N,72.0,Cytotoxicity,SRB
CHEMBL1089635,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c4c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C4=O)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c4c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C4=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,8.22,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,NNYUKHCUMZKJBM-DGMYVURFSA-N,48.0,Cytotoxicity,[3H]thymidine incorporation
CHEMBL4451049,,COc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)/C=C/C(=O)c1ccc(C)cc1)C1CCCCC1,IC50,5.85,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GAIRAQHWWXYQQO-QURGRASLSA-N,72.0,Cytotoxicity,MTT
CHEMBL4634484,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(C)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.61,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,IMZOOIBLUCCSLH-PXCOWHNISA-N,96.0,Antiproliferative activity,MTT
CHEMBL4634155,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NC(C)(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.73,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,URTDCBMFULZXCB-PJWUZBAESA-N,96.0,Antiproliferative activity,MTT
CHEMBL4633371,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1cccc3ncccc13)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.83,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,KSQRXEXFMMPQCN-UNNJENKKSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4437813,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.56,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,WPLVKGDSOQHJGK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4517377,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.12,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BPPIZXAQRSWBHX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4475370,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.52,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LDENNHFIECOFKY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5265913,,C=C(C)[C@H]1CCC2(C=O)OC2C1,IC50,4.66,CHEMBL5234885,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,VOSYWBFRXUHESA-IDKOKCKLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5289138,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccc(Cl)cc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,FTTGDLXSSQOLFF-LBGRBXAQSA-N,,Antiproliferative activity,Unspecified
CHEMBL5195348,,O=C(Nc1nc2ccccc2[nH]1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.35,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GCKVDJPBBGKETN-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL4097158,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ccccc2n1CCCCO,IC50,5.32,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GKMLNDHZKRSYQX-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL5272452,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccn[nH]5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,5.05,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,HGFWFEHZQQWXSB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5192005,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2cc(Cl)cc(Cl)c2c1=O,IC50,5.04,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,XPXLCIVJFFMFBT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5198199,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc(=O)c2cc(Cl)ccc2[nH]1,IC50,5.21,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,RSRJMBPXTHZXAP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4062346,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3cccnc3)cc2)nn2ccnc12,IC50,4.87,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,BKMXVVIHRZYVSO-INIZCTEOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4091820,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3ccncc3)cc2)nn2ccnc12,IC50,5.13,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JDBFJYXPPSRGTL-INIZCTEOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3290921,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YKAPPPKEWGESSK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4643861,,COc1ccc2c(c1)O[C@H]1c3cc(OC)c(OC)cc3OC[C@@H]21,IC50,4.48,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-UGSOOPFHSA-N,72.0,Cytotoxicity,MTT
CHEMBL469708,,COc1ccc2c(c1)OC1c3cc(OC)c(OC)cc3OCC21,IC50,4.86,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3805083,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(Cl)cc2)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,FSJUUMHKAZICMF-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3806288,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4ccc(Br)cc4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.52,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RKICRLQYXPRAQL-SUAVODKESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3805047,,COc1ccc(NCc2cn(CC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@@H]5[C@@H]4CC[C@]4(C)C(=O)CC[C@@H]54)C3)nn2)cc1,IC50,4.01,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,IRXQYSBMUZWEMG-AXOMYGEFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4791977,,CNC(=O)c1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1,IC50,6.15,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YPPUDNFZYQCHLP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4780493,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)C4CCNCC4)cc3)nc12,IC50,5.97,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LBGLUQINWPUOOC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4800645,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)[C@@H]4CCCNC4)cc3)nc12,IC50,6.44,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UDPSCVKNVATZTE-MRXNPFEDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4871194,,CS(=O)(=O)c1ccc(-c2nc3ccccn3c2Sc2cccc3ccccc23)cc1,IC50,4.25,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,XUCNYBYWEJHTDT-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL2172477,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cccnc4C)cn23)nc(C)n1,IC50,6.64,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,YQTDIAJNWCPLOM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2172627,,CNc1cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)nc(C)n1,IC50,6.15,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,BMRLEHIKKZUCGW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4441412,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(COC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.78,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,VRIPLPUPBHVIEP-KHMDBFSKSA-M,,Antiproliferative activity,MTT
CHEMBL5563094,,CCc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1,IC50,5.23,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WLGXZBAICQVSRE-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5574178,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc(OC)c1Br,IC50,5.54,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,KLALLFUUYWKCCC-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL273862,HYDROXYCAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1,IC50,5.54,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,HAWSQZCWOQZXHI-FQEVSTJZSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5574844,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.39,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,LKEWPEIROHRLHI-KHEAGTJRSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5575144,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.08,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,QPNUMAODVVORBN-MFMXYXMPSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5431878,,Cc1cc(Cc2c[nH]c3ccc(F)cc23)cc(C)c1O,IC50,4.26,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,GCQIAAMCCOXMDD-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5437494,,Cc1cc(Cc2cn(C)c3ccccc23)cc(C)c1O,IC50,5.1,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,KSICBPUDEOOBSJ-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL4787572,,Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1,IC50,4.09,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,GTWNYADDKACXSW-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL5572843,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.83,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,FCJFNQFJJLCVAQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4872595,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCCCC(=O)NO)(C3)C2,IC50,5.02,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,BLGDOJXSHOVDCJ-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL3781356,,CS(=O)(=O)c1ccc(-c2ccc3oc(=O)c4[nH]c(=O)n(-c5ccc(CC#N)cc5)c4c3c2)cc1,IC50,4.4,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,HLDPDDVUFNMNBD-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL3601925,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.14,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YCMPAJXRYQKAKZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4283735,,COc1cc(OC)c2c(=O)c(OCCCOc3ccc(/C=C/C(=O)/C=C/c4scnc4C)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.39,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WVNPKIXIDRSNFO-XVNCSPBISA-N,48.0,Antiproliferative activity,MTT
CHEMBL4276849,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccc(Cl)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.68,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RJVSPMPKAQHNKF-JSAVKQRWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3621415,,CCCCCCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,4.82,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,RDUNXYIJQXYURN-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL3582134,,C/C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)[C@@H](CN(C)C)[C@@H]2CC1,IC50,5.06,CHEMBL3584023,Cytotoxicity against human U87MG cells assessed as cell viability after 48 hrs by Alamar Blue assay,U-87MG ATCC,UJNSFDHVIBGEJZ-ONGJMVGKSA-N,48.0,Cytotoxicity,Alamar Blue
CHEMBL3621993,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])cc2)cc1,IC50,5.54,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BWDWZTPOHBSIOC-CXUHLZMHSA-N,72.0,Cytotoxicity,MTT
CHEMBL3621996,,COc1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.97,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YJMOUQWVLIGKPC-LICLKQGHSA-N,72.0,Cytotoxicity,MTT
CHEMBL2441129,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=C(Cl)C(=O)c3ccccc3C2=O)nn1,IC50,5.75,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PPERCHXBOIBCRO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2441128,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=C(Br)C(=O)c3ccccc3C2=O)nn1,IC50,5.66,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,RLTXFXYHQISJCL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4870114,,CC12CC3CC(C)(C1)CC(NS(=O)(=O)c1ccc(/C=C/C(=O)NO)cc1)(C3)C2,IC50,5.7,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,CQPIEFONMMNTCA-VMPITWQZSA-N,1.0,Antiproliferative activity,MTT
CHEMBL4851084,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCC(=O)NO)(C3)C2,IC50,4.73,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,CWIKVVHAHBDBDR-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL4871275,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCCC(=O)NO)(C3)C2,IC50,4.47,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,FFQIAPNNAZFJSB-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL5200657,,COCCN1CCN(c2cccc(F)c2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.4,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,KQUOBMSIJCDOQG-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5277266,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccccn5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.98,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,MSAGIXUBDWCPAH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4065541,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@H](Cc2ccccc2)NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.21,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,JQTYHXXMGULJBL-GHIXNXTASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4452167,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3ccc(NC(=O)OCc4ccccc4)nc3=O)C(F)(F)[C@@H]2O)nn1,IC50,5.67,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,AMCNVJZJFHUOGU-DJAIRROUSA-N,72.0,Cytotoxicity,SRB
CHEMBL1257065,STILONIUM IODIDE,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.36,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,RDTKUZXIHMTSJO-UEIGIMKUSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4280452,,CC[N+](CC)(CC)CCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1.[I-],IC50,6.24,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KTDBKCRZBFSZBP-CALJPSDSSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4293646,,CC[N+](CC)(CC)CCCCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.41,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,FXBKAVKFPWOCQQ-CMBBICFISA-M,72.0,Antiproliferative activity,MTS
CHEMBL4288506,,C(=C/c1ccc(OCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.17,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,CBQLKOLDQYBDLK-QREUMGABSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4292276,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(Cl)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.83,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BTRLTDGZLHFFRU-UVHRBFQASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4288866,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(C)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.72,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QHBSNJNISDFZDK-DRCGVWDTSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4287584,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(CN(C)C)nn3)CC[C@@H]12,IC50,4.89,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FPJJIHRGNDQZBF-XWXXQTTFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4285131,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(F)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.9,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UQSKKVZPQVVURT-DGVIHOGNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4291163,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(C)=O)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.66,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,JZDWHRVMFVGBGO-IUGFVHJESA-N,72.0,Antiproliferative activity,MTT
CHEMBL5089530,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C#N)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.46,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GTGMLRAJBUWXCG-VZHCALMGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5082849,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.67,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,IKANBESOKWBFOM-DKAJQEPCSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5074496,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Cl)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.05,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,JGCYYQSMCMPXED-SMRIDXHDSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5091183,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7nccs7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.77,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,WLZOZZHOZLJSCI-RCGAJBMESA-N,96.0,Antiproliferative activity,MTT
CHEMBL4456054,,Cc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccccc3)sc2c1,IC50,4.63,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CTWYFCWLZHLKTO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4127714,,C[C@H]1[C@H](N2CCN(c3ccc(F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.59,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,CIUGTJDAPFQJON-RRXFZIEKSA-N,72.0,Cytotoxicity,MTT
CHEMBL4159373,,COc1ccc(C(=C(F)F)c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,9.7,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,KVUQMSRUDFEMNF-UHFFFAOYSA-N,72.0,Antiproliferative activity,resazurin-based fluorescence
CHEMBL3416184,,COc1cc2nc(-c3cc(OC(F)(F)F)cc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,6.22,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JBVPCMMERZJZFC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339348,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(O)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.77,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MQOZCTADCBDYAG-XICOUIIWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339350,,COc1cc(/C=N/NC(=O)Cc2ccc(Oc3ccnc4cc(OCCCN5CCOCC5)c(OC)cc34)c(F)c2)ccc1O,IC50,5.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YMAOSZPMGYKLNN-QLQYKETESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339354,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.52,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PZIBOPQOMMNWBQ-LALXJTNGSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339365,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.46,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MQTYXBYTHJGYMD-GKVNEZTPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4862637,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@@H](O)[C@@H]2[C@@H]3C[C@H](O)[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.16,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,JZYCDNBRXQHIMA-GGWWRNHQSA-N,72.0,Anticancer activity,CCK8 reagent
CHEMBL3600438,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cn2n1,IC50,5.97,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RQCGZIMOCDOERZ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3600439,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.0,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ORGODRQWHUVBIJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5093902,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.47,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,VDNKOXGKXPTVCH-BDFBTMKGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5088699,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccccc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.43,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,VHYGQIMOTUOCGE-SMRIDXHDSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5088772,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(OC)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JGPLYADDPRLOJV-VZHCALMGSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4565354,,Nc1nccc(N2CCCC(CCc3ccccc3)C2)n1,IC50,6.0,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LBTBVAZVSLCXCP-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4856711,,Cc1ccc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc1,IC50,4.46,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,CPGBITKHHPQFPE-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4861158,,COc1cc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc(OC)c1OC,IC50,5.32,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,WPCCJSLETMQZDD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5575091,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N[C@@H]1CCNC1)C3,IC50,5.24,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PREHDGJVTUBHPV-LLVKDONJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5583787,,N#CC1(C(=O)NC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.13,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SSCLZFPVEGLVNP-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5289288,,Cc1ccc(F)c(NS(=O)(=O)/C=C/c2cccc(OCCOC3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2)c1,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,PHLBKOVEFMVWTA-IIBVODSDSA-N,,Antiproliferative activity,Unspecified
CHEMBL1822937,,CCCCOc1c(OC)ccc2cc(C(=O)NCc3cn(CCF)nn3)c(=O)[nH]c12,Ki,6.21,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,MEWJSKBKQBTZIF-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1821796,EUPHODENDROPHANE F,CC(=O)OC/C1=C/[C@H]2[C@@H](OC(C)=O)[C@](C)(OC(C)=O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)[C@H](OC(=O)c2cccnc2)[C@H](OC(C)=O)[C@@H]1OC(=O)C(C)C,IC50,4.18,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,LXVCUUREWHBIOM-IICLPEKWSA-N,72.0,Anticancer activity,SRB
CHEMBL5176572,,CCCCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.33,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,VXYALBNZTFRWKJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5193363,,CN(CCCCCCCCN)Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.1,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,VELMLCUIUXYDFS-UHFFFAOYSA-N,72.0,Cytotoxicity,alamar blue
CHEMBL4754919,,C#CCOc1ccc(/C=C/C(=O)c2cccc(OC)c2)cc1OC,IC50,5.84,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KVRBFOWNODELCR-CSKARUKUSA-N,72.0,Cytotoxicity,RRA
CHEMBL2381450,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc([N+](=O)[O-])cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,OGWVNIXGXAVTCX-WKZPCIAFSA-N,48.0,Cytotoxicity,SRB
CHEMBL2392964,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.83,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,USGGPNGHCXQGQY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392967,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.24,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MMLHZEYVLDVWPX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2435962,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5F)n4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.11,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUGDKOZAGJNHHL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1800936,,CC[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.84,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,KFRXJKMLZFERKO-KDOFPFPSSA-N,48.0,Unspecified,Unspecified
CHEMBL4778367,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C(C)C)nc12,IC50,7.07,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DEVYXOKAXWLJRC-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4784940,,CC(=O)c1c(C)c2cnc(Nc3ccc4c(n3)CCN(CCN(C)C)C4)nc2n2cc(C(C)C)nc12,IC50,6.6,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,YSOMCCRHZLRXAQ-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4788224,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)cc1,IC50,5.77,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,QOQHRNUWUVTBOE-YIXHJXPBSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL105821,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1,IC50,9.7,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,UCANOSVRVFBCJE-GKPLWNPISA-N,,Unspecified,Unspecified
CHEMBL3577921,,COc1ncc(-c2cc3c(-c4ccncc4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.36,CHEMBL3579772,Cytotoxicity against human U87MG cells harboring PTEN deletion mutant assessed as growth inhibition after 4 days by CellTiter-Glo luminescent cell viability assay,U-87MG ATCC,IHWMYZQUTPMTII-UHFFFAOYSA-N,96.0,Cytotoxicity,CellTiter-Glo luminescent cell viability
CHEMBL122557,,O=C1c2c(O)ccnc2-c2nccc3c2c1nc1ccccc13,IC50,5.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,MCTCVKDGNCPADW-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3975938,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CC1(C)COC(=O)N1,IC50,7.24,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,OZEBOPTWTROCBM-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5288916,,CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)c2)n1,IC50,4.51,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SPBSZKORELYQFI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4756418,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(-c2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.2,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,WCOXMLFEWOILDZ-PDDLMNHVSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL4166186,,C=C(c1ccc(OC)c(N)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.05,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,PNMBGQAVCUEXEN-UHFFFAOYSA-N,72.0,Antiproliferative activity,resazurin-based fluorescence
CHEMBL1928606,,Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H]3COc4ccccc4[C@H]32)cc1,IC50,4.5,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,ISQKBCDJGDKCMA-DENIHFKCSA-N,72.0,Unspecified,MTT
CHEMBL1914735,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.75,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,GIFGUUZRMKEHAB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914739,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCC(F)(F)CC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.72,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ZVLSVNCJSAVVGW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4558022,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC(=O)OC)CC3)cc2)ncc1Cl,IC50,5.88,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,IFMLFCIKGPQUCD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4440684,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccccc4)CC3)cc2)ncc1Cl,IC50,5.47,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,JYQCJMFJYVZDON-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL1738719,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCOCC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.8,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTARVPHTCQRSDW-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914732,,CN(Cc1ccccc1)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,6.59,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,BCKWCRGCXCOSGR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4159104,,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1,IC50,6.62,CHEMBL4153991,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,SOAVEOJCKVRROO-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5562084,,CC(C)CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.42,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,AVASHGQZRZLOTG-CYBMUJFWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4873517,,CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccc(F)cc4)c3)nc3sccn23)n1,IC50,4.81,CHEMBL4832265,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,AWCIKMLGHHTGHO-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL1927617,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCO)c23)C1=O,IC50,5.37,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IUQCEFOORKUSKN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1927619,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCCN(C)C)c23)C1=O,IC50,6.52,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDJIQIYMQMJOIQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2398336,,COc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.21,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,FFIDHUYNLVXETI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1801036,CYCLOVIOLACIN O13,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.59,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,HHLPYNQQOPKSJQ-XVGLBWMNSA-N,,Cytotoxicity,Unspecified
CHEMBL5090055,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.54,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,GXCNZQOZVJURKD-DXBOVLASSA-N,,Cytotoxicity,Unspecified
CHEMBL4777034,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.68,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CUAAXWZMCZCACR-OLLHKAICSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4789807,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3COCCOCCOCCOCCOCCO3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,6.08,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WWJRXVJEMHEKCV-VAAXJPQESA-N,72.0,Antiproliferative activity,SRB
CHEMBL5278544,,N#CC1=C(N)Oc2c(c(=O)oc3ccc(Br)cc23)C12C(=O)Nc1ccccc12,IC50,4.11,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,RKGJUGSDACTEQU-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL4755661,,Cc1ccnc(NC(c2cccc(F)c2)c2ccc3cccnc3c2O)c1,IC50,5.04,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,OTFQEKBHSZDRLM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4786723,,Cc1ccnc(NC(c2ccc(C(F)(F)F)cc2)c2ccc3cccnc3c2O)c1,IC50,5.68,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NGAWFARRBBNJRI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4797303,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.8,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,NXDNEVNAIVDFGW-LMZWQJSESA-N,72.0,Antiproliferative activity,SRB
CHEMBL3290904,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OHOIQYVRPXKLSA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5184014,,CC(Oc1ccc(-c2ccc(C=CC(=O)O)cc2)cc1C12CC3CC(CC(C3)C1)C2)C(=O)NO,IC50,6.0,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,PIJPEZHKJKJZHS-UHFFFAOYSA-N,24.0,Antiproliferative activity,incubating in drug-free medium for 48 hrs and measured by SRB
CHEMBL4225799,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.54,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PZZLYBFEQUTEIT-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4225944,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(C)(=O)=O,IC50,5.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,QGAOXAMNRDEXDY-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL3357873,,COc1ccc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.32,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZZDDSJQCHASOIC-UHFFFAOYSA-N,2.0,Unspecified,cell-based
CHEMBL4848510,,CSc1ccc(/C=C/c2cc(/C=C3\Sc4ccccc4N3CCCN3CCOCC3)c3ccccc3[n+]2C)cc1.[I-],IC50,4.01,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DROUWMZEXFQPRA-JRUHLWALSA-M,48.0,Antiproliferative activity,MTT
CHEMBL4068974,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(-n2ccnc2)cc1,EC50,4.87,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,CMZRTYGMDDGILK-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3601922,,CCCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.38,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AMIXYWIQKYPHQE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343413,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H]2O1,IC50,5.02,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SFTPJRPHQMDNLY-DDNJDZIRSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343643,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccccc1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.0,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,ZXWDPALQHPNKFF-KBSTVAECSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3343644,,Cc1ccc(N[C@@H]2[C@H]3OC(C)(C)O[C@H]3[C@@H]([C@H]3COC(C)(C)O3)O[P@@]2(=O)c2ccccc2)cc1,IC50,5.27,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,IKVOFDAMYNPSSA-RSERMMFASA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339369,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.41,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PVHJURUEMDDUCX-BOABNOFISA-N,72.0,Antiproliferative activity,MTT
CHEMBL4799122,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc(N4CCOC4=O)c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.5,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,YLJXBMOGMHSNKO-UHUNBADTSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4799459,,CCOC(=O)C1CCC(CNC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,6.21,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CJDXOEPOEHTNCA-BQTGEACFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4798246,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(S(C)(=O)=O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.63,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GWJCJNGBXYSNPJ-HCNZWEOSSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4784511,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCCO)C(=O)C=C(NCCCCO)C1=O)OC,IC50,5.39,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QMEKDPSTHUHPSV-UWQVLHRZSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4796360,,CN1CCN(c2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)n2)CC1,IC50,5.92,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,CIYCHIXAEULMGX-LHHJGKSTSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4779191,,CC1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(Nc4nc(/C=C/c5ccccc5)nc(N5CCOCC5)n4)cc3)cc2)CC1,IC50,6.06,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,LRZBGPLGJHGCGH-FRKPEAEDSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4785380,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)c1,IC50,5.44,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,SESLUDIACMIRCO-KPKJPENVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4869235,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8cc[nH]c8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.49,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,RWDLNVWZZSROOD-KODZDQQCSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL388978,STAUROSPORINE,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,8.01,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,HKSZLNNOFSGOKW-FYTWVXJKSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL5634063,,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@]4(C)C(=CC(=O)O[C@H]4c4coc(C(=O)CCl)c4)[C@]2(C)OC(=O)C[C@@H]13,IC50,5.77,CHEMBL5627877,Anticancer activity against human A-172 cells assessed as reduction in cell viability incubated for 72 hrs by Alamar Blue assay,A-172,SAWWDURHVOQNRR-ADRFUERYSA-N,72.0,Anticancer activity,Alamar Blue
CHEMBL3628032,,C/C=C(\C)C(=O)OCC1=C2/C(=C\[C@@]3(C)CC[C@](O)(O3)[C@H](C)C[C@@H]2O)OC1=O,IC50,5.02,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,CXGKQKUIHGHUEP-BFWKSYKFSA-N,72.0,Antiproliferative activity,cyquant
CHEMBL3621414,,CCCCCCCCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,4.65,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,WYKAGJLKBKZKCZ-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL49642,INDIBULIN,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12,IC50,7.11,CHEMBL5256113,Cytotoxicity against multidrug resistance human U87 cells assessed as cell growth inhibition,U-87MG ATCC,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5279895,,C=C(C)[C@@H]1CC[C@]2(COC(=O)CCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.[Br-],IC50,4.66,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,NXMOMYUADRXZIB-NQZOKFLLSA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL5281628,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccccc3Cl)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,BQGLNCJFOGQRDR-ROQWCOLUSA-N,,Antiproliferative activity,Unspecified
CHEMBL5281508,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3c(Cl)cccc3Cl)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,AAXNPJGPQSXHPI-IBPPZMNKSA-N,,Antiproliferative activity,Unspecified
CHEMBL5218737,,CO[C@@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC([C@H](C)C[C@@H]2C[C@@H]3C[C@H]2C[C@H]3O)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,8.66,CHEMBL5216199,Antitumor activity against human U-87 MG cells assessed as cell growth inhibition,U-87MG ATCC,PWOJHTAZPQKPPN-MCVDMIQGSA-N,,Growth inhibition,Unspecified
CHEMBL5207505,,O=C(O)C=Cc1ccc(-c2ccc(OCC(=O)NO)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,IC50,5.96,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,YJMADWAPLKRSFA-UHFFFAOYSA-N,24.0,Antiproliferative activity,incubating in drug-free medium for 48 hrs and measured by SRB
CHEMBL3409958,,C/C(=N\O)c1cc(-c2ccc(O)c(F)c2)ccc1O,IC50,4.16,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,VYJNYSBKIQUCBW-LZYBPNLTSA-N,96.0,Antiproliferative activity,Unspecified
CHEMBL5201292,,CS(=O)(=O)N1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.99,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,DGVJYSWWBMMKSB-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5192081,,COCCN1CCN(c2ccc(C)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.72,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YLFZSOVLOJKOPG-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL4073794,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5cccc(Cl)c5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.01,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VPMDLQXEBDMFMZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4062438,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.3,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DLSXFVOHVLZRTP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4063742,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.99,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QKPLOCPOKHWCDZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3426496,,C=C1C(=O)[C@H]2C[C@]1(O)CC1=C2[C@]2(C)CCCC(C)(C)[C@H]2CC1,IC50,5.57,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,CHRNFZZARNTWCF-KQEPKPNTSA-N,24.0,Cytotoxicity,MTT
CHEMBL4788576,,CCOc1cc(C(=O)NC2CCNCC2)ccc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.69,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,FEPSYSFWHWLVLS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4799952,,COc1ccccc1-c1csc2cnc(Nc3cc(F)c(C(=O)NC4CCNCC4)cc3F)nc12,IC50,5.83,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IVDWLTZQEUFLDQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4583117,,COc1cc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)cc(Br)c1OC,IC50,4.06,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,SRRTVRYBFLLLEO-ZVBGSRNCSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4453790,,Fc1ccc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)cc1F,IC50,4.36,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,IAURITNYRKQDAX-QPSGOUHRSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5088605,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CCC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,JXGWMVJAVZKEBT-YXZQVLARSA-N,96.0,Antiproliferative activity,MTT
CHEMBL2398340,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4c(c3)OCO4)ccc2NS(C)(=O)=O)c1,IC50,6.92,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,PIWUCDPMEFZJLM-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2313556,,CCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.21,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BDGYFNCAAHFNGL-AHFZSLFQSA-N,72.0,Cytotoxicity,MTT
CHEMBL5285515,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3cccc(Cl)c3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JGZUQRVSEHRGNR-DPKHVTONSA-N,,Antiproliferative activity,Unspecified
CHEMBL5274557,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccc(OC(F)(F)F)cc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,FXVRDIACCMROQQ-KFFRJZQJSA-N,,Antiproliferative activity,Unspecified
CHEMBL3806129,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1,IC50,5.16,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WEJHSCQUSADJPH-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2206905,,COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.12,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,JQXMRKGWLJIJAG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206914,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)C3CC3)c2)n1,IC50,7.44,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FOVDAQSOCPEZCB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206913,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,7.7,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,MYQDIPJMQYEWIZ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2164691,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,6.16,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FZBLAUDIPVURBE-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL2164401,,CCCCCC[n+]1ccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c2c1C.[Br-],IC50,5.51,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,KRSNLGJGHQIGRU-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL5411474,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2ccccc2CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,5.08,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,FVNGGHBJUPVYSQ-RUZHBQKASA-N,48.0,Unspecified,CCK-8
CHEMBL4798470,,CCCCOCCOCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.91,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QYRFNJFXPLGFQD-AMIPGTMGSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4163437,,COC(=O)C1=C(C)NC(C)=C(C(C)=O)C1c1ccc(N(CCCl)CCCl)cc1,IC50,4.62,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,SANFHZBUPNWPLF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL504859,ZYGOSPORAMIDE,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,5.38,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,CKEAPQMIPHEQRF-LVIOGHJBSA-N,,Cytotoxicity,Unspecified
CHEMBL2165016,,COc1ccc(Nc2ncc(CN3CCN(C(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.85,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WNLWNUNVLRWGBW-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165011,,COc1ccc(Nc2ncc(CN3CCC(O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.46,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,PLZWKQZPZPLCFY-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL3354443,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,6.09,CHEMBL3376032,Cytotoxicity against human SF295 cells assessed as growth inhibition after 72 hrs by MTT assay,SF295,LVHKHLZPRPTQJG-OKFZLHBCSA-N,72.0,Cytotoxicity,MTT
CHEMBL2165039,,COc1ccc(Nc2ncccc2-c2nc(C)nc3nc[nH]c23)cn1,IC50,6.55,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,YXRVSHHKBCULEI-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL2165051,,Cc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,8.05,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HQPMEVMEMPHSDM-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4745220,,CSc1cc2c(c3c1C[C@@](C)(O)CC3=O)C(=O)c1ccc([C@H]3CC[C@H](N(C)C)[C@H](C)O3)c(O)c1C2=O,IC50,5.1,CHEMBL4670045,Cytotoxicity against human U87 cells assessed as reduction in cell viability by SRB assay,U-87MG ATCC,ZBALKLFZSLAGHI-KUXCXQJKSA-N,,Cytotoxicity,SRB
CHEMBL83527,PTEROSTILBENE,COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1,IC50,4.47,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,VLEUZFDZJKSGMX-ONEGZZNKSA-N,48.0,Cytotoxicity,MTT
CHEMBL2035490,,CC(=O)Oc1ccc2[se]n(CCn3[se]c4ccc(OC(C)=O)cc4c3=O)c(=O)c2c1,IC50,4.68,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SDTYCQFRHHTONZ-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2035463,,O=c1c2ccccc2[se]n1CCCCCn1[se]c2ccccc2c1=O,IC50,5.22,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OKIJKVDEYDUBKL-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4092551,,O=C(/C=C/c1ccc([N+](=O)[O-])s1)c1ccc(-n2ccnc2)cc1,EC50,5.0,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,OSONMWPTENINFH-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4778320,,Cc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.72,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,OHUPSIYNIKCTNE-CMDGGOBGSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5427602,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccccc3C)ccc2NS(C)(=O)=O)c1,IC50,6.51,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,XEWMFCOWYNRNJR-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4865341,,O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCNCC4)c3c2)cnc1Cl)c1ccccc1,IC50,6.23,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QIWKQWGDKAHMQB-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL244599,,CN(C)CCCN(C)c1cc(Oc2ccc(-n3ccnc3)cc2)nc(Cc2ccc3c(c2)OCO3)n1,IC50,6.66,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,GQYFOXVFQHETME-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL243978,,c1cn(-c2ccc(Oc3nccc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,7.26,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,XPXGYINSBORUMM-UHFFFAOYSA-N,24.0,Unspecified,Unspecified
CHEMBL4163035,,O=C1c2ccccc2C(=O)c2c(-c3ccccc3[N+](=O)[O-])coc21,IC50,5.53,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,NXARMQFGIYKUEY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL508617,,COc1ccc(C(=C(F)F)c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,9.52,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,MBCRBMZSBBOEIB-UHFFFAOYSA-N,72.0,Antiproliferative activity,resazurin-based fluorescence
CHEMBL2333165,WITHAWRIGHTOLIDE,C=C1C(=O)O[C@@H]2C[C@@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]45C[C@H]4CC(=O)[C@]5(C)[C@H]3CC[C@]12C,IC50,5.82,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,RWZUJIPMFKTTKN-LWNWQIFTSA-N,72.0,Cytotoxicity,MTS
CHEMBL1771376,,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(N)c2)c(OC)c1,IC50,8.52,CHEMBL2015273,Cytotoxicity against human U87 cells after 96 hrs by trypan blue exclusion assay,U-87MG ATCC,KUTAVMCJCVADGZ-BQYQJAHWSA-N,96.0,Cytotoxicity,trypan blue exclusion
CHEMBL4084062,,O=C(Nc1ccncc1)Nc1ccc(-c2cc(N3CCOCC3)c3nccn3n2)cc1,IC50,4.96,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,KNESBUDRMICDEI-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4070976,,O=C(Nc1ccc(-c2cc(N3CC4CCC(C3)O4)c3nccn3n2)cc1)Nc1cccnc1,IC50,5.24,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,PKCKCYAOLWSNMX-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4081558,,COc1ccc(NC(=O)Nc2ccc(-c3cc(N4CCOC[C@@H]4C)c4nccn4n3)cc2)cc1,IC50,5.1,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,RXSGPQOOGWNRGY-KRWDZBQOSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2172633,,Cc1nc(Nc2ccc(N3CCOCC3)nn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.51,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,RWELDMOWSUFXDT-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL259225,,COc1ccc(Cn2nnc3c2C(=O)c2cnncc2C3=O)cc1,IC50,6.93,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,ZPZNNDFWFGCXMR-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL3884598,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1OC,IC50,4.94,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FOLXSMCHLAVLAD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3884559,,Cc1ccc(-c2cc3nc4ccccc4nc3c(=O)n2-c2ccccc2)cc1,IC50,4.62,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XWIGUVUPWOQXQA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3885039,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccc(C)cc1,IC50,5.48,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CHWYXVGWFPJTPQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1812545,,Fc1ccc2c(/C=C/c3nnn[nH]3)c[nH]c2c1,IC50,6.17,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,JDBSZVDIUIRSDG-DAFODLJHSA-N,8.0,Unspecified,Unspecified
CHEMBL2088458,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(Cl)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.05,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FDAFULHOWNERPN-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL233930,ASTRAGALIN,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,5.51,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,JPUKWEQWGBDDQB-QSOFNFLRSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL4779081,,CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21,IC50,4.41,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,RBZLXANOQRQGTN-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4208931,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4)c3=O)cc2)ccn1,IC50,4.82,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PCHIOMPKEXUBIZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4214315,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.63,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MJHSGZFYJYAKDV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4798199,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCCCCO)C(=O)C=C(NCCCCCCO)C1=O)OC,IC50,4.94,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CCUXIDYESZWAMT-PHPNYCJASA-N,72.0,Antiproliferative activity,SRB
CHEMBL4098626,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nnc1Cl,IC50,5.62,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,MUHNVADDYLCREH-UHFFFAOYSA-N,,Cytotoxicity,WST1
CHEMBL5175805,,Cc1c2ccncc2c(C(=O)NCc2ccccc2)c2c1[nH]c1ccccc12,IC50,5.77,CHEMBL5127175,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,OOOWESDITGBKBN-UHFFFAOYSA-N,48.0,Antiproliferative activity,SRB
CHEMBL5401830,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCC(=O)NO)CC1)C2,IC50,4.37,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YCICPHILAFCEKI-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4228422,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)C1CC1,IC50,5.19,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VTEMJWZRTCUZNF-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL3092912,,C=CCCCCOc1ccccc1-c1cnc(NC(=O)CCCC=C)n1C,IC50,4.66,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YFIUCUWRXAOMPG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092919,,C=CCCCCOc1ccccc1-c1cnc(OCCOCC=C)n1C,IC50,4.19,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CMRMWVVBROHLFE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092929,,COc1ccccc1-c1cnc(OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)n1C,IC50,4.11,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GQWJGHLDGVKVAR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093015,,C=CCCCCOc1ccccc1-c1cnc(OCCCC=C)n1C,IC50,5.52,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QNRREQOEGKSYOM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093022,,Cn1c2cnc1OCCCCCCCCCCCOc1ccccc1-2,IC50,4.25,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DGYHEGRMGGZWCS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093023,,Cn1c2cnc1OCCCCCCCCCCOc1ccccc1-2,IC50,4.39,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JYDKAGFAKVIWKO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL4086949,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccco4)cc3n2)C[C@H](C)O1,IC50,4.89,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,MFZWCDCACTYPKX-OKILXGFUSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4447343,,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)Nc3ccc(Cl)cc3)CCC[C@]21C,IC50,4.67,CHEMBL4415221,Cytotoxicity activity against human T98G cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,T98G,BBKLOKKZPCGLMA-DOEKTCAHSA-N,72.0,Cytotoxicity,MTT
CHEMBL4226602,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(Cl)s1,IC50,5.09,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,JBLPKNBKTJTXEH-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL1160723,LEVISOPRENALINE,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,IC50,10.3,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,JWZZKOKVBUJMES-NSHDSACASA-N,48.0,Unspecified,Unspecified
CHEMBL229476,,C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.21,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-GTNSWQLSSA-N,48.0,Unspecified,Unspecified
CHEMBL228417,,COc1ccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,IC50,6.47,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-KPZWWZAWSA-N,48.0,Unspecified,Unspecified
CHEMBL155625,INDOLE-3-CARBINOL,OCc1c[nH]c2ccccc12,EC50,3.54,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,IVYPNXXAYMYVSP-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL5412369,,O=C1C=C(Sc2ccc(F)cc2)C(=O)c2c(O)cccc21,IC50,4.76,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,BLOAEHAYJXOIAI-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL5408166,,CC(=O)OC[C@H]1O[C@@H](SC2=C(c3ccc(O)cc3O)C(=O)c3c(O)cccc3C2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.13,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,LTEBXJABOGQTMD-PLOQDKEESA-N,24.0,Cytotoxicity,resazurin
CHEMBL5410666,,COc1ccc([C@H]2[C@H](COC(=O)c3ccc(C(=O)NO)cc3)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,7.25,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,YONFXCGSVGYJHD-CYFREDJKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL866,MYCOPHENOLIC ACID,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,IC50,4.97,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,HPNSFSBZBAHARI-RUDMXATFSA-N,48.0,Cytotoxicity,MTT
CHEMBL4278234,,O=C(COc1ccc(C(=O)/C=C/c2c(F)cccc2F)cc1)Nc1ccc2c(c1)COC2=O,IC50,5.43,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,BDIHMOMPFWOHNY-ZHACJKMWSA-N,48.0,Cytotoxicity,MTT
CHEMBL4461409,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC4OCCO4)CC3)cc2)ncc1Cl,IC50,5.56,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,XCMKUMJDPLUMEU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4061268,,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4cc(N5CCOCC5)c5nccn5n4)cc3)cc2)CC1,IC50,5.31,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VWMSFHKLLJFBIQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3545369,EPACADOSTAT,NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,6.58,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,FBKMWOJEPMPVTQ-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL4567542,,O=C(/C=C/c1ccc(Br)cc1)c1cccc(O)c1,IC50,4.17,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,IIRXFNIZXUTCQA-RMKNXTFCSA-N,72.0,Cytotoxicity,MTT
CHEMBL4459634,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)cc2)cc1,IC50,4.82,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RACOPDZWMOVJGX-BJMVGYQFSA-N,72.0,Cytotoxicity,MTT
CHEMBL4449607,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)c(F)c2)c1,IC50,4.54,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,OMUNGWCVIFBULF-GQCTYLIASA-N,72.0,Cytotoxicity,MTT
CHEMBL4440711,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccc(-c5ccccc5)cc4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.3,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,LHHMPPIBBXYZGO-IKKRBILRSA-M,,Antiproliferative activity,MTT
CHEMBL4748252,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)cc1OC,IC50,4.41,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,GBCHSGFNRBCWDX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4440874,,O=C(/C=C/c1ccccc1)Nc1cc2c(Nc3cc(Cl)cc(Cl)c3)ncnc2s1,IC50,5.35,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GDAAOODIQQYYCC-VOTSOKGWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4778942,,C=CCc1cc(C(C)=O)ccc1OCC=C(C)C,IC50,4.89,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KOLRKUQANUTCKQ-UHFFFAOYSA-N,72.0,Cytotoxicity,RRA
CHEMBL5287303,,NCCCC[C@@H](N)C(=O)N[C@H](CCCCN)C(=O)NC(Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O,IC50,4.77,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,NEIQYEKCZHGMGF-MHJXGLRJSA-N,4.0,Cytotoxicity,MTS
CHEMBL5267172,,NCCCC[C@H](NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,5.18,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,GGAKLYWEFZCVIT-NIEMNNIISA-N,4.0,Cytotoxicity,MTS
CHEMBL4290833,,Cc1ccc(C(=O)c2ccc3c(c2)c2ccccc2n3CC(F)(F)F)c2ccccc12,EC50,5.25,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,QGCINUSCAQKZRG-UHFFFAOYSA-N,72.0,Cytotoxicity,WST-1
CHEMBL5283305,,CCOC(=O)/C(C(C)=O)=C1/SC=C(n2c(CC#N)nc3ccccc32)N1c1ccccc1,IC50,6.64,CHEMBL5245308,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,XZZVSFBNJPKMJR-GHVJWSGMSA-N,,Cytotoxicity,Unspecified
CHEMBL4286146,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(C(F)(F)F)cc2Cl)c1=O,IC50,5.22,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UWVXKIKCLHNUQR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4851018,,c1ccc(Sc2c(-c3ccccc3)nc3sc4ccccc4n23)cc1,IC50,4.2,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,AIAIWRCHFPGNSP-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4868424,,CCc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.21,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,CHMJSPHPRHGXBC-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4791605,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc(Cl)c(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.08,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,PPUFOBOWJQAPEP-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4761565,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)nc(N)c2C#N)cc1,IC50,4.85,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NPQVWIBTCGJRNL-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL178907,,O=[N+]([O-])c1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,4.36,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,XTPPTIANZNOWLE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL360687,,Oc1nc(-c2ccc(Cl)cc2)nc2sc3c(c12)CCCC3,IC50,4.47,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,JANUPDZTKCXNTJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5421446,,CN(C)C1CCN(CC#Cc2nn(C3CCCCC3)c3nc(NC(C)(C)C)ncc23)C1,EC50,5.57,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,UBZCQXOPUDLSQV-UHFFFAOYSA-N,120.0,Antiproliferative activity,PrestoBlue reagent based fluorescence
CHEMBL4289951,,C[N+]1(Cc2ccccc2)C2CCC1CC(OP(=O)([O-])OC[C@H]1O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]1OC(=O)c1ccccc1)C2,IC50,4.3,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,AUYPZBNHPQGOKM-ICBLKLOPSA-N,48.0,Unspecified,MTT
CHEMBL4291998,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccc(/C=C/C(=O)/C=C/c4ccccn4)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.33,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,CPTQMCWMTHOBAE-XQYSVVAESA-N,48.0,Antiproliferative activity,MTT
CHEMBL4286248,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccco3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.97,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,DDYCHWQCWXIEPN-JLXBFWJWSA-N,48.0,Antiproliferative activity,MTT
CHEMBL200215,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5ccccc5[nH]4)cc3)cc2)cc1Br,IC50,5.57,CHEMBL4326337,Antiproliferative activity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ZXCHHWOWYQRGIU-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4576477,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5ccccc5[nH]4)cc3F)cc2)cc1Br,IC50,5.55,CHEMBL4326337,Antiproliferative activity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,WMVLPLMOADXKBC-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5082180,,CCn1c(CO)cc2cc(N(C)c3nc(C)nc4ccccc34)ccc21,IC50,9.29,CHEMBL5056082,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CellTiter-Glo reagent based luminescence assay,U-87MG ATCC,FDENVCDRDMNEBW-UHFFFAOYSA-N,72.0,Cytotoxicity,CellTiter-Glo reagent based luminescence
CHEMBL3408446,,Cc1cccc2c(=O)c3c(NCc4ccncc4)ccc(C(=O)NCCN(C)C)c3[nH]c12,IC50,5.66,CHEMBL3414073,Antiproliferative activity against human A172 cells after 48 hrs by MTT assay,A-172,XLGUMPXXUZHRQM-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3763377,,CCOc1ccc(/C(=C\c2cc(OC)c(OC)c(OC)c2)C(=O)N2CCC=CC2=O)cc1,IC50,5.99,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,AUFHQHMUSWKDHR-XSFVSMFZSA-N,72.0,Cytotoxicity,resazurin reduction
CHEMBL3618233,,COc1ncc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.07,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,JYIYDFDRQAREDE-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3618237,,Cc1nc(N)nc(-c2c(Nc3cccc4[nH]ncc34)nc3ccccn23)n1,IC50,7.5,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,VJDWLNYNYCCEMY-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3618238,,COc1ncc(Nc2nc3ccc(N4CCNCC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.39,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,QRUFDISOBAPRHT-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3810134,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4cccnc4)n3)ccc21,IC50,4.83,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ARKIBANBPWEQHQ-LPYMAVHISA-N,48.0,Cytotoxicity,MTT
CHEMBL4788336,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2cccc(O)c2)cc1,IC50,4.89,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,LUSNWRGCSGDUFN-CCVNUDIWSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL4798707,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2ccccn2)cc1,IC50,4.66,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,HTRWIOXPFBBBCH-CCVNUDIWSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL4790096,,CC1=C[C@@]2(C)[C@@H]3C(=O)[C@]4(C[C@@H]2O)C[C@@](O)(Cc2ccc(cc2)O[C@H]2[C@H]3[C@@H]1[C@]1(C)C[C@H](C)C[C@H](C)[C@@H]21)NC4=O,IC50,4.91,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,OZCVEXIHCIYUCZ-JJTBKSGYSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL4792993,,CCOP(=O)(OCC)C(O)c1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1,IC50,5.71,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,INDQJKBAPRKZIB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4786939,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(C)c3)nc12,IC50,6.34,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,ASCPVWGAFCCXHP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4776781,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C(C)(C)C)nc12,IC50,7.31,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,QCXLRAYMDUWMRT-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4780277,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCC(N(C)C)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.27,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,JVMPHSVTHWBZJL-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4794123,,CNCCN1CCc2nc(Nc3ncc4c(C)c(C(C)=O)c5nc(C(C)C)cn5c4n3)ccc2C1,IC50,6.73,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,ZDIWOUQHEGENJG-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL2103835,,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C,EC50,9.7,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,DASWEROEPLKSEI-UIJRFTGLSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4168005,,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(/C=C/c2ccc(O)c(O)c2)cc1O,EC50,7.6,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,RNBVIZOPZQHBFX-OKGMQGNASA-N,72.0,Antiproliferative activity,MTS
CHEMBL4159671,,C/C(=C\Cc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)[C@@H](O)C3)cc(O)c1O)CCC(O)C(C)(C)O,EC50,6.3,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,OZSHINGQPPSWDW-JADAMXTKSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4166907,,CC(C)=CCC[C@]1(C)Oc2c(O)cc(/C=C/c3cc(O)c4c(c3)OC(C)(C)C(O)C4)cc2C[C@@H]1O,EC50,6.35,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QJSWIQFERWNYJM-XHPROGOUSA-N,72.0,Antiproliferative activity,MTS
CHEMBL388570,,C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,9.85,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-DIFFPNOSSA-N,48.0,Unspecified,Unspecified
CHEMBL4099583,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.81,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,HNJSJKVDJXKHBF-BLMIFYICSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4080633,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCOCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.62,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,KWNJEIUCZHXCQH-HKIQETCMSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4096223,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCNC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.24,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FZQGJDNLXMYXQU-DZLLRAINSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4086970,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H](NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)[C@@H](C)CC)C[C@H]1C(=C)C,IC50,8.0,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,LNMLOIVELKGFHO-KODPKBOBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4079118,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H]2CCCN2C(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.26,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZKEOIBRIAYPMIV-RRXKMURMSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4170303,,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c(O)c(C/C=C(\C)CCC(O)C(C)(C)O)c2)cc1O,EC50,7.0,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,VYHNYBOVGSSVMH-FPZVNABHSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3357148,,C=C[C@@](C)(O)CC/C=C(\C)C(=O)OC[C@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](CO[C@@H]7OC[C@H](O)[C@H](O)[C@H]7O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)CC3)[C@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]3O)[C@@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,IC50,4.83,CHEMBL3385800,Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PSWTYKAGISJRNR-YRGLWYEXSA-N,72.0,Unspecified,sulforhodamine B
CHEMBL422,TRIFLUOPERAZINE,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,EC50,4.87,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,ZEWQUBUPAILYHI-UHFFFAOYSA-N,,Unspecified,Fura-2 AM dye-based
CHEMBL4536596,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(Cl)cc3s2)cc1,IC50,5.06,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,FPDGSJOUIPJMFW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1834956,,O=C(O)c1cc(/C=C/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.16,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,UAHMKJJFOGZIDP-SNAWJCMRSA-N,0.25,Unspecified,Unspecified
CHEMBL1821795,EUPHODENDROPHANE E,C=C1[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)c2ccccc2)[C@@H](OC(C)=O)C(C)(C)/C=C/[C@@H](C)C(=O)[C@@]2(O)C[C@H](C)[C@H](OC(=O)CC)[C@@H]2[C@H]1OC(C)=O,IC50,4.14,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,AJDFLYUZLBJRGW-FFGYUFPDSA-N,72.0,Anticancer activity,SRB
CHEMBL4452177,,Cc1ccc(C(=O)/C=C/C(=O)N(C2CC2)C(C(=O)NCc2ccccc2)c2ncc(C)cn2)cc1,IC50,4.82,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZMLWDTSYBVZHLZ-CCEZHUSRSA-N,72.0,Cytotoxicity,MTT
CHEMBL4764175,,C/C(=C\CC/C(C)=C/CC[C@@H]1[C@@]2(C)CCC(=O)C(C)(C)[C@H]2CC[C@@]1(C)O)CC/C=C(\C)C(=O)OCc1cn(-c2cccc(Cl)c2)nn1,IC50,4.04,CHEMBL4682994,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,RCPXKGSMTTWSML-MJZBXAEKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4284206,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5cc(CC(=O)O)ccc5[nH]4)cc3F)cc2)cc1Br,IC50,5.55,CHEMBL4265452,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,GFYVINPXBSVXAR-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4284717,,C(=C/c1ccc(OCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.19,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,IBFRVLYRRRNWFE-XMXXDQCKSA-M,72.0,Antiproliferative activity,MTS
CHEMBL2392953,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.67,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AXUCCAZTQZZNLL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392961,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GQFDQOGJNMXMEO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3989596,LEURUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@@H](N)CC(C)C)[C@H](O)[C@H](C)O1,IC50,6.22,CHEMBL4015761,Cytotoxicity against human U87MG cells treated with MJ02 assessed as reduction in cell survival after 96 hrs by MTT assay,U-87MG ATCC,HROXIDVVXKDCBD-ZUWKMVCBSA-N,96.0,Cytotoxicity,MTT
CHEMBL3800481,,CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,PSICWGWNIOOULV-UHFFFAOYSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL3797590,,Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,JSPBEUDGGZHEMZ-UHFFFAOYSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL4476042,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCOC)CC3)cc2)ncc1Cl,IC50,6.21,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,VHBOBXDEBONQMT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4785582,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12,IC50,6.8,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,NHLMMNCVSWYEIL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL500508,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc([N+](=O)[O-])c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.38,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,UJTDZRSLKUKGDS-GVQBMFDGSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL500078,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccc(C)cc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.22,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ZNQZXZRYMXGUNT-ALMBTRMVSA-N,,Cytotoxicity,sulforhodamine B
CHEMBL4639289,,CC[C@H]1CCC[C@H](OC(=O)CCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[I-],IC50,5.57,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,MZXDWPDPYCBCEL-JMIXZKEHSA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL1928600,,COc1cc(C=O)cc2c1O[C@@H]1C3=C(OC[C@H]21)C(=O)c1ccccc1C3=O,IC50,5.13,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,BSPXWCBZAVVIAU-VLIAUNLRSA-N,72.0,Unspecified,MTT
CHEMBL235934,CLAUSINE E,COC(=O)c1cc(O)c2[nH]c3ccccc3c2c1,IC50,4.14,CHEMBL1930776,Growth inhibition human T98G cells after 48 hrs by WST-8 based CCK8 assay,T98G,ZWPODTIRGFOENJ-UHFFFAOYSA-N,48.0,Growth inhibition,WST-8 based CCK8
CHEMBL599619,PTEROCARPANQUINONE,O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccccc3[C@H]1CO2,IC50,5.44,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,BUEHOQICFGQBNY-ACJLOTCBSA-N,72.0,Unspecified,MTT
CHEMBL1914736,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.36,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DDYGLALBILACTA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220241,GSK-269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,IC50,5.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,YOVNFNXUCOWYSG-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL222102,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,IC50,4.06,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XRKYMMUGXMWDAO-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4125819,,C=Cc1ccc(OC(=O)c2ccc(O)c(N)c2SC[C@@H](NC(C)=O)C(=O)O)cc1,IC50,5.66,CHEMBL4119405,Cytotoxicity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,JHYFUEHJYLZHTG-OAHLLOKOSA-N,72.0,Cytotoxicity,sulforhodamine B
CHEMBL3927740,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.23,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,JDJLAIIQEOSLBN-RPWWTVJQSA-N,24.0,Unspecified,48 hrs incubation in dark by MTT
CHEMBL1807805,,CC[C@H](N)C(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.35,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,POLHEQGIVQDPGA-MMOPVJDHSA-N,,Antiproliferative activity,Unspecified
CHEMBL1668099,CORNUSALTERIN F,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C=CC(=O)[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.61,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,SRZGQWOHBSWCAT-MHNWUIROSA-N,,Cytotoxicity,SRB
CHEMBL1668104,CORNUSALTERIN K,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CC=C4C(C)(C)C(=O)C[C@@H](O)[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.92,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,FEAAYJYTVFABGY-UHNHVWPPSA-N,,Cytotoxicity,SRB
CHEMBL1668107,(-)-LEUCOPHYLLONE,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.74,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VUTMJNYAUWPTQA-ZLEOEWCPSA-N,,Cytotoxicity,SRB
CHEMBL5220621,,COc1cc(OC)cc(-c2ncccc2CNc2ccc(C)cc2)c1,IC50,4.7,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,PJVCDFODASFIKH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4743394,,CC1=C[C@]2(C)C(=O)C[C@]34C[C@](O)(Cc5ccc(cc5)O[C@H]5[C@@H]([C@@H]1[C@]1(C)C[C@H](C)C[C@H](C)[C@@H]51)[C@H]2C3=O)NC4=O,IC50,5.97,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,DJXHULBSNKVOCR-DDIFOEQUSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL3765646,,COc1cc(Cn2cc(CN3C(=O)c4ccccc4Nc4ccccc43)nn2)cc(OC)c1OC,IC50,5.75,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FTKQQUWXZIHXIO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3600443,,COc1ncc(-c2ccc3nc(NC(=O)N4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.77,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BXDIIOOGLWXHIE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601921,,CNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.19,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MAJONJHMOFHAJV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601927,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCN(C)CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.12,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ITSUIVIXCNLTDI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601928,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.95,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KZBQWFCDLBEVOS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3601929,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.97,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MZVYOYMCEXRORF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3600436,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2n1,IC50,6.12,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DHJDUPOSBIQOLR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL419735,,CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.85,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,DLDMOIDCLHDMPT-URGPHPNLSA-N,,Unspecified,Unspecified
CHEMBL5093864,,COc1ccc(Cn2cc(CNC(=O)[C@]3(C)CC[C@]4(C)CC[C@]5(C)C6=CC=C7C(=CC(=O)C(O)=C7C)[C@]6(C)CC[C@@]5(C)[C@@H]4C3)nn2)cc1,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,VYZSZIMIQTZEEB-MPOPNXFASA-N,96.0,Antiproliferative activity,MTT
CHEMBL5076793,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Br)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZWTPPPFBFCVMIN-SMRIDXHDSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4226926,,COc1ncc(-c2nc3c(C)nc(N)nc3n(C)c2=O)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.2,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VABHZMQJUZDGNK-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4294765,,C[N+](C)(C)CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1,IC50,4.61,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,WBJKHKYBIKTDKR-RCCFBDPRSA-N,48.0,Unspecified,MTT
CHEMBL4538710,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC#N)CC3)cc2)ncc1Cl,IC50,5.76,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,AKGPHMOJVOKNTN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4445960,,CCOC(=O)CSC(=S)N1CCN(C(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)CC1,IC50,5.12,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,WWBCEBIYRDVNAY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4437276,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCOCC4)CC3)cc2)ncc1Cl,IC50,6.33,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,HDKDGZQXCIWANT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3805804,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1,IC50,5.6,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CHIVYXWZAIGRIN-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805926,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(O)cc2)cc1,IC50,5.43,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,RONBAJUFIMRMAK-NXVVXOECSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4174791,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccc(OCCN(CCCl)CCCl)cc1,IC50,4.62,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,MHFKYSJXUZHRBE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4463158,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCO)CC3)cc2)ncc1Cl,IC50,6.15,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,MFQXRBCDXYFWMG-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4476367,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccncc4)CC3)cc2)ncc1Cl,IC50,5.77,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,CLAVOBNQCPZLLN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4525498,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4cccnc4)CC3)cc2)ncc1Cl,IC50,5.82,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZNEWWRLRHOQSJO-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4453262,,CNC(=O)c1ccccc1Nc1ccnc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)n1,IC50,5.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KQBOVKMESRRNOP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4279256,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.53,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RHTQHLXGXSNSRP-XMVQVYPASA-N,72.0,Antiproliferative activity,MTT
CHEMBL1276265,,O=C1c2ccc(Cl)cc2-n2c1nc1ccccc1c2=O,IC50,6.02,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,KHONZILMMZKIQL-UHFFFAOYSA-N,8.0,Unspecified,Unspecified
CHEMBL4444886,,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,9.13,CHEMBL4309336,Antiproliferative activity against human U87MG cells transfected with IDH1 R132H mutant,U-87MG ATCC,KICQCOSIQLKQBA-OZXSUGGESA-N,132.0,Antiproliferative activity,Unspecified
CHEMBL52226,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CCl)OCCO3,IC50,7.27,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,WJHZRWBKASGXFE-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL111477,,CN(C)c1ccnc2c1-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.3,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,UYBWDRPVFJJAOX-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4287819,,COc1ccc(/C=C/C(=O)c2ccc(OCC(=O)Nc3ccc4c(c3)COC4=O)cc2)cc1,IC50,5.31,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ASZAWGVSVIPAKR-YIXHJXPBSA-N,48.0,Cytotoxicity,MTT
CHEMBL110742,,O=C1c2ncccc2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,9.05,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,MNBDHAXJFRIQPS-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4281312,,C(=C/c1ccc(OCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.16,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,XXXQFBDSNLMKFH-RXQWRGDBSA-M,72.0,Antiproliferative activity,MTS
CHEMBL4280635,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(F)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.55,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CYDQIRZQIOCDIS-UVHRBFQASA-N,72.0,Antiproliferative activity,MTT
CHEMBL4294821,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(Cc4ccccc4)nn3)CC[C@@H]12,IC50,4.88,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CLZIQMRGNCTWQV-SBUPNFJNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4280764,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(N3C(=O)c4ccccc4C3=O)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.91,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GPIWVZDXLBSFNC-HCFHHERYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4293071,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CNC(=O)c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.03,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CIGUJYYNCWVQDY-KVUZRMRJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4278041,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(C(=O)OCc3ccc([N+](=O)[O-])cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.7,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UROQQMHVVMNRRL-UTBWARILSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4293259,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(C(F)(F)F)cc5Cl)c4=O)cc3)ccnc21,IC50,4.9,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BPQOIWPXRJBFFE-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4281371,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)c(Cl)c5)c4=O)cc3)ccnc21,IC50,5.63,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DQQVYTMOPDGVEX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4293054,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3)ccnc21,IC50,5.67,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MZFRNRYVIPHDJN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4287907,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(Cl)cc2)c1=O,IC50,5.47,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKHQVCCQVAGYFZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5619323,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccc(C(F)(F)F)cc12)c1c[nH]c2ccc(C(F)(F)F)cc12,IC50,5.11,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,HHNHRKMSQZHDMP-NDEPHWFRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL3911801,,Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1,IC50,4.56,CHEMBL3881188,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation after 72 hrs by Alamar Blue assay,U-87MG ATCC,HDYUXDNMHBQKAU-UHFFFAOYSA-N,72.0,Cytotoxicity,Alamar Blue
CHEMBL388177,,C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,7.83,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-SPLOXXLWSA-N,48.0,Unspecified,Unspecified
CHEMBL3415683,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CC)c(C)c21.[Br-],IC50,6.05,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,JSZFYCAAEFGXHB-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL3415681,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CCC(C)C)c(C)c21.[Br-],IC50,5.82,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,ABRKHCCTKBQBCO-UHFFFAOYSA-M,,Cytotoxicity,MTT
CHEMBL4778059,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)cc1OC,IC50,4.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QIGTZJZYCIYETC-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4799717,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(Cl)c(Cl)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.16,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VAUNCIHMHCCKTR-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4791890,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccccc2)c(C#N)c(=O)[nH]1,IC50,4.56,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,IJSLANCLTAKFPA-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4747829,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2cccc(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.4,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QNPNVJJIHWFAPD-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4793286,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc3c(c2)OCO3)c(C#N)c(=O)[nH]1,IC50,4.25,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,OZGPGYPHRFNYMT-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4765150,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccc(Cl)cc4)n3)s2)cc1,IC50,5.34,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,XUVNDESQVQOWQX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4748991,,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@@]1(C)[C@@H]2C(=O)C[C@@H](c4ccoc4)[C@]2(C)[C@@H](O)C(=O)[C@@H]13,IC50,5.42,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,JOQZKEFBHIMDMX-JIOZLIPLSA-N,,Cytotoxicity,SRB staining
CHEMBL92,DOCETAXEL ANHYDROUS,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,IC50,8.7,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4641965,,CCCC#Cc1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n2ncnc(N)c12,IC50,7.4,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ODOGHCIPJNPLNR-NGFQHRJXSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4644331,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(C#Cc3ccccc3)c12,IC50,4.06,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,XCRZMSZGJGMUNI-DDBAPUKQSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4642282,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccoc3)c12,IC50,6.0,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,DNVDVLAZRSLHRN-ZRJCITRHSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4226543,,COc1ncc(-c2cc3c(C)nc(NC(=O)C4CC4)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.19,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,BUCASPXHFMVOBK-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL5191412,,CCCCN(CC)Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.23,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,KZQKDZDBFPECEU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5266738,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)CCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.7,CHEMBL5228642,Cytotoxicity against human U87 cells,U-87MG ATCC,BGXDEQSJLXURBE-RHSVSJCASA-N,,Cytotoxicity,Unspecified
CHEMBL3301909,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1,IC50,7.23,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,DJEFXYVVRUAFEB-KYZOVJJKSA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL4762068,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3CCC(=O)[C@H](C)O3)[C@H](C)O2)[C@H](C)O1,IC50,5.66,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,VEYVSXCINGFXMS-ILPMSGFSSA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL4450150,,CCOP(=O)(OCC)C(N(OC(C)c1c[nH]cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,RNDBBVMDROJPJH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5564744,,N#CC1(C(=O)NCCSc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.84,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,IWIGGGFCALSMIX-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL3897723,,COc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccc(Cl)cc2)cc1,IC50,9.85,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,YFBBPYBKOLENKT-JNAKGCJYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3900264,,Clc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,IC50,9.38,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,WFLJBHIMLGVBCP-AGFWYPDZSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3966129,,Clc1ccc(C(/C=C/c2ccccc2)=N\Nc2nncc3ccccc23)cc1,IC50,9.28,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IFAAYTNDJIPJBZ-ANPOLSPOSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3903713,,C(=C/c1ccccc1)\C(=N\Nc1nncc2ccccc12)c1ccccc1,IC50,9.48,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IUZQUGLOCXBWCX-QCGZKTFGSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3979610,,Fc1ccc(Nc2nncc3ccccc23)cc1,IC50,9.37,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LOCGWCWPUSRMSW-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3950630,,Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)n1,IC50,9.25,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RXVARTZYPOQZBI-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL3926223,,NS(=O)(=O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.28,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,DIVNHQLVPJIYEC-UHFFFAOYSA-N,72.0,Antiproliferative activity,Sulforhodamine B-stain
CHEMBL4761582,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.35,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,KQGIOFULIYUITH-XXFRDUSWSA-N,,Antiproliferative activity,SRB
CHEMBL1928402,,CC(=O)c1nc(C(=O)NCCc2ccccc2)cc2c1[nH]c1ccccc12,IC50,4.89,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,QPUYCBSQXKSFOO-UHFFFAOYSA-N,,Antiproliferative activity,SRB
CHEMBL3339357,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(Cl)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.4,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VXFKXGMEBXBHBS-QLQYKETESA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339363,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4cccs4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,APUQOERXRBJYOF-FMFFXOCNSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339367,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(O)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.94,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,LCHQLVMHOJANLQ-ICUTVXMZSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4645881,,Cc1c(C(=O)N/N=C\c2ccc(O)cc2O)oc2cccc(O)c12,IC50,5.36,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,PUQINIYVPDTKEP-LSCVHKIXSA-N,,Antiproliferative activity,Unspecified
CHEMBL4632430,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CC3)cc2)n1,IC50,4.36,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GFJVQOGPGWADQB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4639855,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCC3)cc2)n1,IC50,4.24,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NCFQFVDGGRBEDT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4642258,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)n2)cn1,IC50,4.45,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVBXGRYWKSAQLW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4649095,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)n4)cc3)n2)cn1,IC50,4.26,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HVHJKHDMLQCSHC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4752934,,C/C(=C\CC/C(C)=C/CC[C@@H]1[C@@]2(C)CCC(=O)C(C)(C)[C@H]2CC[C@@]1(C)O)CC/C=C(\C)C(=O)OCc1cn(C[C@@H]2O[C@H](n3ccc(=O)[nH]c3=O)C[C@H]2O)nn1,IC50,4.12,CHEMBL4682994,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,YTODEFJNERGMCA-SFPLGXOVSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1927612,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(CCO)c23)C1=O,IC50,5.91,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IZMMYUJCJGTURE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3109414,,CC(=O)O[C@@]1(C)CCC(=O)[C@H](C)CCC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.5,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,VLTIKKJYNDMBON-OUWXYEHJSA-N,24.0,Cytotoxicity,MTT
CHEMBL515,CHLORAMBUCIL,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,IC50,4.73,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,JCKYGMPEJWAADB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4215067,,O=c1c(-c2c(O)cc3c(c2O)C[C@H](O)[C@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.05,CHEMBL4187982,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,LVGLBFQVAZMOBH-LGGPFLRQSA-N,24.0,Cytotoxicity,CCK8
CHEMBL4642396,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.22,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ITURVIGXXSTVPJ-QCOVWQHTSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4638757,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(N)=S)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.64,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,FKTGRRSUPMAQPN-MUUWPGBXSA-N,96.0,Antiproliferative activity,MTT
CHEMBL477923,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.24,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,KTEXNACQROZXEV-QLIGOWBFSA-N,96.0,Antiproliferative activity,MTT
CHEMBL561183,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C=O)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.13,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,TZIPSCRSSJQDML-OOCKOLEWSA-N,96.0,Antiproliferative activity,MTT
CHEMBL261341,,CC(C)Cn1nnc2c1C(=O)c1cnncc1C2=O,IC50,6.85,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,QOVAUBWYDGPSKT-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL261330,,CCCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.75,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,UGVODSLSZYPSHI-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL259989,,Cn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,8.4,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,NPDJZPQYKSWUBJ-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL4870888,,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1C(F)(F)F,IC50,4.05,CHEMBL4810781,Neurotoxicity in human U87 MG cells assessed as cell viability for 24 hrs by MTT assay,U-87MG ATCC,PGJNUZLHOQESIJ-FCXRPNKRSA-N,24.0,Unspecified,MTT
CHEMBL5220783,,COc1ccc(CNc2cccnc2-c2cc(OC)cc(OC)c2)cc1,IC50,5.62,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,HBEMOPXGFXWWGC-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4776452,,CCC(=O)Oc1cccc2ccc(/C=C/c3ccccc3[N+](=O)[O-])nc12,EC50,4.98,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,GDKCQKXZEFPKQP-ZRDIBKRKSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4102608,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1cccc(Br)c1,EC50,5.17,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,VVMBNIZQCAZRDO-GQCTYLIASA-N,72.0,Antiproliferative activity,SRB
CHEMBL5275745,,CC[C@]1(OC(=O)OCc2cc(/C=C/C3=[N+](CCCS(=O)(=O)[O-])c4ccccc4C3)cc(/C=C/C3=[N+](CCCS(=O)(=O)[O-])c4ccccc4C3)c2OCc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)Cc2cc3n(c(=O)c2OC1=O)Cc1cc2ccccc2nc1-3,IC50,7.7,CHEMBL5231221,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability,U-87MG ATCC,BVNSZDGKOZIVLM-WIBDCOBLSA-N,,Antiproliferative activity,Unspecified
CHEMBL4161974,,O=C1c2ccccc2C(=O)c2c(-c3ccc(F)cc3)coc21,IC50,5.2,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RFAKFRFVHNUKKX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4165413,,CSc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.46,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,KPYPFYOXKVMRGM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4177099,,O=C1c2ccccc2C(=O)c2c(-c3cccs3)coc21,IC50,5.3,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,XMJAULWIBAYPCF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4170019,,CCOC(=O)Cc1oc2c(c1-c1cc(OC)c(OC)c(OC)c1)C(=O)c1ccccc1C2=O,IC50,4.99,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,SBUILDHSGAVMRE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1956944,,CC(C)(O)[C@@H]1C[C@H]2[C@@](C)(C[C@@H]3C[C@@]32C)C[C@@H]1O,IC50,5.95,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,QRDWGAFJTAQHKE-QIWTVSAUSA-N,24.0,Cytotoxicity,MTS
CHEMBL352557,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN1CCOCC1,IC50,4.09,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,TYZMMQCZNRBREP-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4065141,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)nnc1Cl,IC50,5.0,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,SBVLCTFHZGZENM-UHFFFAOYSA-N,,Cytotoxicity,WST1
CHEMBL4644711,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.89,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,OATZKDGKJULOEE-SJMAVRMZSA-M,48.0,Antiproliferative activity,Unspecified
CHEMBL5575251,,Nc1nc(-c2ccccc2)cc(-c2ccc(S(N)(=O)=O)cc2)n1,IC50,4.47,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,UXUNOXZFVHSUQD-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL228043,,C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br,IC50,4.19,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UVSVTDVJQAJIFG-VURMDHGXSA-N,,Growth inhibition,Unspecified
CHEMBL2392965,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C(F)(F)F)cc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.0,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CASORRYOKCLYHM-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2313790,,COc1cc(Sc2c(-n3ccnc3)[nH]c3ccccc23)cc(OC)c1OC,IC50,7.07,CHEMBL2321142,Cytotoxicity against human U87MG cells assessed as cell survival after 24 hrs by MTS conversion assay,U-87MG ATCC,AVBIIULMFIIGCG-UHFFFAOYSA-N,24.0,Cytotoxicity,MTS conversion
CHEMBL5282388,,COc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,5.05,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,WTEBNBAKSFFCPW-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL5278825,,c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.57,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,PIKYRJSSRILQPF-UHFFFAOYSA-N,24.0,Antiproliferative activity,MTT
CHEMBL3262868,,COc1ccc(OC)c(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c1,IC50,5.19,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BYDDZSQPFPOZNA-OKCVXOCRSA-N,72.0,Cytotoxicity,MTT
CHEMBL3263124,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3c[nH]c4ccccc34)cc2F)ccn1,IC50,6.16,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,INHLNWGLDZHSOV-WCMJOSRZSA-N,72.0,Cytotoxicity,MTT
CHEMBL5571278,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CCNCC1)C3,IC50,5.85,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,FXNCQKVCGAATHN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2381454,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(CO)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.28,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,ZOPCSEXIYNWPNP-BJMSDPACSA-N,48.0,Cytotoxicity,SRB
CHEMBL5273890,,Cc1ccccc1NS(=O)(=O)/C=C/c1cccc(OCCO[C@@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)c1,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,HEGZCFUAQVLBQV-KKJLATHWSA-N,,Antiproliferative activity,Unspecified
CHEMBL3115966,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4cc(Cl)c(Cl)cc4Cl)nn3)[C@@H]2CC1,IC50,4.77,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,HJWIIMDENOAEFK-ORRPWZRNSA-N,,Cytotoxicity,colorimetric sulphorhodamine B
CHEMBL3115971,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccc(Br)cc4)nn3)[C@@H]2CC1,IC50,4.28,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,TZKODUIENJFEBB-VMAZJTETSA-N,,Cytotoxicity,colorimetric sulphorhodamine B
CHEMBL4552836,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(CNc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(NC(=O)OCc3ccccc3)nc2=O)C1(F)F,IC50,5.42,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,LKZZHMMCAAPJJW-BEYURWCVSA-N,72.0,Cytotoxicity,SRB
CHEMBL4524657,,Cc1cn([C@H]2C[C@H](OC(=O)OC(C)(C)C)[C@@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,5.01,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,OSOCTTLUFUAUDA-KXHDOTFISA-N,72.0,Cytotoxicity,SRB
CHEMBL4513331,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4cccnc4)o3)C2=O)cc1,IC50,4.6,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,SHLANBXRIPRBCH-RYBWPTGJSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL3936933,,[N-]=[N+]=NCC1CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.41,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RWRRUAODLXTKEG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4786625,,Cc1ccc(C(=O)/C=C/C(=O)OCCN(C)C(C(=O)NC2CCCCC2)c2ccc(F)cc2)cc1,IC50,5.23,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,KLJFMKGGTCMJKN-WUKNDPDISA-N,72.0,Cytotoxicity,MTT
CHEMBL4745896,,Cc1ccc(C(C(=O)NC(C)(C)C)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)cc1,IC50,5.16,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JPLCIQRNFUEDHY-CCEZHUSRSA-N,72.0,Cytotoxicity,MTT
CHEMBL2417555,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.7,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,AZPBOWXQOORSRH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417834,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.68,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BLXIBDATVDFOEA-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL209857,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(Br)ccc2O1,IC50,4.96,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,GZJQSNLEMHHIIP-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL610773,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(Cl)ccc2O1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,MPACSKWCHWTFLA-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL611936,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(Br)ccc2O1,IC50,4.62,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,NSCMHWQEWCQUKL-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL595242,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(F)ccc2O1,IC50,5.3,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YWZWRTAQMFMTSJ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2041936,,COc1ccc(Cl)cc1CNC(=S)Nc1ccc([N+](=O)[O-])cc1,IC50,4.46,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,FSPOCHCSOXLMBF-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL4586068,,COc1cc(C(=O)c2cn(-c3ccc(F)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.34,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,ANSTTWYVEJBPTF-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS
CHEMBL4444616,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2F)cc(OC)c1OC,IC50,7.27,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,AOPYZCNEKFOSTL-UHFFFAOYSA-N,48.0,Cytotoxicity,MTS
CHEMBL5567673,,CC(C)NC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.43,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,LRLQSCGBFVRVPC-GFCCVEGCSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4857714,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc(Cl)cc7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.17,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,WMFPXSAAFKGDEW-JKSHRDJASA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL5619004,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCc1ccco1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.34,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,OZENKSHIKBNFBN-YTTGMZPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5618510,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCC1CCOCC1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.53,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LKLFFCBTMAGYQY-XIFFEERXSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5284130,,c1cn2cc(-c3ccc4ncn(C5CCCCC5)c4c3)nc(-c3ccc4ncn(C5CCCCC5)c4c3)c2n1,IC50,6.09,CHEMBL5625479,Growth inhibition of human SF-295 cells,SF295,XEFFCFLZLHGTDK-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL4636420,,COc1ccc2c(c1O)C(=O)c1c3c(cc(O)c1C2=O)[C@@]12O[C@@]1([C@@H](C)O)[C@H](C#C/C=C\C#C[C@H]2O)N3,EC50,9.35,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,DJOMZYYFFHCVSQ-UBZKRVARSA-N,72.0,Cytotoxicity,CellTiter 96 aqueous one solution
CHEMBL4755220,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCCCC2)cc1,IC50,5.96,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,JZNRJZMZSVXVRD-GIJQJNRQSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4799550,,CCCCc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.91,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,DBSVGRDPWNJUBN-VAWYXSNFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5075135,,O=C(NO)c1ccc(CN(Cc2cccnc2)S(=O)(=O)c2cc(F)c(F)c(F)c2F)cc1,IC50,5.7,CHEMBL5042627,Anti-proliferative activity against human U87G cells assessed as cell viability measured after 72 hrs by Cell-Titer assay,U-87MG ATCC,HBOMISXRZUHCSH-UHFFFAOYSA-N,72.0,Antiproliferative activity,Cell-Titer
CHEMBL5189034,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(F)cc1)O2,IC50,6.68,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,DXFZJLAGWYZJCJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL509219,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1N=[N+]=[N-],IC50,5.92,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OURJDSNLCDZIHT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2348734,,CC(=O)Nc1cc(-c2ccccc2)c(=O)[nH]n1,IC50,5.12,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,YLTAJJJPAWSRTK-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL5278357,,COc1ccc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cn1,IC50,6.75,CHEMBL5347390,Antiproliferative activity against human U87 cells incubated for 3 hrs by resazurin dye based assay,U-87MG ATCC,XDLYKKIQACFMJG-UHFFFAOYSA-N,3.0,Antiproliferative activity,resazurin dye based
CHEMBL3805698,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,IDZHBQXXPRSFKI-PFONDFGASA-N,48.0,Antiproliferative activity,MTT
CHEMBL3805065,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,IC50,5.29,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,JFUCGYAMBXSBPL-SEYXRHQNSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3618239,,COc1ccc(Nc2nc3ccc(N4CCNCC4)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.16,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,YBQVCLWCRGNXIX-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL4437294,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,JPGPKRXXXWYEON-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4792743,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)N1CCOCC1,IC50,5.91,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UGYFXTRYBRHBRT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4785079,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CC5(CCOCC5)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.27,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,UQTOSACIYYZMNE-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4792101,,CC(=O)c1c(C)c2cnc(Nc3ccc(CN4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.78,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,KSHZWPCJWQWIST-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4786967,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3C)nc12,IC50,6.6,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,XUKLMBGZXHMYHP-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4550214,,O=C(NO)c1ccc(Cn2c(=O)n(CCc3ccccc3)c(=O)c3ccccc32)cc1,IC50,5.81,CHEMBL5141029,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JBJIKUXUKSADFV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5202357,,COCCN1CCN(c2ccc(OC)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.46,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,SIKDOWIWMSTJIV-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5431398,,Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@@H]2OCCc3cc(Cl)ccc32)[C@@H](O)[C@H]1O,IC50,8.59,CHEMBL5350332,Anti-proliferative activity against human U-87 MG cells assessed as cell growth inhibition incubated for 3 days by CCK-8 assay,U-87MG ATCC,MURBFVDKWOUNSQ-IPXJXJKCSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL3262727,,O=C(/C=C/c1cccc(S(=O)(=O)n2ccc3cccnc32)c1)NO,IC50,5.73,CHEMBL5614538,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,OXPJGPURVBXIAP-VOTSOKGWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4556764,,C[C@H]1C[C@@](C)(O)C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1=O,IC50,6.66,CHEMBL4416282,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by SRB assay,U-87MG ATCC,NFDQYBUVHVRNNY-VATFKXGISA-N,72.0,Antiproliferative activity,SRB
CHEMBL4752642,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,5.66,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,UTSSJQUIRGMHJS-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL4640462,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(C#CC3CC3)c12,IC50,7.52,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,KZXJVSCNNXNJSX-NGFQHRJXSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4638439,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccccc3)c12,IC50,4.12,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,JSZDOJWBOJQLPQ-MIGQKNRLSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4749576,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2cccnc12,IC50,4.43,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,HOKPJBCDXUEGDO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4776896,,Oc1c(C(c2ccc3c(c2)OC(F)(F)O3)N2CCCCC2)ccc2ccoc12,IC50,5.05,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,YWTCGWLCGFLFTK-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4783594,,CN(C)c1nc(/C=C/c2cccc([N+](=O)[O-])c2)nc(Nc2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)n1,IC50,5.29,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,DLQATWWNPBJVMI-GIDUJCDVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4784902,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3ccc(Cl)cc3)nc(N3CCOCC3)n2)cc1,IC50,5.6,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NYYWQGPXVXSKKR-LZWSPWQCSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4789421,,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(Nc4nc(/C=C/c5ccccc5)nc(N5CCOCC5)n4)cc3)cc2)CC1,IC50,6.64,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,FOXFJTSNPCDILE-FRKPEAEDSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4786042,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C3CCCCC3)nc12,IC50,6.91,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,SSQHDFZENWGTNQ-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL2165033,,COc1ccc(Nc2ncc(-c3cnn(C)c3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.47,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KRSNHRXVUCZIHY-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL5076062,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Cl)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.18,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,AWKSMQZRGODOHH-MCLIRCHUSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5080088,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5nccs5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.32,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GJQSIGCKFMWMGG-VZTVURHLSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5275650,,c1ccc(-c2nc(CNc3nccc(NC4CC4)n3)cs2)cc1,IC50,4.14,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,KUTNRROCOWVKIM-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5269859,,CC(C)CNc1ccnc(NCc2csc(-c3ccc(Cl)cc3)n2)n1,IC50,4.78,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,KUONEDFEQUGOFF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5271397,,CC(C)CNc1ccnc(NCc2csc(-c3ccc(C(F)(F)F)cc3)n2)n1,IC50,4.7,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,BPNDTEKFFIXTAK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5288870,,CC(C)CNc1ccnc(NC(=O)c2csc(-c3ccccc3)n2)n1,IC50,4.23,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,WZXXDPKTYAQIAG-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4783539,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.54,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,JAJXESNKQGDUIJ-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL3809774,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(O)cc4)n3)ccc21,IC50,4.88,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,QIDFHLVCKQCNOZ-OEAKJJBVSA-N,48.0,Cytotoxicity,MTT
CHEMBL5279358,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)OC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-].[Br-],IC50,4.29,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,CEXFQWGSZICLHN-JFHYDWJLSA-L,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL233030,,c1cn(-c2ccc(O[C@H]3CCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.8,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WZGVPRAMPUCENN-IBGZPJMESA-N,,Unspecified,Unspecified
CHEMBL4453906,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)C=C(O)C(=O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.68,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,QQAHLBORSCNRPX-QBVDEUJGSA-N,48.0,Cytotoxicity,MTT
CHEMBL4207018,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,5.54,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CJTFWXXRGSFAFF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4218367,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4F)c3=O)cc2)ccn1,IC50,4.99,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UJCIPXGVLWQAMH-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4214300,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(C(F)(F)F)cc4Cl)c3=O)cc2)ccn1,IC50,4.96,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,APGHTOISOKBSEA-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4203396,,Cc1ccc(Nc2nc(C)c(C(=O)c3cnc4ccc(Br)cn34)s2)cc1,IC50,4.28,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,MATXBQCYJIHSDO-UHFFFAOYSA-N,46.0,Cytotoxicity,MTT
CHEMBL5439741,,CC1(C)CCc2c(O)cc(CCc3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](O)CC[C@@]3(C)O4)cc2O1,IC50,7.11,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,VJWKPCYKFHMZSX-ITLAICGJSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5414636,,COc1cc(CCc2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,5.42,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,XZCWUPSHHPDPSM-VOKYQHOCSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5399392,,CC1(C)CCc2c(O)cc(/C=C/c3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](OC=O)CC[C@@]3(C)O4)cc2O1,IC50,7.91,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,GKACSTTYVBTVFY-JCZAHQRISA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL3335765,,O=c1ccc(-c2cccc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.31,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,KWBSFQPATIAOSN-DEOSSOPVSA-N,72.0,Cytotoxicity,WST8
CHEMBL2398338,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(I)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.32,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,UZYGIQDDFAEAQN-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2398337,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,7.05,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ROOGRPRNWIQQDK-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5398001,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.11,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,VHLKUFIUVFOKSP-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5436907,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C#N)c3)ccc2NS(C)(=O)=O)c1,IC50,5.3,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MMKJHFJHDJJWCS-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5413649,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(Br)c3)ccc2NS(C)(=O)=O)c1,IC50,5.57,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,HIOFAGZBNFHBTQ-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL5418601,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccs3)ccc2NS(C)(=O)=O)c1,IC50,5.46,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,LKMLRQDOTROMLW-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL4797378,,Cc1ccc(C)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c1,IC50,4.86,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,SMVGLVQESZULKI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4799197,,Cc1ccnc(NC(c2ccc(OCc3ccccc3)cc2)c2ccc3cccnc3c2O)c1,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,DNOYNFNXZASMBC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343379,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.62,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FTNYLEQWPAHOGD-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3343396,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5Cl)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JLCOBIOZIRCTOF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3623535,,CN(C)CCn1c2c(c3c4ccccc4c(O)cc31)C(=O)c1ccccc1C2=O,IC50,6.77,CHEMBL3626442,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation by MTT assay,U-87MG ATCC,BNGCHTGHSNZIMQ-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL3623536,,CN(C)CCCn1c2c(c3c4ccccc4c(O)cc31)C(=O)c1ccccc1C2=O,IC50,6.49,CHEMBL3626442,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation by MTT assay,U-87MG ATCC,DBMXTOFHRZLJSW-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5566435,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(C(C)C)cc1,IC50,5.37,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,PTQSQMGZFHNZJA-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL4204238,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.47,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IKAFRBGBNHGPLF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4213745,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.58,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASDPCMCMYGUYRD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5418635,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.47,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WCFCCDOJPGJVBQ-XDQLDVNZSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL2297267,,CCCNc1cc(-c2ccccc2)nc2cc(OC)cc(OC)c12,IC50,5.74,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,BJLGSPWOVYBXPO-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL5417824,,Cc1cc(Cc2c[nH]c3ccc([N+](=O)[O-])cc23)cc(C)c1O,IC50,4.13,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WLWADVZEPFXBBL-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL4227319,,Cc1nc(N)nc2sc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,5.24,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,UBCWTPNRACWDAI-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4228112,,Cc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.06,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,WJUJPSLJDDCZAM-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL4225483,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(Cl)s1,IC50,6.16,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,AUQPVAKLJJBNFN-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL5590802,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N1CCNCC1)C3,IC50,5.3,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PIZLVEIDCBQEAF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339368,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.43,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,QWZRHATYSBQMPY-BOABNOFISA-N,72.0,Antiproliferative activity,MTT
CHEMBL3339370,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OAZGFRFNDUWGJE-PTZDRTPLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1822928,,CCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.55,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,JQYZYQKWXGNSIW-UHFFFAOYSA-N,3.0,Unspecified,Unspecified
CHEMBL1774420,CASEARUPESTRIN D,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](OC(=O)/C=C\C=C\CCCCC)[C@H](OC(C)=O)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.37,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,KAIWHFAEAXEXOF-PDNIMGFCSA-N,72.0,Cytotoxicity,MTT
CHEMBL4476032,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.19,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CTERTLMYSCTHRG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4589156,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.78,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DIQRSOSRXNCKNT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4543837,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.25,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CMAXWGUPESWTSJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4436126,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.28,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XUNMGCAUOVQOGB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4452420,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O,IC50,4.7,CHEMBL4417156,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,FOPNWILAJGHOCW-FFJZLYMMSA-N,24.0,Cytotoxicity,CCK8
CHEMBL4580296,,O=C(CCCc1ccc(-c2cc3ccccc3cn2)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL4423119,Cytotoxicity against human U87 cells after 72 hrs by AlamarBlue assay,U-87MG ATCC,AMOLMRUARSNWSM-UHFFFAOYSA-N,72.0,Cytotoxicity,AlamarBlue
CHEMBL2165018,,COc1ccc(Nc2ncc(CN3CCN(S(=O)(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NRFWIMBKAYHJFY-UHFFFAOYSA-N,2.0,Unspecified,AlphaScreen
CHEMBL4447316,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.05,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YNPVEFLXALYKQO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4445854,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.3,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,PUGCWXBHZFBSAI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2164400,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.58,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,TZYCRYUQSNOYGP-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL4457290,,COc1cc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)cc(Br)c1OC,IC50,4.58,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,NVUFJWMQODHBNK-GZIVZEMBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1683545,,C=C(C)CN1CCO[C@@H](C[C@H]2O[C@H]3C[C@H]4O[C@@H](CC[C@@H]5O[C@@H](CC[C@@]67C[C@H]8O[C@H]9[C@@H](O6)[C@H]6O[C@H](CC[C@@H]6O[C@H]9[C@H]8O7)CC(=O)C[C@@H]3[C@H]2OC)CC5=C)C[C@@H](C)C4=C)C1,IC50,9.59,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,JBFLNPIQVUSWKG-BVBWJHDNSA-N,,Antiproliferative activity,Unspecified
CHEMBL4436746,,COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1,IC50,6.48,CHEMBL4309536,Growth inhibition of human SF295 cells incubated for 48 hrs by sulforhodamine B assay,SF295,JNRBIZYBWZXQKC-UHFFFAOYSA-N,48.0,Growth inhibition,sulforhodamine B
CHEMBL4215210,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(OC)cc4)c3=O)cc2)ccn1,IC50,5.14,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SWANNODYZURKDJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4126209,,COc1cc2cc3c(N)n[nH]c3nc2cc1OC,IC50,4.58,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,PWFMGWOLIUNSRG-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5427579,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCN(C)CC3)CC2)n1,IC50,5.78,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,CFBNFHFRAZDQNM-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL2424939,,N#Cc1c(-c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc(-c2cc(Cl)ccc2O)[nH]c1=O,IC50,4.51,CHEMBL5379452,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition,LN-229,NZRBRJQYGLEINZ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL3092913,,C=CCCCCOc1ccccc1-c1cnc(S(=O)(=O)c2ccccc2)n1C,IC50,4.15,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DKDHTSRRZSXYPT-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL2203622,,Cn1c2cnc1OCC/C=C\CCCCOc1ccccc1-2,IC50,4.0,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,AGLKQNJMUAORON-HYXAFXHYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3092930,,C#CCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.46,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JXZDXRISBRZIAA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093018,,C=CCCCCOc1ccc(F)cc1-c1cnc(OCCC=C)n1C,IC50,4.06,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CSIJDNPARFEYCV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL3093027,,Cn1c2cnc1OCCCCCCCCOc1ccc(F)cc1-2,IC50,4.11,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,IGAPMBZCWRQXDN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT-based colorimetric
CHEMBL85048,,COc1cccc2cc(-c3ccccc3)c(O)nc12,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,WKUIEDQCNTVPIR-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL4437779,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(C)cc43)S2)cc1,EC50,6.64,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RXWBUUZJSGAQNO-ZIADKAODSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1927611,,CCCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCN(C)C)C3=O,IC50,5.84,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WGNOVGWSADFUFQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4210516,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,8.7,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,SALXJHIWNUWMJC-RKHHLZPHSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL1914717,,O=S(=O)(Nc1cc(-c2ccc3nnccc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.72,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,VCBPUBKXIUCCIO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914720,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCCCC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.3,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ZCCGGRQYWABCQX-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914737,,CN(C)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.36,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,SFNZMGFKQRJYOV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL1914740,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4C[C@H]5CC[C@H](CC5)C4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.61,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YMALNMKYJXDZRH-HDICACEKSA-N,,Unspecified,Unspecified
CHEMBL1928602,,Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H]3COC4=C(C(=O)c5ccccc5C4=O)[C@H]32)cc1,IC50,5.41,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,NYYWIMCKZBTYCE-OFNKIYASSA-N,72.0,Unspecified,MTT
CHEMBL599620,,O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccc([N+](=O)[O-])cc3[C@H]1CO2,IC50,5.05,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,HKGUYNZPILAARL-ACJLOTCBSA-N,72.0,Unspecified,MTT
CHEMBL3112718,,COc1ncc(-c2cnc3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.2,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PXMBVEZQNFLFAI-UHFFFAOYSA-N,96.0,Antiproliferative activity,Celltiter-Glo luminescence cell viability
CHEMBL5417439,,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@@]1(C)[C@H](C2)C(C)(C)[C@H](O)C[C@@H]1O,IC50,6.29,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,QSGMDCONBUKXFI-ZLSLZSISSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5416867,,C#CCOc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.54,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,OCLGZGCWFAWRSR-UQWWERDESA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL4741608,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)c1,IC50,6.0,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NIXLRJFSGVRJDB-NTEUORMPSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL4440344,,CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,IC50,5.72,CHEMBL4417156,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,LUTSMTMYLLRKGQ-BHUDLXTMSA-N,24.0,Cytotoxicity,CCK8
CHEMBL4781277,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(-c3ccccc3)nc12,IC50,6.38,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DXMKHNHIGFRRCN-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4209066,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4)c3=O)cc2)ccn1,IC50,5.29,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LXOUSUKBGVWKHI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4868381,,CC12CC3CC(C)(C1)CC(NCc1cccc(NC(=O)CCCCCCC(=O)NO)c1)(C3)C2,IC50,5.85,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,HVRZKHZWMPYXIF-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL4860287,,CC12CC3CC(C)(C1)CC(NCc1ccc(NCc4ccc(C(=O)NO)cc4)cc1)(C3)C2,IC50,5.62,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,OYYLVIRWYJWNIM-UHFFFAOYSA-N,1.0,Antiproliferative activity,MTT
CHEMBL36,PYRIMETHAMINE,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,IC50,4.69,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,WKSAUQYGYAYLPV-UHFFFAOYSA-N,,Growth inhibition,Unspecified
CHEMBL105784,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1,IC50,9.22,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KHXJCLMSOWKPMR-BGABXYSRSA-N,,Unspecified,Unspecified
CHEMBL4462577,,COc1ccc(-c2cc(OCCN(C)c3ncc(C(=O)NO)cn3)c3ncnc(C)c3c2)cn1,IC50,6.47,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,GVPYBTYCSMGVJF-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL2407685,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.46,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,OOZUTWKHVKEHJA-HAIPHDKGSA-N,72.0,Cytotoxicity,resazurin
CHEMBL2407575,,CCC1=C[C@@H]2CN(C1)/C(C(=O)OC)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WOCJLYOUBCFBGS-OUEVRHDASA-N,72.0,Cytotoxicity,resazurin
CHEMBL2407572,,CCC1=C[C@@H]2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,6.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,IRMFYALZOGMPTP-WPHLDODYSA-N,72.0,Cytotoxicity,resazurin
CHEMBL415960,,O=c1[nH]c(=O)n([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)cc1F,IC50,4.38,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,FLAHATSCJQFZKB-TYQACLPBSA-N,,Cytotoxicity,Unspecified
CHEMBL443747,,Cc1ccc2c(N3CCN(C)CC3)nc(-c3ccccc3C)cc2c1,IC50,5.18,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,CQNQPKDGOOMWLD-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL3335762,,O=c1ccc(-c2cccc(Cl)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.0,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,ZNHGQRICZRXNDO-DEOSSOPVSA-N,72.0,Cytotoxicity,WST8
CHEMBL3335783,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(-c5ccc(OCCN6CCOCC6)c(Cl)c5)cn4)CCO3)n2)c1,IC50,5.85,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,YYJDVXLJGBXQRF-MHZLTWQESA-N,72.0,Cytotoxicity,WST8
CHEMBL4520508,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.49,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,ZZCQHDGFTSZZOY-BJMVGYQFSA-N,72.0,Cytotoxicity,MTT
CHEMBL4447323,,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.46,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,KMNSOGVLHRWNCE-MDWZMJQESA-N,72.0,Cytotoxicity,MTT
CHEMBL2385199,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C(F)(F)F)ccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.85,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JYQLVVOBTMGKEW-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL539855,,CN1CCOc2cccc3nc(O)c(nc23)-c2cccc3c(=O)n(sc23)CC1.Cl,IC50,7.89,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,UAWACQSTQPYGJL-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3618231,,COc1ccc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.4,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,GMDFBJKMPHZUTJ-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3618240,,COc1ncc(Nc2nc3ccc(N4CCN(C(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,6.53,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,OWFAMDTUROKDJB-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL3618245,,COc1ncc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,8.35,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,IYNZEXDVRAZUPW-UHFFFAOYSA-N,2.0,Unspecified,compound wahout by alpha screen
CHEMBL5281433,,c1ccc(-c2nc(CNc3nccc(NC4CCCCC4)n3)cs2)cc1,IC50,4.93,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ROALZJVDIFVDHW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3715519,,O=C(/C=C/c1ccc2cccc(O)c2n1)c1ccncc1,IC50,5.78,CHEMBL3720731,Inhibition of cell proliferation of human U87MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,DROJYBGOPVMSMV-VOTSOKGWSA-N,48.0,Unspecified,MTT
CHEMBL5618668,,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,BXPIBHVYDBWEDU-NDEPHWFRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL255342,,O=C1/C(=C/c2cccs2)CC/C1=C\c1cccs1,IC50,4.46,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,KPFZCKDPBMGECB-WGDLNXRISA-N,,Growth inhibition,Unspecified
CHEMBL315586,,COc1cc(OC)c2cc(-c3ccc(OC(C)=O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,DPKRAOIUIBYOGG-UHFFFAOYSA-N,,Cytotoxicity,MTT
CHEMBL5185523,,O=C(NC1CCCCC1)c1[nH]cnc1-c1nc2ccccc2[nH]1,IC50,4.21,CHEMBL5117724,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay,LN-229,JABMGIWPHDQZBN-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5191048,,CN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.9,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,VMBGOURPMZPQKK-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5202758,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3CC3)CC2)cc1)OCc1cccnc1,IC50,5.98,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YIZPEFOMDBKNLH-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5198901,,COCCN1CCN(c2ccc(N)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.25,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YNEHDLYTCXJMDF-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5195459,,COCCN1CCN(c2ccc(Br)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.58,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,DNCCJXQJWBFRJN-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5170843,,COCCN1CCN(c2c(C)cccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.0,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,XZKSUYJOLGVZJU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5290555,,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O,IC50,4.73,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,NEIQYEKCZHGMGF-OZUVFQIFSA-N,4.0,Cytotoxicity,MTS
CHEMBL4520892,,Fc1ccc(/C=N/Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1F,IC50,4.52,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,XDKIXIWBMYDGIV-LIMNOBDPSA-N,48.0,Antiproliferative activity,MTT
CHEMBL3600441,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.49,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BQXGFTKZRMUKEA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL3588937,,CC[C@H](C)C(=O)Oc1ccc(/C=C/COC(C)=O)cc1OC,IC50,6.32,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,OGNZVIKZDOKDLK-SYTKJHMZSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL5082185,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.45,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,MZYJAIGPHMIGGJ-MPOPNXFASA-N,96.0,Antiproliferative activity,MTT
CHEMBL4875135,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNC(=O)c3ccco3)c2C1=O,IC50,5.59,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,LLOJEEJKHZKUMN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4848269,,COc1ccc2[nH]cc(CCn3nnc4c3C(C)(C)[C@@H]3CC[C@]5(C)[C@H](CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O)CC[C@]65C)[C@@]3(C)C4)c2c1,IC50,4.36,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,MVMWIJMMJOGXPC-CXAHALKTSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4854240,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@H](O)[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]43)C2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.54,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,RNWIIGNOXMOPCU-HFXUAUAYSA-N,72.0,Anticancer activity,CCK8 reagent
CHEMBL5631831,,C#CCO[C@H]1C=C(C(C)C)[C@]2(CCCC(=O)O2)[C@H]2CC[C@]3(C)C(=CC(=O)O[C@H]3c3ccoc3)[C@]12C,IC50,6.11,CHEMBL5627877,Anticancer activity against human A-172 cells assessed as reduction in cell viability incubated for 72 hrs by Alamar Blue assay,A-172,ZEXXLMFXMQNCPC-UQJYIFJESA-N,72.0,Anticancer activity,Alamar Blue
CHEMBL4206033,BAY1436032,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,IC50,7.82,CHEMBL5625292,Antiproliferative activity against human LN-229 cells assessed as reduction in cell growth incubated for 5 days by Celltiter-Glo assay,LN-229,RNMAUIMMNAHKQR-QFBILLFUSA-N,120.0,Antiproliferative activity,Celltiter-Glo
CHEMBL5631626,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc(F)c(N4C(=O)OCC4(C)C)n3)cc2)CC1,IC50,7.73,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,FUDYXUKVOLBVPN-KRWDZBQOSA-N,132.0,Antiproliferative activity,MTT
CHEMBL1800934,,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,IC50,8.36,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,MLQLUFQBFMFXJO-QKKBWIMNSA-N,48.0,Unspecified,Unspecified
CHEMBL4859606,,CN(C)c1ccc(/C=C/c2cc(/C=C3\Sc4ccccc4N3CCCN3CCOCC3)c3ccccc3[n+]2C)cc1.[I-],IC50,4.82,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,GWKIKXZINVGPPC-UHFFFAOYSA-M,48.0,Antiproliferative activity,MTT
CHEMBL5567846,,COc1ccc(N(Cc2cn(S(=O)(=O)c3ccc(C)cc3)nn2)C2=CC(=O)c3ccccc3C2=O)cc1,IC50,6.38,CHEMBL5514115,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,YYCWDXYXDBGOSK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5573795,,N#CC1=C(N)Oc2c(ccc3cccnc23)C1c1ccc(Cl)c(Cl)c1,IC50,5.21,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,RHAXVWDHVALGPB-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5572022,,N#CC1=C(N)Oc2c(cc(Cl)c3cccnc23)C1c1ccccc1,IC50,5.36,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GOOCOOVJUWBXFS-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5568956,,COc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)c(OC)c1OC,IC50,5.28,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WAEKICOBONBQNO-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5575261,,COc1cc(OC)c(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1OC,IC50,5.33,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GVXBTRKMBKAEMP-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL4789623,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,IC50,5.47,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,NLPAQCHZGISERZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL5572679,,N#CC1(C(=O)Nc2ccc([N+](=O)[O-])cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.71,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,QKMWZJJOEMMGRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5594023,,N#CC1(C(=O)NCCc2ccc(Cl)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.11,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SYLBGAKAQUBPER-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4778389,,C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)[C@H]3O[C@H]3[C@]3(C[C@@H]([C@H](C)O)C(=O)O3)[C@]1(C)[C@@H]2OC(=O)CCCCCCCCCCC,IC50,6.16,CHEMBL4703288,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by CellTiter Glo assay,U-87MG ATCC,DQJKVVGTJNBSOS-FNWZZRCQSA-N,72.0,Antiproliferative activity,CellTiter Glo
CHEMBL5569152,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.54,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,GVMAIWHRYQNXBM-ODVYPAPQSA-N,72.0,Cytotoxicity,CCK8
CHEMBL4636205,,COc1ccc2c(c1)O[C@@H]1c3cc(OC)c(OC)cc3OC[C@H]21,IC50,5.44,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-FZKQIMNGSA-N,72.0,Cytotoxicity,MTT
CHEMBL3797933,,Nc1nc2cc(-c3nn(CC4CCCC4)c4ncnc(N)c34)ccc2o1,EC50,7.89,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,GUFVTKTWKYLOQP-UHFFFAOYSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL3797834,,Nc1nc2cc(-c3nn(CC4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-UHFFFAOYSA-N,120.0,Antiproliferative activity,Prestoblue reagent based
CHEMBL4209984,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.49,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UDAGYKCSEKUJCJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4094401,,C=C(c1ccc(OC)cc1)c1nc(C)cc2ccccc12,IC50,6.52,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,ACIGFOPJVNVVEM-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4104557,,C=C(c1ccc(OC)cc1)c1cc(C(N)=O)nc2ccccc12,IC50,6.62,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,GRCGUFRAVOMYDW-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL1821794,EUPHODENDROPHANE D,C=C1[C@@H](OC(C)=O)[C@@H](OC(=O)c2ccccc2)[C@@H](OC(C)=O)C(C)(C)/C=C/[C@@H](C)C(=O)[C@@]2(O)C[C@H](C)[C@H](OC(=O)C(C)C)[C@@H]2[C@H]1OC(C)=O,IC50,4.28,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ZDNXSCUQPPKQFI-GIDYPEMCSA-N,72.0,Anticancer activity,SRB
CHEMBL4076617,,Cc1cc(=O)n(-c2cccc(C(F)(F)F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)c(F)c1,IC50,5.64,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KLBRHXOKSPCITH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385203,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.61,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LGOXXSVEWLLEKB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2385189,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Br)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.67,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MSITUNSZTDTYHG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4777512,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc(CS(=O)(=O)N(C(C)C)C(C)C)c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.62,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GPZJQNHHEUXZBK-LJRMQGSKSA-N,72.0,Antiproliferative activity,SRB
CHEMBL102809,,O=C1c2cccnc2C(=O)c2ncc(CBr)cc21,IC50,6.3,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,BURDIDMYOSZEKU-UHFFFAOYSA-N,,Cytotoxicity,using SRB
CHEMBL1782894,,CCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.75,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,XFTYNIHRCPHPLE-QQJYNPJZSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL1782908,,CCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.0,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZWDSPRLENGPJSS-GVQBMFDGSA-N,48.0,Cytotoxicity,sulforhodamine B
CHEMBL4100154,,CCCCc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)cc1,EC50,5.24,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,GZGDJNZTNKYESX-PKNBQFBNSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2170092,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2ccc(Cl)nc2)n1,IC50,7.46,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,DDOGMZTWQKWDBQ-UHFFFAOYSA-N,2.0,Unspecified,Unspecified
CHEMBL2164699,,Cc1c2c(cc[n+]1CCO)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,5.54,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,WQWPESUTDGGMLK-UHFFFAOYSA-M,72.0,Growth inhibition,MTT
CHEMBL5562495,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VVLHCHPQYBPEER-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5072935,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.4,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,CUINUPNRWNLOJW-VZTVURHLSA-N,96.0,Antiproliferative activity,MTT
CHEMBL5081089,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C#N)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.33,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,HVZRIWTYRLQBBL-MPOPNXFASA-N,96.0,Antiproliferative activity,MTT
CHEMBL5560744,,O=C(CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O)NCc1ccccc1,IC50,4.75,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DPMNMEXKPODRQY-MRXNPFEDSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5561001,,CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.54,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KLVWGRQAXNOKKU-LLVKDONJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5568088,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NCC(C)C)C(=O)O)cc1,IC50,4.58,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FPNCESYOAUSRJV-CQSZACIVSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5558526,,CCCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.48,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,PIUOPAFPGCAJPW-OAHLLOKOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5078850,,Cc1ccc(NC(=O)C[C@H]2SC(NC(c3ccc(F)cc3)c3c(O)[nH]c(=O)[nH]c3=O)=NC2=O)cc1C,IC50,4.33,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,IOCQRHYFRXFFQW-VTBWFHPJSA-N,24.0,Cytotoxicity,CCK8
CHEMBL1558546,,COc1ccc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)C(C)C)cc2)cc1,IC50,4.25,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,UQCKAVVYNFPENZ-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5284601,,CCN(CC)c1ccc2cc(-c3nc4cc(C5=NCCN5)ccc4[nH]3)c(=O)oc2c1.Cl,IC50,5.85,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,UIOIAAZYDYFLLF-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL9514,NOCODAZOLE,COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1,IC50,7.0,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,KYRVNWMVYQXFEU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter96 Aqueous One Solution cell proliferation
CHEMBL4792276,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)NC,IC50,5.89,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JHGVHNNCSQFDDF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4454458,,COc1cc(-c2ccc(O)c(O)c2)c(OC)c(O)c1-c1ccc(OCC=C(C)C)c(O)c1,IC50,4.86,CHEMBL4344200,Cytotoxicity against human U87 cells after 24 hrs by SRB method,U-87MG ATCC,BAJXGZAFNOHQFY-UHFFFAOYSA-N,24.0,Cytotoxicity,SRB
CHEMBL4072042,,COC(=O)[C@H](NC(=O)COCCOCCOCCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1)C(C)C,IC50,6.96,CHEMBL4041767,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,MVGCPIGVTXRNLD-UUWRZZSWSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4577957,,COc1ccc(C(C(=O)NC(C)(C)C)N(C(=O)/C=C/C(=O)c2ccc(C)cc2)C(C)C)cc1,IC50,6.34,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QTNSHHDKLYQCRG-WUKNDPDISA-N,72.0,Cytotoxicity,MTT
CHEMBL4589636,,COc1cc(C(C(=O)NC(C)(C)C)N(CCC(C)C)C(=O)/C=C/C(=O)c2ccc(F)cc2)cc(OC)c1OC,IC50,5.54,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JUDLAZMMKWRKDD-BUHFOSPRSA-N,72.0,Cytotoxicity,MTT
CHEMBL2407901,,COCCOc1ccc2cc1OCC(=O)N(C)CCCN(C)Cc1c[nH]c3ncnc(c13)N2,IC50,8.3,CHEMBL5513260,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 72 hrs by AlamarBlue assay,U-87MG ATCC,HGGMHYCPDXPSRF-UHFFFAOYSA-N,72.0,Antiproliferative activity,AlamarBlue
CHEMBL2397988,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(O)c2)c(OC)c1,IC50,7.58,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,GZAXTJIYUCUXDY-BQYQJAHWSA-N,96.0,Cytotoxicity,sulforhodamine B
CHEMBL2397992,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(N)c2)c(OC)c1,IC50,8.05,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,OLRRWEXEHIWZJV-BQYQJAHWSA-N,96.0,Cytotoxicity,sulforhodamine B
CHEMBL4446068,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.25,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BCGLFSYECNRIGQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5570163,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1cccc(Cl)c1Cl,IC50,5.43,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,NUPVGXXBPQRNFR-UHFFFAOYSA-N,48.0,Antiproliferative activity,CCK-8
CHEMBL5559617,,N#Cc1ccc2nc(NC(=O)Nc3cccc(Cl)c3)sc2c1,IC50,6.07,CHEMBL5506204,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 6 days by RealTime-Glow MT cell viability assay,LN-229,URCZUKFRZQNQSQ-UHFFFAOYSA-N,144.0,Antiproliferative activity,RealTime-Glow MT cell viability
CHEMBL2417823,,CCOCCNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.09,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WOVOBVDLACIZOX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL2417819,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.51,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,HDBBMQFYARREDI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5193900,,CC(C)N1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.6,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,ZDWBQZIZWCJTMO-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL5203979,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CCO)CC2)cc1)OCc1cccnc1,IC50,6.19,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WYOGQUUJNMLBBR-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK8
CHEMBL4561563,,COc1ccc(-c2cc3c([nH]c(=O)n3-c3cc(OC)c(OC)c(OC)c3)c(C(N)=O)n2)cc1O,IC50,6.25,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WUZIEGHVPAZRFN-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5560224,,COc1cc(-n2cnc3ccc(-c4ccc(C)c(N)c4)nc32)cc(OC)c1OC,IC50,7.82,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WAGLVYSVXYGSOH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4850400,,O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCOCC4)c3c2)cnc1Cl)c1ccccc1,IC50,5.7,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,LXWMLQCBWUVOFP-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL2333591,WITHAMETELIN O,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)CC=CC(=O)[C@]4(C)[C@H]3CC[C@]12C,IC50,5.96,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QDXNBCJROMNCKV-YAZLIRBPSA-N,72.0,Cytotoxicity,MTS
CHEMBL389390,,C[C@@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,6.74,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-APPDUMDISA-N,48.0,Unspecified,Unspecified
CHEMBL5591538,,Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,4.72,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,ABRYOLABXRIXQY-UHFFFAOYSA-N,1.0,Growth inhibition,compound washout and light irradiation measured after 72 hrs by MTT
CHEMBL5427204,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2ccccc2CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,5.2,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,SUXHRWAZLZFIAB-ZBLPZKBESA-N,48.0,Unspecified,CCK-8
CHEMBL5400289,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2cccc(c2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,4.97,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,HVBFVEAXTBQINV-RUZHBQKASA-N,48.0,Unspecified,CCK-8
CHEMBL5180831,,CC(C)=CCC(OC(=O)CCC(=O)Nc1ccc(Oc2ccccc2)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.42,CHEMBL5098102,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,MIBZPPSVQUCRDI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL27,PROPRANOLOL,CC(C)NCC(O)COc1cccc2ccccc12,IC50,4.12,CHEMBL5033045,Antiproliferation activity against human T98G cells measured after 72 hrs by crystal violet staining based assay,T98G,AQHHHDLHHXJYJD-UHFFFAOYSA-N,72.0,Antiproliferative activity,crystal violet staining based
CHEMBL5279871,,Nc1c([N+](=O)[O-])cnc(NC2CCCCC2)c1[N+](=O)[O-],IC50,5.5,CHEMBL5230754,Cytotoxicity against human U87 cells assessed cell growth inhibition incubated for 2 days by MTT assay,U-87MG ATCC,YGFOLYFTLSRURR-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL5179749,,O=C(CCl)n1c(-c2cc3ccccc3oc2=O)nc2ccccc21,IC50,6.47,CHEMBL5126907,Anticancer activity against human U-87 MG cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NPBMRKAPXAXYOK-UHFFFAOYSA-N,72.0,Anticancer activity,MTT
CHEMBL5084521,,CCC1(CCCc2ccccc2)CCN(c2cc(N)nc(N)n2)CC1,IC50,5.6,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,NZZRGWCFVCHLMJ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL2029363,,COc1ccc(/C=C/C(=O)c2cccc(I)c2)cc1,EC50,4.87,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KGQYENFXOZQJMC-JXMROGBWSA-N,72.0,Antiproliferative activity,SRB
CHEMBL2237320,,O=C(O)/C(=C\c1cccc(O)c1O)c1ccccc1,IC50,4.01,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,HVWOBICWAVJFIV-XFXZXTDPSA-N,48.0,Cytotoxicity,SRB
CHEMBL5618805,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@@H]1CCCO1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,MJHSFRDACBYUCG-UDNBHOFDSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5404116,,O=C(Nc1ccc(OS(=O)(=O)c2ccccc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.14,CHEMBL5332778,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition,SNB-75,NYTJZFKTUQYXEN-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4764865,,CCCCCCCCCC(=O)O[C@@H]1[C@@H]2OC(=O)[C@@H]([C@@H]2C(C)C)[C@]2(O)[C@H]3O[C@H]3[C@]3(C[C@](O)([C@H](C)OC)C(=O)O3)[C@]12C,IC50,6.16,CHEMBL4703288,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by CellTiter Glo assay,U-87MG ATCC,JATXQDKTIIOOJF-LGLGYDADSA-N,72.0,Antiproliferative activity,CellTiter Glo
CHEMBL5556585,,N[C@@H]1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,5.7,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DKTKUPGWANWPSS-LLVKDONJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5571085,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CN2CCC1CC2)C3,IC50,5.72,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,CFPMIAZXFUSXFT-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5590332,,NCCNC(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.58,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,UAFZPRBWBJJMKI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5618084,,O=C(NO)c1c(Cl)cc2c(c1Cl)CCN(C(=O)c1cc3ccccc3[nH]1)C2,IC50,5.51,CHEMBL5614661,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,CSPSXNPSWROICV-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL101506,PINOSYLVIN,Oc1cc(O)cc(/C=C/c2ccccc2)c1,IC50,4.05,CHEMBL5614823,Antitumor activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YCVPRTHEGLPYPB-VOTSOKGWSA-N,48.0,Unspecified,CCK-8
CHEMBL4560404,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc(Nc3ccccn3)c3nsnc23)nn1,IC50,6.32,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,ZLFDIBARBTYWTJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5191451,,O=C(NCCc1ccc2c(c1)OCO2)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.63,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GJWCCGFDLGWEPL-UHFFFAOYSA-N,72.0,Cytotoxicity,PrestoBlue reagent based cell viability
CHEMBL4796767,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1,IC50,5.32,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,WYWRHENCLIRCQN-GIDUJCDVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL1963047,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21,IC50,4.57,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,MUEMGQSGNZKFJI-UHFFFAOYSA-O,72.0,Cytotoxicity,alamar blue
CHEMBL5185656,,CCN(Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2)C(C)C,IC50,4.04,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,DKIPQTQYFUGDIF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4789700,,CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1CC=C1C(=O)OC[C@@]12O,IC50,4.98,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,VKALAWOSHGRQLE-UOVKNHIHSA-N,72.0,Antiproliferative activity,sulforhodamine B
CHEMBL4790976,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NNC3=NCCN3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.68,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,MISLLMBLUFYMSV-HSHPMGMFSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4794792,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCN2CCCC2)C(=O)C=C(NCCCN2CCCC2)C1=O)OC,IC50,5.07,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,HVIZDCKOTOTUSS-VIWRZIFASA-N,72.0,Antiproliferative activity,SRB
CHEMBL4795680,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccccc3F)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.98,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CFCPSPSXDXPSNF-TVYXGFEUSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4777420,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(CS(N)(=O)=O)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.56,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,BQRHZZRVKLDJPT-COPNASJUSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4799181,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN3CCCC3=O)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.75,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WXJOUBTZJSXXHL-YFBAPNSQSA-N,72.0,Antiproliferative activity,SRB
CHEMBL3622533,FIMEPINOSTAT,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,IC50,8.15,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,JOWXJLIFIIOYMS-UHFFFAOYSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4576273,,CNC(=S)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,IC50,4.13,CHEMBL4415221,Cytotoxicity activity against human T98G cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,T98G,KOTBLJFSPQDYRP-ILWGZMRPSA-N,72.0,Cytotoxicity,MTT
CHEMBL4065200,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.82,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SIYNNPMXYLMWRK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4084900,,OCCc1c(-c2ccccc2)[nH]c2ccccc12,EC50,3.96,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,BUHQDNJEIACSBT-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL226545,TRYPTOPHOL,OCCc1c[nH]c2ccccc12,EC50,3.24,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,MBBOMCVGYCRMEA-UHFFFAOYSA-N,72.0,Cytotoxicity,SRB
CHEMBL1669125,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.71,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,VKANVHXFBJQXLP-OWIQXKKRSA-N,48.0,Cytotoxicity,MTT
CHEMBL5198581,,c1c(CN2CCCCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.19,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,USYQRHGGZWJHHN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5405131,,CCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.62,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,JWEWUMAOGAJRFE-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5412755,,CC(C)Oc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,6.83,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,JZKJUGGOUQDPMN-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5423916,,C#CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,FZIXQPIRVNNTOM-UHFFFAOYSA-N,72.0,Cytotoxicity,cell titer-glo luminescent
CHEMBL5219304,,N#Cc1c(N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.23,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,SCOWIOYWMUWXIE-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5280637,,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,4.76,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,LTYNXVKTWDPHFB-NIEMNNIISA-N,4.0,Cytotoxicity,MTS
CHEMBL5397397,,COc1ccc([C@H]2[C@H](COC(=O)c3ccc(C(=O)O)cc3)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,6.37,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,XUANTVDRXBBKKU-CYFREDJKSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5394069,,O=C1c2nc3ccccc3c(=O)n2C2C=CC(F)=CC12,IC50,7.22,CHEMBL5386675,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,UCPXJPWNFMCNGL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5574889,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.49,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,AVLMGGDRKCUXNX-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5565419,,N#CC1(C(=O)NCCc2cccc(F)c2)CC2c3ccccc3C1c1ccccc12,IC50,4.48,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,MINIVHBJXIKTDA-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5570552,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(CCl)c3ccccc3C1c1ccccc12,IC50,4.22,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,HJZLJCJZFZIGQD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5589895,,CC12CC(C#N)(C(=O)NCCc3ccc(F)cc3)C(c3ccccc31)c1ccccc12,IC50,4.54,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BMAULUQSRDFIMN-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5569947,,O=C(NCCC1CCN(Cc2ccccc2)CC1)C1(Cl)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.91,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,GRPGOWYCBMOEDP-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5568864,,N#CC1(C(=O)NCCc2ccc(Br)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.01,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,CBORGTCUMVCDNJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5566352,,CC(C)c1cc(-c2cncn2C2CC2)c(O)cc1O,EC50,4.09,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,CDVWSEQXFMRSLI-UHFFFAOYSA-N,72.0,Antiproliferative activity,Alamar Blue
CHEMBL5084833,,O=C(NCCc1ccccc1)c1ccc(N2C[C@@H]3C[C@H](C2)c2cccc(=O)n2C3)c(NS(=O)(=O)c2cccc(Cl)c2)c1,IC50,4.25,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,IBUZEKDFVKRIMO-UKILVPOCSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5091451,,COc1ccc(Cn2c(SCC(=O)n3c4c(c5ccccc53)CCCC4)nc3ccccc32)cc1,IC50,4.05,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,OROYCXKEWCOECY-UHFFFAOYSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5071699,,O=C(C1=C(O)C(=O)N(CCc2c[nH]c3ccccc23)[C@@H]1c1cccc(O)c1)c1ccc(Cl)cc1,IC50,4.26,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,VAJYWPOLVMLRQQ-XMMPIXPASA-N,24.0,Cytotoxicity,CCK8
CHEMBL5201426,,CC(C)=CC[C@@H](OC(=O)CCC(=O)Nc1ccc(Oc2ccccc2)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.42,CHEMBL5138627,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,MIBZPPSVQUCRDI-HHHXNRCGSA-N,48.0,Anticancer activity,MTT
CHEMBL1169610,,N[C@]1(CNC(=O)c2ccc(F)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.44,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,CIUDTEMUAJXOJA-SFHVURJKSA-N,1.0,Unspecified,ELISA
CHEMBL5085058,,Nc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)ncn1,IC50,4.7,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,ZOTMPAOQJWQQTF-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL598013,,NC1(Cc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ncc23)CC1,IC50,7.8,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,ZFVMFXQNRBEZFM-UHFFFAOYSA-N,96.0,Antiproliferative activity,SRB
CHEMBL2407570,,C=CCNC(=O)[C@@H]1[C@H](C(=O)OC)Cc2c([nH]c3ccccc23)[C@@](C(=O)OC)(c2cc3c(cc2OC)N(C)[C@H]2[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]32[C@@H]54)C[C@@H]2C=C(CC)CN1C2,IC50,8.0,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BKGZSICZXAUIEC-AIURUJAXSA-N,72.0,Cytotoxicity,resazurin
CHEMBL4457896,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.76,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DXBRPGIDDDERSJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4465102,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,4.89,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SLMKYOATISOBCY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2407576,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NCc1ccccc1)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.0,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,JYNSQZYXYMMRCR-KCAACJCTSA-N,72.0,Cytotoxicity,resazurin
CHEMBL4862657,,Clc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.52,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,OPJWIMGLGACYQU-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL4859618,,c1ccc(Sc2c(-c3ccsc3)nc3ccccn23)cc1,IC50,4.23,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,JAKCVTVOHLWYMB-UHFFFAOYSA-N,48.0,Anticancer activity,MTT
CHEMBL117427,,COc1cnc2c3c(nccc13)-c1cccnc1C2=O,IC50,7.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,ULSFNUQXUHMWNZ-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL221264,,Cc1cc(N2CCCCC2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,8.39,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,SAKNCIOIYNBASO-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL220771,,Cc1cc(N2CCN(C(=O)C(C)C)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,8.72,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL424756,,Cc1cc(N2CCN(S(C)(=O)=O)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DKDAINNDAVRQIB-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5579660,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.61,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,WJHAJXOQPHTYDU-MFMXYXMPSA-N,72.0,Cytotoxicity,CCK8
CHEMBL4776995,,COCCOCCOCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.1,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CLEROOQKZZNPCB-OHNMWDNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4788059,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(C(=O)OC(C)(C)C)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,7.08,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,VXJBHECSURPXCH-AJRNXTKXSA-N,72.0,Antiproliferative activity,SRB
CHEMBL468384,,CC1(C)CC(NC(=S)Nc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.43,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,UHBQMDJDZKZNBH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL468570,,COc1ccccc1NC(=S)NC1CC(C)(C)Oc2ccc(Br)cc21,IC50,4.38,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YOBAVTGWSRCIHE-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL609853,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(Br)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,ZIJLARUXEXUTGH-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL2041939,,O=[N+]([O-])c1cccc(NC(=S)NC2CCOc3ccc(Cl)cc32)c1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KTZDWMQYTLYXRJ-UHFFFAOYSA-N,72.0,Growth inhibition,MTT
CHEMBL4459344,,O=C(O)CNC1=CC(=O)c2ccccc2C1=O,IC50,5.62,CHEMBL4423116,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JBLAYIBZIRMMIJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4463379,,CC(C)=CCC1=C(NCCCCN(CN)CCCc2ccccc2)C(=O)c2ccccc2C1=O,IC50,5.37,CHEMBL4423115,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KCCDBBFLENUYEW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL3109730,,O=C1C=C(O)C(=O)C(CC2CCC3CCCCC3C2)=C1O,IC50,4.63,CHEMBL4423115,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZYJWXCFHIXLPHN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL373881,,CS(=O)(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.15,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KPPHWLDGUOOBEH-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL290548,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.42,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL497600,,COCOC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,WPYKJACQQNTKNZ-FJNYLYSMSA-N,168.0,Cytotoxicity,Unspecified
CHEMBL4078390,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(CO)cc3n2)C[C@H](C)O1,IC50,5.18,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,PNVPFJFQLFNCRW-TXEJJXNPSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4076699,,Cc1c(-c2ccn[nH]2)sc2c(N3CCOCC3)nc(N3C[C@@H](C)O[C@@H](C)C3)nc12,IC50,5.06,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,XDZQUDSFDVBLAQ-BETUJISGSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL2417817,,O=C(Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1)C1CC1,IC50,4.96,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NPRACIZSBGXOJC-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL1631907,,O=C1[C@@H]2CS[C@]3(C(=O)Nc4ccccc43)N2C(=O)N1Cc1ccc(Cl)cc1,IC50,5.6,CHEMBL4423096,Antiproliferative activity against human U87MG cells after 48 hrs by MTS assay,U-87MG ATCC,POVQHLNFAUGINO-HNAYVOBHSA-N,48.0,Antiproliferative activity,MTS
CHEMBL2419658,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(Cl)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.62,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OISVKZQFIIKGRN-QLQYKETESA-N,72.0,Cytotoxicity,MTT
CHEMBL4591450,,Nc1c(-c2cccnc2)ncc2c1C(=O)c1c(-c3ccccn3)nn(-c3ccc(F)cc3F)c1C2=O,IC50,5.6,CHEMBL4423108,Antiproliferative activity against human U87MG cells after 72 hrs by coulter counting analysis,U-87MG ATCC,IOIRIAXEZBQMFS-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4741412,,Cc1nn(C)c(Oc2cccc(Cl)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.07,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YRHOSPRJJFQXQC-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4789652,,Cc1nn(C)c(Oc2ccc(I)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.78,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,WTFHVKBAPQTCPD-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2035436,,CCOC(=O)/C(C#N)=C/c1c2ccccc2nc2ccccc12,IC50,4.26,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,DQRHRTFTKBWRQW-ACCUITESSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4440446,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)cc1F,IC50,4.09,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,WATIGWMSDNNQOX-HOINCJJXSA-N,72.0,Cytotoxicity,SRB
CHEMBL4475212,,Cc1cn([C@H]2C[C@H](OC(=O)OC(C)(C)C)[C@@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,5.16,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,AYRRJYFNWXNEKO-KXHDOTFISA-N,72.0,Cytotoxicity,SRB
CHEMBL4550927,,O=C(Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](OC(=O)c3ccccc3)C2(F)F)c(=O)n1)c1ccccc1,IC50,5.26,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,MLUVLOZVYSIBBN-VNSBPBJWSA-N,72.0,Cytotoxicity,SRB
CHEMBL4561418,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(COC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(N)nc2=O)C1(F)F,IC50,5.66,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BJQYGWHXZWDCFZ-YFYJLLRASA-N,72.0,Cytotoxicity,SRB
CHEMBL129,ZIDOVUDINE,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,4.92,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,HBOMLICNUCNMMY-XLPZGREQSA-N,72.0,Cytotoxicity,SRB
CHEMBL4444594,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCC(C)O)CC3)cc2)ncc1Cl,IC50,6.06,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,HPSJXDROBGLIOR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4469292,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1Cl,IC50,6.7,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QGKIOGPLCLIXGN-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4514099,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCN(C)CC4)CC3)cc2)ncc1Cl,IC50,6.21,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KGHJJSWYKYIAGJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTS
CHEMBL2381453,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(OC)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.36,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,JHLMREYJLSMARD-BJMSDPACSA-N,48.0,Cytotoxicity,SRB
CHEMBL5078956,,Nc1nccc(N2CCCC(CO)(CCCc3ccccc3)C2)n1,IC50,5.05,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,DTYLCARBXSKICY-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5086648,,Nc1cc(N2CCCC(CCCc3ccccc3)(C(=O)O)C2)nc(N)n1,IC50,4.41,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LJIWGZSNRNUHTR-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL4097507,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.76,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HWSVUGUCKRCZGU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL303697,LIGUSTRAZINE,Cc1nc(C)c(C)nc1C,IC50,4.79,CHEMBL4037667,Antiproliferative activity against human U87MG cells after 72 hrs in presence of piperlongumine by MTT assay,U-87MG ATCC,FINHMKGKINIASC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4104881,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.36,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MOGJDMGFFLJPOL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4289873,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc21,IC50,5.88,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XUCISSARDQCVDI-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4278984,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccccc5)c4=O)cc3)ccnc21,IC50,5.3,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HEXNNTWGHZWZTQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4288088,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(Br)cc2)c1=O,IC50,5.82,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FVZDXCVIWBCBLL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4282597,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccccc2)c1=O,IC50,5.8,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RVDUZURNNZCDII-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5428849,,NCCCCNCCCNC(=O)c1csc(-c2csc(CCN)n2)n1,IC50,4.43,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,UIHHDALTZVAFSF-UHFFFAOYSA-N,72.0,Antiproliferative activity,WST-1
CHEMBL4575344,,CN(CCNCc1ccccn1)CCNCc1ccccn1,IC50,5.17,CHEMBL4381289,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 48 hrs by cell titer-glo assay,LN-229,CHFNQDVXSWSOSP-UHFFFAOYSA-N,48.0,Antiproliferative activity,cell titer-glo
CHEMBL4527563,,COc1ncc(-c2cc(OC3CCOCC3)c3ncnc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.3,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,HLTLYKPFSSMNIF-UHFFFAOYSA-N,72.0,Antiproliferative activity,CTG
CHEMBL237858,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3cccnc3)nccc12,IC50,6.19,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,SRBILTJOWAUJHB-UHFFFAOYSA-N,72.0,Antiviral activity,M33 pseudotyped
CHEMBL3785796,,COc1cc(/C=C/C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.74,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-XWRZMSEUSA-N,,Cytotoxicity,SRB
CHEMBL5184582,,C[C@@H]1C2CCCC3CC[C@]4(C)OO[C@]32[C@H](O[C@@H]1OCCCN=C=S)O4,IC50,5.13,CHEMBL5141030,Antiproliferative activity against human U-87 MG cells assessed as inhibitionof cell growth incubated for 24 to 72 hrs by MTT assay,U-87MG ATCC,BWVBJFMFARXZSB-FHRQGKHISA-N,72.0,Antiproliferative activity,MTT
CHEMBL5619479,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cccc(F)c12)c1c[nH]c2cccc(F)c12,IC50,4.66,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,NCEYYCYQKDMNMV-SANMLTNESA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5619198,,CCCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.7,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,OAHWQNOGENVZIW-QNGWXLTQSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL244424,,CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)Cc1cc2c(cc1[N+](=O)[O-])OCO2)C(N)=O,IC50,4.5,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,AKKCHMMHCPYTQV-ZDUSSCGKSA-N,,Cytotoxicity,Unspecified
CHEMBL244422,,CC(C)C[C@H](NC(=O)Cc1cc2c(cc1[N+](=O)[O-])OCO2)C(N)=O,IC50,4.72,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,DXIGNJWPGZGXNB-JTQLQIEISA-N,,Cytotoxicity,Unspecified
CHEMBL5273431,,Cn1ccc(NC(=O)Nc2ccc(-c3nc(-c4ccc(CN5CCN(S(C)(=O)=O)CC5)s4)nc(N4CCOCC4)n3)cc2)n1,IC50,6.62,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,CFZSBYXRCFGDLU-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL2392821,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.7,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JPILOKCQOSEJCY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392956,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3ccccc3n2)cc1,IC50,5.87,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AINVSYIOEHAUFN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392954,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CBQVYYAOAXGPTL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392822,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.02,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOVWHEAGFGXIPE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392820,,COc1cccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)c1,IC50,6.08,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BGNDGDOLSKHSRL-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2392959,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.82,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RLOWINIQUHNWJO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5184353,,CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.97,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,MFWGVEDLBIPFGB-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5198083,,C=CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,8.24,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,LOSDQHCJIMFLOV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL501411,SPINOSYN A,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,IC50,4.01,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,SRJQTHAZUNRMPR-UYQKXTDMSA-N,48.0,Antiproliferative activity,Unspecified
CHEMBL2206906,,COCCOc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.11,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,LPQNHUUMWHCKNU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206903,,COc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.41,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FMNSKWKSXFWJNP-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206902,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)n1,IC50,6.61,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,OMAOPVVDUUYSAR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206901,,COCCN(C)S(=O)(=O)Nc1cc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cnc1Cl,IC50,7.28,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,GLCIVEQBDOXJQU-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206917,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)n1,IC50,7.07,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,AZUIZZBFQBKTCG-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206916,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C(C)C)c2)n1,IC50,6.39,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,KRDRDADGCWRDPV-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL2206915,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,7.6,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,BRCRBCBCOVSRKR-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL4868061,,Cc1cccc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)c1,IC50,4.63,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,XYBCHHOMYORUSX-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4778600,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2cncnc12,IC50,4.5,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IFAUDODREFDNNI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4757693,,Oc1c(C(c2ccc(F)cc2)N2CCNCC2)ccc2cncnc12,IC50,4.36,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PSTLKJQTFBBOPN-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4785968,,Oc1cc2c(cc1C(c1ccc(F)cc1)N1CCCCC1)OCCO2,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GVIIALXPLGHLMC-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4791006,,COc1cccc(C(c2cc3c(cc2O)OC(F)(F)O3)N2CCOCC2)c1OC,IC50,4.4,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,ZLRIEFNTOOLHMU-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4776561,,Oc1cc2c(cc1C(c1ccc(F)cc1)N1CCCCC1)CCC2,IC50,4.89,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NUDOUHHYOQUTRX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4798777,,Oc1ccc2scnc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,YNJFTLBKDAEMQY-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2180729,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,IC50,6.43,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,SKKKGQUKKUZJRL-UHFFFAOYSA-N,132.0,Unspecified,Unspecified
CHEMBL2297273,,COc1cc(OC)c2c(NC3CCCCC3)cc(-c3ccccc3)nc2c1,IC50,5.22,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,YPHABYOXTFGEGV-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL2297270,,COc1cc(OC)c2c(N3CCCCC3)cc(-c3ccccc3)nc2c1,IC50,4.18,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,FEDOBZBQUWXHKG-UHFFFAOYSA-N,72.0,Unspecified,MTT
CHEMBL1615183,,Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1,IC50,6.78,CHEMBL2175548,Inhibition of mTORC1-mediated pS6 Ser240/244-phosphorylation in human U87MG cells,U-87MG ATCC,DMMFPXAFVNDPCA-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL3594269,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Sc1ccccc1,IC50,6.05,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XTAGJHBSEWJYBQ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL221644,,CC1(C)CCC2=C(O1)c1ccccc1/C(=N/O)C2=O,IC50,5.46,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,ZYGJOALPFNIQHK-VBKFSLOCSA-N,72.0,Cytotoxicity,MTT
CHEMBL5185867,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(Cl)cc1)O2,IC50,6.77,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OLSKPZUKOJUJHV-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL2430036,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7[C@H](O)C(C)(C)CC[C@]7(C(=O)O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,4.24,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YYNGQYRUWXEJIJ-ZNTOFBKISA-N,72.0,Cytotoxicity,MTT
CHEMBL5181773,,CN(Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1)C(=O)CCCCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCCCCC(=O)O)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21,IC50,4.82,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,RGFTYPLHNYSHCT-UHFFFAOYSA-O,72.0,Cytotoxicity,alamar blue
CHEMBL4749385,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2cc(F)c(CO)c(S(C)(=O)=O)c2)c1,IC50,5.07,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HYQGRYRHNUHTJF-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL1800961,,C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.72,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LGUXLVJQUKRZBO-SZNDQCEHSA-N,48.0,Unspecified,Unspecified
CHEMBL1800963,,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,IC50,8.4,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,MLQLUFQBFMFXJO-SZNDQCEHSA-N,48.0,Unspecified,Unspecified
CHEMBL5624772,,O=C(CBr)N1CCN(Cc2ccccc2)C12COC2,IC50,4.84,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,IJUVLJPFJOOTMB-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5629911,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)c(OC)c1OC,IC50,5.7,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,YJIUFCQCXZCPCY-WYMLVPIESA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630884,,COc1cc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc(OC)c1OC,IC50,5.66,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KXLZHAYSAFHCAT-OUKQBFOZSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630623,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)o1)c1ccncc1,IC50,4.98,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,VROPXIBVQDNQDY-SOFGYWHQSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630621,,O=C(/C=C/c1ccncc1)c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1,IC50,5.52,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,HWKVFCNTYRXRDC-IZZDOVSWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5426265,,COc1ncc(-c2cc(OC3CCOCC3)c3ncnc(C)c3c2)cc1N(Cc1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc(F)cc1F,IC50,7.96,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,FMBOZAUZAYJAQV-UHFFFAOYSA-N,72.0,Antiproliferative activity,CTG
CHEMBL2385195,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.46,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FDCKDXZISZRERO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5409120,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,6.42,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,OPHLMZMHCHXHFP-QODMNUCZSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5433829,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)C[C@@H](OC=O)[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,6.3,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,FIHDOLOFALIBNB-XDOKPFJCSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL4641079,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccsc3)c12,IC50,4.24,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,NJZNRDNBXVDDEO-ZRJCITRHSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL4640055,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3)cc2)n1,IC50,4.58,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LOZVEFLIYFPCMV-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4635455,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ncccc4Cl)cc3)n2)cn1,IC50,4.42,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ADAPNHDAVCDSDS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4859691,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.38,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,ZTPKCMSHVVATOJ-JHWQQEMVSA-N,72.0,Anticancer activity,CCK8 reagent
CHEMBL4792320,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2ccco2)cc1,IC50,4.91,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,LWCWWDARQBRUKC-LGJNPRDNSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL4286444,,Cc1cc(=O)c(O)c(C(c2ccc(CCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,IC50,4.57,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,UEJPIJRIQVWZCA-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5440334,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(/C=C/C(=O)NO)c1,IC50,7.14,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,PVWHETLDZLZCTN-WFNSPDMASA-N,48.0,Antiproliferative activity,MTT
CHEMBL4293082,,CC1(C)[C@@H](OC(N)=O)[C@H]2O[C@H]2[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,8.19,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,PRWPKNOLVLDXSO-OYFNOYEBSA-N,72.0,Cytotoxicity,MTS
CHEMBL4280528,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(=O)c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.82,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RCXHJQPQDDODGW-AMERCFFHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4282461,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CNC(=O)/C=C/c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.53,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,SOAATGVSBYXULL-SLJYEFRKSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4798940,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,IC50,6.35,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,DNZPQXXGAMXDHH-FCNQEGBTSA-N,2.0,Cytotoxicity,Cell-titer-blue
CHEMBL4465942,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.94,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VPZGTTFECODUMR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4446129,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.23,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XDGFOYZEECLHHR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4789041,,COc1ccc2cc1Oc1ccc(cc1)Cc1nccc3c4c(c(OC)c(c13)Oc1c3c(cc(OC)c1OC)[C@H](C2)N(C)CC3)OCO4,IC50,6.42,CHEMBL4688075,Anticancer activity against human T98G cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay,T98G,PCEQWUUFUJWIBW-NDEPHWFRSA-N,72.0,Anticancer activity,MTT
CHEMBL5266584,,CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)OCC(O)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@H]2CC1.[Br-],IC50,5.01,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,QDQPHTVQELYRSR-QJYNUPQVSA-M,48.0,Cytotoxicity,MTT based colorimetric
CHEMBL5413573,,NCCCCNCCCNC(=O)c1csc(-c2csc(CCNCc3ccc4scnc4c3)n2)n1,IC50,4.78,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,FXQZOIBTCCOGNX-UHFFFAOYSA-N,72.0,Antiproliferative activity,WST-1
CHEMBL5573821,,Cc1ccc(CCNC(=O)C2(C#N)CC3c4ccccc4C2c2ccccc23)cc1,IC50,4.22,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,LUCOEIXBNKKXSK-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5570551,,N#CC1(C(=O)NCCc2ccc([N+](=O)[O-])cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.62,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,GTSYFCWIXPZHOK-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4792680,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccccc2)c(C#N)c(=O)[nH]1,IC50,4.25,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DCNGLUBPOAYJPH-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4751240,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2cccc(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.55,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QNMGQJMYIJEWAV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4096826,,C=C(c1ccc(OC)cc1)c1cc(C(=O)OC)nc2ccccc12,IC50,8.64,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,SICDWJZZXUDUED-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4077156,,C=C(c1ccc(OC)cc1)c1cc(C(F)(F)F)nc2ccccc12,IC50,7.66,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,UYUDQATZMGXFQX-UHFFFAOYSA-N,72.0,Cytotoxicity,resazurin dye-based fluorimetric
CHEMBL4740296,,CO[C@@]1(C)N(CCc2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.05,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,HJEQLHSAFDJJPU-DEOSSOPVSA-N,,Antiproliferative activity,SRB
CHEMBL1625188,,COc1ccc(CCNCc2ccc(OCc3ccc(Cl)nc3)c(OC)c2)cc1OC,EC50,5.3,CHEMBL5129769,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs,LN-229,XNPRQBVQOJZMMA-UHFFFAOYSA-N,72.0,Antiproliferative activity,Unspecified
CHEMBL4797411,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3F)nc12,IC50,5.62,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LWYQSQHYOQZLGD-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4789212,,COc1cc(C(=O)NC2CCNCC2)c(F)cc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.45,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RRSINXKFGITOLR-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1873475,IBRUTINIB,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,IC50,5.5,CHEMBL4832265,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,XYFPWWZEPKGCCK-GOSISDBHSA-N,48.0,Antiproliferative activity,SRB
CHEMBL4783479,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCN(C2CCN(C)CC2)CC1,IC50,5.19,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,LPFKPANEFAADFV-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5089437,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccc(I)cc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccc(I)cc21,IC50,4.94,CHEMBL5038359,Dark toxicity against human U-87 MG cells incubated for 48 hrs by Alamar blue assay,U-87MG ATCC,FZNGVYVJSVCUNB-UHFFFAOYSA-O,48.0,Unspecified,Alamar blue
CHEMBL5087179,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccc(I)cc4C3(C)C)C[N+](C)(C)C2)=[N+](CCCCCC(=O)O)c2ccc(I)cc21,IC50,4.21,CHEMBL5038359,Dark toxicity against human U-87 MG cells incubated for 48 hrs by Alamar blue assay,U-87MG ATCC,PBMRAVBJOHZYEY-UHFFFAOYSA-P,48.0,Unspecified,Alamar blue
CHEMBL5275748,,Nc1nc(-c2cccc(OCCCN3CCCC3)c2)nc2c1c(=O)oc1cc(OCCCN3CCCC3)ccc12,IC50,4.41,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,PZZLXYMMLWEFMZ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5276542,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5nc[nH]n5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.74,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,OUYPCXLZQOCROY-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5417697,,O=C(Nc1cccc(Cl)c1)Sc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1,IC50,5.38,CHEMBL5333090,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth,U-87MG ATCC,LUMVYWFMNQMBOU-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5287987,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5cncnc5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.83,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,DLYWBQVCKWSDMK-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4748209,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(C)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.29,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RWTHYPRQARXLCM-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5397139,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,10.1,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,MKLAVULUNKJJPK-FYOBYPTESA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5422790,,CN(C)c1ccc(/N=N/c2ccc(S(=O)(=O)NCCc3nc(-c4nc(C(=O)NCCCNCCCCN)cs4)cs3)cc2)cc1,IC50,4.34,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,OZYDGNJHIKBMTD-HEFFKOSUSA-N,72.0,Antiproliferative activity,WST-1
CHEMBL5079362,,O=C1c2cc(I)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,5.13,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,JACXJNXOIHUXIX-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1927614,,CN(C)CCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCN(C)C)C3=O,IC50,6.85,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WXUHPAUCHCAIPF-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5280123,,O=C1c2cccc3cccc(c23)C(=O)N1CCCCOc1ccc(-c2nc3ccc(N4CCOCC4)cc3[nH]2)cc1,IC50,6.96,CHEMBL5245068,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B reagent assay,SNB-75,QGKRJVRREBVWCS-UHFFFAOYSA-N,48.0,Cytotoxicity,sulforhodamine B reagent
CHEMBL1949932,,C=C1CC[C@H](OC)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.27,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,URIJSEIPUOYEFF-YELRADRNSA-N,72.0,Antiproliferative activity,MTS
CHEMBL3621412,,CCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.44,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,JKASRMSRXGFEGS-UHFFFAOYSA-M,24.0,Cytotoxicity,MTT
CHEMBL5573925,,N#CC1(C(=O)NCCC2CCN(Cc3ccc(F)cc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.73,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BJHOYNGWJMVXPJ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5575796,,N#CC1(C(=O)NCCS(=O)(=O)Nc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.58,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,XJSVJCMJVXZLEQ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4856308,,O=C(/C=C/c1ccccc1)O[C@H](c1ccccc1)[C@@H]1O[C@@H]2CC(=O)O[C@@H]2[C@@H]1O,IC50,4.49,CHEMBL4836842,Antiproliferative activity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GDYNBHXFRSGEGM-FXLLVQDUSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5397075,,C=CCOc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.38,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,FCIXCOAOQBTADC-UQWWERDESA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5396667,,CC1(C)CCc2c(O)cc(CCc3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](OC=O)CC[C@@]3(C)O4)cc2O1,IC50,7.17,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,CFKFSLXHHGZHHP-VOKYQHOCSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5402401,,CC1(C)CCc2c(O)cc(/C=C/c3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](O)CC[C@@]3(C)O4)cc2O1,IC50,8.03,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,ZDNJECQLZCXDFY-WQRMQLLLSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5433096,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.32,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WNLPKXXIDNGVIL-SQMHIVSLSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5620207,,C#CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.44,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,SPCWHTKAHOLBOD-PMERELPUSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL4571722,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2)CC1,IC50,7.82,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,NZIKKCSMHNBNPK-WAOWUJCRSA-N,132.0,Antiproliferative activity,MTT
CHEMBL5632259,,C=CC(=O)N1CCN(C(CC)c2ccc([C@H](C)Nc3nccc(N4CCOC4=O)n3)cc2)CC1,IC50,8.66,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,VLZWVMXOKOOBSV-YMXDCFFPSA-N,132.0,Antiproliferative activity,MTT
CHEMBL3220808,,C[C@H]1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OCC[N+](C)(C)Cc4ccccc4)[C@@H]2CC[C@]1(Cl)C3.[Br-],IC50,4.2,CHEMBL4689358,Cytotoxicity against human T98G cells assessed as reduction in cell viability by DAPI staining based assay,T98G,VVEZDYZVKNBPHF-PRQQZGLHSA-M,,Cytotoxicity,DAPI staining based
CHEMBL5281732,,COc1cc(Nc2ccc3nnc(-c4cccs4)n3c2)cc(OC)c1OC,IC50,4.69,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,NEUWAHWZAYQREP-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5620052,,COc1ccc(-c2ccc(C(=O)N3CCc4c(cc(Cl)c(C(=O)NO)c4Cl)C3)cc2)cc1,IC50,5.4,CHEMBL5614661,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,RDTQMQMGGPHOHV-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1173154,,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)cc2)ccc1O,IC50,5.26,CHEMBL4838616,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,NMRUIRRIQNAQEB-VEAXOGKZSA-N,72.0,Cytotoxicity,MTT
CHEMBL4877449,,CC(C)OC(=O)[C@H](N)Cc1cn(C)c2ccccc12.Cl,IC50,6.07,CHEMBL4838616,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SNYZUMLXSTYVPU-BTQNPOSSSA-N,72.0,Cytotoxicity,MTT
CHEMBL5218785,,CCOC(=O)c1c(N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.41,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,DSJIPZTZCBUSIZ-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5219322,,N#Cc1c(N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,5.05,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,VJVXZLADENLGMU-UHFFFAOYSA-N,,Antiproliferative activity,MTT
CHEMBL5207176,,c1c(CN2CCCCCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.26,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,KGYHKHZROFSQOS-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL169372,,CCCN(CCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC)C(=O)OCc1ccccc1,IC50,5.63,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,YAYJCWOTIVMBGB-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL4874975,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(CCc7c[nH]c8ccccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.46,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,CZTODLSQKDVKCS-CYOJNKNFSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL2146196,"cis-Dichloro[(2S,3R,4S)-2-aminomethyl-3,4-(O-isopropylidene)dihydrxypyrrolidine]platinum (II)",,IC50,5.21,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,,,Cytotoxicity,Unspecified
CHEMBL4854989,,C[C@@]1(C(=O)CO)CC[C@@H]2C(=C[C@H]3OC(=O)[C@]4(C)[C@H]3[C@]23CC[C@@]4(O)OC3)C1,IC50,5.66,CHEMBL4842430,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,YKOCFEFYIFARIO-BIVJBNGQSA-N,72.0,Cytotoxicity,MTT
CHEMBL4759979,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1,IC50,5.32,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,VCCVHWUDWBSEKU-GIDUJCDVSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL1554780,,COc1cc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)ccc1O,IC50,4.57,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RADCFXRBORYSKP-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL228996,,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,IC50,8.7,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-SGTLLEGYSA-N,48.0,Unspecified,Unspecified
CHEMBL1800962,,C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,7.14,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LGUXLVJQUKRZBO-QKKBWIMNSA-N,48.0,Unspecified,Unspecified
CHEMBL3113716,,Clc1cccc(/C=N/Nc2cnc3ccccc3n2)c1Cl,IC50,5.21,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,ALKVARZYBSMXMJ-UFWORHAWSA-N,,Cytotoxicity,MTT
CHEMBL5087242,,COc1cc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc(OC)c1OC,IC50,4.26,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,JQJLSDCXRGCLNB-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5094553,,COc1cc(NC(=O)c2ccccc2Nc2cccc(C(F)(F)F)c2)cc(OC)c1OC,IC50,4.28,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,SEDIPHJTXQZFDO-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5090197,,O=C(Nc1ccc2c(c1)OCO2)c1ccccc1Nc1cccc(C(F)(F)F)c1,IC50,4.58,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,JATYNCWXASKYNI-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5090568,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(C(F)(F)F)c2)cc1OC,IC50,4.14,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,MQILAKUASHKEQM-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4750331,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,IC50,4.36,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,TXCLIWYZLLCKOE-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4750598,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(OC)cc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.6,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KLNAFXRJSQSCRM-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4790098,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4cccc(Cl)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.1,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,JSXTVTWUTBNLHE-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5421266,,CNc1ncc2c(C#CCN3CCC(N(C)C)CC3)nn(CC3CCCC3)c2n1,EC50,4.8,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,FCZCQCJUJGYANI-UHFFFAOYSA-N,120.0,Antiproliferative activity,PrestoBlue reagent based fluorescence
CHEMBL5084269,,O=C(C[C@@]1(O)C(=O)N(Cc2cccc(Cl)c2)c2ccccc21)c1ccccn1,IC50,4.56,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,JJOIKBZRLCEZOR-QFIPXVFZSA-N,24.0,Cytotoxicity,CCK8
CHEMBL5267044,,Cc1c(Cl)ccc2c(/C=C3\NC(=O)N(Cc4ccc(F)c(F)c4)C3=O)c[nH]c12,IC50,5.85,CHEMBL5582679,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by MTS assay,U-87MG ATCC,OEXMEVPQEPHTAQ-IDUWFGFVSA-N,72.0,Antiproliferative activity,MTS
CHEMBL4793298,,C[N+](=O)c1ccc(/C=C/C(=O)c2ccc(N3CCOCC3)cc2)o1,EC50,5.01,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,ILLFPXCUYAQGTM-SOFGYWHQSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4073310,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(I)cc1,EC50,5.28,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KYRLMIXZFNCBMW-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4070585,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(N2CCNCC2)cc1,EC50,5.31,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,ZZXWVWNECFVHBY-FNORWQNLSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5089333,,Nc1nc2cc3c(cc2cc1C(=O)NCc1ccccc1)OCO3,IC50,4.12,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,GFOKSVKZSHIVQO-UHFFFAOYSA-N,48.0,Cytotoxicity,MTT
CHEMBL2385197,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)c(F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QDZNZFNADWFZJG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5280867,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)NN5CCOCC5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.57,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,PBSBZNYTIWLPAF-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5283948,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCNC(=O)c2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccn2)C(C)(C)C)cc1,IC50,4.91,CHEMBL5239980,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DQWLHVNWDUFZCJ-JGTDPZFESA-N,48.0,Antiproliferative activity,MTT
CHEMBL5271581,,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)/C=C/c4ccc(F)cc4Cl)C(N)=O)C(=O)O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,IC50,7.79,CHEMBL5254512,Antiproliferative activity against human SF-295 cells assessed inhibition of cell growth incubated for 72 hrs by SRB assay,SF295,ZMDKGABGPBZBQT-QUFZNYFDSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5275603,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccccc4Cl)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JMDVEJHAKIXHJA-VHPJKMJMSA-N,,Antiproliferative activity,Unspecified
CHEMBL5275306,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccccc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MYBTYUMEQPJCTQ-AMYPSBKZSA-N,,Antiproliferative activity,Unspecified
CHEMBL5397623,,COc1cc(CCc2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,5.83,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,IQJLHDQHDSJGOX-MMXANPLTSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5414661,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(C#N)ccc32)cc1,IC50,4.52,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WXVURXPNUZJFDV-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL5419481,,CCC(=O)n1cc(Cc2cc(C)c(O)c(C)c2)c2ccccc21,IC50,4.0,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,COVOZZAUNPLIGT-UHFFFAOYSA-N,2.0,Antiproliferative activity,CCK8
CHEMBL1097310,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.87,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,NJNRIENLQRRMHI-JGFHVXTRSA-N,48.0,Cytotoxicity,MTT
CHEMBL4793784,,Cc1cccc(C(C(=O)NC(C)(C)C)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)c1,IC50,5.1,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AAOVMOLAQUMBGX-BUHFOSPRSA-N,72.0,Cytotoxicity,MTT
CHEMBL5401329,,CC(C)=CCc1c(O)cc(/C=C/c2cc3c(c4c2C=CCO4)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,IC50,6.32,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,GEOMYVWLNBJOIW-MGWHEABOSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescent
CHEMBL5089770,,Nc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)nc(N)n1,IC50,5.0,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LZETYUWTRRRBAK-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5090697,,Nc1nccc(N2CCC(CO)(CCCc3ccccc3)CC2)n1,IC50,5.4,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,XWMNSXWGSICEJS-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL5079071,,Cc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)nc(N)n1,IC50,5.1,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,CILSBPSVDVVHIX-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL1565145,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)cc1OC,IC50,4.74,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,POUGOEFZYGQTHG-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1490147,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1,IC50,4.55,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,VXUBMVYKZKUFMX-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4747596,,COc1cccc(C(c2ccc3cccnc3c2O)N2CCOCC2)c1OC,IC50,4.48,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,QPHWILHOQHBVES-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4785141,,Oc1c(C(c2ccc3c(c2)CCC3)N2CCCCC2)ccc2ccoc12,IC50,5.3,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GWLMNYOYFMJDOR-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4753733,,Oc1c(C(c2ccc(C(F)(F)F)cc2)N2CCCCC2)ccc2ccoc12,IC50,5.3,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,UQOORHXLHLDATJ-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1436701,,COc1cccc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)c1OC,IC50,4.5,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PKUPFNJHQHKECO-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4641440,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(Cl)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.83,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZVXBWXYPCFNKFC-QCOVWQHTSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4645051,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccccn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.52,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,APTONZVHMGOTJT-AICKGTJASA-N,96.0,Antiproliferative activity,MTT
CHEMBL4649423,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(OC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.5,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,AUKMHLNKGDLNTB-FLRPPASCSA-N,96.0,Antiproliferative activity,MTT
CHEMBL4637814,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)NC(C)(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.85,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,NGPVINHTBKPBRU-PJWUZBAESA-N,96.0,Antiproliferative activity,MTT
CHEMBL4748501,,Cc1nn(C)c(Oc2cccc(Br)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.44,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,FWLTXPAKINLDFB-LJUMEUDFSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4753177,,Cc1ccc(Oc2c(/C=N\CCCCCCOc3cc4oc(=O)cc(C)c4cc3Cl)c(C)nn2C)cc1,IC50,4.63,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BKQITERMTHMMCT-MNBJERMJSA-N,72.0,Antiproliferative activity,MTT
CHEMBL1652062,,CC(C)CC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.66,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,UASBUFXONXNWEH-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL220648,,CC(C)CCC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.7,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,UUEPXKOCNLABHE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1652068,,C=CCC1=C(OC2(CC=C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.93,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GVZVMKCRPIVYCI-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL603842,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3)[nH]c21,IC50,4.81,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DONDWNNDTIOAET-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5084279,,Cc1nccc(N2CCCC(CO)(CCCc3ccccc3)C2)n1,IC50,4.72,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,GDBWRIBFQMJODQ-UHFFFAOYSA-N,,Antiproliferative activity,Unspecified
CHEMBL593976,,COc1cc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)ccc1O,IC50,4.87,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FJEOIDUPEMASKE-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL1095219,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](N=[N+]=[N-])[C@H]1Br,IC50,5.71,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SEEHGZFDYGBTEN-IINYFYTJSA-N,72.0,Cytotoxicity,MTT
CHEMBL1668699,,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(Cl)cc6Cl)[nH]c5c4)[nH]c3c2)CC1,IC50,5.82,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CCDYEPLUHUIFGS-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL5181750,,CN(Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1)C(=O)CCCCCCCNC(=O)CCCCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCCCCC(=O)O)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21,IC50,4.92,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,POMJEGFKIONNNS-UHFFFAOYSA-O,72.0,Cytotoxicity,alamar blue
CHEMBL5629866,,O=C(/C=C/c1ccccc1C(=O)N1CCN(Cc2ccccc2)C12COC2)c1ccccc1,IC50,4.98,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RTFCGOREHPBMFR-FOCLMDBBSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5624537,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc1,IC50,5.58,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QMNNVZYERQICFT-XNTDXEJSSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5630858,,COc1cc(/C=C/C(=O)c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)s2)cc(OC)c1OC,IC50,5.7,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,ZTMYZDBKIVWJIQ-MDZDMXLPSA-N,72.0,Antiproliferative activity,MTT
CHEMBL107,COLCHICINE,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,IC50,7.44,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,IAKHMKGGTNLKSZ-INIZCTEOSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5559415,,NC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.58,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JKZNUSZFORUEAM-SECBINFHSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5561148,,CCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.54,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ULRBAUVMGRJVES-CYBMUJFWSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4776893,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3COCCOCCOCCOCCO3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.52,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LCZSGCOURDNTLM-UDKUWUAKSA-N,72.0,Antiproliferative activity,SRB
CHEMBL4796409,,CCOC(=O)N1CCC(NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,5.96,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WKJCZMVINQHESV-ZJPQFJDJSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5639323,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(OCCN3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.92,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,SRTJLCPCKWMLHV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5639819,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1Cl,IC50,5.37,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,LESGNHDGUUOEIU-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5641802,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1C,IC50,4.94,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,YODZWPFTBUADGX-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5186348,,O=C1c2cc(-c3cccnc3)ncc2C(=O)c2c1c(-c1ccccn1)nn2-c1ccc(F)cc1F,IC50,5.6,CHEMBL5141022,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,SPPMCRAMSPCJPH-UHFFFAOYSA-N,,Cytotoxicity,Unspecified
CHEMBL5618297,,Cc1ccc(CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,IC50,4.38,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,ODALRGSBKLSMHT-DHUJRADRSA-N,68.0,Antiproliferative activity,CCK-8
CHEMBL5631386,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc4c(n3)N(C(C)C)C(=O)OC4)cc2)CC1,IC50,8.59,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,AZWXCHCQFFUQCW-SFHVURJKSA-N,132.0,Antiproliferative activity,MTT
CHEMBL4777368,,Cc1c(C#N)c2nc(C(C)C)cn2c2nc(Nc3ccc(N4CCNCC4)cc3)ncc12,IC50,6.23,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DJZJBAJKDQXEMV-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL4781009,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C3CCCC3)nc12,IC50,7.19,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,HWCSIGMWDASGSX-UHFFFAOYSA-N,144.0,Antiproliferative activity,celltiter-glo luminescent cell viability
CHEMBL5569309,,Cc1ccc(-c2snnc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,6.96,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,QYHRZIQZKYOZPD-UHFFFAOYSA-N,72.0,Antiproliferative activity,Alamar Blue
CHEMBL5401077,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccno3)ccc2NS(C)(=O)=O)c1,IC50,5.4,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YLAGZOCVAGVUET-UHFFFAOYSA-N,48.0,Growth inhibition,MTT
CHEMBL2171777,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(O)cc34)[C@H]21,IC50,6.86,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,PLPWVVCBUWODOH-SFHVURJKSA-N,72.0,Cytotoxicity,CCK8
CHEMBL1914715,,O=S(=O)(Nc1cc(-c2ccc3nccnc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.84,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,TZARJJVXWKVJIK-UHFFFAOYSA-N,,Unspecified,Unspecified
CHEMBL5170880,,CC(C)=CC[C@@H](OC(=O)CCC(=O)NCc1ccc(Br)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.46,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,CUAXQQAJPYAQMF-JOCHJYFZSA-N,48.0,Anticancer activity,MTT
CHEMBL4753289,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)cc1,IC50,5.96,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,UDVSQIRATZQDHW-YIXHJXPBSA-N,96.0,Antiproliferative activity,cell-titer glo
CHEMBL5174779,,CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H]2CCC(=O)N2)[C@H](C(C)C)c2ccc3c4c([nH]c3c2)-n2cnc(c2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C4)NC(=O)[C@H](C(C)C)NC1=O,IC50,5.02,CHEMBL5126223,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UCSHFBQCLZMAJY-QFMFBHDYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4874754,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8[nH]ccc8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.42,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,DALIFNQGETXUAC-JDMHCBMBSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4849422,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8cc[nH]c8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.35,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,ZBIKZWWARRAAKU-JDMHCBMBSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4867655,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7cccc8[nH]ccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.2,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,OZXMJUSGUUBKJM-KODZDQQCSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL4847529,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8[nH]ccc8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.48,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,ZMHNXSIWQBGZLF-KODZDQQCSA-N,72.0,Antiproliferative activity,colorimetric MTS viability
CHEMBL2313487,,COc1cc(Cc2c(-c3ccn(S(=O)(=O)c4ccccc4)c3)[nH]c3ccccc23)cc(OC)c1OC,IC50,5.85,CHEMBL5223969,Anticancer activity against U-87 MG assessed as inhibition of cell proliferation incubated for 72 hrs by MTS assay,U-87MG ATCC,KTTHUXOEXYKHFJ-UHFFFAOYSA-N,72.0,Anticancer activity,MTS
CHEMBL5218612,,COc1ccc(-c2ncccc2NCc2ccc(Cl)cc2)cc1OC,IC50,4.67,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,BFORWLHSAYRUPV-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5219155,,COc1cc(OC)cc(-c2ncccc2CNc2ccc(Cl)cc2)c1,IC50,4.55,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MRAYMFLAQBLFKS-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5220864,,COc1cc(-c2ncccc2CNc2ccc(Cl)cc2)cc(OC)c1OC,IC50,4.58,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,NQICJPRQGKQXMO-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5080484,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc1OC,IC50,4.0,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,FIRSADZWNMOOCD-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL4779569,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)[C@H]4CCCNC4)cc3)nc12,IC50,6.52,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UDPSCVKNVATZTE-INIZCTEOSA-N,72.0,Antiproliferative activity,MTT
CHEMBL4797985,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)CN)cc3)nc12,IC50,6.68,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YSSRLUNVDUOKSW-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5171079,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN1CC(C1)C(=O)NCCCCCC(=O)N1CCN(CC1)CC2=C,IC50,4.46,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,VTFHDQRAUJFACR-DOBADDLBSA-N,48.0,Antiproliferative activity,CCK8
CHEMBL2017654,,N#Cc1ccc(-c2c(-c3ncn[nH]3)sc(N3CCOCC3)c2C#N)c(F)c1,IC50,5.64,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,MUENOTXSRZEFJV-UHFFFAOYSA-N,72.0,Antiproliferative activity,CellTiter-Glo luminescence
CHEMBL59030,,O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1,IC50,5.44,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,NAXSRXHZFIBFMI-UHFFFAOYSA-N,168.0,Antiproliferative activity,CCK8
CHEMBL4520989,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(F)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,JXEQVHSNFMQGEZ-NLDKGBHCSA-N,,Unspecified,Cell-titer-Glo luminescent cell viability
CHEMBL5438210,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)/C=C/[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.89,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,NLLURLYURZLKHG-ZVOQMXLTSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5422756,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)NC[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.52,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,YLGDVHWMOAKENB-JYRFQQDJSA-N,18.0,Antiproliferative activity,CellTiter-Glo Luminescent Cell Viability
CHEMBL5218538,,COc1cc(-c2ncccc2NCc2cccc(N)c2)cc(OC)c1OC,IC50,4.31,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,RCVKUIIKFRQFBK-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5562891,,COc1ccc(Cn2cncc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,4.42,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,KXIIWOMODNECDD-UHFFFAOYSA-N,72.0,Antiproliferative activity,Alamar Blue
CHEMBL3220804,,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)CCCCCCCCCCCC[N+](C)(C)CCOC(=O)[C@]3(C)CCC[C@@]4(C)[C@@H]5CC[C@@]6(C)C[C@]5(CC[C@@H]43)CC6=O)(CC1=O)C2.[Br-].[Br-],IC50,4.4,CHEMBL4689358,Cytotoxicity against human T98G cells assessed as reduction in cell viability by DAPI staining based assay,T98G,XMBQLZUGOZTXPX-UTZVVGESSA-L,,Cytotoxicity,DAPI staining based
CHEMBL4562297,,CC(C)(C)NC(=O)C(c1ccc(F)cc1)N(C(=O)/C=C/C(=O)c1ccc(F)cc1)C1CC1,IC50,6.1,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RSPCURGJZZDUBD-CCEZHUSRSA-N,72.0,Cytotoxicity,MTT
CHEMBL4452505,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(OC)cc3s2)cc1,IC50,5.23,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AEALTSKEFAKWGA-UHFFFAOYSA-N,72.0,Cytotoxicity,MTT
CHEMBL4440660,,COc1cc(/C=N/Nc2nc(-c3ccccc3)cs2)cc(Br)c1OC,IC50,4.13,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,DOMXUSJBUFQIGN-KEBDBYFISA-N,48.0,Antiproliferative activity,MTT
CHEMBL4474520,,COc1cc(/C=N/Nc2nc(-c3ccccc3)cs2)c(Br)c(Br)c1OC,IC50,4.7,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,JKKQMALDUFGQOD-ZVBGSRNCSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5417673,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.81,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,ULBGHKPEHFWLSO-ZBLPZKBESA-N,48.0,Unspecified,CCK-8
CHEMBL5557636,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NCc2ccccc2)C(=O)O)cc1,IC50,4.76,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YJZSRDUHGUXYJX-QGZVFWFLSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5172767,,COc1ccc(-c2ccc3[nH]c(=O)c4nnn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.78,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RGHLRMNPUGUZEY-UHFFFAOYSA-N,,Antiproliferative activity,CCK8
CHEMBL5565225,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.34,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HDDMOGVZHHEKBP-MJUOCMCKSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5569667,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.28,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HWVVCICHVKNWIN-ODVYPAPQSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5565980,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.52,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HZGSFNWDPQBDQH-KHEAGTJRSA-N,72.0,Cytotoxicity,CCK8
CHEMBL5219713,,COc1ccc(CNc2cccnc2-c2ccc(OC)c(OC)c2)cc1,IC50,4.33,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,PFIILSKISYJSFI-UHFFFAOYSA-N,48.0,Antiproliferative activity,MTT
CHEMBL5423893,,O=C1C=C(c2ccc(O)cc2O)C(=O)c2c(O)cccc21,IC50,5.29,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,LWCAHETWUAFCPC-UHFFFAOYSA-N,24.0,Cytotoxicity,resazurin
CHEMBL4287207,,O=C(/C=C/c1ccc(Oc2cc(=O)oc3ccccc23)cc1)/C=C/c1ccccn1,IC50,4.29,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PWVODMRQWPRDJJ-UHSWXSRBSA-N,48.0,Antiproliferative activity,MTT
CHEMBL4649297,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(/C=C/c3ccccc3)c12,IC50,5.41,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,SLEURXSVSUEDBN-LKKVPXNQSA-N,72.0,Antiproliferative activity,IncuCyte live-cell imaging
CHEMBL5595426,,N#CC1(C(=O)NCCCc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.7,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UAFFOKVVUMXPMA-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5571773,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(CO)c3ccccc3C1c1ccccc12,IC50,4.82,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UVKBAIRBMCIXFU-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5590378,,N#CC1(C(=O)NCCS(=O)(=O)c2ccc(Cl)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.04,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UJRAACISRFBVIZ-UHFFFAOYSA-N,72.0,Antiproliferative activity,CCK-8
CHEMBL5565987,,O=C(Nc1ncc([N+](=O)[O-])s1)c1cccc(-c2ccccn2)n1,IC50,5.94,CHEMBL5527512,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay,U-87MG ATCC,UQIHIFJLHVPGPK-UHFFFAOYSA-N,72.0,Antiproliferative activity,SRB
CHEMBL5558740,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,IC50,5.58,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZJEUDIZHIOQKSL-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
CHEMBL5562753,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.54,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZJSVPMISCNDWRC-UHFFFAOYSA-N,72.0,Antiproliferative activity,MTT
